data_5l7m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5l7m _Structure_validation_residue.Date_analyzed 2017-06-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 14' ' ' SER . 47.1 t . . . . . 0 C--O 1.244 0.79 0 N-CA-C 110.143 -0.317 . . . . 71.51 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 p -53.83 -47.14 71.21 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.427 -0.806 . . . . 73.02 110.235 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.34 168.1 40.71 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 115.835 -0.62 . . . . 73.05 113.298 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 172.41 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.688 1.195 . . . . 74.31 109.403 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -124.05 147.65 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.24 0.543 . . . . 72.25 111.496 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 p -97.52 -14.55 21.02 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.117 0.967 . . . . 75.43 111.219 168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.3 m -99.24 143.28 29.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.89 0.876 . . . . 73.31 109.753 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.22 122.96 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.63 -0.878 . . . . 71.31 108.63 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.82 136.82 24.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 115.993 -0.549 . . . . 70.54 109.577 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 121.88 27.21 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.659 0.6 . . . . 72.32 112.477 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.49 -31.03 61.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.713 1.205 . . . . 75.14 110.777 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.58 -31.9 53.37 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.67 0.788 . . . . 73.44 111.373 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 pt -90.59 8.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 111.579 0.215 . . . . 71.24 111.579 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.55 HG13 HD12 ' A' ' 65' ' ' LEU . 29.8 mm -75.64 136.81 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.422 -0.955 . . . . 75.4 108.422 173.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' HA ' ' HZ3' ' A' ' 48' ' ' LYS . 35.5 t70 -106.76 -55.44 2.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.948 0.499 . . . . 74.33 109.966 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 24.4 ptt180 -147.6 159.15 44.09 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.489 0.662 . . . . 74.22 110.769 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -111.53 110.76 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.23 -1.35 . . . . 74.1 108.741 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 26.7 tt0 -100.98 142.58 32.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.482 1.113 . . . . 72.41 108.125 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -112.74 136.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 122.882 0.473 . . . . 74.51 110.725 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.7 m -114.37 97.09 45.12 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.605 -0.887 . . . . 73.32 108.605 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' HG23 ' A' ' 41' ' ' THR . 72.5 Cg_endo -73.39 167.24 27.8 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 122.428 2.085 . . . . 73.33 112.748 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 148.48 93.07 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.466 2.111 . . . . 63.13 112.194 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 -16.52 55.09 Favored Glycine 0 N--CA 1.474 1.218 0 CA-C-N 116.52 -0.309 . . . . 74.22 112.752 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 22.32 1.71 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.982 0.913 . . . . 73.45 111.103 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.97 -5.89 84.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.04 -0.424 . . . . 42.13 112.04 -166.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 m -99.02 116.78 65.05 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.34 1.056 . . . . 75.32 109.497 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.26 -20.09 49.56 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.429 2.086 . . . . 53.03 111.558 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 10.3 mmpt? -125.48 145.82 49.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.653 1.181 . . . . 73.03 110.089 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 33' ' ' PRO . 9.0 m -72.61 115.52 11.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.362 -0.977 . . . . 75.12 108.362 172.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -120.08 140.43 51.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.1 0.409 . . . . 72.15 110.865 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.0 t -91.09 120.51 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.923 0.889 . . . . 70.22 110.145 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' SG ' ' A' ' 54' ' ' CYS . 57.8 t -91.14 117.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.854 0.861 . . . . 75.42 108.814 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.12 128.68 44.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.633 -0.506 . . . . 74.43 109.633 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.551 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 50.0 m95 -104.64 116.28 31.78 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.452 -1.684 . . . . 72.43 106.452 166.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.46 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 41.8 p -87.19 172.14 10.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.959 0.409 . . . . 75.21 111.273 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HZ3' ' HA ' ' A' ' 27' ' ' ASP . 41.6 mmtm -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.895 0.878 . . . . 65.11 111.033 173.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 mpt? -83.72 -0.84 52.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.025 0.93 . . . . 73.13 111.246 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.67 19.37 9.77 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.183 1.393 . . . . 74.31 111.634 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 21.7 ttmm -72.05 124.96 26.06 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.73 -0.841 . . . . 74.3 108.73 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.31 113.35 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.222 1.009 . . . . 72.22 108.32 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.26 154.48 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.895 0.878 . . . . 64.3 109.398 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.536 ' SG ' HG22 ' A' ' 44' ' ' VAL . 24.2 m -116.93 117.95 31.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.385 -0.968 . . . . 72.22 108.385 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.11 160.33 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.814 0.846 . . . . 75.51 109.512 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -62.94 133.64 95.4 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.043 0.537 . . . . 65.22 110.273 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 -32.87 59.32 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.825 2.35 . . . . 74.24 112.414 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -100.82 25.26 8.14 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.577 -0.738 . . . . 73.22 111.477 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.06 131.86 47.67 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.287 -0.635 . . . . 75.41 109.287 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -57.65 -34.03 68.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.857 1.263 . . . . 74.31 112.927 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -78.57 -34.43 46.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.39 0.676 . . . . 74.33 111.648 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -70.59 -20.62 62.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.661 0.784 . . . . 72.4 111.457 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -51.99 -37.6 53.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.851 0.86 . . . . 73.3 111.706 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -72.38 -29.65 63.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 73.41 111.317 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.55 HD12 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -73.55 -38.33 65.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 74.03 109.71 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.63 -29.39 65.75 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.737 0.815 . . . . 74.04 110.427 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -81.13 -23.43 38.35 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.634 0.774 . . . . 74.41 110.805 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.13 -37.56 66.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.272 0.629 . . . . 73.35 111.28 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.79 -29.7 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.562 0.345 . . . . 74.25 111.919 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.477 0.907 0 C-N-CA 123.114 0.566 . . . . 72.33 109.527 176.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 107.835 -1.172 . . . . 53.33 107.835 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.5 p -55.31 -28.22 52.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.243 1.017 . . . . 64.14 111.866 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.16 161.94 15.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.093 -1.203 . . . . 62.04 110.093 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.2 m -102.81 143.24 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.21 -1.033 . . . . 73.43 108.21 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.9 pt -99.87 139.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.599 -0.728 . . . . 74.53 110.439 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m -103.48 7.54 37.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.908 0.883 . . . . 61.42 111.105 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 m -74.37 137.86 43.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.557 0.743 . . . . 74.3 110.321 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -73.05 111.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.102 -1.073 . . . . 64.14 108.102 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -114.27 128.2 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.958 0.903 . . . . 70.32 109.225 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.99 162.79 16.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.096 -0.502 . . . . 60.03 112.712 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.33 -21.99 60.61 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.824 0.85 . . . . 71.44 111.469 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -53.55 -30.72 43.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 73.23 112.038 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.503 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 36.1 pt -119.8 -3.46 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 71.41 113.044 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.58 135.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 118.749 0.704 . . . . 75.12 109.704 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.91 -56.86 2.35 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.241 0.616 . . . . 74.02 110.411 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -143.42 147.55 34.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.566 0.746 . . . . 65.23 109.746 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.8 mt -108.16 112.33 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.928 -1.138 . . . . 71.42 107.928 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.16 104.42 14.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.097 -0.705 . . . . 73.35 109.097 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.85 140.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.922 -0.77 . . . . 73.24 108.922 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -111.99 92.9 19.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.793 -0.818 . . . . 73.33 108.793 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.74 149.87 38.93 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.365 2.71 . . . . 74.1 113.089 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 90.0 Cg_endo -74.36 2.26 6.45 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.719 2.28 . . . . 73.43 114.166 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.72 47.53 3.59 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 112.196 -0.362 . . . . 73.02 112.196 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -144.21 5.22 1.27 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.597 1.159 . . . . 74.32 110.683 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.95 44.79 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.675 -0.514 . . . . 73.32 112.739 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.6 m -82.68 126.61 72.88 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 108.595 -0.891 . . . . 75.42 108.595 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.61 -42.79 44.08 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.652 2.235 . . . . 62.21 113.565 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.92 164.56 12.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.22 0.608 . . . . 71.03 110.238 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 12.7 t -86.1 128.46 34.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.459 -0.941 . . . . 74.01 108.459 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -108.21 119.07 38.44 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.616 -0.513 . . . . 60.22 109.616 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.52 102.34 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.696 -0.483 . . . . 75.24 109.696 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -99.45 107.52 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.0 -1.111 . . . . 74.41 108.0 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -103.9 133.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.404 -0.591 . . . . 71.41 109.404 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -102.79 130.0 49.63 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.615 1.166 . . . . 74.22 108.422 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.5 p -87.07 176.89 7.39 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.388 0.675 . . . . 73.12 110.52 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 41.4 mtmt -71.58 -24.48 61.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.077 0.551 . . . . 72.53 110.726 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.76 -2.66 37.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.175 0.99 . . . . 74.1 110.569 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 68.84 14.64 8.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.462 1.505 . . . . 74.21 110.826 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.17 131.78 39.58 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.856 -1.164 . . . . 75.31 107.856 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.22 121.28 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.344 -0.844 . . . . 74.52 109.817 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -119.01 134.0 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.805 -0.813 . . . . 74.03 108.805 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 44.4 t -110.92 126.24 54.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.862 0.865 . . . . 74.04 109.568 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.42 164.29 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.218 1.007 . . . . 73.43 109.394 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.27 161.3 55.03 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 115.137 -0.938 . . . . 64.42 110.052 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.4 -18.19 63.49 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.84 2.36 . . . . 75.53 112.748 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.07 25.51 7.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.8 0.84 . . . . 75.35 110.62 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 136.09 36.11 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.85 0.46 . . . . 53.25 110.363 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.21 -50.52 71.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.008 0.923 . . . . 73.02 112.748 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -66.86 -28.69 68.54 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.881 0.472 . . . . 71.3 110.948 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.2 tp -67.25 -30.3 70.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.216 1.006 . . . . 75.12 111.683 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -54.17 -35.92 62.82 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.764 0.826 . . . . 73.11 111.63 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.24 -42.22 84.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.103 -0.953 . . . . 73.3 109.651 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.86 -32.37 72.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.406 1.082 . . . . 74.12 110.443 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -38.57 79.47 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.444 0.698 . . . . 72.43 110.178 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -68.96 -37.73 79.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.324 -0.25 . . . . 65.23 110.324 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.54 -37.98 86.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.012 0.525 . . . . 65.01 112.15 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.16 -11.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-O 120.927 0.394 . . . . 73.45 111.117 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.92 -0.771 . . . . 74.55 108.92 172.498 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.123 -0.325 . . . . 75.12 110.123 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -57.35 -31.08 65.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.19 0.996 . . . . 72.02 112.212 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.46 -173.34 15.97 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.46 -0.791 . . . . 75.11 111.562 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 55' ' ' VAL . 99.5 t -99.68 129.35 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.17 -1.048 . . . . 71.35 108.17 -175.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.455 HD11 HG23 ' A' ' 53' ' ' ILE . 37.9 pt -84.15 140.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 123.361 0.413 . . . . 72.0 110.228 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 p -90.39 -4.18 57.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.794 0.838 . . . . 72.42 111.446 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.9 m -88.41 142.84 27.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.598 0.759 . . . . 62.42 109.878 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.74 112.38 22.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.839 -1.171 . . . . 73.13 107.839 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -72.68 143.09 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.186 0.594 . . . . 72.05 110.556 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 123.27 30.18 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.83 0.706 . . . . 64.44 112.574 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD23 ' HG3' ' A' ' 64' ' ' ARG . 9.8 mp -67.41 -22.41 65.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.209 0.604 . . . . 75.45 111.428 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -74.43 -26.08 59.84 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.435 0.694 . . . . 74.52 111.683 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.487 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 47.8 pt -97.65 3.44 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 122.149 -0.344 . . . . 73.32 111.525 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 65' ' ' LEU . 27.5 mm -72.05 130.18 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 109.566 -0.531 . . . . 74.11 109.566 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -102.03 -59.43 1.7 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.452 0.701 . . . . 64.42 110.81 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -146.29 150.18 35.28 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.71 0.404 . . . . 75.21 110.684 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.24 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.115 0.966 . . . . 73.14 108.946 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -97.44 147.6 24.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.922 1.289 . . . . 75.25 109.101 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.17 142.9 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.677 -0.49 . . . . 75.32 109.677 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.2 m -121.78 109.78 33.89 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.992 0.917 . . . . 75.32 109.098 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.12 155.3 17.11 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.625 2.216 . . . . 53.51 113.085 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.1 173.66 14.06 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.733 2.289 . . . . 72.34 112.051 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 -26.13 8.66 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 116.775 -0.193 . . . . 74.42 113.384 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.8 23.49 3.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.135 0.974 . . . . 63.02 110.816 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.59 -19.53 44.63 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.905 -0.589 . . . . 65.21 112.235 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.8 m -80.46 119.3 75.93 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.034 0.417 . . . . 53.22 109.941 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.81 -22.7 74.92 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.13 2.553 . . . . 75.23 113.327 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 172.24 17.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.494 0.718 . . . . 75.15 109.713 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -75.04 133.86 41.53 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.131 -0.692 . . . . 73.22 109.131 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.84 124.97 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.081 0.467 . . . . 73.11 110.532 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.27 113.84 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.223 1.009 . . . . 72.12 109.1 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.76 109.68 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.417 -0.957 . . . . 71.02 108.417 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.9 mt -98.65 136.35 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.431 -0.581 . . . . 70.34 109.431 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -114.39 129.03 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.121 1.369 . . . . 73.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 p -90.46 172.22 8.87 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.777 0.431 . . . . 75.54 110.758 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 19.5 ptpt -69.16 -31.25 69.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.681 0.793 . . . . 64.24 111.133 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.1 ptm -78.42 4.62 12.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.89 0.876 . . . . 74.43 110.729 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 63.36 25.0 14.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.839 1.656 . . . . 73.41 112.14 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -76.5 128.57 35.02 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.276 -1.379 . . . . 64.33 107.276 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -100.56 131.0 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.66 1.184 . . . . 71.25 109.64 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 17' ' ' ILE . 32.2 pt -133.25 156.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.886 0.874 . . . . 72.03 108.672 171.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.1 p -137.15 122.48 19.4 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.128 -0.693 . . . . 64.03 109.128 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' HG22 ' A' ' 16' ' ' VAL . 35.6 m -126.4 150.95 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.382 0.673 . . . . 75.44 109.785 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.57 152.97 67.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.349 -0.611 . . . . 71.31 109.349 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.53 -4.87 6.11 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.018 2.479 . . . . 73.25 115.259 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -84.07 -11.63 56.38 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.096 0.559 . . . . 72.11 112.147 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 113.63 3.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.65 -0.87 . . . . 63.24 108.65 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 17.5 mtpp -77.72 -20.86 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.722 0.638 . . . . 74.53 112.722 -171.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -75.5 -14.91 60.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.376 0.27 . . . . 74.42 111.171 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.5 tp -70.52 -29.4 65.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.672 0.389 . . . . 73.23 110.041 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -64.45 -19.69 65.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.455 0.302 . . . . 72.22 111.754 175.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HG3' HD23 ' A' ' 23' ' ' LEU . 1.1 tpm_? -65.76 -44.11 86.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.942 0.497 . . . . 74.31 109.691 170.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 HD12 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -66.78 -41.27 87.95 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.826 0.85 . . . . 72.23 110.28 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.35 -36.63 81.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.425 0.69 . . . . 73.13 110.759 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.72 -29.08 56.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.399 0.68 . . . . 74.45 110.956 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -74.26 -51.12 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.373 0.669 . . . . 74.2 111.072 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.77 -34.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.988 0.515 . . . . 74.44 110.747 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 108.031 -1.1 . . . . 75.44 108.031 175.773 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 109.495 -0.557 . . . . 72.41 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 t -100.0 10.7 40.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.218 0.607 . . . . 72.42 111.01 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 172.3 46.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.3 -0.72 . . . . 37.63 111.3 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 33.9 m -100.21 140.13 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 117.325 0.562 . . . . 71.41 109.895 -174.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.95 146.24 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.501 0.72 . . . . 72.1 110.705 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 p -92.87 -2.2 56.08 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.315 -0.857 . . . . 65.13 111.394 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.6 m -60.47 118.82 6.96 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.49 -0.559 . . . . 73.44 109.49 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.27 111.19 3.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.822 -0.807 . . . . 64.21 108.822 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.52 132.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.249 0.62 . . . . 75.2 109.4 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.51 145.56 27.9 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.998 -0.546 . . . . 71.23 112.501 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.16 -33.66 72.49 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.103 0.961 . . . . 71.14 110.513 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.8 -28.71 68.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.834 0.853 . . . . 75.24 111.62 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -103.92 12.42 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 111.931 0.345 . . . . 75.31 111.931 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 mm -76.9 122.24 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.196 -1.039 . . . . 64.32 108.196 169.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -90.06 -58.86 2.36 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.37 -0.604 . . . . 74.44 109.37 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -146.95 155.67 42.46 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.183 0.593 . . . . 74.21 109.749 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.8 mt -113.95 108.15 24.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.202 -1.036 . . . . 64.44 108.202 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -99.47 137.75 37.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.616 0.766 . . . . 73.55 108.968 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.15 129.24 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.3 -0.63 . . . . 73.43 109.3 172.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -106.98 115.18 60.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.855 0.862 . . . . 70.31 108.984 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.35 166.17 29.31 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.642 2.228 . . . . 71.41 111.724 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.73 84.09 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.434 2.089 . . . . 72.14 112.191 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.33 -179.48 39.77 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.676 -1.147 . . . . 70.13 110.677 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 65.42 18.89 11.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.636 1.174 . . . . 74.34 111.77 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.52 10.71 53.08 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 122.763 0.22 . . . . 60.52 113.568 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.36 117.43 33.09 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 108.059 -1.089 . . . . 64.54 108.059 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.4 5.86 5.79 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.566 2.178 . . . . 70.43 113.603 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -153.01 173.32 15.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.191 0.596 . . . . 73.41 110.776 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -86.8 121.29 29.1 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.55 -0.907 . . . . 72.01 108.55 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.9 134.51 45.78 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.052 0.541 . . . . 64.45 109.967 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 101.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.788 -0.819 . . . . 71.35 108.788 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.12 108.96 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.899 0.88 . . . . 74.53 109.262 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.5 mt -95.43 130.56 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.197 -0.668 . . . . 75.13 109.197 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -97.68 125.78 42.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.662 -1.607 . . . . 74.41 106.662 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.9 p -89.47 169.42 11.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.025 0.375 . . . . 64.42 110.531 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.9 -25.99 63.96 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.988 0.915 . . . . 71.34 111.519 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -80.39 1.67 28.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.888 0.875 . . . . 70.32 110.542 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.03 22.92 11.16 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.151 1.78 . . . . 65.31 112.162 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -79.95 123.78 28.1 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 106.664 -1.606 . . . . 74.34 106.664 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.19 124.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.844 -0.799 . . . . 72.12 108.844 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.2 pt -132.67 158.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.123 0.969 . . . . 75.21 109.265 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 55.6 m -120.37 149.94 41.54 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.107 -1.072 . . . . 73.45 108.107 167.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.92 163.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.416 0.687 . . . . 73.12 109.817 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.37 128.24 84.72 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.051 0.54 . . . . 64.25 110.098 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.53 -29.97 80.73 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.55 2.833 . . . . 75.55 113.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -89.09 16.98 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.424 0.69 . . . . 72.22 112.702 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 125.9 28.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.587 -0.894 . . . . 63.43 108.587 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.1 -37.36 81.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.675 0.79 . . . . 73.53 111.772 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 70.5 p-90 -63.49 -34.47 77.84 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.036 0.446 . . . . 74.32 110.474 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.11 -34.49 73.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.54 -0.754 . . . . 72.31 110.476 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.05 -38.95 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.708 0.803 . . . . 75.13 110.779 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -61.59 -48.43 80.99 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.86 -1.064 . . . . 74.41 110.072 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.44 -36.19 77.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.646 0.778 . . . . 63.44 111.025 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.95 -36.38 67.14 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.485 0.714 . . . . 71.4 110.637 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -75.36 -23.0 57.1 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.899 0.48 . . . . 74.53 110.284 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -67.1 -43.91 81.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.062 0.945 . . . . 71.32 110.716 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.9 m -90.78 -8.05 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 123.619 0.574 . . . . 75.13 112.045 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 CA--C 1.55 0.973 0 C-N-CA 123.379 0.672 . . . . 65.53 109.565 177.786 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.499 ' SG ' HG21 ' A' ' 44' ' ' VAL . 55.5 m . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 110.202 -0.296 . . . . 74.43 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -82.81 -153.16 0.12 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.677 -0.692 . . . . 71.21 109.403 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.72 158.27 36.95 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-O 120.955 0.197 . . . . 75.35 112.853 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.98 146.8 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.215 -1.032 . . . . 70.14 108.215 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.29 145.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.223 0.535 . . . . 71.13 110.904 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -128.72 31.1 5.01 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.749 1.22 . . . . 64.34 108.289 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -140.57 142.21 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.708 1.203 . . . . 64.41 108.271 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.12 114.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.367 -0.605 . . . . 75.43 109.367 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.02 139.03 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.233 0.613 . . . . 74.15 109.583 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.92 131.81 11.0 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.796 0.685 . . . . 63.42 112.928 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' ND1' ' A' ' 68' ' ' HIS . 7.4 tt -54.46 -31.55 55.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.868 1.267 . . . . 74.1 110.747 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -58.35 -35.26 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.018 1.327 . . . . 72.4 112.445 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.4 pt -96.81 -6.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 119.098 -0.477 . . . . 71.41 111.46 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -75.01 130.26 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.221 -0.659 . . . . 74.34 109.221 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.86 -53.94 2.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.212 0.605 . . . . 55.2 109.562 174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -139.11 141.14 38.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.011 0.524 . . . . 73.41 110.188 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.1 mt -119.22 107.94 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.37 -1.344 . . . . 73.52 107.37 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -105.3 138.99 40.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.141 -1.059 . . . . 64.42 108.141 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -116.33 110.97 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.43 -0.952 . . . . 75.35 108.43 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -89.43 121.09 69.6 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.505 -0.554 . . . . 65.52 109.505 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.1 148.89 83.38 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.33 2.687 . . . . 72.11 113.636 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.86 100.57 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.886 2.391 . . . . 72.22 112.142 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.97 -5.52 4.71 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-N 115.478 -0.783 . . . . 71.13 112.31 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -89.68 41.08 1.02 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.686 0.795 . . . . 73.25 111.047 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -19.75 47.92 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.501 -0.772 . . . . 63.1 112.775 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.37 116.11 39.58 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.125 -1.435 . . . . 74.14 107.125 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.02 -39.02 40.63 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.932 3.088 . . . . 75.32 113.48 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -106.58 157.81 17.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.666 0.786 . . . . 71.44 109.297 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -61.07 115.7 3.96 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.939 0.774 . . . . 75.31 109.703 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -110.87 110.79 21.54 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.34 103.04 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.732 -0.84 . . . . 73.53 108.732 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 54' ' ' CYS . 44.5 t -90.27 108.12 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.7 -0.852 . . . . 71.35 108.7 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 ' HB ' HG13 ' A' ' 53' ' ' ILE . 62.3 mt -106.23 119.97 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.559 0.743 . . . . 73.14 109.133 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -94.71 124.86 38.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.117 -1.068 . . . . 75.25 108.117 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.8 p -84.81 163.68 18.93 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.906 -0.405 . . . . 52.31 109.906 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -71.61 -10.98 60.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.228 0.611 . . . . 71.5 111.512 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 ptp -90.81 4.79 50.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.54 0.736 . . . . 61.1 110.772 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 68.3 22.23 8.13 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.3 1.44 . . . . 74.41 112.648 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -84.74 128.95 34.86 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.538 -0.912 . . . . 75.12 108.538 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.45 114.02 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.643 -0.873 . . . . 73.44 108.643 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.484 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.8 pt -125.16 128.5 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.257 -1.016 . . . . 72.05 108.257 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 44' ' ' VAL . 94.9 m -120.74 138.0 54.21 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.152 -0.343 . . . . 64.22 110.469 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG13 ' HE1' ' A' ' 61' ' ' TRP . 28.5 m -130.43 167.05 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.913 0.885 . . . . 73.33 110.958 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -73.75 153.92 89.28 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 114.427 -1.26 . . . . 72.45 110.329 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.4 -28.54 71.46 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.909 2.406 . . . . 65.34 113.2 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -107.48 24.71 12.46 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.419 0.687 . . . . 73.43 111.672 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.24 124.32 21.87 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.398 -0.964 . . . . 50.21 108.398 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -70.83 -30.7 67.2 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.987 0.515 . . . . 71.32 111.502 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.474 ' O ' HD21 ' A' ' 65' ' ' LEU . 15.4 p-90 -64.34 -32.32 73.88 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.207 -0.664 . . . . 74.02 109.207 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.1 tp -73.29 -37.86 66.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.775 . . . . 75.12 110.555 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.11 -44.16 95.07 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.993 0.517 . . . . 75.52 111.177 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 61' ' ' TRP . 13.5 ptm180 -67.86 -31.59 71.51 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.917 0.487 . . . . 75.12 111.2 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 61' ' ' TRP . 2.6 mm? -59.71 -47.94 83.63 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.596 0.759 . . . . 73.14 110.044 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.66 -34.77 78.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.914 0.886 . . . . 71.24 111.664 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -69.78 -32.61 71.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.632 0.773 . . . . 63.12 110.641 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' ND1' HD13 ' A' ' 23' ' ' LEU . 29.7 t-80 -74.64 -30.6 61.69 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.03 0.532 . . . . 72.53 111.545 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 65' ' ' LEU . 80.6 t -64.76 -49.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 109.145 -0.687 . . . . 74.14 109.145 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 108.319 -0.993 . . . . 72.01 108.319 173.345 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--O 1.239 0.543 0 CA-C-O 121.008 0.433 . . . . 63.44 109.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 p -104.26 -55.2 2.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.001 0.92 . . . . 71.54 109.364 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.18 167.96 35.7 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.247 -0.888 . . . . 73.22 111.186 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.26 156.44 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.257 0.528 . . . . 71.21 110.314 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.38 149.88 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 74.31 110.313 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -111.36 12.53 21.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.043 0.937 . . . . 73.41 110.764 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.0 m -93.93 144.44 25.45 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.746 0.818 . . . . 74.11 109.88 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.26 110.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.701 -1.222 . . . . 74.33 107.701 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.77 124.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.894 -0.78 . . . . 74.22 108.894 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 147.57 30.35 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.774 0.671 . . . . 71.22 113.859 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.45 -33.36 65.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.974 0.909 . . . . 72.55 110.486 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.25 -34.28 72.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.986 0.914 . . . . 55.45 112.241 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.9 pt -107.0 13.36 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.693 0.397 . . . . 72.24 111.776 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.4 129.27 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.627 -0.879 . . . . 73.52 108.627 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.92 -59.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.822 -0.436 . . . . 63.31 109.822 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 -143.74 139.65 29.56 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.397 0.679 . . . . 73.31 109.703 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -107.33 119.48 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.139 0.975 . . . . 71.1 109.638 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 44' ' ' VAL . 24.4 tp60 -105.68 135.24 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.321 -1.363 . . . . 74.32 107.321 170.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.11 127.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.621 -0.511 . . . . 64.23 109.621 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -118.08 103.6 49.63 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 108.836 -0.802 . . . . 72.13 108.836 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.75 170.42 12.69 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.438 2.758 . . . . 72.3 112.063 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.82 99.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.263 1.975 . . . . 71.53 111.408 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.83 164.52 29.09 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.591 -1.404 . . . . 37.96 109.591 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 66.09 19.43 11.16 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.307 1.051 . . . . 63.43 110.363 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.32 8.46 87.56 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.205 -0.907 . . . . 73.44 113.325 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.2 m -84.87 136.87 38.34 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.305 0.642 . . . . 71.44 109.667 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.31 -52.72 0.77 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.845 2.363 . . . . 74.13 114.206 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -135.04 177.4 7.84 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.261 1.025 . . . . 63.45 109.647 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -67.17 110.37 3.44 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.203 -0.666 . . . . 74.25 109.203 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -111.41 112.5 24.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.714 1.206 . . . . 75.22 108.425 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.67 101.13 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.323 -0.991 . . . . 72.51 108.323 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 85.9 t -92.21 110.03 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.112 0.965 . . . . 74.51 108.814 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.57 128.81 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.006 -0.434 . . . . 75.2 110.557 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -88.76 123.9 33.62 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.448 -1.315 . . . . 75.33 107.448 168.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -84.87 174.41 9.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.812 0.445 . . . . 75.14 110.463 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.57 -21.88 65.41 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.497 0.719 . . . . 72.2 111.114 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 50.1 mtm -76.64 -4.4 42.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.438 1.095 . . . . 74.43 110.51 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 60.58 23.56 13.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.839 1.656 . . . . 75.11 111.364 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -85.6 124.24 31.92 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 106.758 -1.571 . . . . 72.01 106.758 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -88.62 130.37 38.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.77 -0.826 . . . . 71.05 108.77 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.0 pt -129.68 157.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 75.12 109.114 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.3 m -126.8 118.1 23.98 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.246 -1.02 . . . . 52.45 108.246 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.58 155.26 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.946 0.498 . . . . 64.02 110.094 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.77 165.54 17.75 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.8 0.84 . . . . 73.35 109.181 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.88 0.19 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.436 2.091 . . . . 72.45 114.126 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -70.11 -25.48 63.52 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.523 0.729 . . . . 64.24 110.963 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.9 112.96 3.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.365 0.666 . . . . 75.03 110.427 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 60' ' ' LYS . 4.6 ttmp? -70.49 -33.17 70.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.33 0.652 . . . . 73.24 111.389 -173.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -65.46 -27.42 68.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.661 0.385 . . . . 73.14 111.132 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.4 tp -67.02 -33.5 75.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.016 0.926 . . . . 74.05 111.768 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.53 -22.46 66.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.297 0.239 . . . . 75.43 110.929 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -69.97 -39.25 76.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.389 0.676 . . . . 70.31 110.206 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.73 -41.88 74.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.138 0.975 . . . . 64.41 109.74 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.96 -25.63 61.94 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.054 -0.976 . . . . 74.21 111.656 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -29.96 31.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.025 -0.732 . . . . 74.24 109.025 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.65 -28.64 69.25 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.03 0.532 . . . . 74.54 111.398 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.89 -3.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.2 0.6 . . . . 72.5 111.734 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 . . . . . 0 N--CA 1.483 1.21 0 C-N-CA 123.914 0.886 . . . . 72.3 110.393 175.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 t . . . . . 0 C--O 1.24 0.567 0 CA-C-O 120.974 0.416 . . . . 64.53 111.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -132.44 12.98 4.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.141 0.976 . . . . 64.14 110.979 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.37 175.99 50.59 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.766 -0.652 . . . . 73.31 112.996 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.31 170.93 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.447 0.699 . . . . 75.22 109.957 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.89 137.65 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.274 0.559 . . . . 73.41 111.639 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -83.54 -38.88 21.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.041 0.937 . . . . 73.43 110.042 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m -68.12 121.35 15.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.267 1.027 . . . . 75.21 110.125 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.0 116.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.748 0.655 . . . . 75.34 110.128 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.24 134.84 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.93 0.892 . . . . 70.45 109.446 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.7 139.28 22.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 113.987 0.355 . . . . 62.0 113.987 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.6 -37.53 65.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.483 1.113 . . . . 73.21 110.823 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -65.58 -34.07 77.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.733 0.813 . . . . 71.3 111.842 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.626 ' HB ' ' HE3' ' A' ' 49' ' ' MET . 33.7 pt -90.74 -3.79 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 119.565 -0.255 . . . . 74.24 111.41 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.548 HD12 HG23 ' A' ' 45' ' ' ILE . 39.0 mm -71.97 137.47 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.698 -0.853 . . . . 75.13 108.698 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -104.95 -55.3 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.275 -0.639 . . . . 74.23 109.275 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -143.01 142.11 31.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.342 -0.845 . . . . 65.2 109.342 -171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.24 106.57 21.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.029 -1.471 . . . . 73.44 107.029 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.02 103.5 15.35 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.05 -1.093 . . . . 74.04 108.05 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.64 109.44 21.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.616 -1.253 . . . . 71.15 107.616 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -106.54 114.37 62.08 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.389 0.676 . . . . 73.25 109.216 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 160.33 49.66 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.484 2.123 . . . . 55.34 111.797 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 150.96 74.99 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.864 . . . . 72.51 111.095 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.54 -52.61 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 C-N-CA 121.357 -0.449 . . . . 38.13 112.556 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -146.66 107.9 4.23 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.32 0.648 . . . . 74.32 109.575 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.28 -17.73 9.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.76 -0.655 . . . . 52.22 114.578 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.4 m -88.52 115.52 63.6 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.571 -0.9 . . . . 74.14 108.571 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.79 -68.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.696 2.264 . . . . 73.01 111.665 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -103.79 179.22 4.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.547 0.739 . . . . 71.33 109.083 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.3 m -64.89 109.96 2.27 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.157 -0.683 . . . . 74.11 109.157 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -89.76 111.96 23.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.353 -0.98 . . . . 73.41 108.353 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.42 101.19 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.512 -0.921 . . . . 63.4 108.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.1 t -96.49 109.71 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.068 0.947 . . . . 61.41 108.572 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.548 HG23 HD12 ' A' ' 26' ' ' ILE . 58.5 mt -94.71 136.83 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.811 -0.811 . . . . 74.11 108.811 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -110.31 117.6 34.07 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.07 -1.456 . . . . 70.42 107.07 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.47 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 60.0 p -82.31 160.81 22.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.687 -0.486 . . . . 73.15 109.687 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 59.6 pttt -71.05 -10.95 60.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.76 0.824 . . . . 72.41 112.972 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.626 ' HE3' ' HB ' ' A' ' 25' ' ' ILE . 3.1 mpp? -92.7 10.79 29.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.145 0.578 . . . . 72.24 110.153 170.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 69.82 15.2 7.97 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.2 1.4 . . . . 74.43 112.931 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 8.0 tmtm? -84.3 123.46 30.19 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.559 -1.275 . . . . 71.13 107.559 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 t -98.84 139.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.124 0.57 . . . . 74.35 109.478 -171.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.57 156.21 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.077 0.951 . . . . 72.21 109.909 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.22 137.27 47.36 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.087 -1.449 . . . . 72.33 107.087 166.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.5 159.28 41.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.838 -0.801 . . . . 73.45 108.838 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -91.21 139.87 25.65 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 115.788 -0.642 . . . . 74.31 110.133 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.06 -12.08 32.98 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.025 2.484 . . . . 74.34 113.771 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -97.99 8.88 44.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.612 0.765 . . . . 65.14 112.357 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.59 122.58 20.0 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.037 -0.727 . . . . 53.42 109.037 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.69 ' HA ' HE21 ' A' ' 63' ' ' GLN . 21.7 ptmt -63.55 -39.39 94.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.978 0.911 . . . . 74.14 112.583 -167.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -68.16 -35.19 77.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.477 0.711 . . . . 74.32 110.64 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 54.6 tp -66.06 -36.22 82.63 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.411 0.684 . . . . 72.43 110.644 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 60' ' ' LYS . 48.7 mt-30 -56.97 -42.05 79.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.735 0.647 . . . . 74.51 109.823 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -63.85 -36.13 82.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.327 0.651 . . . . 73.52 110.906 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.33 -43.29 99.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.248 0.619 . . . . 73.03 109.992 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 82.0 mt -71.98 -23.01 61.35 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.171 -0.922 . . . . 73.32 111.182 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 4.7 mmp_? -88.39 -20.68 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.43 0.692 . . . . 72.24 111.575 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -78.37 -30.61 48.04 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.192 0.597 . . . . 74.3 110.911 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 m -80.07 -13.85 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.679 0.276 . . . . 74.53 110.655 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 123.628 0.771 . . . . 74.31 109.403 172.472 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 14' ' ' SER . 9.8 t . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 110.125 -0.324 . . . . 71.54 110.125 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 20.8 m -93.62 -50.08 5.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.59 0.756 . . . . 74.12 110.738 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.22 -121.54 0.83 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.788 -0.451 . . . . 73.52 112.682 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.12 162.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.599 1.159 . . . . 72.03 110.044 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.62 151.26 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.14 0.576 . . . . 73.43 110.727 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 m -110.56 11.78 22.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.034 0.934 . . . . 74.33 111.45 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 154.91 43.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.166 0.587 . . . . 72.41 110.417 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.89 141.93 14.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.197 -0.668 . . . . 74.45 109.197 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.79 144.34 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.467 1.107 . . . . 72.33 109.04 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 25' ' ' ILE . . . -62.7 123.39 30.41 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.912 -0.382 . . . . 63.23 113.426 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.54 -34.19 68.88 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.258 1.023 . . . . 72.22 110.755 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.55 -28.33 63.79 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.886 0.874 . . . . 62.25 111.998 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 22' ' ' GLY . 17.8 pt -90.72 -0.41 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 118.131 0.423 . . . . 74.24 111.152 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 45' ' ' ILE . 36.4 mm -77.31 111.9 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.372 -0.603 . . . . 50.43 109.372 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.15 -53.71 4.89 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.47 -0.566 . . . . 74.31 109.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -153.72 147.42 25.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.448 -0.797 . . . . 74.12 110.105 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -113.34 123.19 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.529 -0.915 . . . . 73.13 108.529 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -94.54 111.05 22.81 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.342 -0.985 . . . . 71.41 108.342 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.74 131.69 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.112 0.482 . . . . 72.44 109.9 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 p -122.49 136.23 26.37 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.1 0.96 . . . . 75.31 108.978 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -61.21 169.84 5.81 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.156 2.571 . . . . 74.44 113.814 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.37 170.99 14.84 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 121.805 1.67 . . . . 64.51 111.589 168.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -177.18 48.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.55 -0.295 . . . . 71.1 112.523 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 64.17 14.31 8.52 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.743 1.217 . . . . 75.53 111.317 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.72 -20.27 36.98 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.947 0.784 . . . . 54.23 112.731 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 m -84.72 124.95 72.36 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 117.639 0.72 . . . . 72.43 109.073 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.0 -69.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.794 2.329 . . . . 63.03 113.696 -172.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -100.68 179.97 4.26 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.399 1.08 . . . . 75.21 108.579 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 m -64.12 109.13 1.73 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.022 -1.473 . . . . 74.34 107.022 162.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -90.54 112.78 24.6 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 74.35 109.682 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 102.13 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.137 -0.69 . . . . 75.21 109.137 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.03 111.66 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.962 -1.125 . . . . 62.32 107.962 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.57 HG22 HD12 ' A' ' 26' ' ' ILE . 54.5 mt -94.39 136.27 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.805 -0.443 . . . . 73.13 109.805 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -114.71 114.0 25.04 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 124.878 1.271 . . . . 74.34 108.053 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.2 p -80.29 169.17 18.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.429 0.292 . . . . 75.11 111.073 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.75 -20.62 64.38 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.002 0.921 . . . . 74.31 112.0 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.8 ptp -91.49 8.86 34.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.515 0.726 . . . . 64.01 110.906 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 67.68 21.55 9.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.987 1.315 . . . . 75.12 111.523 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -81.01 123.06 28.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.011 -1.477 . . . . 74.53 107.011 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.86 130.19 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.603 -0.888 . . . . 75.13 108.603 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.38 153.96 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.263 0.625 . . . . 73.12 109.836 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 92.8 m -109.54 128.76 55.43 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.231 -0.895 . . . . 64.21 108.632 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.14 140.6 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.499 -0.926 . . . . 64.41 108.499 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -79.66 128.1 75.77 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.19 -21.32 27.8 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.923 3.082 . . . . 74.45 114.558 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -73.28 -7.48 51.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.202 0.601 . . . . 74.43 112.459 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.04 123.03 16.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.858 0.863 . . . . 64.52 110.696 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -66.5 -38.33 87.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.022 -0.99 . . . . 74.21 111.914 -172.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.846 0.459 . . . . 72.14 111.425 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.55 -27.0 63.81 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.569 0.747 . . . . 75.54 110.921 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -59.95 -25.92 65.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.046 0.538 . . . . 72.24 111.698 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.77 -41.68 97.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.2 0.6 . . . . 75.22 109.903 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.04 -40.35 82.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.532 0.733 . . . . 75.14 110.0 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.86 -31.29 72.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.392 0.677 . . . . 74.43 110.812 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -78.23 -34.14 49.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.125 0.57 . . . . 73.34 111.058 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.585 0.354 . . . . 73.3 111.64 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.43 -11.51 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.011 0.375 . . . . 74.32 112.011 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 124.175 0.99 . . . . 65.43 111.417 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 109.665 -0.494 . . . . 74.54 109.665 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 t -51.97 -31.98 31.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.67 1.188 . . . . 75.3 112.125 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.73 -169.86 34.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.323 -0.711 . . . . 70.44 111.323 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.68 129.95 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.399 -0.963 . . . . 72.44 108.399 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.633 HD13 HG13 ' A' ' 55' ' ' VAL . 2.2 pp -114.26 144.69 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.162 0.585 . . . . 74.25 109.584 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.0 m -133.95 34.2 3.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.91 0.884 . . . . 62.13 109.429 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 m -126.53 138.89 53.54 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.964 -1.016 . . . . 74.13 108.906 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -74.25 110.85 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.406 -1.331 . . . . 74.42 107.406 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.75 139.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.478 -0.564 . . . . 73.45 109.478 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.36 128.58 33.37 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.756 0.66 . . . . 54.31 113.28 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.65 -30.17 63.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.057 0.943 . . . . 74.32 109.943 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -54.77 -35.49 63.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 73.01 112.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.0 pt -104.49 -3.88 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 119.266 -0.397 . . . . 74.33 112.013 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 45' ' ' ILE . 41.1 mm -71.13 110.97 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.684 -0.858 . . . . 72.52 108.684 172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB2' ' HD2' ' A' ' 48' ' ' LYS . 24.0 t70 -85.75 -56.6 3.41 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.198 0.599 . . . . 75.15 110.712 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -160.69 143.88 13.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.209 -0.663 . . . . 75.43 109.209 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.12 123.99 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.215 -0.661 . . . . 74.2 109.215 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -103.98 116.82 32.94 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.864 0.866 . . . . 71.24 109.012 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.36 112.83 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.294 0.638 . . . . 71.34 110.165 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 11.0 m -89.84 116.65 66.88 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 108.935 -0.765 . . . . 75.54 108.935 169.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.81 157.73 36.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.812 2.341 . . . . 72.55 112.535 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.38 122.08 10.76 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.607 2.204 . . . . 74.25 111.294 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.64 -159.59 23.49 Favored Glycine 0 C--O 1.241 0.546 0 N-CA-C 110.221 -1.152 . . . . 72.23 110.221 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 63.82 30.09 14.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 72.43 111.641 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.87 20.5 61.17 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.423 -0.353 . . . . 37.99 112.914 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 53.4 t -138.32 133.34 17.1 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.888 0.875 . . . . 71.54 109.965 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.72 -9.31 13.35 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.336 2.024 . . . . 63.51 112.616 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 16.5 tppt? -101.29 155.09 18.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.806 1.242 . . . . 65.22 110.163 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -86.43 115.23 23.8 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.183 -1.043 . . . . 74.14 108.183 164.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 42.7 tt0 -83.21 112.97 20.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.04 102.15 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.539 -1.282 . . . . 73.24 107.539 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.11 135.27 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.934 0.894 . . . . 74.12 109.061 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.637 HG22 HD12 ' A' ' 26' ' ' ILE . 60.9 mt -110.29 121.78 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.624 0.37 . . . . 73.45 110.083 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.15 127.04 32.74 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.998 -1.112 . . . . 71.01 107.998 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.7 p -84.66 178.42 7.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.408 0.683 . . . . 75.44 110.359 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HD2' ' HB2' ' A' ' 27' ' ' ASP . 14.4 mmmm -66.02 -23.52 66.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.277 0.56 . . . . 74.13 110.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.3 mtm -79.8 -1.45 38.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.458 1.103 . . . . 73.23 110.434 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 65.2 14.51 9.44 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.986 1.714 . . . . 75.3 111.919 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HZ3' HG22 ' A' ' 53' ' ' ILE . 14.1 tmtt? -79.77 125.97 30.35 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.248 -1.019 . . . . 73.24 108.248 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.92 122.65 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 75.54 109.386 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.451 HG22 ' HZ3' ' A' ' 51' ' ' LYS . 39.1 pt -108.11 149.93 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.147 -1.057 . . . . 74.5 108.147 169.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.97 118.68 37.42 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.515 0.726 . . . . 63.11 109.355 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.633 HG13 HD13 ' A' ' 17' ' ' ILE . 32.8 m -124.69 156.06 32.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 123.524 0.73 . . . . 70.34 109.55 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.55 152.95 78.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.558 -0.904 . . . . 73.53 108.558 168.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.54 -27.0 69.69 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.839 1.693 . . . . 65.14 111.261 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.89 12.67 36.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.313 1.045 . . . . 72.33 112.208 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.97 56.58 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.041 0.536 . . . . 75.14 109.985 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.96 -40.99 97.67 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.973 0.731 . . . . 73.22 112.973 -166.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -77.84 -17.48 57.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.073 0.397 . . . . 73.14 112.073 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.49 -21.59 66.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 64.23 110.712 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -56.4 -23.97 41.66 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.092 0.957 . . . . 65.45 113.139 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.99 -46.94 82.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.927 0.491 . . . . 74.22 110.274 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.52 -37.96 55.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.369 -0.832 . . . . 75.54 110.472 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.05 -35.62 78.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 75.34 110.547 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -75.03 -41.38 59.34 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.309 0.243 . . . . 73.32 110.682 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -68.66 -36.11 78.14 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.27 0.47 . . . . 64.35 112.27 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.0 -28.81 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.025 0.44 . . . . 74.33 110.137 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 123.834 0.853 . . . . 55.13 111.049 176.861 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 16' ' ' VAL . 52.9 t . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.236 -0.653 . . . . 74.14 109.236 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.9 m -114.54 123.88 50.47 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.185 0.994 . . . . 71.44 109.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.33 90.24 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 O-C-N 123.773 0.671 . . . . 72.2 111.736 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.676 HG21 ' SG ' ' A' ' 13' ' ' CYS . 22.7 t -100.5 128.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.808 -0.812 . . . . 74.22 108.808 -173.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.413 HD13 HG12 ' A' ' 55' ' ' VAL . 2.7 pp -124.74 147.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.082 0.553 . . . . 74.23 109.986 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.4 m -117.76 22.68 12.17 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.489 1.115 . . . . 72.5 109.122 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.5 m -93.72 146.57 23.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.753 1.221 . . . . 74.3 109.994 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.63 112.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.359 -0.978 . . . . 45.3 108.359 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -90.5 143.33 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.664 0.786 . . . . 74.25 109.548 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 118.09 13.73 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.881 0.738 . . . . 72.12 112.011 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.3 -30.81 52.22 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.767 1.227 . . . . 72.44 110.995 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.47 -35.79 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.399 0.679 . . . . 72.32 111.942 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.417 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt -86.19 -6.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 111.957 0.354 . . . . 73.11 111.957 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 HG21 ' A' ' 45' ' ' ILE . 44.5 mm -72.9 129.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.364 -0.976 . . . . 74.54 108.364 176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -117.16 -58.64 2.04 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.633 0.373 . . . . 63.45 111.055 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -144.81 127.47 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.849 0.46 . . . . 74.34 109.906 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -110.79 140.66 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.359 1.064 . . . . 71.53 109.71 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.37 127.17 25.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.979 1.312 . . . . 73.25 108.082 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.52 139.43 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 122.576 0.35 . . . . 74.43 111.253 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 28.5 m -111.06 118.36 48.16 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.06 0.944 . . . . 71.15 109.099 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.44 147.18 36.19 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.025 1.816 . . . . 73.51 111.156 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.75 144.7 92.75 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.61 2.207 . . . . 73.32 112.59 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.02 -32.8 7.1 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.066 -0.516 . . . . 72.4 112.534 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -80.59 77.76 7.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.636 0.774 . . . . 72.53 110.426 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.37 -2.92 18.12 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 115.808 -0.633 . . . . 63.04 114.501 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.08 138.26 17.72 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 74.44 109.139 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.71 16.61 1.78 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.868 2.379 . . . . 73.21 114.034 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -152.16 173.21 15.23 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.277 0.631 . . . . 75.44 110.572 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 m -81.2 131.32 35.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.402 0.681 . . . . 75.42 110.114 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 19.9 tt0 -115.05 126.33 54.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.915 -1.143 . . . . 74.1 107.915 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.08 102.68 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.283 -1.006 . . . . 64.4 108.283 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.91 130.56 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.144 0.978 . . . . 73.32 109.083 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.61 HG21 HD11 ' A' ' 26' ' ' ILE . 52.3 mt -121.16 129.85 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.256 -0.646 . . . . 75.13 109.256 173.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -99.53 124.56 44.81 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.969 1.307 . . . . 75.24 107.523 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.8 p -84.9 170.64 12.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.883 0.473 . . . . 74.13 110.792 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 18.6 ptpt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 75.51 110.845 170.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.96 -8.29 56.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.186 0.994 . . . . 74.24 110.647 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.09 21.17 7.41 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.074 1.349 . . . . 75.32 109.246 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -100.43 133.09 45.38 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.25 1.02 . . . . 72.53 108.364 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.42 124.04 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.128 0.971 . . . . 73.24 110.397 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.432 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.6 pt -120.61 139.04 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.62 117.02 32.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.228 -1.397 . . . . 61.32 107.228 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG12 HD13 ' A' ' 17' ' ' ILE . 7.2 m -117.55 166.35 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.176 0.59 . . . . 75.51 111.073 -168.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.18 139.09 56.21 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 115.299 -0.864 . . . . 74.24 109.512 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.1 -43.57 28.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.422 2.081 . . . . 74.24 112.721 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -85.08 21.96 1.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.93 0.492 . . . . 73.53 111.461 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.84 124.65 21.33 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.145 -0.687 . . . . 72.4 109.145 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.92 -32.89 74.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.252 1.021 . . . . 75.34 112.316 -169.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -74.12 -29.96 62.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.05 0.54 . . . . 75.34 111.154 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.7 tp -67.44 -23.55 65.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.674 0.79 . . . . 74.43 110.869 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -57.77 -38.04 74.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.753 0.821 . . . . 73.32 111.171 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -69.7 -31.39 69.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.119 0.568 . . . . 75.13 110.74 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.9 -35.58 69.75 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.454 -0.572 . . . . 61.42 109.454 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -66.04 -40.33 90.9 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.342 0.657 . . . . 74.43 110.129 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -70.33 -35.84 73.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.31 0.644 . . . . 73.42 111.05 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.78 -44.84 92.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.736 0.414 . . . . 70.21 110.412 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 m -82.37 -20.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.85 -0.614 . . . . 62.01 111.534 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 . . . . . 0 N--CA 1.478 0.961 0 C-N-CA 123.024 0.529 . . . . 73.13 109.96 178.858 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.24 0.6 0 N-CA-C 109.125 -0.695 . . . . 62.02 109.125 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 p -64.01 -49.58 71.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.745 0.818 . . . . 75.01 110.539 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.61 172.03 32.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.027 -0.988 . . . . 74.23 111.236 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.56 148.2 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.024 0.53 . . . . 64.21 109.788 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.8 pt -83.53 133.06 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.582 -0.735 . . . . 74.43 111.566 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.0 m -85.07 -41.04 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.374 -0.83 . . . . 74.22 109.354 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.8 m -92.45 129.29 38.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.007 . . . . 74.24 108.806 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.52 129.68 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.739 0.649 . . . . 72.53 109.627 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 53' ' ' ILE . 71.1 t -84.23 130.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.508 0.723 . . . . 72.41 110.236 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.22 134.2 42.67 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.284 0.99 . . . . 63.2 113.602 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.63 -33.81 66.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.432 1.093 . . . . 74.13 110.474 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.05 -34.54 77.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.225 1.01 . . . . 62.4 111.913 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.465 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 25.4 pt -97.59 -5.78 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 118.925 -0.559 . . . . 64.51 112.096 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 45' ' ' ILE . 38.9 mm -65.58 103.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.215 -1.031 . . . . 71.35 108.215 171.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -85.72 -55.07 4.15 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.31 0.644 . . . . 63.15 109.618 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -148.99 143.4 26.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.987 -0.551 . . . . 73.53 110.526 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.65 118.46 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.332 1.053 . . . . 75.3 108.647 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -106.62 143.88 34.09 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.036 -1.098 . . . . 74.1 108.036 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.5 t -120.1 124.95 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.167 -1.049 . . . . 74.3 108.167 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -88.48 111.37 43.3 Favored Pre-proline 0 C--O 1.251 1.156 0 N-CA-C 108.143 -1.058 . . . . 71.13 108.143 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.2 151.39 49.09 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.862 2.375 . . . . 74.24 112.266 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.76 158.07 43.35 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.342 2.028 . . . . 61.32 112.164 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.99 -19.1 44.17 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.738 -0.479 . . . . 73.11 113.734 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -83.45 66.17 8.75 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.736 0.814 . . . . 73.34 109.844 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.6 -18.12 6.04 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 115.422 -0.808 . . . . 41.3 113.839 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -139.67 129.44 14.01 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.629 1.172 . . . . 70.41 108.563 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.25 32.91 0.45 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.003 2.469 . . . . 64.45 112.676 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.31 126.78 50.35 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.565 0.746 . . . . 74.52 110.773 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -88.61 121.35 30.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.714 0.805 . . . . 75.12 108.914 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -144.3 163.6 33.22 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.29 0.567 . . . . 65.34 110.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.4 t -121.41 104.16 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.576 1.15 . . . . 75.42 108.277 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.54 108.98 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.616 1.166 . . . . 71.53 108.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 26' ' ' ILE . 69.7 mt -107.91 134.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.562 -0.712 . . . . 75.02 110.391 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.17 124.89 48.55 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.831 1.252 . . . . 75.4 107.749 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -80.23 179.06 7.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.508 0.323 . . . . 71.51 110.302 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 52.5 mtmt -62.35 -28.63 69.89 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.264 0.554 . . . . 73.42 110.617 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 49' ' ' MET . 0.9 OUTLIER -86.28 7.05 26.89 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.748 1.219 . . . . 75.12 111.028 177.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 63.74 15.61 9.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.305 1.442 . . . . 74.13 111.793 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -72.68 128.46 35.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.789 -1.189 . . . . 74.13 107.789 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.83 118.5 35.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.033 -0.985 . . . . 73.23 109.051 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.595 HG22 HG22 ' A' ' 21' ' ' VAL . 7.2 pt -110.98 157.11 11.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.626 -1.25 . . . . 74.4 107.626 167.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.9 t -139.83 116.61 10.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.482 -0.933 . . . . 73.23 108.482 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 158.12 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 75.11 109.434 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.22 151.35 78.27 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.425 -0.583 . . . . 61.31 109.425 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.74 -16.41 37.18 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.262 2.641 . . . . 73.4 114.053 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -91.29 18.99 6.34 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.13 0.972 . . . . 75.54 112.386 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 128.07 34.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.152 -0.684 . . . . 71.11 109.152 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 11.1 mmpt? -66.99 -38.5 86.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.703 0.801 . . . . 71.53 112.584 -172.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -63.55 -33.24 75.15 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.131 0.491 . . . . 74.54 110.156 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.15 -31.15 43.91 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.057 -0.974 . . . . 74.31 110.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -31.95 73.14 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 110.143 -0.318 . . . . 73.44 110.143 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.7 -42.12 92.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.289 0.635 . . . . 74.41 110.199 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' O ' HG11 ' A' ' 69' ' ' VAL . 4.5 mm? -64.1 -42.7 96.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.444 0.698 . . . . 62.24 110.269 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.77 -31.64 72.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.241 0.617 . . . . 70.23 111.072 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -78.77 -27.04 44.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.1 0.96 . . . . 73.44 110.804 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -83.69 -29.27 27.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.252 0.621 . . . . 73.43 112.067 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 65' ' ' LEU . 24.4 m -70.45 -24.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 110.104 -0.332 . . . . 74.4 110.104 176.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.555 1.157 0 N-CA-C 107.441 -1.318 . . . . 60.42 107.441 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.04 0.448 . . . . 73.23 110.166 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.53 ' H ' ' HB2' ' A' ' 54' ' ' CYS . 23.1 t -87.34 31.29 0.74 Allowed 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 125.092 1.357 . . . . 75.11 111.212 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.06 -142.23 20.52 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.365 -0.294 . . . . 54.12 112.365 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.03 133.38 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.644 -1.243 . . . . 73.33 107.644 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.7 pp -125.52 150.43 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 122.862 0.465 . . . . 74.32 111.424 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -97.32 2.21 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.285 1.034 . . . . 70.3 110.982 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 m -74.9 98.08 3.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.251 0.62 . . . . 61.11 109.523 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.66 109.69 6.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.124 -1.436 . . . . 73.21 107.124 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.1 t -100.39 139.41 21.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.429 0.691 . . . . 72.2 109.987 -173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.77 136.8 38.65 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 124.015 0.822 . . . . 75.24 112.565 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 64' ' ' ARG . 10.8 mp -60.89 -29.41 69.55 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.936 0.894 . . . . 71.51 110.542 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.61 -33.19 67.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.327 1.451 . . . . 74.42 112.794 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.559 HG21 ' HE2' ' A' ' 48' ' ' LYS . 43.4 pt -110.21 7.46 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.519 0.328 . . . . 73.24 111.869 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD13 HG21 ' A' ' 45' ' ' ILE . 39.5 mm -73.86 111.48 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.393 -0.966 . . . . 74.04 108.393 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.2 -56.66 3.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.484 0.713 . . . . 74.51 110.652 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -153.58 138.26 16.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 63.12 109.856 -174.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.7 128.8 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.122 -1.066 . . . . 75.45 108.122 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.583 ' HB2' HG22 ' A' ' 44' ' ' VAL . 19.4 mt-30 -116.88 138.99 51.15 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.632 -0.877 . . . . 74.13 108.632 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.69 119.24 49.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.683 -0.858 . . . . 71.23 108.683 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.7 p -101.37 112.76 65.54 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.423 -0.954 . . . . 72.54 108.423 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.63 161.05 47.43 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.373 2.715 . . . . 73.22 112.677 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 119.72 6.14 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.526 2.151 . . . . 74.15 111.453 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.74 -39.08 1.24 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 116.131 -0.486 . . . . 74.54 112.231 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -77.22 77.99 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.219 0.607 . . . . 75.03 110.144 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.68 14.51 55.22 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.17 -0.468 . . . . 60.54 113.872 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.89 133.79 15.59 Favored Pre-proline 0 C--N 1.356 0.881 0 C-N-CA 123.422 0.689 . . . . 72.41 110.161 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.94 -38.19 10.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.132 2.554 . . . . 55.24 112.914 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.563 ' HB2' ' HZ3' ' A' ' 40' ' ' LYS . 4.8 ttmp? -118.43 159.24 23.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.769 0.828 . . . . 72.42 110.491 -174.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -62.96 120.86 12.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.102 0.961 . . . . 72.32 109.9 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -108.55 117.55 34.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.501 0.72 . . . . 75.31 109.299 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.35 106.49 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.816 0.846 . . . . 75.32 109.423 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 30' ' ' GLN . 5.8 m -104.71 125.33 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.046 0.539 . . . . 71.22 109.789 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 26' ' ' ILE . 46.3 mt -114.37 120.11 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.728 0.811 . . . . 74.44 108.978 -175.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.401 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 66.9 m95 -86.57 128.25 34.97 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.236 1.014 . . . . 75.4 108.484 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.401 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 47.6 p -83.62 179.68 7.55 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.328 0.651 . . . . 74.41 110.17 172.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HE2' HG21 ' A' ' 25' ' ' ILE . 41.8 mtmt -66.2 -29.67 69.98 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.394 0.278 . . . . 64.23 111.065 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -77.09 -7.3 55.5 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.501 0.72 . . . . 71.21 110.294 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 70.04 23.51 5.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 125.934 1.694 . . . . 75.15 111.408 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 8.2 tmtm? -75.01 123.69 25.62 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.278 -1.378 . . . . 74.32 107.278 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.19 126.58 43.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.342 0.657 . . . . 75.32 109.422 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 17' ' ' ILE . 46.6 pt -117.64 157.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.479 -1.304 . . . . 75.43 107.479 170.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.53 ' HB2' ' H ' ' A' ' 14' ' ' SER . 13.4 t -133.93 134.15 42.27 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.203 0.456 . . . . 63.21 109.939 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' HE1' ' A' ' 61' ' ' TRP . 31.0 m -133.95 164.94 33.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 C-N-CA 124.344 1.058 . . . . 73.42 109.598 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -81.57 159.16 67.46 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.367 -1.288 . . . . 65.0 109.846 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.68 -12.95 37.97 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.928 2.419 . . . . 74.21 112.028 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -83.52 -8.65 59.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.811 0.844 . . . . 73.04 111.432 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.87 132.37 49.23 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.735 0.814 . . . . 75.34 112.161 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.2 -36.45 69.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 74.23 112.491 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.665 ' HE1' HG11 ' A' ' 55' ' ' VAL . 7.7 p-90 -74.75 -23.15 58.51 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.565 0.346 . . . . 74.42 110.368 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.81 -28.5 69.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.097 0.959 . . . . 74.34 110.59 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.77 -34.78 73.44 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.632 0.773 . . . . 74.54 110.571 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HB3' HD23 ' A' ' 23' ' ' LEU . 95.5 mtt180 -66.95 -39.49 87.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.572 0.749 . . . . 72.23 111.009 176.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.1 -38.08 72.36 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.544 0.738 . . . . 74.32 110.858 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.53 -49.66 57.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.611 -0.722 . . . . 70.31 109.682 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -67.62 -24.03 65.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.588 -0.733 . . . . 75.22 111.315 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.658 0.783 . . . . 64.14 111.119 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.89 -29.78 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 122.723 0.409 . . . . 65.14 111.039 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 123.467 0.707 . . . . 70.24 110.45 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 110.056 -0.35 . . . . 73.3 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.9 m -99.18 -6.91 27.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.288 0.635 . . . . 64.41 111.255 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.92 165.23 10.18 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 111.521 -0.632 . . . . 74.23 111.521 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.228 -1.026 . . . . 75.35 108.228 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.87 143.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.062 0.458 . . . . 74.4 110.581 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -100.5 -57.1 2.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.016 0.926 . . . . 72.34 108.733 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -67.32 127.54 33.04 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.814 0.846 . . . . 74.13 110.45 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.89 139.47 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 124.007 0.817 . . . . 74.22 110.668 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.97 144.66 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.361 1.064 . . . . 74.24 109.949 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.64 135.62 25.22 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.561 0.538 . . . . 73.01 114.253 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.71 -18.76 63.05 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.176 0.99 . . . . 63.11 111.578 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -59.52 -35.79 74.86 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.413 1.085 . . . . 72.15 111.746 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.85 -1.92 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 119.324 -0.37 . . . . 75.42 111.793 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 45' ' ' ILE . 50.2 mm -78.37 124.62 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.963 -0.755 . . . . 64.03 108.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.13 -57.15 2.08 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.172 0.589 . . . . 71.22 110.26 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -142.99 153.81 43.37 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.142 0.977 . . . . 75.53 109.519 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.03 113.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.747 0.819 . . . . 74.42 109.103 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -96.93 106.66 19.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.652 0.781 . . . . 64.02 109.139 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.89 117.73 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.033 -0.729 . . . . 71.11 109.033 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.4 m -89.47 112.68 53.02 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.701 0.8 . . . . 72.42 108.949 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.63 152.48 64.83 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.08 1.853 . . . . 75.45 111.999 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.79 109.38 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.828 2.352 . . . . 75.24 111.928 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.53 -27.79 0.96 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.868 -0.606 . . . . 41.23 112.181 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.36 68.88 10.62 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.748 0.819 . . . . 61.44 110.515 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.62 -3.79 40.02 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.338 -0.846 . . . . 62.53 114.145 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -132.89 125.55 19.28 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 124.233 1.013 . . . . 74.12 109.443 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.45 -17.79 30.1 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.498 2.132 . . . . 52.01 112.941 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -110.77 173.75 6.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.787 0.835 . . . . 72.12 110.165 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -85.43 113.82 22.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.867 -0.79 . . . . 75.04 108.867 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -101.74 111.13 23.27 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.21 -0.663 . . . . 74.2 109.21 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.3 t -92.63 99.81 10.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.328 -0.99 . . . . 73.33 108.328 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.11 107.02 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.093 -1.077 . . . . 74.5 108.093 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 53' ' ' ILE . 58.5 mt -98.1 128.74 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.507 0.723 . . . . 73.2 109.493 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -102.91 121.45 42.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.137 0.975 . . . . 74.42 108.712 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -80.95 170.66 15.98 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.695 0.398 . . . . 74.31 111.106 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -69.31 -12.32 61.56 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.89 0.876 . . . . 75.11 111.605 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 ptp -101.94 18.28 21.03 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.921 0.888 . . . . 71.33 110.302 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 61.6 7.48 1.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.381 1.473 . . . . 75.12 113.902 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -73.14 128.52 35.71 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.281 -1.007 . . . . 72.04 108.281 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.95 119.21 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.867 -1.06 . . . . 73.32 109.791 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 45' ' ' ILE . 23.9 pt -127.71 145.12 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.06 -1.089 . . . . 72.13 108.06 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.9 m -120.44 142.51 49.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.708 -0.479 . . . . 62.31 109.708 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG13 ' HE1' ' A' ' 61' ' ' TRP . 29.9 m -126.37 159.67 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 122.969 0.508 . . . . 74.05 109.712 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -74.96 146.32 82.42 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.085 -0.962 . . . . 74.35 109.476 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.87 -23.72 76.33 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.981 2.454 . . . . 72.53 113.1 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -106.23 22.91 14.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.714 0.806 . . . . 63.31 111.405 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.82 135.03 49.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.136 -0.69 . . . . 74.13 109.136 171.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.81 -39.53 90.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 71.51 111.703 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.545 ' HE1' HG13 ' A' ' 55' ' ' VAL . 2.4 p-90 -69.36 -30.16 68.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.77 0.428 . . . . 71.31 110.035 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.5 tp -68.27 -34.22 75.79 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.247 0.619 . . . . 74.4 110.838 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -57.19 -32.69 66.72 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.128 0.49 . . . . 72.41 110.976 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.31 -45.48 80.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.105 -0.952 . . . . 74.2 109.582 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.73 -42.99 97.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.834 . . . . 71.44 110.599 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.62 -49.16 74.37 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.963 0.79 . . . . 63.44 110.506 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -72.34 -27.11 62.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.308 0.485 . . . . 64.42 112.308 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.18 -42.12 47.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.361 0.664 . . . . 73.04 110.995 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.32 -28.24 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 116.389 -0.369 . . . . 73.42 110.493 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 N--CA 1.48 1.063 0 C-N-CA 123.187 0.595 . . . . 71.34 110.02 176.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.267 -0.642 . . . . 73.22 109.267 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 t -93.37 99.6 12.08 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.247 0.619 . . . . 73.22 109.43 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.03 -148.11 50.83 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.516 0.51 . . . . 42.42 113.152 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.21 129.12 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.365 -0.976 . . . . 73.32 108.365 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.8 pt -102.03 119.01 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.368 -0.604 . . . . 72.41 109.368 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 p -97.49 5.98 48.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.609 0.764 . . . . 74.44 110.833 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.9 m -77.69 127.67 32.82 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.882 0.873 . . . . 65.14 109.798 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.78 111.12 10.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 107.274 -1.38 . . . . 71.52 107.274 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.43 139.06 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.186 -0.915 . . . . 75.22 109.022 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 124.63 36.9 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.005 0.816 . . . . 54.51 112.496 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.32 -34.29 70.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.508 0.723 . . . . 72.45 109.491 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.84 -34.13 77.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.781 0.832 . . . . 74.14 111.681 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.4 pt -92.06 3.61 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.049 -0.407 . . . . 70.42 112.067 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 45' ' ' ILE . 35.3 mm -78.96 132.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 108.546 -0.909 . . . . 73.42 108.546 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.15 -56.03 2.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.218 0.607 . . . . 72.33 109.893 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -144.83 155.88 43.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.328 0.651 . . . . 72.04 110.974 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.408 HD12 ' HG ' ' A' ' 65' ' ' LEU . 68.1 mt -113.73 112.05 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.759 1.223 . . . . 74.41 108.058 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -103.69 127.36 51.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.799 -0.815 . . . . 72.04 108.799 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.26 120.6 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.371 0.668 . . . . 72.34 109.406 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.1 m -95.12 110.35 49.65 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.549 -0.908 . . . . 71.11 108.549 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.49 156.44 64.03 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.871 2.38 . . . . 71.42 112.638 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.11 165.3 21.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.383 2.055 . . . . 75.51 112.026 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.43 -51.9 4.63 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.496 -0.32 . . . . 64.15 112.425 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -76.55 80.68 3.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.946 0.898 . . . . 75.12 110.856 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.3 -15.14 9.49 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.657 -0.701 . . . . 43.0 114.66 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.91 132.96 23.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.89 5.74 6.13 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.665 2.243 . . . . 74.1 112.912 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.2 159.61 42.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.404 1.082 . . . . 75.12 109.52 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -80.78 114.31 19.58 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.267 -1.012 . . . . 70.02 108.267 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.27 117.22 33.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 72.42 109.733 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.67 102.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.706 -0.85 . . . . 72.15 108.706 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.1 t -92.05 108.53 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.874 -1.158 . . . . 74.51 107.874 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 26' ' ' ILE . 60.2 mt -94.56 138.02 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.155 -0.683 . . . . 71.45 109.155 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -104.58 119.91 40.09 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.268 -1.382 . . . . 70.32 107.268 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.3 p -77.09 168.63 19.76 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.331 0.395 . . . . 74.44 110.215 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -73.47 -10.87 60.17 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.114 0.566 . . . . 73.34 111.226 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.72 -5.34 58.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.584 1.154 . . . . 71.13 110.127 168.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.97 18.91 10.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.16 1.784 . . . . 74.4 112.234 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -79.03 133.74 36.8 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.755 -0.657 . . . . 74.45 109.913 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.01 117.77 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.47 -1.241 . . . . 75.54 108.46 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.4 pt -126.64 148.05 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.258 0.623 . . . . 75.4 109.478 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -111.85 130.96 55.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.171 -1.048 . . . . 54.1 108.171 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.03 165.6 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.31 0.644 . . . . 73.32 110.25 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -74.35 135.55 75.85 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.274 0.629 . . . . 74.01 109.885 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.69 -29.07 69.1 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.762 2.308 . . . . 71.13 112.831 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -88.76 4.57 47.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.698 0.799 . . . . 75.3 112.313 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.1 120.31 8.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.837 -0.431 . . . . 72.41 109.837 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.49 -36.73 74.22 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.241 1.016 . . . . 70.42 113.078 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -68.46 -31.59 70.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.234 0.614 . . . . 74.23 111.106 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.72 -37.75 65.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.095 0.958 . . . . 75.22 110.84 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -42.69 82.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.891 0.877 . . . . 72.51 112.565 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -71.4 -27.69 63.5 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 116.112 -0.495 . . . . 75.03 111.464 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HG ' HD12 ' A' ' 29' ' ' ILE . 33.5 tp -78.28 -25.83 46.85 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.494 0.718 . . . . 74.22 110.097 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.09 -28.61 54.58 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.73 0.812 . . . . 75.21 109.99 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -74.49 -31.12 62.09 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.591 0.356 . . . . 75.25 110.544 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.57 -37.36 85.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.237 0.615 . . . . 73.35 111.514 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.39 -12.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 116.096 -0.502 . . . . 64.53 111.104 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 CA--C 1.548 0.9 0 C-N-CA 123.678 0.791 . . . . 74.32 109.881 178.007 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.242 0.683 0 N-CA-C 107.732 -1.21 . . . . 75.53 107.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -81.46 73.4 8.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 64.32 110.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.71 -142.53 48.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.492 -0.776 . . . . 71.21 113.181 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.87 153.74 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.75 0.82 . . . . 73.43 109.264 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.3 pp -128.69 131.28 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.249 0.547 . . . . 72.31 109.875 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -89.93 -10.16 46.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.726 0.811 . . . . 55.53 111.596 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 m -64.19 127.21 30.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.709 0.803 . . . . 72.32 111.247 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.65 114.26 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 108.276 -1.009 . . . . 75.33 108.276 172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.53 127.0 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.468 0.707 . . . . 74.42 109.63 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.0 160.67 17.7 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.777 -0.647 . . . . 52.4 113.378 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.6 -33.82 68.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.012 1.325 . . . . 63.13 111.215 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -58.97 -32.22 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.044 0.938 . . . . 73.34 111.865 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.11 5.83 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 112.435 0.532 . . . . 72.12 112.435 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.619 HG13 HD11 ' A' ' 65' ' ' LEU . 21.7 mm -77.42 113.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.786 -0.82 . . . . 71.53 108.786 170.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.58 -55.97 3.73 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.697 -0.482 . . . . 62.21 109.697 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -157.34 143.62 17.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.673 0.789 . . . . 75.21 109.891 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.7 mt -120.88 139.73 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.276 1.03 . . . . 75.23 109.493 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.41 143.09 47.39 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.682 -0.858 . . . . 73.15 108.682 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.2 138.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 109.229 -0.656 . . . . 72.21 109.229 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.8 p -119.9 143.2 34.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 123.626 0.77 . . . . 71.24 109.279 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.77 163.45 26.27 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.077 2.518 . . . . 75.51 113.652 -170.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.94 130.04 14.01 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.435 2.09 . . . . 75.03 110.878 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.68 -162.01 30.03 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.356 -0.698 . . . . 74.31 111.356 -170.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.35 17.48 11.0 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.03 0.932 . . . . 72.24 111.451 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.44 41.21 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.674 -0.694 . . . . 73.31 112.828 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.5 m -85.06 135.75 39.15 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.763 0.825 . . . . 61.43 109.398 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.55 -63.34 0.19 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.994 2.463 . . . . 75.22 113.333 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.548 ' HZ2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -132.66 -177.27 4.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.323 -0.991 . . . . 74.43 108.323 179.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' THR . 24.2 m -57.59 110.13 0.83 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.806 -0.813 . . . . 61.41 108.806 166.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -104.33 119.39 38.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.959 -0.756 . . . . 71.11 108.959 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.45 102.48 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.885 -0.783 . . . . 75.24 108.885 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.61 134.35 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.553 -0.906 . . . . 72.44 108.553 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 61.8 mt -133.01 125.54 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.329 -0.619 . . . . 72.12 109.329 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.82 123.43 36.08 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.064 -1.087 . . . . 73.44 108.064 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.0 p -84.58 179.46 7.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.247 0.619 . . . . 74.24 110.87 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.93 -24.41 64.28 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.119 0.568 . . . . 71.22 111.809 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.528 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 25.0 ptp -90.93 12.4 19.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.271 0.628 . . . . 72.5 110.766 172.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.56 22.44 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.839 1.656 . . . . 73.23 112.461 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HB2' ' HG3' ' A' ' 49' ' ' MET . 2.0 tmtp? -74.75 123.77 25.56 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.622 -1.622 . . . . 74.55 106.622 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.34 121.53 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.301 1.041 . . . . 72.42 108.523 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.417 ' HB ' HG12 ' A' ' 17' ' ' ILE . 30.0 pt -125.56 147.51 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 108.522 -0.918 . . . . 73.13 108.522 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.35 118.42 25.02 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.813 -1.18 . . . . 74.13 107.813 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.88 164.57 21.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.582 0.753 . . . . 74.1 109.911 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.45 147.56 92.74 Favored Pre-proline 0 N--CA 1.474 0.744 0 O-C-N 123.936 0.773 . . . . 74.04 110.186 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.42 -9.19 19.26 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.981 2.454 . . . . 74.11 113.582 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -111.44 26.15 10.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.989 0.916 . . . . 74.3 111.952 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 131.46 44.06 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 108.643 -0.873 . . . . 74.55 108.643 168.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.23 -47.94 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 71.33 112.844 -167.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.9 -24.47 64.31 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.673 0.389 . . . . 74.23 111.849 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.02 -32.13 72.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.033 0.533 . . . . 75.51 110.237 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.72 -23.63 67.44 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.172 0.589 . . . . 71.55 111.476 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -69.58 -40.55 76.67 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.415 0.686 . . . . 73.14 110.3 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.619 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -71.33 -34.73 70.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.499 0.72 . . . . 73.53 110.26 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.15 -37.81 72.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.539 0.736 . . . . 72.42 110.012 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.85 -40.82 97.47 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.755 0.822 . . . . 75.23 109.96 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -59.12 -40.65 86.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.565 1.146 . . . . 64.31 112.056 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -85.93 -14.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 115.9 -0.591 . . . . 73.13 112.346 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 122.716 0.406 . . . . 71.34 111.783 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.237 0.446 0 CA-C-O 120.899 0.38 . . . . 63.43 110.431 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 t -83.8 -28.18 28.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.995 0.918 . . . . 65.23 110.611 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.63 174.89 15.73 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 109.849 -1.3 . . . . 71.13 109.849 -173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.3 m -101.76 147.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 117.273 0.537 . . . . 75.53 110.468 -173.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.95 131.98 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.853 -0.612 . . . . 74.22 109.531 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -85.73 -47.94 9.3 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.524 0.73 . . . . 72.43 110.017 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 122.26 28.2 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.011 0.924 . . . . 74.23 108.822 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -54.54 113.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.688 0.795 . . . . 73.13 111.502 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.77 141.6 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.691 -0.686 . . . . 75.22 109.98 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.19 131.23 32.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.674 0.609 . . . . 70.15 112.569 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.1 -33.13 68.77 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.159 0.984 . . . . 74.31 109.716 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.06 -34.48 77.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.203 1.001 . . . . 73.24 111.815 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -95.4 16.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 122.222 -0.299 . . . . 71.5 111.395 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 45' ' ' ILE . 50.4 mm -79.94 129.22 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.006 -0.738 . . . . 74.15 109.006 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -94.89 -56.13 2.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 64.24 110.535 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -156.03 142.47 18.52 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.737 -0.665 . . . . 72.12 109.414 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -108.82 138.13 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.392 1.077 . . . . 75.14 108.821 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -136.66 111.55 8.86 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.687 -0.857 . . . . 72.44 108.687 171.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.9 123.15 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.102 -0.703 . . . . 74.03 109.102 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.3 m -87.28 110.88 37.2 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.043 0.937 . . . . 71.44 109.241 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.41 154.14 55.75 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.911 2.407 . . . . 74.35 112.877 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.25 164.81 33.35 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.353 2.035 . . . . 63.43 112.235 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.49 4.8 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.144 -0.48 . . . . 73.43 112.712 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.51 88.94 0.35 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.271 1.028 . . . . 55.32 110.451 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.9 -18.54 3.87 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.067 0.841 . . . . 64.4 114.625 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.2 m -139.19 132.62 15.8 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 63.3 109.43 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.5 -9.97 20.25 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.734 2.289 . . . . 73.03 112.088 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 10.3 mmpt? -116.1 137.64 51.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.165 0.986 . . . . 73.43 110.248 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.5 m -69.19 138.48 54.11 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.725 0.81 . . . . 70.23 109.423 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.23 145.99 49.68 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.274 -1.01 . . . . 72.34 108.274 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.19 103.32 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.067 -1.086 . . . . 74.55 108.067 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.04 124.05 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.235 -1.024 . . . . 73.23 108.235 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 26' ' ' ILE . 66.8 mt -119.39 137.22 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 123.271 0.628 . . . . 60.32 110.002 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -91.62 131.93 36.68 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.923 -1.14 . . . . 75.01 107.923 166.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.5 p -86.43 172.07 10.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.368 0.667 . . . . 74.31 109.895 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -75.61 -7.61 54.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.372 0.669 . . . . 72.51 111.328 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.5 mtm -83.61 -7.09 59.58 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.942 0.897 . . . . 75.53 109.435 167.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 65.18 24.6 12.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.207 1.803 . . . . 74.33 110.536 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.46 125.97 32.84 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.737 -1.579 . . . . 73.14 106.737 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.53 122.85 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.101 -1.074 . . . . 75.44 108.101 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -127.19 155.89 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.648 -0.871 . . . . 73.02 108.648 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 39.6 m -111.63 151.19 29.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.91 -1.515 . . . . 64.45 106.91 165.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.06 129.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.602 -1.259 . . . . 71.31 107.602 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.478 HD21 ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -54.07 129.08 57.96 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.493 0.717 . . . . 65.11 109.734 176.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.02 -14.45 41.6 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.511 2.141 . . . . 63.01 113.59 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -85.91 3.89 39.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.081 0.552 . . . . 74.11 111.947 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 120.85 10.53 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 123.414 0.686 . . . . 61.13 109.747 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.23 -31.54 71.97 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.762 1.225 . . . . 74.22 112.082 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -79.51 -23.51 42.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.25 1.02 . . . . 73.32 111.418 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.96 -27.58 68.35 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.892 0.877 . . . . 71.53 111.347 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.1 -35.86 69.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.817 0.847 . . . . 75.53 111.545 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -69.0 -34.06 74.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.405 0.682 . . . . 74.22 110.57 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.4 mp -70.22 -41.7 73.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.248 -0.649 . . . . 62.33 109.248 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.77 -38.35 88.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.749 0.82 . . . . 75.35 110.516 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -63.72 -34.16 77.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.863 0.865 . . . . 74.31 110.785 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -71.98 -33.71 68.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.922 0.489 . . . . 72.3 110.619 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 65' ' ' LEU . 97.4 t -71.99 -30.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.348 0.659 . . . . 71.05 109.414 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 107.854 -1.165 . . . . 73.5 107.854 171.64 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 107.501 -1.296 . . . . 74.35 107.501 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 t -72.36 94.18 1.59 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.277 0.631 . . . . 61.42 111.08 -170.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.1 67.6 0.24 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.708 -0.557 . . . . 42.34 111.708 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.62 170.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.541 0.737 . . . . 71.03 110.882 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.53 147.42 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.37 0.668 . . . . 73.0 110.822 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.9 p -108.76 17.71 21.57 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.974 0.909 . . . . 64.12 110.679 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t -143.9 150.09 37.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.909 0.884 . . . . 73.31 109.176 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.02 130.49 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 108.99 -0.745 . . . . 75.45 108.99 168.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.34 147.22 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.525 -0.916 . . . . 74.33 108.525 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.44 118.99 10.42 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.568 0.543 . . . . 72.54 112.836 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.32 -34.49 73.89 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.686 0.794 . . . . 75.44 110.216 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.67 -32.36 73.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.831 0.852 . . . . 75.55 111.765 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.11 15.03 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 111.733 0.271 . . . . 73.34 111.733 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.72 122.88 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.989 -0.745 . . . . 60.44 108.989 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.69 -56.24 3.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.101 -0.703 . . . . 74.2 109.101 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -160.86 137.06 8.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.327 -0.851 . . . . 74.11 110.44 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.69 108.54 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 108.68 -0.859 . . . . 75.43 108.68 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -101.63 115.28 30.16 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.425 -0.954 . . . . 72.22 108.425 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -85.94 121.88 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 107.96 -1.126 . . . . 74.02 107.96 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 m -105.68 126.3 31.11 Favored Pre-proline 0 C--O 1.247 0.973 0 C-N-CA 123.572 0.749 . . . . 75.21 109.777 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.02 153.3 58.87 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.541 2.16 . . . . 75.32 112.219 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HB3' ' H ' ' A' ' 40' ' ' LYS . 11.1 Cg_endo -52.76 92.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.419 2.746 . . . . 73.15 114.109 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.4 14.52 10.07 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.334 -0.848 . . . . 75.43 111.487 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -73.23 -14.53 61.36 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.427 1.091 . . . . 74.43 111.124 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.03 -14.66 48.55 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.834 0.73 . . . . 61.14 111.289 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -131.54 156.73 79.73 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.335 1.454 . . . . 75.51 109.002 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.52 81.96 0.55 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.085 2.523 . . . . 74.31 112.325 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' H ' ' HB3' ' A' ' 34' ' ' PRO . 27.8 mmmt -142.77 121.26 12.44 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.946 0.898 . . . . 74.44 110.087 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 m -79.23 114.74 18.41 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.995 -1.113 . . . . 73.13 107.995 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -94.56 108.29 20.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.526 -0.916 . . . . 75.51 108.526 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.8 101.57 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.3 -1.0 . . . . 64.04 108.3 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.2 t -96.2 108.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.359 -0.837 . . . . 64.32 109.057 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.0 mt -104.75 121.92 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.925 -0.769 . . . . 74.41 108.925 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -95.23 131.71 40.99 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 124.175 0.99 . . . . 75.2 108.899 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.8 p -90.46 169.75 10.79 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 123.214 0.606 . . . . 73.13 110.278 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -73.37 -17.13 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.637 0.775 . . . . 74.1 110.891 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.7 mtt -79.86 6.72 10.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.482 0.713 . . . . 73.32 110.837 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 65.7 17.21 10.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.486 1.114 . . . . 75.05 111.877 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -91.8 130.28 37.6 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.357 -0.979 . . . . 75.34 108.357 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -85.92 128.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.207 -0.906 . . . . 71.45 109.84 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 45' ' ' ILE . 42.8 pt -128.53 156.08 40.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 108.013 -1.106 . . . . 72.12 108.013 167.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -133.07 136.02 45.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.962 -0.755 . . . . 70.32 108.962 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.43 163.57 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.507 0.723 . . . . 71.41 109.728 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -86.0 146.18 42.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.78 -1.1 . . . . 72.42 108.391 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.16 -10.06 24.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.074 2.516 . . . . 75.23 113.522 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -75.2 -12.54 60.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.139 0.576 . . . . 70.24 111.712 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.96 115.36 2.36 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.09 0.956 . . . . 72.24 110.573 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -66.32 -32.6 74.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.21 112.278 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.3 p-90 -70.92 -26.23 63.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.933 0.493 . . . . 75.34 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.4 -30.17 70.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 75.33 110.761 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -59.26 -27.07 65.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 63.13 111.399 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -62.63 -47.54 83.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.863 0.727 . . . . 75.4 110.037 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.3 mm? -69.84 -46.52 65.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.15 -0.932 . . . . 73.45 110.189 -177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.22 -46.16 90.72 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.1 0.875 . . . . 74.13 111.222 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -79.03 -18.35 53.71 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.965 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.26 -30.43 64.85 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.469 0.308 . . . . 75.22 110.473 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 65' ' ' LEU . 49.0 t -68.65 -23.62 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 109.805 -0.443 . . . . 72.42 109.805 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.901 0.858 . . . . 70.12 109.553 173.641 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.662 -0.495 . . . . 71.13 109.662 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 t -102.98 39.02 1.62 Allowed 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.343 -0.984 . . . . 65.24 108.343 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.18 -149.07 24.77 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.211 -0.904 . . . . 37.32 111.037 -171.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.56 170.08 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.911 0.884 . . . . 74.33 109.76 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 19' ' ' THR . 2.6 pp -81.82 150.64 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.283 0.563 . . . . 70.12 110.524 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.5 p -113.65 8.18 17.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.037 0.935 . . . . 63.03 111.435 171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.408 ' O ' HD12 ' A' ' 17' ' ' ILE . 41.0 m -136.71 129.7 30.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.913 0.885 . . . . 75.12 109.251 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.3 t -65.85 113.3 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.658 -0.867 . . . . 63.34 108.658 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -77.01 126.59 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.186 -0.915 . . . . 72.34 110.554 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.03 137.4 38.39 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.924 0.765 . . . . 62.33 113.596 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.3 -36.53 71.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.022 0.929 . . . . 75.13 110.39 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -61.82 -34.18 75.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.852 0.861 . . . . 72.24 111.98 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.52 -4.82 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 119.278 -0.392 . . . . 70.31 111.742 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.3 mm -68.51 114.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.832 -0.803 . . . . 73.34 108.832 171.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -89.81 -52.85 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.412 -0.588 . . . . 74.32 109.412 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.647 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 6.2 ptp180 -152.05 145.63 24.93 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.3 -0.409 . . . . 62.5 110.3 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.51 108.63 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.838 -1.171 . . . . 74.33 107.838 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -103.0 121.93 43.57 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.772 -0.825 . . . . 72.31 108.772 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.53 113.54 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.837 -1.171 . . . . 72.41 107.837 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -96.4 106.91 32.42 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 109.59 -0.522 . . . . 74.31 109.59 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.41 163.82 37.45 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.104 1.869 . . . . 74.35 111.522 174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 97.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.468 2.778 . . . . 74.52 112.98 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -92.22 0.09 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.413 -0.358 . . . . 63.14 113.164 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.77 79.34 6.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.384 0.673 . . . . 72.44 111.692 -170.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.32 -20.85 3.82 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.105 -0.952 . . . . 73.23 114.638 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.7 m -89.73 114.54 61.03 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 108.503 -0.925 . . . . 64.33 108.503 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HG2' ' HD2' ' A' ' 40' ' ' LYS . 89.9 Cg_endo -83.41 -6.54 10.93 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.614 2.209 . . . . 52.43 113.504 -175.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HD2' ' HG2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.87 172.09 12.05 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.084 0.954 . . . . 73.33 109.209 175.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.3 m -73.05 115.61 12.58 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.679 -0.692 . . . . 64.32 110.183 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -124.04 114.44 19.74 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.223 1.009 . . . . 70.12 108.479 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.43 104.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.923 0.489 . . . . 74.33 110.063 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG12 ' SG ' ' A' ' 54' ' ' CYS . 35.3 m -92.37 111.69 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.814 0.816 . . . . 75.22 109.238 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.71 134.53 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.264 0.626 . . . . 74.23 109.565 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 66.4 m95 -96.34 130.03 43.54 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.332 -0.988 . . . . 74.43 108.332 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 78.3 p -84.13 169.02 15.28 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.477 0.486 . . . . 73.04 109.704 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -21.47 66.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.178 0.591 . . . . 74.5 110.533 172.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.0 mtm -85.02 2.35 43.55 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.829 1.252 . . . . 75.42 110.915 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.86 38.57 11.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.895 1.678 . . . . 73.31 112.704 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -90.73 135.65 33.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.472 -1.24 . . . . 70.15 109.467 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -98.1 115.8 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.429 -0.952 . . . . 75.55 108.429 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 46.4 pt -119.16 149.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.291 0.636 . . . . 70.03 109.478 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 44' ' ' VAL . 92.6 m -115.07 117.83 31.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.391 0.676 . . . . 70.44 109.532 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.55 154.29 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.274 1.03 . . . . 73.44 108.877 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -77.21 148.26 77.66 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.874 0.47 . . . . 74.3 110.477 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -64.47 -13.67 39.86 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.879 2.386 . . . . 64.31 113.078 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -107.42 18.41 21.59 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.716 0.806 . . . . 71.53 111.871 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.84 123.21 19.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.851 -1.166 . . . . 74.31 107.851 167.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -56.25 -44.52 79.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.219 1.008 . . . . 74.31 112.19 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.0 p-90 -64.24 -38.16 90.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.814 0.445 . . . . 74.14 111.135 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.93 -33.65 76.06 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.559 0.744 . . . . 74.2 110.99 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -54.26 -38.61 66.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 72.03 111.132 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.48 -37.95 86.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.643 . . . . 74.43 110.372 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.81 -41.93 91.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.767 0.827 . . . . 73.44 109.924 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 -24.97 62.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.231 1.012 . . . . 73.44 110.984 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -83.46 -35.64 24.78 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.951 0.5 . . . . 55.31 109.844 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -75.88 -23.13 55.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.957 0.503 . . . . 74.35 111.626 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 p -77.22 -17.86 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 110.032 -0.359 . . . . 75.11 110.032 174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.35 -0.982 . . . . 75.33 108.35 168.457 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.237 0.409 0 N-CA-C 107.91 -1.145 . . . . 60.14 107.91 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -86.71 40.51 0.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.138 0.975 . . . . 65.4 111.188 -174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.21 165.65 12.82 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.826 -0.624 . . . . 74.42 112.284 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -100.0 168.61 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 109.282 -0.636 . . . . 73.41 109.282 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.92 138.15 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.129 0.572 . . . . 71.41 110.086 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -98.18 7.04 46.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.796 0.839 . . . . 73.23 109.638 172.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -118.28 128.61 54.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.293 1.037 . . . . 65.01 109.283 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.44 126.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 109.156 -0.683 . . . . 74.2 109.156 170.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.65 142.21 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 122.803 0.441 . . . . 71.5 110.167 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.66 135.82 15.95 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.268 -0.424 . . . . 41.01 112.35 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.35 -34.25 70.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.45 0.7 . . . . 72.02 109.962 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -62.25 -32.64 73.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.295 1.038 . . . . 65.24 112.309 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -98.42 4.18 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 111.905 0.335 . . . . 74.12 111.905 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 45' ' ' ILE . 32.7 mm -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.371 -0.603 . . . . 74.35 109.371 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.32 -57.95 2.1 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.796 -0.446 . . . . 55.25 109.796 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -145.9 144.37 30.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.043 0.937 . . . . 75.23 109.364 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -107.9 109.33 27.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.226 -1.027 . . . . 73.24 108.226 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -93.06 127.2 38.51 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.535 -0.913 . . . . 74.33 108.535 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.6 111.51 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 107.956 -1.127 . . . . 74.3 107.956 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 m -113.74 127.28 27.0 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 109.143 -0.688 . . . . 72.11 109.143 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.24 154.44 5.78 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.574 3.516 . . . . 74.41 114.159 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.97 -177.05 2.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.224 2.616 . . . . 71.32 113.63 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.13 76.55 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.018 -0.537 . . . . 52.53 113.288 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -90.51 72.35 6.91 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.465 -0.939 . . . . 62.45 108.465 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.42 -13.45 11.12 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.384 -0.676 . . . . 73.31 114.601 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.53 146.39 47.84 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.915 0.886 . . . . 71.22 109.874 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HD2' ' HZ1' ' A' ' 40' ' ' LYS . 5.3 Cg_exo -75.04 -7.56 19.23 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.239 2.626 . . . . 73.32 113.915 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HZ1' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mppt? -100.13 150.45 22.49 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.095 0.558 . . . . 71.41 109.994 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.9 m -67.57 134.16 50.74 Favored 'General case' 0 C--O 1.242 0.666 0 O-C-N 123.93 0.768 . . . . 75.12 109.757 170.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.88 119.79 28.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.099 -0.704 . . . . 74.11 109.099 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.77 103.5 15.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.265 -1.013 . . . . 63.15 108.265 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.22 114.56 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.779 -0.823 . . . . 73.34 108.779 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.61 HG23 HD13 ' A' ' 26' ' ' ILE . 54.7 mt -95.06 121.61 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.351 -0.611 . . . . 74.21 109.351 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -86.95 123.67 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.912 -1.144 . . . . 72.45 107.912 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.417 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 46.3 p -87.78 179.22 6.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.015 0.526 . . . . 71.5 111.016 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.76 -14.08 60.67 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.374 0.67 . . . . 72.21 111.737 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -94.5 0.94 55.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.551 0.74 . . . . 74.11 110.33 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.18 23.6 10.9 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.879 1.671 . . . . 73.51 112.909 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 50.1 tttp -71.52 123.81 23.25 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.877 -1.157 . . . . 63.22 107.877 169.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t -96.01 111.26 25.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.468 -1.308 . . . . 71.13 107.468 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.19 136.89 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.515 -0.92 . . . . 73.22 108.515 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.61 117.55 34.4 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.003 -1.11 . . . . 64.42 108.003 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.81 164.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 74.22 109.812 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.44 141.43 73.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.324 -0.621 . . . . 73.21 109.324 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.06 -23.95 78.44 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.782 2.321 . . . . 64.03 112.765 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.71 31.48 5.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.591 0.757 . . . . 71.11 110.663 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 126.06 27.39 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -68.68 -30.17 68.79 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.614 0.766 . . . . 73.15 112.936 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -74.1 -23.36 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.986 0.514 . . . . 70.14 111.603 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.97 -21.81 65.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.841 0.856 . . . . 74.2 110.631 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -58.18 -30.8 66.7 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.105 0.962 . . . . 75.4 111.522 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -65.59 -36.93 85.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.408 0.683 . . . . 75.23 110.708 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.62 -37.28 65.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.272 0.629 . . . . 75.12 109.687 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -67.55 -33.27 74.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.776 0.83 . . . . 74.13 110.51 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -74.65 -36.96 62.85 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.899 1.28 . . . . 75.3 110.552 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -69.32 -35.43 75.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.441 0.697 . . . . 74.43 111.038 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.98 -7.81 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 116.18 -0.464 . . . . 75.23 111.233 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.05 -0.722 . . . . 62.32 109.05 175.183 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.451 -0.574 . . . . 70.13 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -110.28 10.14 23.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.907 0.883 . . . . 54.22 109.915 174.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.69 -82.5 1.07 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.778 0.704 . . . . 71.04 111.415 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.85 168.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.536 1.134 . . . . 72.51 109.955 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.9 pt -123.75 144.07 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.805 -0.813 . . . . 75.34 108.805 167.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -77.24 -41.05 42.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.535 0.734 . . . . 64.15 111.328 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.5 p -81.85 144.71 30.82 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.223 1.009 . . . . 75.5 111.632 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.7 t -85.4 115.42 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.499 -0.926 . . . . 73.52 108.499 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.6 134.17 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.625 0.77 . . . . 65.14 109.523 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.13 140.07 30.51 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.762 0.664 . . . . 72.33 114.23 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.22 -37.15 71.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.996 0.918 . . . . 70.54 110.907 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.14 -21.63 60.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.404 0.682 . . . . 74.41 112.099 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.38 4.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 122.173 -0.329 . . . . 73.42 111.276 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 45' ' ' ILE . 47.2 mm -74.23 123.4 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.842 0.857 . . . . 74.12 108.94 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.28 -55.92 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.999 0.52 . . . . 74.11 110.604 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -149.4 136.21 19.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.912 0.485 . . . . 54.21 110.165 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.94 145.01 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.476 1.11 . . . . 74.03 109.296 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -136.55 126.11 25.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.182 0.993 . . . . 75.2 108.543 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.87 112.54 40.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.445 0.698 . . . . 73.33 109.293 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 22.4 m -87.59 123.63 69.1 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.515 0.726 . . . . 72.02 109.489 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.35 139.94 67.82 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.28 2.653 . . . . 73.5 113.789 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.78 99.99 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.292 2.662 . . . . 72.03 112.544 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.52 -45.74 0.26 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.985 -0.552 . . . . 44.23 112.207 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.03 75.01 9.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.578 0.751 . . . . 62.52 110.582 -173.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.67 26.7 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.709 0.643 . . . . 41.05 114.709 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -122.42 130.82 24.52 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.749 0.82 . . . . 73.23 108.957 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.48 -4.83 13.18 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.73 2.287 . . . . 73.55 113.352 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -123.06 161.56 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.83 0.852 . . . . 75.12 110.392 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.4 m -69.31 113.78 6.96 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.961 -0.755 . . . . 72.01 108.961 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 40.8 tt0 -96.49 130.44 43.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.351 0.66 . . . . 73.51 109.518 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.88 101.36 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.159 -1.052 . . . . 70.31 108.159 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -108.1 125.13 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.802 0.841 . . . . 72.15 109.037 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.57 HG23 HD12 ' A' ' 26' ' ' ILE . 63.2 mt -118.72 129.66 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.405 0.682 . . . . 72.55 109.829 -175.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -86.96 124.73 33.48 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.44 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 47.5 p -81.96 173.53 12.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.228 0.611 . . . . 62.42 109.573 172.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.66 -12.0 60.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.943 0.402 . . . . 73.34 110.919 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -85.98 1.91 48.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.939 0.896 . . . . 74.42 110.773 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 67.72 11.69 8.49 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.589 1.556 . . . . 65.32 111.618 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 5.1 ttmp? -73.45 126.02 29.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.991 -0.744 . . . . 73.33 108.991 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.07 102.51 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.476 -1.305 . . . . 74.42 107.476 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.6 pt -98.92 154.01 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.361 -0.978 . . . . 74.32 108.361 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 t -135.46 128.79 32.11 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.948 -1.13 . . . . 63.21 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.3 160.11 29.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 123.919 0.888 . . . . 75.34 109.51 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.491 HD21 ' N ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.6 148.32 65.51 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.109 -1.071 . . . . 75.24 108.109 173.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.59 -28.19 64.02 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.76 2.306 . . . . 75.4 113.997 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -90.5 2.58 55.59 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.42 0.526 . . . . 72.51 112.42 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.31 30.84 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.796 0.839 . . . . 65.51 112.277 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -50.64 37.87 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.391 1.476 . . . . 74.43 112.334 -162.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -76.2 -20.19 57.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.046 0.139 . . . . 75.52 111.182 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.82 -28.67 69.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.461 0.705 . . . . 71.03 110.174 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -61.7 -19.05 61.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.708 . . . . 54.31 112.428 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -71.8 -38.02 70.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.994 0.517 . . . . 74.22 109.75 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.55 -37.05 65.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.764 0.826 . . . . 71.51 109.124 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -71.35 -29.54 65.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.233 -0.894 . . . . 71.14 110.875 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -81.47 -34.54 31.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.055 0.542 . . . . 73.04 110.794 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -67.83 -31.99 72.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.186 0.594 . . . . 75.13 111.001 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.99 -6.28 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.091 0.472 . . . . 74.32 110.873 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 N--CA 1.474 0.765 0 C-N-CA 124.015 0.926 . . . . 73.42 110.884 176.146 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.6 pt . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 121.479 0.657 . . . . 75.4 110.55 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.32 142.33 50.45 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.963 -0.562 . . . . 62.25 109.678 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 170.43 8.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.01 0.924 . . . . 73.05 109.146 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.63 99.35 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.666 0.787 . . . . 72.43 111.203 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -82.52 127.38 33.27 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.424 -0.807 . . . . 74.42 109.81 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -75.54 143.59 42.36 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.255 -1.017 . . . . 75.22 108.255 168.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -141.55 163.41 32.99 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.766 0.826 . . . . 74.13 109.562 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -67.76 136.97 55.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.052 -0.722 . . . . 72.13 109.052 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -152.0 163.85 38.41 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.759 -0.83 . . . . 72.22 108.759 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -141.62 -179.6 6.26 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.571 0.748 . . . . 72.13 110.403 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.1 p -64.65 114.96 4.77 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.319 -0.855 . . . . 60.43 109.642 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -73.27 120.53 19.02 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.394 -0.595 . . . . 75.13 109.394 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 14' ' ' SER . 47.1 t -81.03 168.13 19.01 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.626 0.77 . . . . 71.51 110.143 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 p -53.83 -47.14 71.21 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.427 -0.806 . . . . 73.02 110.235 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.34 168.1 40.71 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 115.835 -0.62 . . . . 73.05 113.298 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 172.41 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.688 1.195 . . . . 74.31 109.403 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -124.05 147.65 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.24 0.543 . . . . 72.25 111.496 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 p -97.52 -14.55 21.02 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.117 0.967 . . . . 75.43 111.219 168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.3 m -99.24 143.28 29.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.89 0.876 . . . . 73.31 109.753 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.22 122.96 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.63 -0.878 . . . . 71.31 108.63 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.82 136.82 24.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 115.993 -0.549 . . . . 70.54 109.577 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 121.88 27.21 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.659 0.6 . . . . 72.32 112.477 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.49 -31.03 61.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.713 1.205 . . . . 75.14 110.777 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.58 -31.9 53.37 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.67 0.788 . . . . 73.44 111.373 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 pt -90.59 8.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 111.579 0.215 . . . . 71.24 111.579 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.55 HG13 HD12 ' A' ' 65' ' ' LEU . 29.8 mm -75.64 136.81 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.422 -0.955 . . . . 75.4 108.422 173.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' HA ' ' HZ3' ' A' ' 48' ' ' LYS . 35.5 t70 -106.76 -55.44 2.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.948 0.499 . . . . 74.33 109.966 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 24.4 ptt180 -147.6 159.15 44.09 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.489 0.662 . . . . 74.22 110.769 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -111.53 110.76 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.23 -1.35 . . . . 74.1 108.741 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 26.7 tt0 -100.98 142.58 32.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.482 1.113 . . . . 72.41 108.125 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -112.74 136.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 122.882 0.473 . . . . 74.51 110.725 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.7 m -114.37 97.09 45.12 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.605 -0.887 . . . . 73.32 108.605 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' HG23 ' A' ' 41' ' ' THR . 72.5 Cg_endo -73.39 167.24 27.8 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 122.428 2.085 . . . . 73.33 112.748 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 148.48 93.07 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.466 2.111 . . . . 63.13 112.194 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 -16.52 55.09 Favored Glycine 0 N--CA 1.474 1.218 0 CA-C-N 116.52 -0.309 . . . . 74.22 112.752 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 22.32 1.71 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.982 0.913 . . . . 73.45 111.103 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.97 -5.89 84.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.04 -0.424 . . . . 42.13 112.04 -166.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 m -99.02 116.78 65.05 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.34 1.056 . . . . 75.32 109.497 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.26 -20.09 49.56 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.429 2.086 . . . . 53.03 111.558 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 10.3 mmpt? -125.48 145.82 49.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.653 1.181 . . . . 73.03 110.089 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 33' ' ' PRO . 9.0 m -72.61 115.52 11.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.362 -0.977 . . . . 75.12 108.362 172.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -120.08 140.43 51.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.1 0.409 . . . . 72.15 110.865 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.0 t -91.09 120.51 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.923 0.889 . . . . 70.22 110.145 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' SG ' ' A' ' 54' ' ' CYS . 57.8 t -91.14 117.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.854 0.861 . . . . 75.42 108.814 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.12 128.68 44.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.633 -0.506 . . . . 74.43 109.633 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.551 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 50.0 m95 -104.64 116.28 31.78 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.452 -1.684 . . . . 72.43 106.452 166.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.46 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 41.8 p -87.19 172.14 10.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.959 0.409 . . . . 75.21 111.273 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HZ3' ' HA ' ' A' ' 27' ' ' ASP . 41.6 mmtm -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.895 0.878 . . . . 65.11 111.033 173.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 mpt? -83.72 -0.84 52.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.025 0.93 . . . . 73.13 111.246 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.67 19.37 9.77 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.183 1.393 . . . . 74.31 111.634 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 21.7 ttmm -72.05 124.96 26.06 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.73 -0.841 . . . . 74.3 108.73 172.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.31 113.35 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.222 1.009 . . . . 72.22 108.32 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.26 154.48 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.895 0.878 . . . . 64.3 109.398 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.536 ' SG ' HG22 ' A' ' 44' ' ' VAL . 24.2 m -116.93 117.95 31.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.385 -0.968 . . . . 72.22 108.385 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.11 160.33 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.814 0.846 . . . . 75.51 109.512 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -62.94 133.64 95.4 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.043 0.537 . . . . 65.22 110.273 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 -32.87 59.32 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.825 2.35 . . . . 74.24 112.414 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -100.82 25.26 8.14 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.577 -0.738 . . . . 73.22 111.477 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.06 131.86 47.67 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.287 -0.635 . . . . 75.41 109.287 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -57.65 -34.03 68.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.857 1.263 . . . . 74.31 112.927 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -78.57 -34.43 46.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.39 0.676 . . . . 74.33 111.648 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -70.59 -20.62 62.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.661 0.784 . . . . 72.4 111.457 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -51.99 -37.6 53.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.851 0.86 . . . . 73.3 111.706 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -72.38 -29.65 63.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 73.41 111.317 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.55 HD12 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -73.55 -38.33 65.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 74.03 109.71 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.63 -29.39 65.75 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.737 0.815 . . . . 74.04 110.427 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -81.13 -23.43 38.35 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.634 0.774 . . . . 74.41 110.805 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.13 -37.56 66.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.272 0.629 . . . . 73.35 111.28 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.79 -29.7 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.562 0.345 . . . . 74.25 111.919 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -95.26 159.46 15.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.114 0.566 . . . . 72.33 109.527 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.5 t -74.25 139.89 44.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.127 -0.488 . . . . 71.43 110.012 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.3 -55.4 3.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.069 -0.715 . . . . 72.14 109.069 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.1 t -167.74 -172.09 1.78 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.07 0.948 . . . . 75.13 109.021 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 tt -153.51 135.24 14.49 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.978 -0.749 . . . . 71.32 108.978 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 t -148.2 148.03 30.08 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.443 0.697 . . . . 70.4 109.545 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.9 p -153.21 148.1 26.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.61 0.764 . . . . 70.43 109.71 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -112.64 92.02 18.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.858 0.863 . . . . 75.04 110.615 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.35 110.21 2.2 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.539 2.159 . . . . 72.53 111.317 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -148.98 135.52 19.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.423 0.689 . . . . 74.14 109.315 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.99 134.29 78.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.289 -0.862 . . . . 74.43 109.222 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.85 103.51 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.276 1.984 . . . . 75.24 111.813 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.7 85.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 122.706 1.241 . . . . 74.14 110.044 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 t -93.74 88.16 5.71 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.541 -1.209 . . . . 74.32 108.218 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -79.73 73.0 6.46 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.427 0.691 . . . . 74.23 109.904 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -65.17 118.13 8.78 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.966 -0.753 . . . . 74.43 108.966 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -158.9 96.67 1.36 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.828 -0.624 . . . . 74.31 109.393 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.12 -39.78 15.24 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.694 -0.685 . . . . 74.12 109.488 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.979 0 C-N-CA 125.395 1.478 . . . . 64.22 108.172 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.359 -0.608 . . . . 73.13 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.0 149.91 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.346 1.058 . . . . 73.45 108.697 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 136.94 33.83 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.897 -0.779 . . . . 70.4 108.897 175.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.31 114.15 8.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.187 -0.671 . . . . 73.1 109.187 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.92 97.41 6.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.944 0.498 . . . . 74.42 110.088 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -75.84 96.54 3.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.44 -0.8 . . . . 74.44 109.212 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -64.31 101.36 0.42 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.977 0.911 . . . . 71.53 111.636 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -99.0 93.68 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.069 -0.715 . . . . 63.43 109.069 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.98 97.87 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.747 -0.661 . . . . 73.32 110.659 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -156.95 -178.23 7.21 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.216 -1.031 . . . . 72.13 108.216 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.9 m -69.96 114.42 8.12 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.637 -0.875 . . . . 73.55 108.637 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -79.39 118.85 21.66 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.909 -0.774 . . . . 65.2 108.909 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.17 110.76 23.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.835 -1.172 . . . . 53.33 107.835 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.5 p -55.31 -28.22 52.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.243 1.017 . . . . 64.14 111.866 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.16 161.94 15.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.093 -1.203 . . . . 62.04 110.093 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.2 m -102.81 143.24 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.21 -1.033 . . . . 73.43 108.21 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.9 pt -99.87 139.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.599 -0.728 . . . . 74.53 110.439 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m -103.48 7.54 37.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.908 0.883 . . . . 61.42 111.105 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 m -74.37 137.86 43.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.557 0.743 . . . . 74.3 110.321 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -73.05 111.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.102 -1.073 . . . . 64.14 108.102 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -114.27 128.2 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.958 0.903 . . . . 70.32 109.225 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.99 162.79 16.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.096 -0.502 . . . . 60.03 112.712 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.33 -21.99 60.61 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.824 0.85 . . . . 71.44 111.469 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -53.55 -30.72 43.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 73.23 112.038 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.503 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 36.1 pt -119.8 -3.46 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 71.41 113.044 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.58 135.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 118.749 0.704 . . . . 75.12 109.704 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.91 -56.86 2.35 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.241 0.616 . . . . 74.02 110.411 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -143.42 147.55 34.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.566 0.746 . . . . 65.23 109.746 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.8 mt -108.16 112.33 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.928 -1.138 . . . . 71.42 107.928 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.16 104.42 14.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.097 -0.705 . . . . 73.35 109.097 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.85 140.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.922 -0.77 . . . . 73.24 108.922 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -111.99 92.9 19.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.793 -0.818 . . . . 73.33 108.793 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.74 149.87 38.93 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.365 2.71 . . . . 74.1 113.089 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 90.0 Cg_endo -74.36 2.26 6.45 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.719 2.28 . . . . 73.43 114.166 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.72 47.53 3.59 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 112.196 -0.362 . . . . 73.02 112.196 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -144.21 5.22 1.27 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.597 1.159 . . . . 74.32 110.683 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.95 44.79 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.675 -0.514 . . . . 73.32 112.739 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 28.6 m -82.68 126.61 72.88 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 108.595 -0.891 . . . . 75.42 108.595 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.61 -42.79 44.08 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.652 2.235 . . . . 62.21 113.565 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.92 164.56 12.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.22 0.608 . . . . 71.03 110.238 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 12.7 t -86.1 128.46 34.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.459 -0.941 . . . . 74.01 108.459 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -108.21 119.07 38.44 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.616 -0.513 . . . . 60.22 109.616 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.52 102.34 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.696 -0.483 . . . . 75.24 109.696 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -99.45 107.52 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.0 -1.111 . . . . 74.41 108.0 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -103.9 133.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.404 -0.591 . . . . 71.41 109.404 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -102.79 130.0 49.63 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.615 1.166 . . . . 74.22 108.422 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.5 p -87.07 176.89 7.39 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.388 0.675 . . . . 73.12 110.52 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 41.4 mtmt -71.58 -24.48 61.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.077 0.551 . . . . 72.53 110.726 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.76 -2.66 37.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.175 0.99 . . . . 74.1 110.569 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 68.84 14.64 8.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.462 1.505 . . . . 74.21 110.826 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.17 131.78 39.58 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.856 -1.164 . . . . 75.31 107.856 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.22 121.28 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.344 -0.844 . . . . 74.52 109.817 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -119.01 134.0 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.805 -0.813 . . . . 74.03 108.805 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 44.4 t -110.92 126.24 54.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.862 0.865 . . . . 74.04 109.568 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.42 164.29 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.218 1.007 . . . . 73.43 109.394 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.27 161.3 55.03 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 115.137 -0.938 . . . . 64.42 110.052 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.4 -18.19 63.49 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.84 2.36 . . . . 75.53 112.748 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.07 25.51 7.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.8 0.84 . . . . 75.35 110.62 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 136.09 36.11 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.85 0.46 . . . . 53.25 110.363 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.21 -50.52 71.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.008 0.923 . . . . 73.02 112.748 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -66.86 -28.69 68.54 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.881 0.472 . . . . 71.3 110.948 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.2 tp -67.25 -30.3 70.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.216 1.006 . . . . 75.12 111.683 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -54.17 -35.92 62.82 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.764 0.826 . . . . 73.11 111.63 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.24 -42.22 84.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.103 -0.953 . . . . 73.3 109.651 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.86 -32.37 72.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.406 1.082 . . . . 74.12 110.443 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -38.57 79.47 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.444 0.698 . . . . 72.43 110.178 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -68.96 -37.73 79.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.324 -0.25 . . . . 65.23 110.324 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.54 -37.98 86.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.012 0.525 . . . . 65.01 112.15 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.16 -11.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-O 120.927 0.394 . . . . 73.45 111.117 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -80.14 124.84 29.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.92 -0.771 . . . . 74.55 108.92 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.7 p -68.99 -2.66 10.43 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.128 0.971 . . . . 64.35 113.175 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 24.0 tptp -71.86 -34.57 69.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.435 0.694 . . . . 72.13 109.928 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.7 m -85.39 147.28 26.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.868 0.867 . . . . 75.12 110.878 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.0 tp -77.14 89.15 3.63 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.054 -0.721 . . . . 36.91 109.054 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.8 m -148.11 -158.84 0.95 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.461 -1.311 . . . . 75.53 107.461 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.7 t -70.38 92.39 0.8 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.305 -0.998 . . . . 72.54 108.305 167.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.3 p -73.35 119.08 73.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.703 0.801 . . . . 74.14 110.614 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -91.51 110.51 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.444 2.096 . . . . 72.42 110.826 165.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -49.0 129.55 17.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.873 0.869 . . . . 73.15 111.302 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -112.86 93.25 23.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.057 0.943 . . . . 73.3 108.905 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 80.37 0.88 Allowed 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.55 2.166 . . . . 73.02 111.26 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.8 p -152.06 162.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.468 1.107 . . . . 73.02 108.779 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.3 p -62.48 97.96 0.11 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 109.063 -0.718 . . . . 74.54 109.063 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -131.37 156.81 44.89 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.093 0.957 . . . . 72.42 108.955 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -75.42 93.9 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.843 -0.799 . . . . 75.14 108.843 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -60.18 140.16 57.12 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.932 -1.031 . . . . 75.44 109.758 171.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.82 26.72 14.43 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.962 0.905 . . . . 75.32 112.331 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' HB2' ' HE2' ' A' ' 72' ' ' LYS . . . . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.673 -0.679 . . . . 70.12 110.578 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 110.369 -0.234 . . . . 75.41 110.369 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.03 116.84 23.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.225 -1.028 . . . . 74.14 108.225 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -71.06 91.23 0.88 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 75.21 110.978 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.71 94.89 1.41 Allowed 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.612 -0.885 . . . . 61.34 108.612 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -66.96 117.61 9.28 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.973 0.909 . . . . 75.53 111.713 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -70.75 -9.73 57.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.092 0.957 . . . . 74.32 111.46 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 t -107.28 145.65 32.48 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.543 -0.91 . . . . 62.12 108.543 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -74.15 135.4 42.86 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 122.613 0.365 . . . . 61.02 110.059 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.79 89.14 1.8 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.343 -0.984 . . . . 74.21 108.343 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.71 160.74 31.1 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.835 -1.075 . . . . 73.33 110.744 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 m -71.65 107.14 4.35 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.73 121.05 37.04 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.514 -1.291 . . . . 73.31 107.514 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -118.4 166.16 13.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.025 0.53 . . . . 75.12 110.123 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -57.35 -31.08 65.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.19 0.996 . . . . 72.02 112.212 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.46 -173.34 15.97 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.46 -0.791 . . . . 75.11 111.562 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 55' ' ' VAL . 99.5 t -99.68 129.35 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.17 -1.048 . . . . 71.35 108.17 -175.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.455 HD11 HG23 ' A' ' 53' ' ' ILE . 37.9 pt -84.15 140.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 123.361 0.413 . . . . 72.0 110.228 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 p -90.39 -4.18 57.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.794 0.838 . . . . 72.42 111.446 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.9 m -88.41 142.84 27.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.598 0.759 . . . . 62.42 109.878 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.74 112.38 22.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.839 -1.171 . . . . 73.13 107.839 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -72.68 143.09 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.186 0.594 . . . . 72.05 110.556 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 123.27 30.18 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.83 0.706 . . . . 64.44 112.574 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD23 ' HG3' ' A' ' 64' ' ' ARG . 9.8 mp -67.41 -22.41 65.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.209 0.604 . . . . 75.45 111.428 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -74.43 -26.08 59.84 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.435 0.694 . . . . 74.52 111.683 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.487 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 47.8 pt -97.65 3.44 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 122.149 -0.344 . . . . 73.32 111.525 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 65' ' ' LEU . 27.5 mm -72.05 130.18 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 109.566 -0.531 . . . . 74.11 109.566 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -102.03 -59.43 1.7 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.452 0.701 . . . . 64.42 110.81 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -146.29 150.18 35.28 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.71 0.404 . . . . 75.21 110.684 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.24 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.115 0.966 . . . . 73.14 108.946 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -97.44 147.6 24.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.922 1.289 . . . . 75.25 109.101 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.17 142.9 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.677 -0.49 . . . . 75.32 109.677 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.2 m -121.78 109.78 33.89 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.992 0.917 . . . . 75.32 109.098 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.12 155.3 17.11 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.625 2.216 . . . . 53.51 113.085 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.1 173.66 14.06 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.733 2.289 . . . . 72.34 112.051 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 -26.13 8.66 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 116.775 -0.193 . . . . 74.42 113.384 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.8 23.49 3.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.135 0.974 . . . . 63.02 110.816 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.59 -19.53 44.63 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.905 -0.589 . . . . 65.21 112.235 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.8 m -80.46 119.3 75.93 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.034 0.417 . . . . 53.22 109.941 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.81 -22.7 74.92 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.13 2.553 . . . . 75.23 113.327 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 172.24 17.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.494 0.718 . . . . 75.15 109.713 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -75.04 133.86 41.53 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.131 -0.692 . . . . 73.22 109.131 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.84 124.97 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.081 0.467 . . . . 73.11 110.532 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.27 113.84 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.223 1.009 . . . . 72.12 109.1 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.76 109.68 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.417 -0.957 . . . . 71.02 108.417 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.9 mt -98.65 136.35 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.431 -0.581 . . . . 70.34 109.431 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -114.39 129.03 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.121 1.369 . . . . 73.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 p -90.46 172.22 8.87 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.777 0.431 . . . . 75.54 110.758 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 19.5 ptpt -69.16 -31.25 69.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.681 0.793 . . . . 64.24 111.133 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.1 ptm -78.42 4.62 12.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.89 0.876 . . . . 74.43 110.729 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 63.36 25.0 14.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.839 1.656 . . . . 73.41 112.14 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -76.5 128.57 35.02 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.276 -1.379 . . . . 64.33 107.276 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -100.56 131.0 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.66 1.184 . . . . 71.25 109.64 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 17' ' ' ILE . 32.2 pt -133.25 156.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.886 0.874 . . . . 72.03 108.672 171.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.1 p -137.15 122.48 19.4 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.128 -0.693 . . . . 64.03 109.128 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' HA ' HG22 ' A' ' 16' ' ' VAL . 35.6 m -126.4 150.95 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.382 0.673 . . . . 75.44 109.785 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.57 152.97 67.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.349 -0.611 . . . . 71.31 109.349 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.53 -4.87 6.11 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.018 2.479 . . . . 73.25 115.259 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -84.07 -11.63 56.38 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.096 0.559 . . . . 72.11 112.147 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 113.63 3.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.65 -0.87 . . . . 63.24 108.65 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 17.5 mtpp -77.72 -20.86 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.722 0.638 . . . . 74.53 112.722 -171.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -75.5 -14.91 60.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.376 0.27 . . . . 74.42 111.171 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.5 tp -70.52 -29.4 65.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.672 0.389 . . . . 73.23 110.041 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -64.45 -19.69 65.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.455 0.302 . . . . 72.22 111.754 175.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HG3' HD23 ' A' ' 23' ' ' LEU . 1.1 tpm_? -65.76 -44.11 86.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.942 0.497 . . . . 74.31 109.691 170.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 HD12 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -66.78 -41.27 87.95 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.826 0.85 . . . . 72.23 110.28 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.35 -36.63 81.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.425 0.69 . . . . 73.13 110.759 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.72 -29.08 56.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.399 0.68 . . . . 74.45 110.956 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -74.26 -51.12 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.373 0.669 . . . . 74.2 111.072 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.77 -34.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.988 0.515 . . . . 74.44 110.747 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -102.92 96.87 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.031 -1.1 . . . . 75.44 108.031 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 t -157.85 108.56 2.2 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.495 -1.298 . . . . 54.35 107.495 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -76.76 -17.97 58.74 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.001 0.92 . . . . 74.42 110.719 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.0 p -117.97 74.06 0.93 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.965 0.906 . . . . 62.04 109.758 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 tt -140.56 104.79 4.82 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.287 -1.005 . . . . 75.34 108.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.8 p -96.5 128.1 43.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.679 -0.859 . . . . 74.42 108.679 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 m -82.77 115.51 21.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.486 0.714 . . . . 65.11 110.36 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 p -63.28 135.84 96.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.407 0.683 . . . . 72.34 110.466 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.54 94.87 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.732 2.288 . . . . 71.21 112.338 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -103.83 136.4 43.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.523 -1.217 . . . . 74.52 108.427 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -136.69 100.55 10.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.191 0.596 . . . . 53.14 110.145 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.48 -174.64 2.07 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.131 1.887 . . . . 74.21 111.438 169.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.79 78.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.526 -1.287 . . . . 75.21 107.526 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 p -84.01 75.71 10.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.822 0.82 . . . . 64.12 110.453 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -151.43 148.8 28.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.745 -1.116 . . . . 75.53 108.52 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -130.13 171.53 12.75 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.135 0.974 . . . . 73.34 109.341 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -17.58 61.16 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 121.97 0.108 . . . . 74.32 110.807 173.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -50.56 20.78 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.092 0.557 . . . . 72.41 109.743 169.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 124.324 1.05 . . . . 53.51 108.79 178.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.858 -0.423 . . . . 73.25 109.858 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.7 tp -130.36 151.64 50.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.495 1.118 . . . . 75.34 108.362 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -115.18 140.42 49.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.688 . . . . 71.2 109.676 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.27 105.02 17.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.932 0.893 . . . . 64.4 109.006 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -76.49 82.37 3.19 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 74.11 110.062 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.5 151.96 51.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.94 0.896 . . . . 75.3 109.787 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -75.48 85.96 2.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.464 -0.939 . . . . 72.14 108.464 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -87.65 107.32 18.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.473 -0.785 . . . . 74.55 109.266 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.82 -12.4 58.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.259 1.024 . . . . 71.1 110.913 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -82.24 174.59 11.02 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.565 0.746 . . . . 74.11 110.25 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 p -79.14 114.88 18.44 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.334 -0.988 . . . . 64.2 108.334 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -78.17 135.49 37.64 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.031 0.443 . . . . 73.45 110.049 -177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.44 149.47 32.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.125 0.97 . . . . 72.41 109.495 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 t -100.0 10.7 40.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.218 0.607 . . . . 72.42 111.01 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 172.3 46.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.3 -0.72 . . . . 37.63 111.3 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 33.9 m -100.21 140.13 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 117.325 0.562 . . . . 71.41 109.895 -174.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.95 146.24 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.501 0.72 . . . . 72.1 110.705 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 p -92.87 -2.2 56.08 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.315 -0.857 . . . . 65.13 111.394 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.6 m -60.47 118.82 6.96 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.49 -0.559 . . . . 73.44 109.49 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.27 111.19 3.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.822 -0.807 . . . . 64.21 108.822 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.52 132.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.249 0.62 . . . . 75.2 109.4 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.51 145.56 27.9 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.998 -0.546 . . . . 71.23 112.501 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.16 -33.66 72.49 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.103 0.961 . . . . 71.14 110.513 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.8 -28.71 68.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.834 0.853 . . . . 75.24 111.62 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -103.92 12.42 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 111.931 0.345 . . . . 75.31 111.931 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 mm -76.9 122.24 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.196 -1.039 . . . . 64.32 108.196 169.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -90.06 -58.86 2.36 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.37 -0.604 . . . . 74.44 109.37 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -146.95 155.67 42.46 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.183 0.593 . . . . 74.21 109.749 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.8 mt -113.95 108.15 24.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.202 -1.036 . . . . 64.44 108.202 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -99.47 137.75 37.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.616 0.766 . . . . 73.55 108.968 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.15 129.24 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.3 -0.63 . . . . 73.43 109.3 172.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -106.98 115.18 60.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.855 0.862 . . . . 70.31 108.984 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.35 166.17 29.31 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.642 2.228 . . . . 71.41 111.724 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.73 84.09 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.434 2.089 . . . . 72.14 112.191 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.33 -179.48 39.77 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.676 -1.147 . . . . 70.13 110.677 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 65.42 18.89 11.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.636 1.174 . . . . 74.34 111.77 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.52 10.71 53.08 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 122.763 0.22 . . . . 60.52 113.568 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.36 117.43 33.09 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 108.059 -1.089 . . . . 64.54 108.059 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.4 5.86 5.79 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.566 2.178 . . . . 70.43 113.603 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -153.01 173.32 15.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.191 0.596 . . . . 73.41 110.776 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -86.8 121.29 29.1 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.55 -0.907 . . . . 72.01 108.55 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.9 134.51 45.78 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.052 0.541 . . . . 64.45 109.967 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 101.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.788 -0.819 . . . . 71.35 108.788 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.12 108.96 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.899 0.88 . . . . 74.53 109.262 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.5 mt -95.43 130.56 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.197 -0.668 . . . . 75.13 109.197 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -97.68 125.78 42.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.662 -1.607 . . . . 74.41 106.662 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.9 p -89.47 169.42 11.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.025 0.375 . . . . 64.42 110.531 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.9 -25.99 63.96 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.988 0.915 . . . . 71.34 111.519 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -80.39 1.67 28.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.888 0.875 . . . . 70.32 110.542 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.03 22.92 11.16 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.151 1.78 . . . . 65.31 112.162 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -79.95 123.78 28.1 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 106.664 -1.606 . . . . 74.34 106.664 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.19 124.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.844 -0.799 . . . . 72.12 108.844 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.2 pt -132.67 158.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.123 0.969 . . . . 75.21 109.265 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 55.6 m -120.37 149.94 41.54 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.107 -1.072 . . . . 73.45 108.107 167.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.92 163.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.416 0.687 . . . . 73.12 109.817 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.37 128.24 84.72 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.051 0.54 . . . . 64.25 110.098 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.53 -29.97 80.73 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.55 2.833 . . . . 75.55 113.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -89.09 16.98 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.424 0.69 . . . . 72.22 112.702 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 125.9 28.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.587 -0.894 . . . . 63.43 108.587 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.1 -37.36 81.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.675 0.79 . . . . 73.53 111.772 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 70.5 p-90 -63.49 -34.47 77.84 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.036 0.446 . . . . 74.32 110.474 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.11 -34.49 73.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.54 -0.754 . . . . 72.31 110.476 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.05 -38.95 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.708 0.803 . . . . 75.13 110.779 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -61.59 -48.43 80.99 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.86 -1.064 . . . . 74.41 110.072 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.44 -36.19 77.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.646 0.778 . . . . 63.44 111.025 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.95 -36.38 67.14 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.485 0.714 . . . . 71.4 110.637 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -75.36 -23.0 57.1 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.899 0.48 . . . . 74.53 110.284 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -67.1 -43.91 81.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.062 0.945 . . . . 71.32 110.716 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.9 m -90.78 -8.05 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 123.619 0.574 . . . . 75.13 112.045 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -79.11 167.46 21.0 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.379 0.672 . . . . 65.53 109.565 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -66.31 169.49 7.21 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.68 0.792 . . . . 54.33 111.203 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mttp 56.22 37.53 28.92 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.111 0.964 . . . . 71.44 110.929 -170.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 t -154.59 -161.47 1.22 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.558 1.143 . . . . 61.34 108.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 91.5 0.11 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.937 0.895 . . . . 71.42 110.055 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 p -101.83 129.5 48.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.328 -0.851 . . . . 71.22 109.394 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.0 p -79.0 -75.84 0.22 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.184 0.594 . . . . 75.13 110.858 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.7 p -90.57 120.25 68.95 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.381 0.672 . . . . 70.11 110.648 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.58 96.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.748 2.299 . . . . 73.24 111.334 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 50.5 tt0 -123.5 162.59 22.6 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.503 1.121 . . . . 74.31 108.646 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.11 98.13 5.23 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.081 0.953 . . . . 73.2 109.906 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 93.3 Cg_endo -87.05 142.65 6.51 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.857 2.371 . . . . 74.54 111.676 175.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.91 -19.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 123.442 0.697 . . . . 74.45 111.133 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 116.38 8.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.731 0.813 . . . . 64.13 109.803 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 10.4 mmpt? -67.74 133.29 49.02 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.745 0.818 . . . . 74.23 110.432 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -66.45 108.98 2.57 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.197 0.936 . . . . 75.32 109.795 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -65.6 103.51 0.87 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.63 71.73 10.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.711 0.804 . . . . 74.22 108.838 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 124.128 0.971 . . . . 73.42 108.738 -178.515 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.4 mt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 121.007 0.432 . . . . 71.12 109.875 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.66 106.45 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.757 -0.831 . . . . 73.22 108.757 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -88.04 97.66 11.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 75.1 110.087 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.94 10.09 2.06 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.411 1.084 . . . . 73.02 112.418 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -129.82 113.06 14.21 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.631 1.173 . . . . 62.22 108.963 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -84.59 103.2 13.5 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.406 -0.961 . . . . 72.32 108.406 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -71.83 90.27 1.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.705 0.764 . . . . 75.34 109.26 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.66 137.1 32.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.805 -1.089 . . . . 65.15 111.408 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -84.54 -32.08 24.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 75.23 109.561 169.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -66.01 153.69 41.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.469 0.708 . . . . 74.44 111.822 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' SG ' HG22 ' A' ' 32' ' ' THR . 32.4 m -78.04 116.06 18.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.246 -1.02 . . . . 74.25 108.246 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -84.44 125.1 32.04 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.775 0.321 . . . . 72.32 110.838 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.499 ' SG ' HG21 ' A' ' 44' ' ' VAL . 55.5 m -142.32 150.72 41.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.21 1.004 . . . . 74.43 110.202 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -82.81 -153.16 0.12 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.677 -0.692 . . . . 71.21 109.403 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.72 158.27 36.95 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-O 120.955 0.197 . . . . 75.35 112.853 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.98 146.8 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.215 -1.032 . . . . 70.14 108.215 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.29 145.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.223 0.535 . . . . 71.13 110.904 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -128.72 31.1 5.01 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.749 1.22 . . . . 64.34 108.289 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -140.57 142.21 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.708 1.203 . . . . 64.41 108.271 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.12 114.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.367 -0.605 . . . . 75.43 109.367 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.02 139.03 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.233 0.613 . . . . 74.15 109.583 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.92 131.81 11.0 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.796 0.685 . . . . 63.42 112.928 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' ND1' ' A' ' 68' ' ' HIS . 7.4 tt -54.46 -31.55 55.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.868 1.267 . . . . 74.1 110.747 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -58.35 -35.26 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.018 1.327 . . . . 72.4 112.445 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.4 pt -96.81 -6.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 119.098 -0.477 . . . . 71.41 111.46 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -75.01 130.26 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.221 -0.659 . . . . 74.34 109.221 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.86 -53.94 2.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.212 0.605 . . . . 55.2 109.562 174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -139.11 141.14 38.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.011 0.524 . . . . 73.41 110.188 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 90.1 mt -119.22 107.94 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.37 -1.344 . . . . 73.52 107.37 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -105.3 138.99 40.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.141 -1.059 . . . . 64.42 108.141 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -116.33 110.97 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.43 -0.952 . . . . 75.35 108.43 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.615 HG22 ' SG ' ' A' ' 11' ' ' CYS . 9.6 m -89.43 121.09 69.6 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.505 -0.554 . . . . 65.52 109.505 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.1 148.89 83.38 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.33 2.687 . . . . 72.11 113.636 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.86 100.57 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.886 2.391 . . . . 72.22 112.142 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.97 -5.52 4.71 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-N 115.478 -0.783 . . . . 71.13 112.31 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -89.68 41.08 1.02 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.686 0.795 . . . . 73.25 111.047 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -19.75 47.92 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.501 -0.772 . . . . 63.1 112.775 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.37 116.11 39.58 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.125 -1.435 . . . . 74.14 107.125 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.02 -39.02 40.63 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.932 3.088 . . . . 75.32 113.48 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -106.58 157.81 17.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.666 0.786 . . . . 71.44 109.297 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -61.07 115.7 3.96 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.939 0.774 . . . . 75.31 109.703 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -110.87 110.79 21.54 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.34 103.04 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.732 -0.84 . . . . 73.53 108.732 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 54' ' ' CYS . 44.5 t -90.27 108.12 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.7 -0.852 . . . . 71.35 108.7 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 ' HB ' HG13 ' A' ' 53' ' ' ILE . 62.3 mt -106.23 119.97 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.559 0.743 . . . . 73.14 109.133 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -94.71 124.86 38.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.117 -1.068 . . . . 75.25 108.117 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.8 p -84.81 163.68 18.93 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.906 -0.405 . . . . 52.31 109.906 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -71.61 -10.98 60.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.228 0.611 . . . . 71.5 111.512 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 ptp -90.81 4.79 50.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.54 0.736 . . . . 61.1 110.772 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 68.3 22.23 8.13 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.3 1.44 . . . . 74.41 112.648 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -84.74 128.95 34.86 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.538 -0.912 . . . . 75.12 108.538 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.45 114.02 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.643 -0.873 . . . . 73.44 108.643 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.484 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.8 pt -125.16 128.5 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.257 -1.016 . . . . 72.05 108.257 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 44' ' ' VAL . 94.9 m -120.74 138.0 54.21 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.152 -0.343 . . . . 64.22 110.469 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG13 ' HE1' ' A' ' 61' ' ' TRP . 28.5 m -130.43 167.05 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.913 0.885 . . . . 73.33 110.958 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -73.75 153.92 89.28 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 114.427 -1.26 . . . . 72.45 110.329 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.4 -28.54 71.46 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.909 2.406 . . . . 65.34 113.2 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -107.48 24.71 12.46 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.419 0.687 . . . . 73.43 111.672 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.24 124.32 21.87 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.398 -0.964 . . . . 50.21 108.398 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -70.83 -30.7 67.2 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.987 0.515 . . . . 71.32 111.502 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.474 ' O ' HD21 ' A' ' 65' ' ' LEU . 15.4 p-90 -64.34 -32.32 73.88 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.207 -0.664 . . . . 74.02 109.207 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.1 tp -73.29 -37.86 66.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.775 . . . . 75.12 110.555 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.11 -44.16 95.07 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.993 0.517 . . . . 75.52 111.177 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 61' ' ' TRP . 13.5 ptm180 -67.86 -31.59 71.51 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.917 0.487 . . . . 75.12 111.2 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 61' ' ' TRP . 2.6 mm? -59.71 -47.94 83.63 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.596 0.759 . . . . 73.14 110.044 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.66 -34.77 78.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.914 0.886 . . . . 71.24 111.664 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -69.78 -32.61 71.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.632 0.773 . . . . 63.12 110.641 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' ND1' HD13 ' A' ' 23' ' ' LEU . 29.7 t-80 -74.64 -30.6 61.69 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.03 0.532 . . . . 72.53 111.545 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 65' ' ' LEU . 80.6 t -64.76 -49.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 109.145 -0.687 . . . . 74.14 109.145 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -95.91 61.63 2.18 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.319 -0.993 . . . . 72.01 108.319 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -72.57 -27.72 62.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.209 -0.905 . . . . 72.4 109.43 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -86.16 117.87 25.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.949 . . . . 74.42 109.025 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.0 m -68.25 130.88 44.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.595 0.758 . . . . 72.41 110.887 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.8 tp 67.32 28.96 7.75 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.865 1.266 . . . . 72.01 111.107 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 t -86.72 121.56 29.4 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.945 -0.472 . . . . 64.04 110.299 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -114.57 25.79 10.73 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.28 1.032 . . . . 72.33 110.12 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 p -127.39 64.13 61.21 Favored Pre-proline 0 CA--C 1.56 1.345 0 C-N-CA 123.267 0.627 . . . . 72.32 110.997 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -86.31 145.01 8.23 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.188 1.925 . . . . 71.44 111.939 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -82.79 74.81 9.73 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.23 -1.026 . . . . 63.45 108.23 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.78 144.05 51.4 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.394 -1.275 . . . . 72.4 109.908 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 29' ' ' ILE . 65.4 Cg_endo -65.98 87.87 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.967 2.445 . . . . 73.33 112.493 -175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.1 m -81.43 -15.89 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 115.244 -0.889 . . . . 53.52 110.944 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -68.82 91.74 0.47 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.583 0.706 . . . . 75.24 109.99 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -85.75 75.49 10.06 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.491 -1.3 . . . . 73.21 107.491 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -122.22 98.53 5.97 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.307 -0.861 . . . . 74.53 110.276 -170.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -97.0 74.86 2.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.525 -0.761 . . . . 75.22 109.477 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.7 154.92 33.74 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.543 -0.753 . . . . 75.32 109.467 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 109.233 -0.655 . . . . 71.31 109.233 178.689 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.977 -0.379 . . . . 74.24 109.977 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.74 128.41 34.79 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.557 -0.534 . . . . 75.41 109.557 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.26 155.12 21.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 65.0 109.198 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.74 121.98 45.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.207 0.603 . . . . 55.54 110.102 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.35 84.4 5.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.084 0.553 . . . . 73.24 110.044 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -61.93 143.42 56.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.833 -1.076 . . . . 74.44 111.225 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.4 m -141.93 123.0 14.6 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.888 0.875 . . . . 73.51 109.16 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.87 150.22 47.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.35 0.66 . . . . 75.03 110.018 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.36 90.19 0.94 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.485 0.714 . . . . 73.14 111.358 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.64 171.67 9.85 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.648 0.779 . . . . 73.54 109.101 168.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.416 ' SG ' ' HB ' ' A' ' 32' ' ' THR . 74.1 m -75.69 113.03 12.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.411 -1.329 . . . . 73.41 107.411 168.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -71.77 120.87 17.98 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 120.953 0.406 . . . . 75.15 110.596 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.9 t -118.54 158.94 24.44 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.194 0.998 . . . . 63.44 109.851 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 p -104.26 -55.2 2.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.001 0.92 . . . . 71.54 109.364 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.18 167.96 35.7 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.247 -0.888 . . . . 73.22 111.186 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.26 156.44 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.257 0.528 . . . . 71.21 110.314 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.38 149.88 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 74.31 110.313 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -111.36 12.53 21.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.043 0.937 . . . . 73.41 110.764 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.0 m -93.93 144.44 25.45 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.746 0.818 . . . . 74.11 109.88 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.26 110.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.701 -1.222 . . . . 74.33 107.701 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.77 124.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.894 -0.78 . . . . 74.22 108.894 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 147.57 30.35 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.774 0.671 . . . . 71.22 113.859 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.45 -33.36 65.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.974 0.909 . . . . 72.55 110.486 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.25 -34.28 72.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.986 0.914 . . . . 55.45 112.241 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.9 pt -107.0 13.36 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.693 0.397 . . . . 72.24 111.776 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.4 129.27 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.627 -0.879 . . . . 73.52 108.627 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.92 -59.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.822 -0.436 . . . . 63.31 109.822 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 -143.74 139.65 29.56 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.397 0.679 . . . . 73.31 109.703 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -107.33 119.48 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.139 0.975 . . . . 71.1 109.638 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 44' ' ' VAL . 24.4 tp60 -105.68 135.24 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.321 -1.363 . . . . 74.32 107.321 170.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.11 127.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.621 -0.511 . . . . 64.23 109.621 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.416 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 29.9 p -118.08 103.6 49.63 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 108.836 -0.802 . . . . 72.13 108.836 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.75 170.42 12.69 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.438 2.758 . . . . 72.3 112.063 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.82 99.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.263 1.975 . . . . 71.53 111.408 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.83 164.52 29.09 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.591 -1.404 . . . . 37.96 109.591 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 66.09 19.43 11.16 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.307 1.051 . . . . 63.43 110.363 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.32 8.46 87.56 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.205 -0.907 . . . . 73.44 113.325 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.2 m -84.87 136.87 38.34 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.305 0.642 . . . . 71.44 109.667 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.31 -52.72 0.77 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.845 2.363 . . . . 74.13 114.206 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -135.04 177.4 7.84 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.261 1.025 . . . . 63.45 109.647 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -67.17 110.37 3.44 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.203 -0.666 . . . . 74.25 109.203 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -111.41 112.5 24.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.714 1.206 . . . . 75.22 108.425 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.67 101.13 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.323 -0.991 . . . . 72.51 108.323 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 85.9 t -92.21 110.03 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.112 0.965 . . . . 74.51 108.814 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.57 128.81 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.006 -0.434 . . . . 75.2 110.557 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -88.76 123.9 33.62 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.448 -1.315 . . . . 75.33 107.448 168.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -84.87 174.41 9.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.812 0.445 . . . . 75.14 110.463 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.57 -21.88 65.41 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.497 0.719 . . . . 72.2 111.114 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 50.1 mtm -76.64 -4.4 42.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.438 1.095 . . . . 74.43 110.51 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 60.58 23.56 13.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.839 1.656 . . . . 75.11 111.364 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -85.6 124.24 31.92 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 106.758 -1.571 . . . . 72.01 106.758 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -88.62 130.37 38.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.77 -0.826 . . . . 71.05 108.77 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.0 pt -129.68 157.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 75.12 109.114 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.3 m -126.8 118.1 23.98 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.246 -1.02 . . . . 52.45 108.246 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.58 155.26 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.946 0.498 . . . . 64.02 110.094 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.77 165.54 17.75 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.8 0.84 . . . . 73.35 109.181 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.88 0.19 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.436 2.091 . . . . 72.45 114.126 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -70.11 -25.48 63.52 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.523 0.729 . . . . 64.24 110.963 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.9 112.96 3.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.365 0.666 . . . . 75.03 110.427 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 60' ' ' LYS . 4.6 ttmp? -70.49 -33.17 70.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.33 0.652 . . . . 73.24 111.389 -173.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -65.46 -27.42 68.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.661 0.385 . . . . 73.14 111.132 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.4 tp -67.02 -33.5 75.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.016 0.926 . . . . 74.05 111.768 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.53 -22.46 66.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.297 0.239 . . . . 75.43 110.929 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -69.97 -39.25 76.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.389 0.676 . . . . 70.31 110.206 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.73 -41.88 74.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.138 0.975 . . . . 64.41 109.74 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.96 -25.63 61.94 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.054 -0.976 . . . . 74.21 111.656 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -29.96 31.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.025 -0.732 . . . . 74.24 109.025 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.65 -28.64 69.25 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.03 0.532 . . . . 74.54 111.398 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.89 -3.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.2 0.6 . . . . 72.5 111.734 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -91.42 157.67 16.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.914 0.886 . . . . 72.3 110.393 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -60.8 132.99 55.62 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.201 1.0 . . . . 74.5 112.586 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -111.16 4.45 19.3 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.566 0.747 . . . . 63.23 111.034 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -75.23 90.78 2.6 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.091 0.472 . . . . 65.15 110.495 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.65 147.5 23.23 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.307 -0.627 . . . . 74.43 109.307 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.8 p -80.86 145.94 31.11 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.97 0.908 . . . . 75.14 110.196 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.4 p -65.35 109.47 2.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.395 0.678 . . . . 72.23 110.495 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.6 m -68.75 115.57 32.15 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.356 0.662 . . . . 73.52 109.336 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.48 174.13 13.1 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.571 2.181 . . . . 75.32 112.084 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -62.75 135.07 57.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.076 -0.511 . . . . 74.25 110.679 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.7 140.56 40.99 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.297 -0.865 . . . . 73.45 110.033 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 102.83 0.46 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.231 1.954 . . . . 73.23 110.915 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.99 109.22 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.067 0.947 . . . . 62.25 110.36 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.5 t -130.51 127.81 39.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.542 -0.91 . . . . 74.43 108.542 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -66.85 133.07 49.34 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.347 0.404 . . . . 62.22 110.124 177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -109.52 102.83 11.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.342 0.657 . . . . 74.43 109.48 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -82.32 108.24 15.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.678 -0.86 . . . . 72.33 108.678 170.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.78 161.37 24.54 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.748 -0.66 . . . . 63.03 110.187 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 C-N-CA 123.765 0.826 . . . . 73.52 109.221 179.46 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.9 pt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.979 0.419 . . . . 71.31 110.645 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.21 107.17 3.06 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.257 -1.757 . . . . 73.14 106.257 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -71.54 169.91 14.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.157 0.583 . . . . 74.14 111.97 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.18 30.5 1.27 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.685 1.194 . . . . 75.22 108.972 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -66.64 158.5 29.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.244 0.618 . . . . 74.21 111.674 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -64.83 92.33 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.269 1.027 . . . . 74.35 110.779 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -124.24 113.28 18.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.864 0.865 . . . . 63.51 110.228 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -167.61 148.79 5.45 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.172 1.389 . . . . 62.41 108.475 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp 62.87 24.44 14.55 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.159 0.984 . . . . 74.24 110.082 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -155.97 177.25 11.62 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.875 0.87 . . . . 75.43 110.636 -173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 61.7 m -71.79 115.85 11.48 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.195 0.998 . . . . 38.13 109.52 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.99 144.56 56.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.401 0.68 . . . . 75.54 110.765 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.5 166.59 22.85 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.255 0.622 . . . . 64.53 111.026 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -132.44 12.98 4.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.141 0.976 . . . . 64.14 110.979 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.37 175.99 50.59 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.766 -0.652 . . . . 73.31 112.996 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.31 170.93 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.447 0.699 . . . . 75.22 109.957 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.89 137.65 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.274 0.559 . . . . 73.41 111.639 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -83.54 -38.88 21.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.041 0.937 . . . . 73.43 110.042 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m -68.12 121.35 15.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.267 1.027 . . . . 75.21 110.125 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.0 116.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.748 0.655 . . . . 75.34 110.128 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.24 134.84 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.93 0.892 . . . . 70.45 109.446 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.7 139.28 22.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 113.987 0.355 . . . . 62.0 113.987 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.6 -37.53 65.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.483 1.113 . . . . 73.21 110.823 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -65.58 -34.07 77.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.733 0.813 . . . . 71.3 111.842 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.626 ' HB ' ' HE3' ' A' ' 49' ' ' MET . 33.7 pt -90.74 -3.79 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 119.565 -0.255 . . . . 74.24 111.41 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.548 HD12 HG23 ' A' ' 45' ' ' ILE . 39.0 mm -71.97 137.47 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.698 -0.853 . . . . 75.13 108.698 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -104.95 -55.3 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.275 -0.639 . . . . 74.23 109.275 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -143.01 142.11 31.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.342 -0.845 . . . . 65.2 109.342 -171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.24 106.57 21.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.029 -1.471 . . . . 73.44 107.029 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.02 103.5 15.35 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.05 -1.093 . . . . 74.04 108.05 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.64 109.44 21.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.616 -1.253 . . . . 71.15 107.616 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -106.54 114.37 62.08 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.389 0.676 . . . . 73.25 109.216 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 160.33 49.66 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.484 2.123 . . . . 55.34 111.797 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 150.96 74.99 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.864 . . . . 72.51 111.095 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.54 -52.61 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 C-N-CA 121.357 -0.449 . . . . 38.13 112.556 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -146.66 107.9 4.23 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.32 0.648 . . . . 74.32 109.575 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.28 -17.73 9.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.76 -0.655 . . . . 52.22 114.578 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 21.4 m -88.52 115.52 63.6 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.571 -0.9 . . . . 74.14 108.571 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.79 -68.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.696 2.264 . . . . 73.01 111.665 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -103.79 179.22 4.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.547 0.739 . . . . 71.33 109.083 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.3 m -64.89 109.96 2.27 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.157 -0.683 . . . . 74.11 109.157 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -89.76 111.96 23.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.353 -0.98 . . . . 73.41 108.353 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.42 101.19 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.512 -0.921 . . . . 63.4 108.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.1 t -96.49 109.71 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.068 0.947 . . . . 61.41 108.572 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.548 HG23 HD12 ' A' ' 26' ' ' ILE . 58.5 mt -94.71 136.83 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.811 -0.811 . . . . 74.11 108.811 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -110.31 117.6 34.07 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.07 -1.456 . . . . 70.42 107.07 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.47 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 60.0 p -82.31 160.81 22.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.687 -0.486 . . . . 73.15 109.687 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 59.6 pttt -71.05 -10.95 60.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.76 0.824 . . . . 72.41 112.972 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.626 ' HE3' ' HB ' ' A' ' 25' ' ' ILE . 3.1 mpp? -92.7 10.79 29.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.145 0.578 . . . . 72.24 110.153 170.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 69.82 15.2 7.97 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.2 1.4 . . . . 74.43 112.931 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 8.0 tmtm? -84.3 123.46 30.19 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.559 -1.275 . . . . 71.13 107.559 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 t -98.84 139.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.124 0.57 . . . . 74.35 109.478 -171.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.57 156.21 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.077 0.951 . . . . 72.21 109.909 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.22 137.27 47.36 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.087 -1.449 . . . . 72.33 107.087 166.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.5 159.28 41.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.838 -0.801 . . . . 73.45 108.838 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -91.21 139.87 25.65 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 115.788 -0.642 . . . . 74.31 110.133 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.06 -12.08 32.98 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.025 2.484 . . . . 74.34 113.771 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -97.99 8.88 44.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.612 0.765 . . . . 65.14 112.357 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.59 122.58 20.0 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.037 -0.727 . . . . 53.42 109.037 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.69 ' HA ' HE21 ' A' ' 63' ' ' GLN . 21.7 ptmt -63.55 -39.39 94.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.978 0.911 . . . . 74.14 112.583 -167.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -68.16 -35.19 77.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.477 0.711 . . . . 74.32 110.64 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 54.6 tp -66.06 -36.22 82.63 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.411 0.684 . . . . 72.43 110.644 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 60' ' ' LYS . 48.7 mt-30 -56.97 -42.05 79.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.735 0.647 . . . . 74.51 109.823 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -63.85 -36.13 82.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.327 0.651 . . . . 73.52 110.906 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.33 -43.29 99.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.248 0.619 . . . . 73.03 109.992 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 82.0 mt -71.98 -23.01 61.35 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.171 -0.922 . . . . 73.32 111.182 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 4.7 mmp_? -88.39 -20.68 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.43 0.692 . . . . 72.24 111.575 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -78.37 -30.61 48.04 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.192 0.597 . . . . 74.3 110.911 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 m -80.07 -13.85 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.679 0.276 . . . . 74.53 110.655 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.84 142.99 58.24 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.628 0.771 . . . . 74.31 109.403 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.98 94.22 0.13 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.543 0.687 . . . . 75.31 110.792 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -80.86 145.26 31.46 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.863 1.265 . . . . 73.4 110.287 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.3 t -69.67 82.82 0.43 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.855 0.836 . . . . 74.13 108.996 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -142.72 143.72 32.38 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.449 1.5 . . . . 72.12 107.704 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -58.23 101.12 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.585 0.754 . . . . 72.04 111.898 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -87.14 167.95 13.7 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.661 -0.7 . . . . 71.42 110.292 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 t -153.06 154.4 30.91 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.989 0.916 . . . . 75.25 108.777 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.61 103.95 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 121.967 1.778 . . . . 64.04 111.717 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -80.98 133.52 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.115 -0.698 . . . . 75.13 109.115 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.5 125.8 91.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.433 0.693 . . . . 73.55 109.611 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.83 144.08 94.37 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 121.911 1.74 . . . . 75.22 111.161 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.36 104.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.589 -0.893 . . . . 73.02 108.589 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.0 t -65.23 90.99 0.1 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.988 0.805 . . . . 53.44 109.509 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HB2' ' HZ1' ' A' ' 84' ' ' LYS . 9.7 mtmp? -91.41 128.82 37.39 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.325 -0.991 . . . . 75.15 108.325 176.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -61.35 164.18 5.82 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.809 0.844 . . . . 75.14 112.648 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -77.53 87.58 3.86 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.773 -0.825 . . . . 74.33 108.773 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.53 88.7 7.02 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.57 -0.741 . . . . 71.34 109.356 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.442 0 CA-C-N 115.135 -0.939 . . . . 63.43 110.563 -176.563 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.297 0.094 . . . . 63.43 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 pp -166.34 11.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.385 0.513 . . . . 73.42 112.385 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.39 139.64 24.17 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.647 1.179 . . . . 73.41 112.222 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.04 124.73 25.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.585 0.754 . . . . 64.42 110.435 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -78.38 -29.14 47.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.426 0.691 . . . . 70.34 109.645 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -119.72 150.06 41.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.371 0.668 . . . . 74.34 109.698 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -152.32 -179.69 7.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.966 0.906 . . . . 75.12 109.639 -176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -138.76 126.46 22.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.85 0.86 . . . . 74.44 109.548 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -99.56 100.59 11.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.197 0.599 . . . . 71.13 109.493 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.91 166.35 13.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.956 0.902 . . . . 73.31 108.932 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.3 m -70.93 113.99 8.54 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.108 -0.701 . . . . 72.23 109.108 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -90.08 143.87 26.39 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.635 0.774 . . . . 75.34 111.55 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 14' ' ' SER . 9.8 t -146.56 163.91 34.27 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.533 1.133 . . . . 71.54 110.125 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 20.8 m -93.62 -50.08 5.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.59 0.756 . . . . 74.12 110.738 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.22 -121.54 0.83 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.788 -0.451 . . . . 73.52 112.682 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.12 162.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.599 1.159 . . . . 72.03 110.044 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.62 151.26 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.14 0.576 . . . . 73.43 110.727 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 m -110.56 11.78 22.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.034 0.934 . . . . 74.33 111.45 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 154.91 43.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.166 0.587 . . . . 72.41 110.417 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.89 141.93 14.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.197 -0.668 . . . . 74.45 109.197 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.79 144.34 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.467 1.107 . . . . 72.33 109.04 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 25' ' ' ILE . . . -62.7 123.39 30.41 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.912 -0.382 . . . . 63.23 113.426 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.54 -34.19 68.88 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.258 1.023 . . . . 72.22 110.755 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.55 -28.33 63.79 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.886 0.874 . . . . 62.25 111.998 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 22' ' ' GLY . 17.8 pt -90.72 -0.41 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 118.131 0.423 . . . . 74.24 111.152 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 45' ' ' ILE . 36.4 mm -77.31 111.9 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.372 -0.603 . . . . 50.43 109.372 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.15 -53.71 4.89 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.47 -0.566 . . . . 74.31 109.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -153.72 147.42 25.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.448 -0.797 . . . . 74.12 110.105 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -113.34 123.19 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.529 -0.915 . . . . 73.13 108.529 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -94.54 111.05 22.81 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.342 -0.985 . . . . 71.41 108.342 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.74 131.69 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.112 0.482 . . . . 72.44 109.9 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 p -122.49 136.23 26.37 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.1 0.96 . . . . 75.31 108.978 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -61.21 169.84 5.81 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.156 2.571 . . . . 74.44 113.814 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.37 170.99 14.84 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 121.805 1.67 . . . . 64.51 111.589 168.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -177.18 48.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.55 -0.295 . . . . 71.1 112.523 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 64.17 14.31 8.52 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.743 1.217 . . . . 75.53 111.317 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.72 -20.27 36.98 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.947 0.784 . . . . 54.23 112.731 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 m -84.72 124.95 72.36 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 117.639 0.72 . . . . 72.43 109.073 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.0 -69.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.794 2.329 . . . . 63.03 113.696 -172.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -100.68 179.97 4.26 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.399 1.08 . . . . 75.21 108.579 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 m -64.12 109.13 1.73 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.022 -1.473 . . . . 74.34 107.022 162.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -90.54 112.78 24.6 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 74.35 109.682 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 102.13 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.137 -0.69 . . . . 75.21 109.137 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.03 111.66 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.962 -1.125 . . . . 62.32 107.962 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.57 HG22 HD12 ' A' ' 26' ' ' ILE . 54.5 mt -94.39 136.27 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.805 -0.443 . . . . 73.13 109.805 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -114.71 114.0 25.04 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 124.878 1.271 . . . . 74.34 108.053 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.2 p -80.29 169.17 18.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.429 0.292 . . . . 75.11 111.073 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.75 -20.62 64.38 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.002 0.921 . . . . 74.31 112.0 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.8 ptp -91.49 8.86 34.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.515 0.726 . . . . 64.01 110.906 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 67.68 21.55 9.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.987 1.315 . . . . 75.12 111.523 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -81.01 123.06 28.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.011 -1.477 . . . . 74.53 107.011 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.86 130.19 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.603 -0.888 . . . . 75.13 108.603 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.8 pt -134.38 153.96 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.263 0.625 . . . . 73.12 109.836 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 92.8 m -109.54 128.76 55.43 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.231 -0.895 . . . . 64.21 108.632 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.14 140.6 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.499 -0.926 . . . . 64.41 108.499 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -79.66 128.1 75.77 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.19 -21.32 27.8 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.923 3.082 . . . . 74.45 114.558 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -73.28 -7.48 51.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.202 0.601 . . . . 74.43 112.459 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.04 123.03 16.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.858 0.863 . . . . 64.52 110.696 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -66.5 -38.33 87.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.022 -0.99 . . . . 74.21 111.914 -172.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.846 0.459 . . . . 72.14 111.425 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.55 -27.0 63.81 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.569 0.747 . . . . 75.54 110.921 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -59.95 -25.92 65.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.046 0.538 . . . . 72.24 111.698 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.77 -41.68 97.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.2 0.6 . . . . 75.22 109.903 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.04 -40.35 82.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.532 0.733 . . . . 75.14 110.0 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.86 -31.29 72.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.392 0.677 . . . . 74.43 110.812 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -78.23 -34.14 49.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.125 0.57 . . . . 73.34 111.058 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.585 0.354 . . . . 73.3 111.64 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.43 -11.51 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.011 0.375 . . . . 74.32 112.011 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -65.84 157.57 30.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.175 0.99 . . . . 65.43 111.417 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.9 m -55.51 149.46 13.58 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.927 0.891 . . . . 63.14 111.549 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HZ1' ' HB2' ' A' ' 72' ' ' LYS . 4.6 ttmp? 78.98 -2.98 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.07 1.748 . . . . 71.2 112.374 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -78.04 150.1 33.88 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.543 -0.723 . . . . 72.23 110.156 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.535 ' H ' HD21 ' A' ' 74' ' ' LEU . 2.2 pt? -87.82 20.66 2.94 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.873 0.469 . . . . 73.02 111.287 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.4 p -79.79 170.35 16.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.719 0.808 . . . . 74.45 110.087 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 m -82.27 90.33 6.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.173 -0.677 . . . . 65.11 109.173 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.8 p -93.29 156.4 40.09 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.86 0.864 . . . . 71.22 109.284 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.03 -171.21 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.317 2.012 . . . . 63.05 111.224 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -67.33 106.77 2.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.493 -0.929 . . . . 75.31 108.493 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 112.27 11.19 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 109.482 -0.562 . . . . 74.42 109.482 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.22 -172.9 1.49 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.848 2.366 . . . . 54.3 111.642 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.48 91.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-O 122.241 1.019 . . . . 72.24 110.141 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 p -75.51 131.19 39.91 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.512 -1.222 . . . . 63.44 108.831 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.56 110.75 0.6 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.168 0.987 . . . . 73.42 110.632 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 -62.2 97.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.044 1.338 . . . . 73.31 111.929 -167.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.71 12.82 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.745 1.618 . . . . 70.43 112.613 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.95 167.34 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.192 0.997 . . . . 63.25 110.463 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.447 0.699 . . . . 64.1 110.085 179.407 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.723 -0.473 . . . . 71.32 109.723 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.89 19.89 3.85 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.542 0.737 . . . . 71.21 112.786 -174.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.7 166.5 12.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.677 0.791 . . . . 73.11 112.128 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 71.35 10.18 6.61 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.009 1.323 . . . . 65.11 112.133 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -100.86 129.71 46.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.923 0.889 . . . . 72.51 109.53 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -132.94 137.1 46.48 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.454 1.101 . . . . 72.54 109.001 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 p -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.121 0.568 . . . . 72.53 110.801 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -69.28 105.01 2.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.11 -0.7 . . . . 74.33 109.11 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.66 112.52 3.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.796 -0.816 . . . . 74.34 108.796 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -139.49 -164.46 1.68 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.219 1.008 . . . . 75.35 108.355 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.38 110.46 3.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.316 0.507 . . . . 72.52 109.986 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -91.95 120.78 32.92 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.392 -0.595 . . . . 75.31 109.392 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.1 t -92.96 115.27 27.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.74 -0.663 . . . . 74.54 109.665 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 t -51.97 -31.98 31.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.67 1.188 . . . . 75.3 112.125 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.73 -169.86 34.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.323 -0.711 . . . . 70.44 111.323 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.68 129.95 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.399 -0.963 . . . . 72.44 108.399 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.633 HD13 HG13 ' A' ' 55' ' ' VAL . 2.2 pp -114.26 144.69 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.162 0.585 . . . . 74.25 109.584 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.0 m -133.95 34.2 3.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.91 0.884 . . . . 62.13 109.429 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 m -126.53 138.89 53.54 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.964 -1.016 . . . . 74.13 108.906 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -74.25 110.85 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.406 -1.331 . . . . 74.42 107.406 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.75 139.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.478 -0.564 . . . . 73.45 109.478 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.36 128.58 33.37 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.756 0.66 . . . . 54.31 113.28 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.65 -30.17 63.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.057 0.943 . . . . 74.32 109.943 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -54.77 -35.49 63.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 73.01 112.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.0 pt -104.49 -3.88 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 119.266 -0.397 . . . . 74.33 112.013 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 45' ' ' ILE . 41.1 mm -71.13 110.97 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.684 -0.858 . . . . 72.52 108.684 172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB2' ' HD2' ' A' ' 48' ' ' LYS . 24.0 t70 -85.75 -56.6 3.41 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.198 0.599 . . . . 75.15 110.712 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -160.69 143.88 13.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.209 -0.663 . . . . 75.43 109.209 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.12 123.99 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.215 -0.661 . . . . 74.2 109.215 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -103.98 116.82 32.94 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.864 0.866 . . . . 71.24 109.012 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.36 112.83 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.294 0.638 . . . . 71.34 110.165 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 11.0 m -89.84 116.65 66.88 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 108.935 -0.765 . . . . 75.54 108.935 169.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.81 157.73 36.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.812 2.341 . . . . 72.55 112.535 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.38 122.08 10.76 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.607 2.204 . . . . 74.25 111.294 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.64 -159.59 23.49 Favored Glycine 0 C--O 1.241 0.546 0 N-CA-C 110.221 -1.152 . . . . 72.23 110.221 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 63.82 30.09 14.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 72.43 111.641 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.87 20.5 61.17 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.423 -0.353 . . . . 37.99 112.914 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 53.4 t -138.32 133.34 17.1 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.888 0.875 . . . . 71.54 109.965 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.72 -9.31 13.35 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.336 2.024 . . . . 63.51 112.616 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 16.5 tppt? -101.29 155.09 18.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.806 1.242 . . . . 65.22 110.163 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -86.43 115.23 23.8 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.183 -1.043 . . . . 74.14 108.183 164.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 42.7 tt0 -83.21 112.97 20.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.04 102.15 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.539 -1.282 . . . . 73.24 107.539 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.11 135.27 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.934 0.894 . . . . 74.12 109.061 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.637 HG22 HD12 ' A' ' 26' ' ' ILE . 60.9 mt -110.29 121.78 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.624 0.37 . . . . 73.45 110.083 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.15 127.04 32.74 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.998 -1.112 . . . . 71.01 107.998 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.7 p -84.66 178.42 7.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.408 0.683 . . . . 75.44 110.359 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HD2' ' HB2' ' A' ' 27' ' ' ASP . 14.4 mmmm -66.02 -23.52 66.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.277 0.56 . . . . 74.13 110.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.3 mtm -79.8 -1.45 38.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.458 1.103 . . . . 73.23 110.434 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 65.2 14.51 9.44 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.986 1.714 . . . . 75.3 111.919 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HZ3' HG22 ' A' ' 53' ' ' ILE . 14.1 tmtt? -79.77 125.97 30.35 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.248 -1.019 . . . . 73.24 108.248 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.92 122.65 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 75.54 109.386 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.451 HG22 ' HZ3' ' A' ' 51' ' ' LYS . 39.1 pt -108.11 149.93 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.147 -1.057 . . . . 74.5 108.147 169.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.97 118.68 37.42 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.515 0.726 . . . . 63.11 109.355 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.633 HG13 HD13 ' A' ' 17' ' ' ILE . 32.8 m -124.69 156.06 32.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 123.524 0.73 . . . . 70.34 109.55 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.55 152.95 78.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.558 -0.904 . . . . 73.53 108.558 168.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.54 -27.0 69.69 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.839 1.693 . . . . 65.14 111.261 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.89 12.67 36.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.313 1.045 . . . . 72.33 112.208 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.97 56.58 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.041 0.536 . . . . 75.14 109.985 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.96 -40.99 97.67 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.973 0.731 . . . . 73.22 112.973 -166.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -77.84 -17.48 57.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.073 0.397 . . . . 73.14 112.073 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.49 -21.59 66.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 64.23 110.712 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -56.4 -23.97 41.66 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.092 0.957 . . . . 65.45 113.139 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.99 -46.94 82.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.927 0.491 . . . . 74.22 110.274 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.52 -37.96 55.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.369 -0.832 . . . . 75.54 110.472 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.05 -35.62 78.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 75.34 110.547 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -75.03 -41.38 59.34 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.309 0.243 . . . . 73.32 110.682 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -68.66 -36.11 78.14 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.27 0.47 . . . . 64.35 112.27 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.0 -28.81 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.025 0.44 . . . . 74.33 110.137 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -78.97 -18.68 53.3 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.834 0.853 . . . . 55.13 111.049 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -66.84 161.71 23.25 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.063 0.545 . . . . 71.02 111.343 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -63.54 101.29 0.32 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.166 0.586 . . . . 71.02 110.184 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 p -120.98 165.6 15.02 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.326 1.05 . . . . 74.21 110.492 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.0 79.43 2.19 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.609 0.719 . . . . 64.22 109.547 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.2 p -88.55 146.7 25.0 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.059 0.944 . . . . 71.15 110.584 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 p -65.7 -17.21 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.984 0.914 . . . . 74.05 111.9 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.4 m -124.93 106.33 28.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.016 0.926 . . . . 61.43 109.663 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.42 160.87 37.23 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.769 2.313 . . . . 74.03 111.674 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.55 128.91 50.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.784 -0.45 . . . . 74.11 109.784 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.65 129.56 93.4 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 108.999 -0.741 . . . . 62.24 108.999 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.07 140.7 95.03 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.998 1.798 . . . . 64.14 111.181 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.75 138.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.616 0.766 . . . . 73.44 112.015 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -77.76 71.04 4.22 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.632 0.729 . . . . 72.42 109.483 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.29 166.98 22.15 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.992 -1.004 . . . . 74.42 110.048 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.06 142.28 51.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.825 0.45 . . . . 72.13 110.431 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -86.63 96.51 10.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.324 1.05 . . . . 74.51 109.423 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.07 88.65 0.29 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.303 -0.628 . . . . 74.35 109.303 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.013 0.925 . . . . 72.42 110.302 -175.446 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.712 -0.477 . . . . 75.41 109.712 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.14 120.62 33.64 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.682 -0.859 . . . . 75.44 108.682 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.45 143.45 40.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.915 0.886 . . . . 63.35 110.932 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.98 137.74 25.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 63.24 110.197 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.14 151.03 33.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.304 0.642 . . . . 73.23 109.53 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.98 10.68 34.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.497 0.719 . . . . 72.45 111.583 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -63.92 93.03 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.079 0.952 . . . . 75.31 110.253 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.8 83.15 0.14 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.92 1.288 . . . . 64.43 110.659 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.4 134.29 34.89 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.458 0.647 . . . . 72.35 109.549 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -85.99 -170.28 3.03 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.678 -0.86 . . . . 53.54 108.678 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 42' ' ' GLU . 73.0 m -52.08 114.06 1.21 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.567 0.347 . . . . 51.41 110.99 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.46 120.61 27.97 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.216 -1.402 . . . . 75.42 107.216 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 16' ' ' VAL . 52.9 t -143.04 102.99 4.1 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.236 -0.653 . . . . 74.14 109.236 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.9 m -114.54 123.88 50.47 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.185 0.994 . . . . 71.44 109.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.33 90.24 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 O-C-N 123.773 0.671 . . . . 72.2 111.736 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.676 HG21 ' SG ' ' A' ' 13' ' ' CYS . 22.7 t -100.5 128.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.808 -0.812 . . . . 74.22 108.808 -173.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.413 HD13 HG12 ' A' ' 55' ' ' VAL . 2.7 pp -124.74 147.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.082 0.553 . . . . 74.23 109.986 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.4 m -117.76 22.68 12.17 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.489 1.115 . . . . 72.5 109.122 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.5 m -93.72 146.57 23.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.753 1.221 . . . . 74.3 109.994 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.63 112.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.359 -0.978 . . . . 45.3 108.359 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -90.5 143.33 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.664 0.786 . . . . 74.25 109.548 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 118.09 13.73 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.881 0.738 . . . . 72.12 112.011 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.3 -30.81 52.22 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.767 1.227 . . . . 72.44 110.995 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.47 -35.79 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.399 0.679 . . . . 72.32 111.942 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt -86.19 -6.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 111.957 0.354 . . . . 73.11 111.957 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 HG21 ' A' ' 45' ' ' ILE . 44.5 mm -72.9 129.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.364 -0.976 . . . . 74.54 108.364 176.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -117.16 -58.64 2.04 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.633 0.373 . . . . 63.45 111.055 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -144.81 127.47 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.849 0.46 . . . . 74.34 109.906 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -110.79 140.66 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.359 1.064 . . . . 71.53 109.71 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.37 127.17 25.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.979 1.312 . . . . 73.25 108.082 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.52 139.43 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 122.576 0.35 . . . . 74.43 111.253 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 28.5 m -111.06 118.36 48.16 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.06 0.944 . . . . 71.15 109.099 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.44 147.18 36.19 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.025 1.816 . . . . 73.51 111.156 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.75 144.7 92.75 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.61 2.207 . . . . 73.32 112.59 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.02 -32.8 7.1 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.066 -0.516 . . . . 72.4 112.534 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -80.59 77.76 7.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.636 0.774 . . . . 72.53 110.426 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.37 -2.92 18.12 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 115.808 -0.633 . . . . 63.04 114.501 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.08 138.26 17.72 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 74.44 109.139 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.71 16.61 1.78 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.868 2.379 . . . . 73.21 114.034 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -152.16 173.21 15.23 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.277 0.631 . . . . 75.44 110.572 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 m -81.2 131.32 35.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.402 0.681 . . . . 75.42 110.114 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 19.9 tt0 -115.05 126.33 54.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.915 -1.143 . . . . 74.1 107.915 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.08 102.68 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.283 -1.006 . . . . 64.4 108.283 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.91 130.56 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.144 0.978 . . . . 73.32 109.083 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.61 HG21 HD11 ' A' ' 26' ' ' ILE . 52.3 mt -121.16 129.85 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.256 -0.646 . . . . 75.13 109.256 173.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -99.53 124.56 44.81 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.969 1.307 . . . . 75.24 107.523 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.8 p -84.9 170.64 12.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.883 0.473 . . . . 74.13 110.792 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 18.6 ptpt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 75.51 110.845 170.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.96 -8.29 56.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.186 0.994 . . . . 74.24 110.647 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.09 21.17 7.41 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.074 1.349 . . . . 75.32 109.246 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -100.43 133.09 45.38 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.25 1.02 . . . . 72.53 108.364 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.42 124.04 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.128 0.971 . . . . 73.24 110.397 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.432 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.6 pt -120.61 139.04 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.62 117.02 32.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.228 -1.397 . . . . 61.32 107.228 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG12 HD13 ' A' ' 17' ' ' ILE . 7.2 m -117.55 166.35 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.176 0.59 . . . . 75.51 111.073 -168.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.18 139.09 56.21 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 115.299 -0.864 . . . . 74.24 109.512 174.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.1 -43.57 28.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.422 2.081 . . . . 74.24 112.721 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -85.08 21.96 1.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.93 0.492 . . . . 73.53 111.461 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.84 124.65 21.33 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.145 -0.687 . . . . 72.4 109.145 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.92 -32.89 74.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.252 1.021 . . . . 75.34 112.316 -169.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -74.12 -29.96 62.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.05 0.54 . . . . 75.34 111.154 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.7 tp -67.44 -23.55 65.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.674 0.79 . . . . 74.43 110.869 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -57.77 -38.04 74.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.753 0.821 . . . . 73.32 111.171 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -69.7 -31.39 69.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.119 0.568 . . . . 75.13 110.74 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.9 -35.58 69.75 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.454 -0.572 . . . . 61.42 109.454 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -66.04 -40.33 90.9 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.342 0.657 . . . . 74.43 110.129 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -70.33 -35.84 73.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.31 0.644 . . . . 73.42 111.05 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.78 -44.84 92.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.736 0.414 . . . . 70.21 110.412 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 m -82.37 -20.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.85 -0.614 . . . . 62.01 111.534 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.99 153.25 38.61 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.024 0.529 . . . . 73.13 109.96 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -60.32 148.3 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.401 1.081 . . . . 74.12 111.205 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER 69.48 67.62 0.25 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.384 1.474 . . . . 74.15 109.177 -175.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.7 p -139.52 -176.22 4.47 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.84 -1.073 . . . . 64.05 109.566 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.33 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.574 0.75 . . . . 72.42 110.275 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.1 t -168.58 148.48 4.49 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.925 1.29 . . . . 54.52 108.704 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 p -97.02 77.59 2.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.245 0.618 . . . . 52.21 111.055 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 m -89.66 118.33 68.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.788 -0.819 . . . . 71.25 108.788 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.13 89.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.622 2.215 . . . . 70.4 111.205 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -136.18 130.43 33.19 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.494 1.118 . . . . 64.23 108.595 -170.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.11 134.54 90.46 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.41 0.684 . . . . 71.53 110.708 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.54 94.07 0.43 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.271 1.981 . . . . 74.14 111.687 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.44 146.86 12.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 116.074 -0.512 . . . . 71.1 110.49 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 t -66.42 152.39 45.2 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.394 -0.821 . . . . 63.12 110.327 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.63 114.93 26.73 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.332 -0.988 . . . . 72.14 108.332 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -61.36 115.86 4.19 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 123.674 0.609 . . . . 73.25 109.857 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -83.93 158.23 21.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.164 0.585 . . . . 72.32 109.897 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.04 105.25 9.13 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.193 -1.04 . . . . 73.44 108.193 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 123.721 0.808 . . . . 72.52 110.768 -175.104 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.15 -0.685 . . . . 70.11 109.15 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.92 159.02 34.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.127 0.971 . . . . 74.32 111.02 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -120.91 166.83 13.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.576 0.75 . . . . 70.1 110.762 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.99 -25.01 10.94 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.569 0.748 . . . . 72.54 111.824 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -144.69 95.37 2.69 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.325 0.65 . . . . 72.45 110.646 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.48 -27.87 60.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.158 0.583 . . . . 73.41 109.464 164.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 m -69.12 123.41 21.0 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.873 -1.058 . . . . 61.14 110.902 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -101.71 129.83 47.96 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.376 -0.972 . . . . 71.23 108.376 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.91 98.43 0.28 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.688 0.795 . . . . 75.13 110.541 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.07 -107.85 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.3 1.04 . . . . 65.24 109.196 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -88.61 113.66 24.41 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.948 -1.13 . . . . 74.31 107.948 171.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -85.12 118.33 24.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.614 0.766 . . . . 71.23 109.15 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.3 t -144.57 105.24 4.14 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.125 -0.695 . . . . 62.02 109.125 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 p -64.01 -49.58 71.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.745 0.818 . . . . 75.01 110.539 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.61 172.03 32.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.027 -0.988 . . . . 74.23 111.236 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.56 148.2 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.024 0.53 . . . . 64.21 109.788 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.8 pt -83.53 133.06 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.582 -0.735 . . . . 74.43 111.566 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.0 m -85.07 -41.04 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.374 -0.83 . . . . 74.22 109.354 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.8 m -92.45 129.29 38.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.007 . . . . 74.24 108.806 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.52 129.68 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.739 0.649 . . . . 72.53 109.627 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 53' ' ' ILE . 71.1 t -84.23 130.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.508 0.723 . . . . 72.41 110.236 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.22 134.2 42.67 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.284 0.99 . . . . 63.2 113.602 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.63 -33.81 66.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.432 1.093 . . . . 74.13 110.474 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.05 -34.54 77.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.225 1.01 . . . . 62.4 111.913 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.465 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 25.4 pt -97.59 -5.78 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 118.925 -0.559 . . . . 64.51 112.096 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 45' ' ' ILE . 38.9 mm -65.58 103.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.215 -1.031 . . . . 71.35 108.215 171.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -85.72 -55.07 4.15 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.31 0.644 . . . . 63.15 109.618 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -148.99 143.4 26.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.987 -0.551 . . . . 73.53 110.526 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.65 118.46 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.332 1.053 . . . . 75.3 108.647 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -106.62 143.88 34.09 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.036 -1.098 . . . . 74.1 108.036 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.5 t -120.1 124.95 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.167 -1.049 . . . . 74.3 108.167 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -88.48 111.37 43.3 Favored Pre-proline 0 C--O 1.251 1.156 0 N-CA-C 108.143 -1.058 . . . . 71.13 108.143 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.2 151.39 49.09 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.862 2.375 . . . . 74.24 112.266 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.76 158.07 43.35 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.342 2.028 . . . . 61.32 112.164 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.99 -19.1 44.17 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.738 -0.479 . . . . 73.11 113.734 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -83.45 66.17 8.75 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.736 0.814 . . . . 73.34 109.844 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.6 -18.12 6.04 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 115.422 -0.808 . . . . 41.3 113.839 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -139.67 129.44 14.01 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.629 1.172 . . . . 70.41 108.563 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.25 32.91 0.45 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.003 2.469 . . . . 64.45 112.676 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.31 126.78 50.35 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.565 0.746 . . . . 74.52 110.773 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -88.61 121.35 30.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.714 0.805 . . . . 75.12 108.914 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -144.3 163.6 33.22 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.29 0.567 . . . . 65.34 110.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.4 t -121.41 104.16 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.576 1.15 . . . . 75.42 108.277 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.54 108.98 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.616 1.166 . . . . 71.53 108.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 26' ' ' ILE . 69.7 mt -107.91 134.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.562 -0.712 . . . . 75.02 110.391 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.17 124.89 48.55 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.831 1.252 . . . . 75.4 107.749 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -80.23 179.06 7.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.508 0.323 . . . . 71.51 110.302 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 52.5 mtmt -62.35 -28.63 69.89 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.264 0.554 . . . . 73.42 110.617 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 49' ' ' MET . 0.9 OUTLIER -86.28 7.05 26.89 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.748 1.219 . . . . 75.12 111.028 177.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 63.74 15.61 9.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.305 1.442 . . . . 74.13 111.793 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -72.68 128.46 35.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.789 -1.189 . . . . 74.13 107.789 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.83 118.5 35.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.033 -0.985 . . . . 73.23 109.051 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.595 HG22 HG22 ' A' ' 21' ' ' VAL . 7.2 pt -110.98 157.11 11.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.626 -1.25 . . . . 74.4 107.626 167.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.9 t -139.83 116.61 10.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.482 -0.933 . . . . 73.23 108.482 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 158.12 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 75.11 109.434 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.22 151.35 78.27 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.425 -0.583 . . . . 61.31 109.425 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.74 -16.41 37.18 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.262 2.641 . . . . 73.4 114.053 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -91.29 18.99 6.34 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.13 0.972 . . . . 75.54 112.386 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 128.07 34.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.152 -0.684 . . . . 71.11 109.152 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 11.1 mmpt? -66.99 -38.5 86.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.703 0.801 . . . . 71.53 112.584 -172.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -63.55 -33.24 75.15 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.131 0.491 . . . . 74.54 110.156 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.15 -31.15 43.91 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.057 -0.974 . . . . 74.31 110.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -31.95 73.14 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 110.143 -0.318 . . . . 73.44 110.143 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.7 -42.12 92.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.289 0.635 . . . . 74.41 110.199 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' O ' HG11 ' A' ' 69' ' ' VAL . 4.5 mm? -64.1 -42.7 96.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.444 0.698 . . . . 62.24 110.269 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.77 -31.64 72.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.241 0.617 . . . . 70.23 111.072 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -78.77 -27.04 44.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.1 0.96 . . . . 73.44 110.804 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -83.69 -29.27 27.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.252 0.621 . . . . 73.43 112.067 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 65' ' ' LEU . 24.4 m -70.45 -24.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 110.104 -0.332 . . . . 74.4 110.104 176.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.03 122.12 14.16 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.441 -1.318 . . . . 60.42 107.441 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -55.68 142.96 32.1 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.486 1.114 . . . . 55.44 112.055 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 8.9 mtpm? 62.54 52.81 2.81 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.111 0.965 . . . . 73.42 111.212 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.1 p -91.76 169.32 10.8 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.956 -1.02 . . . . 73.12 109.825 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -53.88 103.08 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.656 0.782 . . . . 74.44 112.025 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 m -141.97 9.35 1.92 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.753 1.221 . . . . 64.33 110.348 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -98.15 111.48 23.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.093 0.957 . . . . 61.44 110.76 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -96.76 104.65 19.1 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.157 0.983 . . . . 75.32 109.299 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -55.76 95.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.448 2.765 . . . . 74.14 113.89 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -85.38 94.34 8.94 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.187 -1.042 . . . . 55.05 108.187 170.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.73 33.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 73.2 110.013 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.66 111.52 0.75 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.019 2.479 . . . . 65.13 111.896 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.15 121.36 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.814 0.696 . . . . 71.21 109.492 -171.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.9 p -99.55 30.84 3.4 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 73.21 111.492 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -84.65 80.59 9.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.422 0.629 . . . . 75.55 110.508 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.25 140.79 1.18 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.375 1.47 . . . . 75.43 107.8 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -62.63 1.57 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.7 -1.222 . . . . 75.24 107.7 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.94 73.65 6.71 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 71.32 110.444 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.913 0.885 . . . . 52.11 109.061 -178.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.567 -0.16 . . . . 74.21 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 pp -103.56 171.39 7.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.895 -0.78 . . . . 65.43 108.895 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 169.39 17.74 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.316 0.579 . . . . 72.45 111.119 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.28 139.02 37.24 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.43 -1.322 . . . . 65.03 107.43 169.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -74.65 91.72 2.37 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.258 -0.645 . . . . 72.51 109.258 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -73.75 89.9 1.82 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 115.69 -0.687 . . . . 71.44 109.346 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 t -66.54 2.57 1.25 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.841 1.256 . . . . 70.12 112.747 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -45.29 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.086 1.354 . . . . 72.44 110.588 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.35 77.37 8.23 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.895 0.855 . . . . 74.25 109.417 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -142.34 155.56 45.18 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.437 -1.256 . . . . 73.32 109.568 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 85.2 m -66.43 133.41 50.39 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.593 -0.891 . . . . 74.31 108.593 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -83.55 128.18 34.31 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.248 -0.649 . . . . 72.55 109.248 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.2 t -144.73 133.74 22.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.357 0.663 . . . . 73.23 110.166 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.53 ' H ' ' HB2' ' A' ' 54' ' ' CYS . 23.1 t -87.34 31.29 0.74 Allowed 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 125.092 1.357 . . . . 75.11 111.212 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.06 -142.23 20.52 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.365 -0.294 . . . . 54.12 112.365 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.03 133.38 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.644 -1.243 . . . . 73.33 107.644 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.7 pp -125.52 150.43 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 122.862 0.465 . . . . 74.32 111.424 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -97.32 2.21 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.285 1.034 . . . . 70.3 110.982 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 m -74.9 98.08 3.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.251 0.62 . . . . 61.11 109.523 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.66 109.69 6.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.124 -1.436 . . . . 73.21 107.124 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.1 t -100.39 139.41 21.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.429 0.691 . . . . 72.2 109.987 -173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.77 136.8 38.65 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 124.015 0.822 . . . . 75.24 112.565 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 64' ' ' ARG . 10.8 mp -60.89 -29.41 69.55 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.936 0.894 . . . . 71.51 110.542 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.61 -33.19 67.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.327 1.451 . . . . 74.42 112.794 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.559 HG21 ' HE2' ' A' ' 48' ' ' LYS . 43.4 pt -110.21 7.46 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.519 0.328 . . . . 73.24 111.869 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD13 HG21 ' A' ' 45' ' ' ILE . 39.5 mm -73.86 111.48 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.393 -0.966 . . . . 74.04 108.393 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.2 -56.66 3.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.484 0.713 . . . . 74.51 110.652 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -153.58 138.26 16.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 63.12 109.856 -174.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.7 128.8 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.122 -1.066 . . . . 75.45 108.122 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.583 ' HB2' HG22 ' A' ' 44' ' ' VAL . 19.4 mt-30 -116.88 138.99 51.15 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.632 -0.877 . . . . 74.13 108.632 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.69 119.24 49.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.683 -0.858 . . . . 71.23 108.683 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.7 p -101.37 112.76 65.54 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.423 -0.954 . . . . 72.54 108.423 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.63 161.05 47.43 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.373 2.715 . . . . 73.22 112.677 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 119.72 6.14 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.526 2.151 . . . . 74.15 111.453 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.74 -39.08 1.24 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 116.131 -0.486 . . . . 74.54 112.231 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -77.22 77.99 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.219 0.607 . . . . 75.03 110.144 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.68 14.51 55.22 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.17 -0.468 . . . . 60.54 113.872 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 31.9 p -139.89 133.79 15.59 Favored Pre-proline 0 C--N 1.356 0.881 0 C-N-CA 123.422 0.689 . . . . 72.41 110.161 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.94 -38.19 10.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.132 2.554 . . . . 55.24 112.914 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.563 ' HB2' ' HZ3' ' A' ' 40' ' ' LYS . 4.8 ttmp? -118.43 159.24 23.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.769 0.828 . . . . 72.42 110.491 -174.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -62.96 120.86 12.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.102 0.961 . . . . 72.32 109.9 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -108.55 117.55 34.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.501 0.72 . . . . 75.31 109.299 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.35 106.49 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.816 0.846 . . . . 75.32 109.423 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 30' ' ' GLN . 5.8 m -104.71 125.33 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.046 0.539 . . . . 71.22 109.789 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 26' ' ' ILE . 46.3 mt -114.37 120.11 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.728 0.811 . . . . 74.44 108.978 -175.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.401 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 66.9 m95 -86.57 128.25 34.97 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.236 1.014 . . . . 75.4 108.484 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.401 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 47.6 p -83.62 179.68 7.55 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.328 0.651 . . . . 74.41 110.17 172.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HE2' HG21 ' A' ' 25' ' ' ILE . 41.8 mtmt -66.2 -29.67 69.98 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.394 0.278 . . . . 64.23 111.065 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -77.09 -7.3 55.5 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.501 0.72 . . . . 71.21 110.294 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 70.04 23.51 5.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 125.934 1.694 . . . . 75.15 111.408 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 8.2 tmtm? -75.01 123.69 25.62 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.278 -1.378 . . . . 74.32 107.278 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.19 126.58 43.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.342 0.657 . . . . 75.32 109.422 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 17' ' ' ILE . 46.6 pt -117.64 157.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.479 -1.304 . . . . 75.43 107.479 170.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.53 ' HB2' ' H ' ' A' ' 14' ' ' SER . 13.4 t -133.93 134.15 42.27 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.203 0.456 . . . . 63.21 109.939 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' HE1' ' A' ' 61' ' ' TRP . 31.0 m -133.95 164.94 33.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 C-N-CA 124.344 1.058 . . . . 73.42 109.598 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -81.57 159.16 67.46 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.367 -1.288 . . . . 65.0 109.846 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.68 -12.95 37.97 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.928 2.419 . . . . 74.21 112.028 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -83.52 -8.65 59.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.811 0.844 . . . . 73.04 111.432 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.87 132.37 49.23 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.735 0.814 . . . . 75.34 112.161 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.2 -36.45 69.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 74.23 112.491 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.665 ' HE1' HG11 ' A' ' 55' ' ' VAL . 7.7 p-90 -74.75 -23.15 58.51 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.565 0.346 . . . . 74.42 110.368 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.81 -28.5 69.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.097 0.959 . . . . 74.34 110.59 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.77 -34.78 73.44 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.632 0.773 . . . . 74.54 110.571 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HB3' HD23 ' A' ' 23' ' ' LEU . 95.5 mtt180 -66.95 -39.49 87.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.572 0.749 . . . . 72.23 111.009 176.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.1 -38.08 72.36 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.544 0.738 . . . . 74.32 110.858 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.53 -49.66 57.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.611 -0.722 . . . . 70.31 109.682 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -67.62 -24.03 65.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.588 -0.733 . . . . 75.22 111.315 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.658 0.783 . . . . 64.14 111.119 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.89 -29.78 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 122.723 0.409 . . . . 65.14 111.039 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -88.55 154.7 20.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.467 0.707 . . . . 70.24 110.45 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -65.86 125.5 25.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.336 -0.616 . . . . 64.03 109.336 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -90.0 -73.4 0.52 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.975 -0.75 . . . . 75.13 108.975 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m -156.62 100.2 1.92 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.166 0.986 . . . . 72.04 108.78 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tt -69.34 93.21 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.206 -1.035 . . . . 71.43 108.206 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -107.66 176.59 5.1 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.974 -1.012 . . . . 70.35 108.983 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.1 p -75.04 127.69 33.82 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.056 -0.72 . . . . 70.22 109.056 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.6 t -72.7 123.53 89.66 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.171 -0.678 . . . . 73.11 109.171 176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 122.78 12.28 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.295 1.997 . . . . 74.13 112.269 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.37 141.76 58.16 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.945 0.498 . . . . 71.24 111.084 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.52 123.76 20.59 Favored Pre-proline 0 C--O 1.244 0.791 0 C-N-CA 123.843 0.857 . . . . 74.31 108.795 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.79 101.73 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.09 1.86 . . . . 75.22 111.143 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.12 146.89 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 75.25 110.973 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -78.15 73.58 4.71 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.759 0.79 . . . . 75.32 109.829 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -163.61 111.31 1.18 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.633 -1.988 . . . . 73.51 105.633 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.65 162.31 14.87 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.026 0.93 . . . . 72.54 108.666 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -67.14 -34.27 77.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.734 0.813 . . . . 75.54 110.552 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.8 -0.3 37.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.773 0.829 . . . . 74.51 111.947 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.143 0 C-N-CA 122.804 0.441 . . . . 71.54 110.161 -177.448 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 75.51 108.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.04 92.1 3.79 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.574 0.75 . . . . 71.51 109.348 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.28 84.11 6.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.53 0.732 . . . . 70.42 109.349 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.93 16.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.662 0.385 . . . . 70.11 110.524 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -84.07 88.2 7.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.409 0.684 . . . . 65.02 110.135 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -100.45 141.76 32.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.041 -0.726 . . . . 74.23 109.041 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 m -69.28 86.6 0.41 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.883 0.849 . . . . 62.4 109.725 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -122.49 138.28 54.61 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.738 -1.119 . . . . 71.21 108.828 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.77 95.73 2.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.377 -0.971 . . . . 74.52 108.377 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.55 173.76 11.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.914 1.286 . . . . 74.04 108.208 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.567 ' SG ' HG23 ' A' ' 32' ' ' THR . 14.0 m -77.42 117.07 18.54 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.956 0.502 . . . . 72.12 110.066 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -67.37 132.79 48.38 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.176 0.591 . . . . 74.23 110.081 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 41.8 t -146.57 155.61 42.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.526 0.73 . . . . 73.3 110.056 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.9 m -99.18 -6.91 27.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.288 0.635 . . . . 64.41 111.255 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.92 165.23 10.18 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 111.521 -0.632 . . . . 74.23 111.521 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.228 -1.026 . . . . 75.35 108.228 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.87 143.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.062 0.458 . . . . 74.4 110.581 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -100.5 -57.1 2.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.016 0.926 . . . . 72.34 108.733 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -67.32 127.54 33.04 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.814 0.846 . . . . 74.13 110.45 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.89 139.47 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 124.007 0.817 . . . . 74.22 110.668 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.97 144.66 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.361 1.064 . . . . 74.24 109.949 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.64 135.62 25.22 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.561 0.538 . . . . 73.01 114.253 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.71 -18.76 63.05 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.176 0.99 . . . . 63.11 111.578 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -59.52 -35.79 74.86 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.413 1.085 . . . . 72.15 111.746 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.85 -1.92 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 119.324 -0.37 . . . . 75.42 111.793 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 45' ' ' ILE . 50.2 mm -78.37 124.62 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.963 -0.755 . . . . 64.03 108.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.13 -57.15 2.08 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.172 0.589 . . . . 71.22 110.26 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -142.99 153.81 43.37 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.142 0.977 . . . . 75.53 109.519 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.03 113.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.747 0.819 . . . . 74.42 109.103 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -96.93 106.66 19.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.652 0.781 . . . . 64.02 109.139 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.89 117.73 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.033 -0.729 . . . . 71.11 109.033 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.567 HG23 ' SG ' ' A' ' 11' ' ' CYS . 8.4 m -89.47 112.68 53.02 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.701 0.8 . . . . 72.42 108.949 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.63 152.48 64.83 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.08 1.853 . . . . 75.45 111.999 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.79 109.38 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.828 2.352 . . . . 75.24 111.928 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.53 -27.79 0.96 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.868 -0.606 . . . . 41.23 112.181 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.36 68.88 10.62 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.748 0.819 . . . . 61.44 110.515 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.62 -3.79 40.02 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.338 -0.846 . . . . 62.53 114.145 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -132.89 125.55 19.28 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 124.233 1.013 . . . . 74.12 109.443 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.45 -17.79 30.1 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.498 2.132 . . . . 52.01 112.941 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -110.77 173.75 6.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.787 0.835 . . . . 72.12 110.165 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -85.43 113.82 22.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.867 -0.79 . . . . 75.04 108.867 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -101.74 111.13 23.27 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.21 -0.663 . . . . 74.2 109.21 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.3 t -92.63 99.81 10.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.328 -0.99 . . . . 73.33 108.328 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.11 107.02 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.093 -1.077 . . . . 74.5 108.093 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 53' ' ' ILE . 58.5 mt -98.1 128.74 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.507 0.723 . . . . 73.2 109.493 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -102.91 121.45 42.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.137 0.975 . . . . 74.42 108.712 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -80.95 170.66 15.98 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.695 0.398 . . . . 74.31 111.106 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -69.31 -12.32 61.56 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.89 0.876 . . . . 75.11 111.605 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 ptp -101.94 18.28 21.03 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.921 0.888 . . . . 71.33 110.302 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 61.6 7.48 1.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.381 1.473 . . . . 75.12 113.902 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -73.14 128.52 35.71 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.281 -1.007 . . . . 72.04 108.281 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.95 119.21 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.867 -1.06 . . . . 73.32 109.791 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 45' ' ' ILE . 23.9 pt -127.71 145.12 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.06 -1.089 . . . . 72.13 108.06 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.9 m -120.44 142.51 49.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.708 -0.479 . . . . 62.31 109.708 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG13 ' HE1' ' A' ' 61' ' ' TRP . 29.9 m -126.37 159.67 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 122.969 0.508 . . . . 74.05 109.712 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -74.96 146.32 82.42 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.085 -0.962 . . . . 74.35 109.476 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.87 -23.72 76.33 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.981 2.454 . . . . 72.53 113.1 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -106.23 22.91 14.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.714 0.806 . . . . 63.31 111.405 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.82 135.03 49.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.136 -0.69 . . . . 74.13 109.136 171.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.81 -39.53 90.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 71.51 111.703 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.545 ' HE1' HG13 ' A' ' 55' ' ' VAL . 2.4 p-90 -69.36 -30.16 68.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.77 0.428 . . . . 71.31 110.035 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.5 tp -68.27 -34.22 75.79 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.247 0.619 . . . . 74.4 110.838 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -57.19 -32.69 66.72 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.128 0.49 . . . . 72.41 110.976 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.31 -45.48 80.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.105 -0.952 . . . . 74.2 109.582 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.73 -42.99 97.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.834 . . . . 71.44 110.599 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.62 -49.16 74.37 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.963 0.79 . . . . 63.44 110.506 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -72.34 -27.11 62.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.308 0.485 . . . . 64.42 112.308 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.18 -42.12 47.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.361 0.664 . . . . 73.04 110.995 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.32 -28.24 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 116.389 -0.369 . . . . 73.42 110.493 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -81.3 149.58 28.89 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.187 0.595 . . . . 71.34 110.02 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m 71.31 16.44 6.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.42 1.488 . . . . 71.24 110.945 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -109.34 103.1 11.97 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.664 0.786 . . . . 74.21 109.107 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 t -85.78 64.01 8.37 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.705 0.802 . . . . 73.22 109.406 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.23 113.3 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.046 -1.094 . . . . 73.52 108.046 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.2 m -76.87 81.42 3.44 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.397 0.617 . . . . 73.12 110.373 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.4 t -81.07 116.31 20.95 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.965 -0.754 . . . . 73.13 108.965 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 p -95.24 137.49 22.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.605 0.762 . . . . 74.1 110.611 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.95 170.29 20.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.512 2.142 . . . . 74.43 113.064 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.35 147.43 41.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.133 0.973 . . . . 75.43 109.349 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.16 111.17 12.45 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.666 0.787 . . . . 63.24 111.359 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 150.25 26.83 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.153 1.902 . . . . 52.12 112.511 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p 40.45 82.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 126.274 1.83 . . . . 72.32 114.125 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 t -85.93 95.0 9.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 74.44 108.871 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -165.18 150.02 9.13 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.956 0.502 . . . . 75.32 111.265 -171.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -136.47 158.35 44.63 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.985 1.314 . . . . 65.32 108.897 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -80.66 87.83 5.77 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.65 -0.87 . . . . 75.34 108.65 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 65.68 9.3 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.573 0.749 . . . . 73.23 110.16 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.898 -1.046 . . . . 72.14 109.513 -176.002 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.62 ' H2 ' HD11 ' A' ' 1' ' ' ILE . 2.2 mp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.735 -0.839 . . . . 74.5 108.735 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.19 156.96 45.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.033 0.933 . . . . 74.13 108.979 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.43 139.3 35.28 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.82 0.848 . . . . 44.31 109.337 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.99 116.22 21.51 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.123 0.569 . . . . 73.32 109.62 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -72.73 100.75 2.92 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.249 -0.649 . . . . 74.03 109.249 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -76.65 126.75 31.52 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.551 -0.749 . . . . 74.42 109.973 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 140.37 38.11 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.002 0.921 . . . . 72.44 109.041 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.87 42.81 1.12 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.192 0.597 . . . . 73.5 110.265 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tt -61.03 -39.79 91.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 74.51 110.215 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -132.05 175.59 9.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 122.989 0.515 . . . . 73.24 111.477 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.0 p -62.0 115.73 4.32 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.287 -0.869 . . . . 51.12 110.137 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -90.13 122.02 32.71 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.221 0.608 . . . . 73.24 110.682 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 t -143.4 126.07 15.98 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.838 0.855 . . . . 73.22 109.267 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 t -93.37 99.6 12.08 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.247 0.619 . . . . 73.22 109.43 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.03 -148.11 50.83 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.516 0.51 . . . . 42.42 113.152 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.21 129.12 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.365 -0.976 . . . . 73.32 108.365 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.8 pt -102.03 119.01 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.368 -0.604 . . . . 72.41 109.368 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 p -97.49 5.98 48.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.609 0.764 . . . . 74.44 110.833 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.9 m -77.69 127.67 32.82 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.882 0.873 . . . . 65.14 109.798 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.78 111.12 10.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 107.274 -1.38 . . . . 71.52 107.274 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.43 139.06 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.186 -0.915 . . . . 75.22 109.022 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 124.63 36.9 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.005 0.816 . . . . 54.51 112.496 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.32 -34.29 70.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.508 0.723 . . . . 72.45 109.491 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.84 -34.13 77.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.781 0.832 . . . . 74.14 111.681 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.4 pt -92.06 3.61 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.049 -0.407 . . . . 70.42 112.067 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 45' ' ' ILE . 35.3 mm -78.96 132.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 108.546 -0.909 . . . . 73.42 108.546 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.15 -56.03 2.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.218 0.607 . . . . 72.33 109.893 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -144.83 155.88 43.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.328 0.651 . . . . 72.04 110.974 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.408 HD12 ' HG ' ' A' ' 65' ' ' LEU . 68.1 mt -113.73 112.05 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.759 1.223 . . . . 74.41 108.058 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -103.69 127.36 51.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.799 -0.815 . . . . 72.04 108.799 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.26 120.6 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.371 0.668 . . . . 72.34 109.406 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.1 m -95.12 110.35 49.65 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.549 -0.908 . . . . 71.11 108.549 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.49 156.44 64.03 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.871 2.38 . . . . 71.42 112.638 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.11 165.3 21.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.383 2.055 . . . . 75.51 112.026 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.43 -51.9 4.63 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.496 -0.32 . . . . 64.15 112.425 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -76.55 80.68 3.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.946 0.898 . . . . 75.12 110.856 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.3 -15.14 9.49 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.657 -0.701 . . . . 43.0 114.66 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.91 132.96 23.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.89 5.74 6.13 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.665 2.243 . . . . 74.1 112.912 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.2 159.61 42.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.404 1.082 . . . . 75.12 109.52 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -80.78 114.31 19.58 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.267 -1.012 . . . . 70.02 108.267 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.27 117.22 33.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 72.42 109.733 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.67 102.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.706 -0.85 . . . . 72.15 108.706 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.1 t -92.05 108.53 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.874 -1.158 . . . . 74.51 107.874 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 26' ' ' ILE . 60.2 mt -94.56 138.02 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.155 -0.683 . . . . 71.45 109.155 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -104.58 119.91 40.09 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.268 -1.382 . . . . 70.32 107.268 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.3 p -77.09 168.63 19.76 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.331 0.395 . . . . 74.44 110.215 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -73.47 -10.87 60.17 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.114 0.566 . . . . 73.34 111.226 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.72 -5.34 58.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.584 1.154 . . . . 71.13 110.127 168.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.97 18.91 10.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.16 1.784 . . . . 74.4 112.234 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -79.03 133.74 36.8 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.755 -0.657 . . . . 74.45 109.913 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.01 117.77 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.47 -1.241 . . . . 75.54 108.46 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.4 pt -126.64 148.05 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.258 0.623 . . . . 75.4 109.478 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -111.85 130.96 55.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.171 -1.048 . . . . 54.1 108.171 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.03 165.6 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.31 0.644 . . . . 73.32 110.25 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -74.35 135.55 75.85 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.274 0.629 . . . . 74.01 109.885 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.69 -29.07 69.1 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.762 2.308 . . . . 71.13 112.831 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -88.76 4.57 47.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.698 0.799 . . . . 75.3 112.313 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.1 120.31 8.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.837 -0.431 . . . . 72.41 109.837 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.49 -36.73 74.22 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.241 1.016 . . . . 70.42 113.078 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -68.46 -31.59 70.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.234 0.614 . . . . 74.23 111.106 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.72 -37.75 65.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.095 0.958 . . . . 75.22 110.84 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -42.69 82.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.891 0.877 . . . . 72.51 112.565 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -71.4 -27.69 63.5 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 116.112 -0.495 . . . . 75.03 111.464 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HG ' HD12 ' A' ' 29' ' ' ILE . 33.5 tp -78.28 -25.83 46.85 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.494 0.718 . . . . 74.22 110.097 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.09 -28.61 54.58 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.73 0.812 . . . . 75.21 109.99 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -74.49 -31.12 62.09 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.591 0.356 . . . . 75.25 110.544 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.57 -37.36 85.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.237 0.615 . . . . 73.35 111.514 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.39 -12.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 116.096 -0.502 . . . . 64.53 111.104 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.16 111.07 21.76 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.678 0.791 . . . . 74.32 109.881 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 p -89.73 130.14 36.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.449 0.699 . . . . 74.33 110.336 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -74.04 93.16 2.22 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.813 -0.81 . . . . 54.03 108.813 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 p -145.77 19.64 1.47 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.37 1.068 . . . . 73.31 109.965 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.37 73.58 0.41 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.88 1.272 . . . . 74.53 108.561 -168.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.8 m -70.97 106.88 3.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.622 -1.172 . . . . 71.42 109.631 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -80.05 154.32 28.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.144 0.578 . . . . 71.41 110.299 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.0 p -62.49 136.67 96.01 Favored Pre-proline 0 CA--C 1.556 1.192 0 O-C-N 123.959 0.787 . . . . 72.42 110.492 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.52 127.09 7.44 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.661 2.907 . . . . 60.54 114.153 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -82.39 13.31 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.911 0.884 . . . . 72.41 111.641 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.67 83.06 20.38 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.227 1.011 . . . . 74.41 108.301 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.17 160.5 47.14 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.301 2.001 . . . . 73.31 110.757 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.78 109.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.34 -0.985 . . . . 75.01 108.34 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.1 m -75.16 73.13 2.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.91 0.884 . . . . 61.44 111.128 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.25 104.35 13.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.077 -1.453 . . . . 53.43 107.077 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -114.97 150.33 35.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.415 0.686 . . . . 72.21 109.441 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 122.81 30.73 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.903 -1.147 . . . . 75.01 107.903 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -115.58 145.05 43.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.57 0.748 . . . . 75.1 109.403 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.445 0.698 . . . . 72.41 110.945 -179.452 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.617 -0.512 . . . . 73.41 109.617 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.97 103.06 9.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.737 -1.579 . . . . 73.35 106.737 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.95 90.13 2.98 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.44 -0.578 . . . . 63.13 109.44 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.64 142.78 58.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.231 0.613 . . . . 74.21 109.937 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -63.86 112.11 2.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.282 0.633 . . . . 72.32 109.304 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.16 137.45 54.89 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.109 0.963 . . . . 74.33 110.921 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -60.09 161.22 7.08 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.857 1.263 . . . . 74.24 112.386 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -102.01 174.71 5.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.689 0.796 . . . . 74.33 109.997 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp 65.67 26.12 11.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.886 1.274 . . . . 73.33 110.172 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -96.54 174.27 6.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.887 -1.051 . . . . 73.14 110.73 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.479 ' SG ' ' HB ' ' A' ' 32' ' ' THR . 72.7 m -76.23 125.28 28.87 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.784 0.833 . . . . 75.44 110.109 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -76.33 117.38 17.95 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.68 -0.859 . . . . 75.41 108.68 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.48 109.84 20.78 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.732 -1.21 . . . . 75.53 107.732 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -81.46 73.4 8.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 64.32 110.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.71 -142.53 48.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.492 -0.776 . . . . 71.21 113.181 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.87 153.74 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.75 0.82 . . . . 73.43 109.264 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.3 pp -128.69 131.28 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.249 0.547 . . . . 72.31 109.875 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -89.93 -10.16 46.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.726 0.811 . . . . 55.53 111.596 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 m -64.19 127.21 30.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.709 0.803 . . . . 72.32 111.247 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.65 114.26 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 108.276 -1.009 . . . . 75.33 108.276 172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.53 127.0 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.468 0.707 . . . . 74.42 109.63 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.0 160.67 17.7 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.777 -0.647 . . . . 52.4 113.378 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.6 -33.82 68.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.012 1.325 . . . . 63.13 111.215 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -58.97 -32.22 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.044 0.938 . . . . 73.34 111.865 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.11 5.83 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 112.435 0.532 . . . . 72.12 112.435 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.619 HG13 HD11 ' A' ' 65' ' ' LEU . 21.7 mm -77.42 113.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.786 -0.82 . . . . 71.53 108.786 170.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.58 -55.97 3.73 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.697 -0.482 . . . . 62.21 109.697 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -157.34 143.62 17.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.673 0.789 . . . . 75.21 109.891 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.7 mt -120.88 139.73 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.276 1.03 . . . . 75.23 109.493 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.41 143.09 47.39 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.682 -0.858 . . . . 73.15 108.682 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.2 138.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 109.229 -0.656 . . . . 72.21 109.229 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 71.8 p -119.9 143.2 34.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 123.626 0.77 . . . . 71.24 109.279 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.77 163.45 26.27 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.077 2.518 . . . . 75.51 113.652 -170.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.94 130.04 14.01 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.435 2.09 . . . . 75.03 110.878 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.68 -162.01 30.03 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.356 -0.698 . . . . 74.31 111.356 -170.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.35 17.48 11.0 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.03 0.932 . . . . 72.24 111.451 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.44 41.21 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.674 -0.694 . . . . 73.31 112.828 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.5 m -85.06 135.75 39.15 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.763 0.825 . . . . 61.43 109.398 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.55 -63.34 0.19 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.994 2.463 . . . . 75.22 113.333 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.548 ' HZ2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -132.66 -177.27 4.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.323 -0.991 . . . . 74.43 108.323 179.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' THR . 24.2 m -57.59 110.13 0.83 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.806 -0.813 . . . . 61.41 108.806 166.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -104.33 119.39 38.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.959 -0.756 . . . . 71.11 108.959 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.45 102.48 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.885 -0.783 . . . . 75.24 108.885 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.61 134.35 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.553 -0.906 . . . . 72.44 108.553 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 61.8 mt -133.01 125.54 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.329 -0.619 . . . . 72.12 109.329 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.82 123.43 36.08 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.064 -1.087 . . . . 73.44 108.064 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.0 p -84.58 179.46 7.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.247 0.619 . . . . 74.24 110.87 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.93 -24.41 64.28 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.119 0.568 . . . . 71.22 111.809 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.528 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 25.0 ptp -90.93 12.4 19.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.271 0.628 . . . . 72.5 110.766 172.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.56 22.44 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.839 1.656 . . . . 73.23 112.461 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HB2' ' HG3' ' A' ' 49' ' ' MET . 2.0 tmtp? -74.75 123.77 25.56 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.622 -1.622 . . . . 74.55 106.622 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.34 121.53 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.301 1.041 . . . . 72.42 108.523 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.417 ' HB ' HG12 ' A' ' 17' ' ' ILE . 30.0 pt -125.56 147.51 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 108.522 -0.918 . . . . 73.13 108.522 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.35 118.42 25.02 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.813 -1.18 . . . . 74.13 107.813 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.88 164.57 21.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.582 0.753 . . . . 74.1 109.911 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.45 147.56 92.74 Favored Pre-proline 0 N--CA 1.474 0.744 0 O-C-N 123.936 0.773 . . . . 74.04 110.186 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.42 -9.19 19.26 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.981 2.454 . . . . 74.11 113.582 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -111.44 26.15 10.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.989 0.916 . . . . 74.3 111.952 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 131.46 44.06 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 108.643 -0.873 . . . . 74.55 108.643 168.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.23 -47.94 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 71.33 112.844 -167.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.9 -24.47 64.31 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.673 0.389 . . . . 74.23 111.849 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.02 -32.13 72.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.033 0.533 . . . . 75.51 110.237 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.72 -23.63 67.44 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.172 0.589 . . . . 71.55 111.476 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -69.58 -40.55 76.67 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.415 0.686 . . . . 73.14 110.3 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.619 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -71.33 -34.73 70.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.499 0.72 . . . . 73.53 110.26 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.15 -37.81 72.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.539 0.736 . . . . 72.42 110.012 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.85 -40.82 97.47 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.755 0.822 . . . . 75.23 109.96 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -59.12 -40.65 86.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.565 1.146 . . . . 64.31 112.056 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -85.93 -14.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 115.9 -0.591 . . . . 73.13 112.346 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -25.42 11.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.716 0.406 . . . . 71.34 111.783 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.5 p -127.36 -159.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.176 0.591 . . . . 61.22 110.282 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -59.5 162.36 5.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.133 0.973 . . . . 73.34 112.276 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.0 t -144.77 153.82 42.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.586 -0.733 . . . . 64.24 110.923 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.74 104.0 14.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.907 -0.775 . . . . 74.43 108.907 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -72.02 113.99 9.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.996 0.919 . . . . 65.5 109.822 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -76.02 160.59 29.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.368 0.667 . . . . 74.11 110.19 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.8 p -61.17 132.05 92.31 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.499 1.12 . . . . 63.34 110.923 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.29 104.88 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.339 2.692 . . . . 74.53 112.297 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.09 127.06 37.42 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.673 -1.149 . . . . 74.13 110.229 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -118.69 107.01 43.2 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.912 0.885 . . . . 73.13 109.092 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.25 151.64 58.5 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.663 2.242 . . . . 55.32 112.317 171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.63 123.94 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.291 -0.633 . . . . 73.11 109.291 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -78.0 157.79 29.52 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.034 0.533 . . . . 64.35 109.684 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -60.19 122.31 14.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.585 0.754 . . . . 75.32 109.729 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 123.39 11.4 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.316 1.01 . . . . 75.55 110.986 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -111.01 111.91 23.36 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.512 0.725 . . . . 73.42 109.147 -171.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.03 81.71 0.67 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.85 -0.796 . . . . 54.12 108.85 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 C-N-CA 124.389 1.076 . . . . 65.22 110.283 -169.554 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 110.22 -0.289 . . . . 73.34 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -155.8 130.86 9.33 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.03 0.932 . . . . 74.2 108.546 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.78 157.74 27.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.212 0.605 . . . . 62.22 109.871 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.97 68.1 9.33 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.47 0.708 . . . . 61.43 110.469 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.79 121.77 41.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.062 -1.088 . . . . 74.24 108.062 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -97.97 -37.71 9.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.337 0.655 . . . . 74.31 109.955 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 t -149.39 144.1 26.17 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.608 -0.724 . . . . 75.14 110.366 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -127.04 115.48 19.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.646 1.178 . . . . 72.44 107.833 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.59 135.75 50.07 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.767 0.427 . . . . 73.24 111.013 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 pttt 179.74 174.25 0.85 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.918 1.687 . . . . 74.4 108.145 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 32' ' ' THR . 11.2 m -81.59 121.21 26.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.564 0.746 . . . . 38.27 109.638 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -78.99 138.14 37.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.916 -0.772 . . . . 74.11 108.916 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.76 148.3 33.96 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.546 0.739 . . . . 63.43 110.431 -170.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 t -83.8 -28.18 28.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.995 0.918 . . . . 65.23 110.611 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.63 174.89 15.73 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 109.849 -1.3 . . . . 71.13 109.849 -173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.3 m -101.76 147.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 117.273 0.537 . . . . 75.53 110.468 -173.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.95 131.98 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.853 -0.612 . . . . 74.22 109.531 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -85.73 -47.94 9.3 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.524 0.73 . . . . 72.43 110.017 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 122.26 28.2 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.011 0.924 . . . . 74.23 108.822 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -54.54 113.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.688 0.795 . . . . 73.13 111.502 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.77 141.6 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.691 -0.686 . . . . 75.22 109.98 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.19 131.23 32.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.674 0.609 . . . . 70.15 112.569 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.1 -33.13 68.77 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.159 0.984 . . . . 74.31 109.716 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.06 -34.48 77.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.203 1.001 . . . . 73.24 111.815 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -95.4 16.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 122.222 -0.299 . . . . 71.5 111.395 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 45' ' ' ILE . 50.4 mm -79.94 129.22 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.006 -0.738 . . . . 74.15 109.006 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -94.89 -56.13 2.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 64.24 110.535 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -156.03 142.47 18.52 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.737 -0.665 . . . . 72.12 109.414 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -108.82 138.13 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.392 1.077 . . . . 75.14 108.821 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -136.66 111.55 8.86 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.687 -0.857 . . . . 72.44 108.687 171.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.9 123.15 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.102 -0.703 . . . . 74.03 109.102 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.47 HG23 ' SG ' ' A' ' 11' ' ' CYS . 22.3 m -87.28 110.88 37.2 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.043 0.937 . . . . 71.44 109.241 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.41 154.14 55.75 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.911 2.407 . . . . 74.35 112.877 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.25 164.81 33.35 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.353 2.035 . . . . 63.43 112.235 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.49 4.8 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.144 -0.48 . . . . 73.43 112.712 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.51 88.94 0.35 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.271 1.028 . . . . 55.32 110.451 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.9 -18.54 3.87 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.067 0.841 . . . . 64.4 114.625 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.2 m -139.19 132.62 15.8 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 63.3 109.43 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.5 -9.97 20.25 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.734 2.289 . . . . 73.03 112.088 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 10.3 mmpt? -116.1 137.64 51.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.165 0.986 . . . . 73.43 110.248 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.5 m -69.19 138.48 54.11 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.725 0.81 . . . . 70.23 109.423 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.23 145.99 49.68 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.274 -1.01 . . . . 72.34 108.274 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.19 103.32 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.067 -1.086 . . . . 74.55 108.067 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.04 124.05 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.235 -1.024 . . . . 73.23 108.235 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 26' ' ' ILE . 66.8 mt -119.39 137.22 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 123.271 0.628 . . . . 60.32 110.002 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -91.62 131.93 36.68 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.923 -1.14 . . . . 75.01 107.923 166.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.5 p -86.43 172.07 10.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.368 0.667 . . . . 74.31 109.895 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -75.61 -7.61 54.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.372 0.669 . . . . 72.51 111.328 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.5 mtm -83.61 -7.09 59.58 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.942 0.897 . . . . 75.53 109.435 167.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 65.18 24.6 12.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.207 1.803 . . . . 74.33 110.536 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.46 125.97 32.84 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.737 -1.579 . . . . 73.14 106.737 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.53 122.85 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.101 -1.074 . . . . 75.44 108.101 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -127.19 155.89 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.648 -0.871 . . . . 73.02 108.648 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 39.6 m -111.63 151.19 29.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.91 -1.515 . . . . 64.45 106.91 165.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.06 129.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.602 -1.259 . . . . 71.31 107.602 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.478 HD21 ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -54.07 129.08 57.96 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.493 0.717 . . . . 65.11 109.734 176.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.02 -14.45 41.6 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.511 2.141 . . . . 63.01 113.59 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -85.91 3.89 39.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.081 0.552 . . . . 74.11 111.947 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 120.85 10.53 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 123.414 0.686 . . . . 61.13 109.747 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.23 -31.54 71.97 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.762 1.225 . . . . 74.22 112.082 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -79.51 -23.51 42.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.25 1.02 . . . . 73.32 111.418 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.96 -27.58 68.35 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.892 0.877 . . . . 71.53 111.347 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.1 -35.86 69.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.817 0.847 . . . . 75.53 111.545 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -69.0 -34.06 74.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.405 0.682 . . . . 74.22 110.57 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.4 mp -70.22 -41.7 73.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.248 -0.649 . . . . 62.33 109.248 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.77 -38.35 88.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.749 0.82 . . . . 75.35 110.516 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -63.72 -34.16 77.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.863 0.865 . . . . 74.31 110.785 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -71.98 -33.71 68.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.922 0.489 . . . . 72.3 110.619 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 65' ' ' LEU . 97.4 t -71.99 -30.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.348 0.659 . . . . 71.05 109.414 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -71.88 90.19 1.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.854 -1.165 . . . . 73.5 107.854 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.3 p -108.86 177.86 4.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.776 1.231 . . . . 71.32 110.886 -170.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.94 151.22 40.42 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.517 0.727 . . . . 74.11 109.298 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 p -69.14 76.1 0.34 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.724 1.21 . . . . 72.23 111.753 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.69 131.47 40.9 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.63 1.172 . . . . 73.32 108.065 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.0 p -66.43 90.37 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.302 0.641 . . . . 72.5 110.167 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.4 t -63.26 113.45 3.2 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.491 1.116 . . . . 73.24 110.28 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.0 t -79.02 141.2 58.28 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 118.421 -0.799 . . . . 73.51 109.142 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.76 83.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.723 2.282 . . . . 75.4 112.425 171.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.2 -20.78 54.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.514 -0.766 . . . . 74.22 111.014 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.08 84.33 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.233 0.613 . . . . 54.03 109.621 174.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.03 150.67 38.38 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.269 1.979 . . . . 75.12 112.007 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.91 110.64 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.67 -1.233 . . . . 72.54 107.67 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.0 t -137.22 168.34 19.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.044 0.938 . . . . 64.01 109.992 -171.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -66.36 129.08 38.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.463 0.705 . . . . 73.24 111.828 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -120.93 98.41 5.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.714 1.205 . . . . 72.11 107.845 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -72.58 -40.02 66.93 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.692 -0.855 . . . . 71.43 108.692 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.94 164.5 15.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.845 -1.07 . . . . 62.1 110.215 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.893 0 C-N-CA 124.385 1.074 . . . . 64.41 108.954 177.09 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.533 ' H2 ' HD13 ' A' ' 1' ' ' ILE . 3.7 mp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.164 -1.05 . . . . 54.34 108.164 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.0 mt -102.53 124.5 48.19 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.498 -0.927 . . . . 74.2 108.498 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.9 134.99 35.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.119 0.567 . . . . 65.11 110.631 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.96 97.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.037 0.935 . . . . 72.4 111.565 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -66.49 123.4 19.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.284 -0.636 . . . . 65.25 109.284 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.59 138.91 41.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.44 -0.578 . . . . 70.42 109.44 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -82.74 155.13 24.44 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 123.886 0.741 . . . . 74.51 110.346 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -74.69 -3.97 34.57 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.632 0.773 . . . . 64.42 111.481 175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.28 149.71 44.97 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.114 0.965 . . . . 73.22 111.358 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -53.87 131.48 40.0 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.048 -0.978 . . . . 75.0 110.618 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' HG3' ' A' ' 40' ' ' LYS . 26.3 p -67.32 135.57 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.222 1.009 . . . . 65.14 112.02 -169.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -91.79 161.55 14.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.126 . . . . 74.32 109.635 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 t -94.76 119.96 34.21 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.501 -1.296 . . . . 74.35 107.501 165.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 t -72.36 94.18 1.59 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.277 0.631 . . . . 61.42 111.08 -170.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.1 67.6 0.24 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.708 -0.557 . . . . 42.34 111.708 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.62 170.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.541 0.737 . . . . 71.03 110.882 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.53 147.42 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.37 0.668 . . . . 73.0 110.822 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.9 p -108.76 17.71 21.57 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.974 0.909 . . . . 64.12 110.679 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t -143.9 150.09 37.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.909 0.884 . . . . 73.31 109.176 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.02 130.49 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 108.99 -0.745 . . . . 75.45 108.99 168.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.34 147.22 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.525 -0.916 . . . . 74.33 108.525 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.44 118.99 10.42 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.568 0.543 . . . . 72.54 112.836 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.32 -34.49 73.89 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.686 0.794 . . . . 75.44 110.216 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.67 -32.36 73.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.831 0.852 . . . . 75.55 111.765 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.11 15.03 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 111.733 0.271 . . . . 73.34 111.733 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.72 122.88 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.989 -0.745 . . . . 60.44 108.989 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.69 -56.24 3.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.101 -0.703 . . . . 74.2 109.101 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -160.86 137.06 8.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.327 -0.851 . . . . 74.11 110.44 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.69 108.54 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 108.68 -0.859 . . . . 75.43 108.68 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -101.63 115.28 30.16 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.425 -0.954 . . . . 72.22 108.425 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -85.94 121.88 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 107.96 -1.126 . . . . 74.02 107.96 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 m -105.68 126.3 31.11 Favored Pre-proline 0 C--O 1.247 0.973 0 C-N-CA 123.572 0.749 . . . . 75.21 109.777 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.02 153.3 58.87 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.541 2.16 . . . . 75.32 112.219 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HB3' ' H ' ' A' ' 40' ' ' LYS . 11.1 Cg_endo -52.76 92.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.419 2.746 . . . . 73.15 114.109 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.4 14.52 10.07 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.334 -0.848 . . . . 75.43 111.487 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -73.23 -14.53 61.36 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.427 1.091 . . . . 74.43 111.124 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.03 -14.66 48.55 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.834 0.73 . . . . 61.14 111.289 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -131.54 156.73 79.73 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.335 1.454 . . . . 75.51 109.002 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.52 81.96 0.55 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.085 2.523 . . . . 74.31 112.325 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 27.8 mmmt -142.77 121.26 12.44 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.946 0.898 . . . . 74.44 110.087 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 m -79.23 114.74 18.41 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.995 -1.113 . . . . 73.13 107.995 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -94.56 108.29 20.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.526 -0.916 . . . . 75.51 108.526 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.8 101.57 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.3 -1.0 . . . . 64.04 108.3 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.2 t -96.2 108.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.359 -0.837 . . . . 64.32 109.057 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.0 mt -104.75 121.92 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.925 -0.769 . . . . 74.41 108.925 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -95.23 131.71 40.99 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 124.175 0.99 . . . . 75.2 108.899 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.8 p -90.46 169.75 10.79 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 123.214 0.606 . . . . 73.13 110.278 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -73.37 -17.13 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.637 0.775 . . . . 74.1 110.891 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.7 mtt -79.86 6.72 10.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.482 0.713 . . . . 73.32 110.837 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 65.7 17.21 10.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.486 1.114 . . . . 75.05 111.877 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -91.8 130.28 37.6 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.357 -0.979 . . . . 75.34 108.357 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -85.92 128.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.207 -0.906 . . . . 71.45 109.84 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.446 HG13 ' HB ' ' A' ' 45' ' ' ILE . 42.8 pt -128.53 156.08 40.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 108.013 -1.106 . . . . 72.12 108.013 167.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -133.07 136.02 45.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.962 -0.755 . . . . 70.32 108.962 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.43 163.57 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.507 0.723 . . . . 71.41 109.728 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -86.0 146.18 42.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.78 -1.1 . . . . 72.42 108.391 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.16 -10.06 24.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.074 2.516 . . . . 75.23 113.522 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -75.2 -12.54 60.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.139 0.576 . . . . 70.24 111.712 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.96 115.36 2.36 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.09 0.956 . . . . 72.24 110.573 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -66.32 -32.6 74.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.21 112.278 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.3 p-90 -70.92 -26.23 63.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.933 0.493 . . . . 75.34 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.4 -30.17 70.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 75.33 110.761 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -59.26 -27.07 65.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 63.13 111.399 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -62.63 -47.54 83.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.863 0.727 . . . . 75.4 110.037 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.3 mm? -69.84 -46.52 65.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.15 -0.932 . . . . 73.45 110.189 -177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.22 -46.16 90.72 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.1 0.875 . . . . 74.13 111.222 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -79.03 -18.35 53.71 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.965 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.26 -30.43 64.85 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.469 0.308 . . . . 75.22 110.473 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 65' ' ' LEU . 49.0 t -68.65 -23.62 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 109.805 -0.443 . . . . 72.42 109.805 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.71 85.12 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.901 0.858 . . . . 70.12 109.553 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 t -117.77 174.62 6.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.565 -1.198 . . . . 74.4 109.303 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -76.99 172.29 13.42 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.919 0.488 . . . . 71.43 110.901 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.5 m -68.14 85.66 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.386 0.675 . . . . 64.43 110.586 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 mt -82.24 83.7 7.32 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.674 -1.232 . . . . 75.01 107.674 175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.4 t -65.76 98.54 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.969 -1.014 . . . . 72.1 110.204 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 p -75.28 161.16 29.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.061 -0.972 . . . . 74.55 110.19 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -77.04 151.6 81.87 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.158 0.583 . . . . 74.14 110.041 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.18 148.47 49.38 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.33 112.498 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -140.91 130.52 24.06 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.399 0.68 . . . . 74.22 109.948 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.57 123.48 66.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.643 0.777 . . . . 61.43 109.744 175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.09 107.84 0.29 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.622 2.215 . . . . 74.44 112.202 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.95 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.789 -0.641 . . . . 72.52 110.328 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.0 p -166.89 84.26 0.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.315 0.646 . . . . 63.3 110.387 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -86.15 107.58 17.93 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.058 0.543 . . . . 71.41 110.045 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -73.03 99.0 2.64 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.032 -0.729 . . . . 73.24 109.032 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.29 115.94 11.04 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.413 -0.958 . . . . 73.13 108.413 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.55 105.58 1.54 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.106 -1.072 . . . . 70.11 108.106 169.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 O-C-N 124.35 1.031 . . . . 72.52 111.014 -173.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.573 -0.529 . . . . 75.34 109.573 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -76.43 -12.46 60.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.01 0.524 . . . . 75.12 111.42 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.12 145.29 46.53 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.101 -0.703 . . . . 64.44 109.101 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.63 -178.25 6.15 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.462 0.705 . . . . 73.54 110.348 -172.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -68.54 127.8 34.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.482 0.713 . . . . 73.41 110.85 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -110.78 128.97 55.95 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.804 1.242 . . . . 73.5 109.575 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -89.43 112.8 24.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.592 0.757 . . . . 70.42 110.188 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.74 -60.48 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.777 -0.453 . . . . 74.14 109.777 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 53.4 65.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.066 1.346 . . . . 75.02 112.662 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -163.99 -173.72 3.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.23 1.012 . . . . 75.31 109.257 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 32' ' ' THR . 2.6 m -53.02 137.57 32.7 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.092 0.957 . . . . 73.11 109.699 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -65.32 118.34 9.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.3 m -143.7 132.04 22.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 71.13 109.662 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 t -102.98 39.02 1.62 Allowed 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.343 -0.984 . . . . 65.24 108.343 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.18 -149.07 24.77 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.211 -0.904 . . . . 37.32 111.037 -171.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.56 170.08 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.911 0.884 . . . . 74.33 109.76 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 19' ' ' THR . 2.6 pp -81.82 150.64 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.283 0.563 . . . . 70.12 110.524 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.5 p -113.65 8.18 17.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.037 0.935 . . . . 63.03 111.435 171.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.408 ' O ' HD12 ' A' ' 17' ' ' ILE . 41.0 m -136.71 129.7 30.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.913 0.885 . . . . 75.12 109.251 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.3 t -65.85 113.3 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.658 -0.867 . . . . 63.34 108.658 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -77.01 126.59 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.186 -0.915 . . . . 72.34 110.554 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.03 137.4 38.39 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.924 0.765 . . . . 62.33 113.596 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.3 -36.53 71.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.022 0.929 . . . . 75.13 110.39 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -61.82 -34.18 75.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.852 0.861 . . . . 72.24 111.98 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.52 -4.82 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 119.278 -0.392 . . . . 70.31 111.742 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.3 mm -68.51 114.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.832 -0.803 . . . . 73.34 108.832 171.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -89.81 -52.85 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.412 -0.588 . . . . 74.32 109.412 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.647 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 6.2 ptp180 -152.05 145.63 24.93 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.3 -0.409 . . . . 62.5 110.3 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.51 108.63 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.838 -1.171 . . . . 74.33 107.838 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -103.0 121.93 43.57 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.772 -0.825 . . . . 72.31 108.772 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.53 113.54 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.837 -1.171 . . . . 72.41 107.837 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.502 HG21 ' SG ' ' A' ' 11' ' ' CYS . 7.2 m -96.4 106.91 32.42 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 109.59 -0.522 . . . . 74.31 109.59 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.41 163.82 37.45 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.104 1.869 . . . . 74.35 111.522 174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 97.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.468 2.778 . . . . 74.52 112.98 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -92.22 0.09 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.413 -0.358 . . . . 63.14 113.164 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.77 79.34 6.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.384 0.673 . . . . 72.44 111.692 -170.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.32 -20.85 3.82 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.105 -0.952 . . . . 73.23 114.638 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.7 m -89.73 114.54 61.03 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 108.503 -0.925 . . . . 64.33 108.503 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HG2' ' HD2' ' A' ' 40' ' ' LYS . 89.9 Cg_endo -83.41 -6.54 10.93 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.614 2.209 . . . . 52.43 113.504 -175.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HD2' ' HG2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.87 172.09 12.05 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.084 0.954 . . . . 73.33 109.209 175.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.3 m -73.05 115.61 12.58 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.679 -0.692 . . . . 64.32 110.183 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -124.04 114.44 19.74 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.223 1.009 . . . . 70.12 108.479 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.43 104.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.923 0.489 . . . . 74.33 110.063 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG12 ' SG ' ' A' ' 54' ' ' CYS . 35.3 m -92.37 111.69 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.814 0.816 . . . . 75.22 109.238 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.71 134.53 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.264 0.626 . . . . 74.23 109.565 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.647 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 66.4 m95 -96.34 130.03 43.54 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.332 -0.988 . . . . 74.43 108.332 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 78.3 p -84.13 169.02 15.28 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.477 0.486 . . . . 73.04 109.704 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -21.47 66.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.178 0.591 . . . . 74.5 110.533 172.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.0 mtm -85.02 2.35 43.55 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.829 1.252 . . . . 75.42 110.915 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.86 38.57 11.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.895 1.678 . . . . 73.31 112.704 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -90.73 135.65 33.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.472 -1.24 . . . . 70.15 109.467 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -98.1 115.8 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.429 -0.952 . . . . 75.55 108.429 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 46.4 pt -119.16 149.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.291 0.636 . . . . 70.03 109.478 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 44' ' ' VAL . 92.6 m -115.07 117.83 31.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.391 0.676 . . . . 70.44 109.532 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.55 154.29 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.274 1.03 . . . . 73.44 108.877 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -77.21 148.26 77.66 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.874 0.47 . . . . 74.3 110.477 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -64.47 -13.67 39.86 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.879 2.386 . . . . 64.31 113.078 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -107.42 18.41 21.59 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.716 0.806 . . . . 71.53 111.871 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.84 123.21 19.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.851 -1.166 . . . . 74.31 107.851 167.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -56.25 -44.52 79.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.219 1.008 . . . . 74.31 112.19 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.0 p-90 -64.24 -38.16 90.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.814 0.445 . . . . 74.14 111.135 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.93 -33.65 76.06 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.559 0.744 . . . . 74.2 110.99 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -54.26 -38.61 66.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 72.03 111.132 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.48 -37.95 86.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.643 . . . . 74.43 110.372 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.81 -41.93 91.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.767 0.827 . . . . 73.44 109.924 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 -24.97 62.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.231 1.012 . . . . 73.44 110.984 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -83.46 -35.64 24.78 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.951 0.5 . . . . 55.31 109.844 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -75.88 -23.13 55.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.957 0.503 . . . . 74.35 111.626 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 5.4 p -77.22 -17.86 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 110.032 -0.359 . . . . 75.11 110.032 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.68 138.41 40.01 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.35 -0.982 . . . . 75.33 108.35 168.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.466 ' HG ' ' HB2' ' A' ' 74' ' ' LEU . 11.9 t 63.65 37.97 9.78 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.484 1.114 . . . . 73.32 109.23 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 59.3 tttm -59.64 -36.95 77.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.72 1.608 . . . . 74.23 112.337 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.8 p -121.87 73.2 1.06 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.777 0.831 . . . . 75.01 109.19 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 71' ' ' SER . 50.8 tp -95.12 142.85 27.09 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.942 -1.026 . . . . 65.01 108.471 173.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.5 p -60.65 107.74 0.73 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.592 -0.522 . . . . 71.11 109.592 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.4 t -69.82 151.46 45.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.927 -0.579 . . . . 62.54 109.915 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.0 p -78.18 156.71 78.98 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.406 0.682 . . . . 74.51 110.018 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 -171.12 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.127 1.885 . . . . 62.31 112.942 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -139.08 28.67 2.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.784 0.834 . . . . 74.44 110.101 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 72.03 134.86 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 125.48 1.512 . . . . 62.22 111.604 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.85 177.78 2.71 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 123.043 2.495 . . . . 72.44 112.376 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.76 107.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.573 0 CA-C-O 122.018 0.913 . . . . 72.42 112.855 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -78.03 111.89 14.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.555 -1.202 . . . . 72.13 109.274 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -74.93 100.25 4.07 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.109 0.564 . . . . 73.54 109.959 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -69.04 147.26 51.79 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.343 -0.844 . . . . 74.02 109.8 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -65.83 100.87 0.59 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.792 0.683 . . . . 64.42 110.078 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.7 175.97 8.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.918 0.887 . . . . 75.42 109.84 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.422 0.689 . . . . 75.52 109.53 -178.062 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 112.286 0.476 . . . . 74.51 112.286 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -69.68 102.71 1.94 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.438 0.695 . . . . 73.41 110.387 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.92 131.63 36.1 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.317 1.047 . . . . 74.1 111.438 172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.54 133.93 35.19 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.352 0.661 . . . . 75.21 111.154 -173.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.1 -60.07 1.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.393 1.077 . . . . 72.23 109.71 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -66.75 -46.94 73.79 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.708 0.63 . . . . 72.44 110.293 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -83.34 137.31 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.636 -0.875 . . . . 54.22 108.636 168.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -93.71 107.3 19.19 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.978 -1.119 . . . . 75.45 107.978 169.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.31 -46.17 81.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.679 -0.86 . . . . 73.02 108.679 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 14.0 ptmm? -98.8 171.67 7.94 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.597 -0.728 . . . . 75.42 110.478 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 5.5 p -59.99 149.98 30.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.705 1.202 . . . . 60.21 111.485 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' NH2' HE22 ' A' ' 30' ' ' GLN . 24.6 ttp180 -64.78 118.81 9.51 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.878 0.736 . . . . 72.21 110.411 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t -146.32 107.17 4.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.611 -1.177 . . . . 60.14 107.91 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -86.71 40.51 0.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.138 0.975 . . . . 65.4 111.188 -174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.21 165.65 12.82 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.826 -0.624 . . . . 74.42 112.284 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -100.0 168.61 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 109.282 -0.636 . . . . 73.41 109.282 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.92 138.15 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.129 0.572 . . . . 71.41 110.086 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -98.18 7.04 46.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.796 0.839 . . . . 73.23 109.638 172.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -118.28 128.61 54.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.293 1.037 . . . . 65.01 109.283 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.44 126.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 109.156 -0.683 . . . . 74.2 109.156 170.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.65 142.21 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 122.803 0.441 . . . . 71.5 110.167 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.66 135.82 15.95 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.268 -0.424 . . . . 41.01 112.35 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.35 -34.25 70.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.45 0.7 . . . . 72.02 109.962 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -62.25 -32.64 73.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.295 1.038 . . . . 65.24 112.309 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -98.42 4.18 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 111.905 0.335 . . . . 74.12 111.905 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 45' ' ' ILE . 32.7 mm -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.371 -0.603 . . . . 74.35 109.371 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.32 -57.95 2.1 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.796 -0.446 . . . . 55.25 109.796 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -145.9 144.37 30.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.043 0.937 . . . . 75.23 109.364 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -107.9 109.33 27.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.226 -1.027 . . . . 73.24 108.226 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.457 HE22 ' NH2' ' A' ' 12' ' ' ARG . 31.7 tt0 -93.06 127.2 38.51 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.535 -0.913 . . . . 74.33 108.535 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.6 111.51 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 107.956 -1.127 . . . . 74.3 107.956 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 m -113.74 127.28 27.0 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 109.143 -0.688 . . . . 72.11 109.143 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.24 154.44 5.78 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.574 3.516 . . . . 74.41 114.159 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.97 -177.05 2.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.224 2.616 . . . . 71.32 113.63 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.13 76.55 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.018 -0.537 . . . . 52.53 113.288 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -90.51 72.35 6.91 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.465 -0.939 . . . . 62.45 108.465 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 10' ' ' LYS . . . 77.42 -13.45 11.12 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.384 -0.676 . . . . 73.31 114.601 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.53 146.39 47.84 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.915 0.886 . . . . 71.22 109.874 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HD2' ' HZ1' ' A' ' 40' ' ' LYS . 5.3 Cg_exo -75.04 -7.56 19.23 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.239 2.626 . . . . 73.32 113.915 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HZ1' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mppt? -100.13 150.45 22.49 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.095 0.558 . . . . 71.41 109.994 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.9 m -67.57 134.16 50.74 Favored 'General case' 0 C--O 1.242 0.666 0 O-C-N 123.93 0.768 . . . . 75.12 109.757 170.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 6.4 pt-20 -87.88 119.79 28.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.099 -0.704 . . . . 74.11 109.099 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.77 103.5 15.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.265 -1.013 . . . . 63.15 108.265 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.22 114.56 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.779 -0.823 . . . . 73.34 108.779 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.61 HG23 HD13 ' A' ' 26' ' ' ILE . 54.7 mt -95.06 121.61 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.351 -0.611 . . . . 74.21 109.351 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -86.95 123.67 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.912 -1.144 . . . . 72.45 107.912 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.417 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 46.3 p -87.78 179.22 6.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.015 0.526 . . . . 71.5 111.016 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.76 -14.08 60.67 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.374 0.67 . . . . 72.21 111.737 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -94.5 0.94 55.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.551 0.74 . . . . 74.11 110.33 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.18 23.6 10.9 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.879 1.671 . . . . 73.51 112.909 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 50.1 tttp -71.52 123.81 23.25 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.877 -1.157 . . . . 63.22 107.877 169.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t -96.01 111.26 25.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.468 -1.308 . . . . 71.13 107.468 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.19 136.89 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.515 -0.92 . . . . 73.22 108.515 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.61 117.55 34.4 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.003 -1.11 . . . . 64.42 108.003 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.81 164.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 74.22 109.812 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.44 141.43 73.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.324 -0.621 . . . . 73.21 109.324 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.06 -23.95 78.44 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.782 2.321 . . . . 64.03 112.765 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.71 31.48 5.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.591 0.757 . . . . 71.11 110.663 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 126.06 27.39 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -68.68 -30.17 68.79 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.614 0.766 . . . . 73.15 112.936 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -74.1 -23.36 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.986 0.514 . . . . 70.14 111.603 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.97 -21.81 65.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.841 0.856 . . . . 74.2 110.631 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -58.18 -30.8 66.7 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.105 0.962 . . . . 75.4 111.522 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -65.59 -36.93 85.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.408 0.683 . . . . 75.23 110.708 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.62 -37.28 65.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.272 0.629 . . . . 75.12 109.687 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -67.55 -33.27 74.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.776 0.83 . . . . 74.13 110.51 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -74.65 -36.96 62.85 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.899 1.28 . . . . 75.3 110.552 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -69.32 -35.43 75.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.441 0.697 . . . . 74.43 111.038 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.98 -7.81 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 116.18 -0.464 . . . . 75.23 111.233 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.18 124.97 34.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.05 -0.722 . . . . 62.32 109.05 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.7 t -108.51 147.58 31.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.908 0.483 . . . . 63.3 110.303 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -146.55 119.02 8.45 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.66 1.184 . . . . 71.44 108.057 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -67.04 134.17 51.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.544 -0.909 . . . . 72.34 108.544 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.48 97.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.743 0.817 . . . . 73.42 110.287 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 m -116.02 178.96 4.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.858 0.863 . . . . 71.11 111.226 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -70.5 92.72 0.84 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.461 0.704 . . . . 71.14 109.601 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 t -101.89 107.08 50.74 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.82 0.848 . . . . 73.13 110.505 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.57 126.67 19.67 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.894 2.396 . . . . 75.44 113.118 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.0 145.73 29.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.507 0.723 . . . . 72.33 110.261 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.35 148.32 88.27 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.539 0.736 . . . . 60.54 109.515 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -55.51 137.97 79.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.935 2.424 . . . . 75.33 112.098 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.79 92.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 122.168 0.985 . . . . 73.24 110.905 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 p -68.72 141.62 55.22 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.282 -1.326 . . . . 64.23 109.571 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.01 148.11 44.82 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.298 0.639 . . . . 73.04 110.182 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -75.1 102.84 5.05 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.094 -1.447 . . . . 75.54 107.094 170.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -56.61 101.85 0.07 Allowed 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.35 1.06 . . . . 64.51 110.512 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.37 147.99 35.8 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.392 0.677 . . . . 74.43 110.491 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 C-N-CA 123.491 0.716 . . . . 73.04 110.054 179.116 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.643 -0.502 . . . . 73.11 109.643 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.49 162.8 13.49 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.43 0.692 . . . . 73.14 110.292 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.11 85.49 2.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.687 0.756 . . . . 71.43 109.934 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.37 119.8 8.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.078 -0.964 . . . . 55.4 110.104 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -59.79 -24.9 64.5 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.66 0.784 . . . . 73.24 111.737 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 t80 61.07 59.48 2.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.587 1.155 . . . . 74.34 110.688 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -76.06 84.32 2.93 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 123.17 1.462 . . . . 64.42 110.786 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -118.96 18.87 13.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.198 -1.364 . . . . 73.44 110.737 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.93 -18.7 65.46 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.294 0.638 . . . . 73.52 111.025 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.741 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -88.05 127.43 35.4 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.351 -0.981 . . . . 73.12 108.351 172.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 39.8 m -58.28 124.52 19.77 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.864 0.865 . . . . 64.0 111.611 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -90.68 120.15 31.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.203 0.601 . . . . 75.22 110.558 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.3 t -140.34 167.8 21.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.928 0.891 . . . . 70.13 109.451 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -110.28 10.14 23.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.907 0.883 . . . . 54.22 109.915 174.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.69 -82.5 1.07 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.778 0.704 . . . . 71.04 111.415 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.85 168.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.536 1.134 . . . . 72.51 109.955 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.9 pt -123.75 144.07 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.805 -0.813 . . . . 75.34 108.805 167.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -77.24 -41.05 42.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.535 0.734 . . . . 64.15 111.328 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.5 p -81.85 144.71 30.82 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.223 1.009 . . . . 75.5 111.632 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.7 t -85.4 115.42 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.499 -0.926 . . . . 73.52 108.499 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.6 134.17 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.625 0.77 . . . . 65.14 109.523 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.13 140.07 30.51 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.762 0.664 . . . . 72.33 114.23 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.22 -37.15 71.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.996 0.918 . . . . 70.54 110.907 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.14 -21.63 60.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.404 0.682 . . . . 74.41 112.099 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.38 4.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 122.173 -0.329 . . . . 73.42 111.276 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 45' ' ' ILE . 47.2 mm -74.23 123.4 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.842 0.857 . . . . 74.12 108.94 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.28 -55.92 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.999 0.52 . . . . 74.11 110.604 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -149.4 136.21 19.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.912 0.485 . . . . 54.21 110.165 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.94 145.01 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.476 1.11 . . . . 74.03 109.296 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -136.55 126.11 25.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.182 0.993 . . . . 75.2 108.543 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.87 112.54 40.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.445 0.698 . . . . 73.33 109.293 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 22.4 m -87.59 123.63 69.1 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.515 0.726 . . . . 72.02 109.489 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.35 139.94 67.82 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.28 2.653 . . . . 73.5 113.789 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.78 99.99 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.292 2.662 . . . . 72.03 112.544 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.52 -45.74 0.26 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.985 -0.552 . . . . 44.23 112.207 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.482 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.5 t30 -83.03 75.01 9.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.578 0.751 . . . . 62.52 110.582 -173.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.741 ' HA3' ' HA ' ' A' ' 10' ' ' LYS . . . 85.18 -18.67 26.7 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.709 0.643 . . . . 41.05 114.709 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.9 p -122.42 130.82 24.52 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.749 0.82 . . . . 73.23 108.957 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.48 -4.83 13.18 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.73 2.287 . . . . 73.55 113.352 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -123.06 161.56 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.83 0.852 . . . . 75.12 110.392 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.4 m -69.31 113.78 6.96 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.961 -0.755 . . . . 72.01 108.961 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 40.8 tt0 -96.49 130.44 43.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.351 0.66 . . . . 73.51 109.518 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.88 101.36 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.159 -1.052 . . . . 70.31 108.159 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -108.1 125.13 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.802 0.841 . . . . 72.15 109.037 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.57 HG23 HD12 ' A' ' 26' ' ' ILE . 63.2 mt -118.72 129.66 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.405 0.682 . . . . 72.55 109.829 -175.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -86.96 124.73 33.48 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.44 ' HG1' ' HB3' ' A' ' 51' ' ' LYS . 47.5 p -81.96 173.53 12.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.228 0.611 . . . . 62.42 109.573 172.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.66 -12.0 60.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.943 0.402 . . . . 73.34 110.919 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -85.98 1.91 48.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.939 0.896 . . . . 74.42 110.773 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 67.72 11.69 8.49 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.589 1.556 . . . . 65.32 111.618 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HB3' ' HG1' ' A' ' 47' ' ' THR . 5.1 ttmp? -73.45 126.02 29.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.991 -0.744 . . . . 73.33 108.991 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.07 102.51 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.476 -1.305 . . . . 74.42 107.476 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.6 pt -98.92 154.01 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.361 -0.978 . . . . 74.32 108.361 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 t -135.46 128.79 32.11 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.948 -1.13 . . . . 63.21 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.3 160.11 29.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 123.919 0.888 . . . . 75.34 109.51 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.491 HD21 ' N ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.6 148.32 65.51 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.109 -1.071 . . . . 75.24 108.109 173.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.59 -28.19 64.02 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.76 2.306 . . . . 75.4 113.997 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -90.5 2.58 55.59 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.42 0.526 . . . . 72.51 112.42 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.31 30.84 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.796 0.839 . . . . 65.51 112.277 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -50.64 37.87 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.391 1.476 . . . . 74.43 112.334 -162.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -76.2 -20.19 57.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.046 0.139 . . . . 75.52 111.182 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.82 -28.67 69.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.461 0.705 . . . . 71.03 110.174 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -61.7 -19.05 61.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.708 . . . . 54.31 112.428 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -71.8 -38.02 70.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.994 0.517 . . . . 74.22 109.75 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.55 -37.05 65.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.764 0.826 . . . . 71.51 109.124 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -71.35 -29.54 65.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.233 -0.894 . . . . 71.14 110.875 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -81.47 -34.54 31.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.055 0.542 . . . . 73.04 110.794 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -67.83 -31.99 72.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.186 0.594 . . . . 75.13 111.001 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.99 -6.28 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.091 0.472 . . . . 74.32 110.873 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.15 19.36 20.64 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.015 0.926 . . . . 73.42 110.884 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.8 m -66.24 137.29 56.86 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.441 -0.578 . . . . 65.15 109.441 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -56.91 151.83 13.93 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.226 0.611 . . . . 72.22 110.929 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t -81.54 25.46 0.52 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.445 0.698 . . . . 71.51 111.025 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.71 97.1 0.2 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.92 1.288 . . . . 74.12 108.837 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 m -81.86 71.16 8.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.742 0.817 . . . . 41.12 109.62 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.9 p -74.45 116.03 14.66 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.679 -1.146 . . . . 72.22 109.965 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.4 m -73.31 111.92 13.75 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.814 0.846 . . . . 75.1 110.247 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.28 111.95 3.37 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 121.824 1.683 . . . . 74.44 111.407 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.59 143.08 27.18 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.948 -0.76 . . . . 75.54 108.948 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.42 43.04 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.762 0.825 . . . . 73.52 109.033 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.33 154.32 53.64 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.044 1.83 . . . . 73.4 112.222 167.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.0 t 71.1 4.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.853 1.261 . . . . 74.53 111.655 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -72.93 146.28 46.2 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 121.585 -0.697 . . . . 72.14 109.748 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.43 109.6 2.8 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.836 0.854 . . . . 75.42 109.993 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -73.16 98.86 2.69 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.95 0.5 . . . . 74.53 110.579 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -71.99 122.56 21.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.878 0.871 . . . . 65.34 109.165 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.82 73.76 4.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.726 0.774 . . . . 72.21 109.843 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-N 115.06 -0.973 . . . . 74.24 108.827 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 14' ' ' SER . 47.1 t . . . . . 0 C--O 1.244 0.79 0 N-CA-C 110.143 -0.317 . . . . 71.510000000000005 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 p -53.83 -47.14 71.21 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.427 -0.806 . . . . 73.019999999999996 110.235 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.34 168.1 40.71 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 115.835 -0.62 . . . . 73.049999999999997 113.298 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 172.41 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.688 1.195 . . . . 64.5 109.403 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -124.05 147.65 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.24 0.543 . . . . 72.25 111.496 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 p -97.52 -14.55 21.02 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.219 168.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.3 m -99.24 143.28 29.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.89 0.876 . . . . 73.310000000000002 109.753 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.22 122.96 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.82 136.82 24.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 115.993 -0.549 . . . . 52.240000000000002 109.577 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 121.88 27.21 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.659 0.6 . . . . 72.319999999999993 112.477 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.49 -31.03 61.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.713 1.205 . . . . 73.409999999999997 110.777 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.58 -31.9 53.37 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.67 0.788 . . . . 73.439999999999998 111.373 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 pt -90.59 8.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 111.579 0.215 . . . . 71.239999999999995 111.579 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.451 HG13 HD11 ' A' ' 65' ' ' LEU . 29.8 mm -75.64 136.81 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.422 -0.955 . . . . 71.219999999999999 108.422 173.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.76 -55.44 2.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.948 0.499 . . . . 62.340000000000003 109.966 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 24.4 ptt180 -147.6 159.15 44.09 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.489 0.662 . . . . 73.439999999999998 110.769 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 43' ' ' VAL . 76.7 mt -111.53 110.76 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.23 -1.35 . . . . 74.099999999999994 108.741 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 26.7 tt0 -100.98 142.58 32.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.482 1.113 . . . . 54.240000000000002 108.125 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -112.74 136.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 122.882 0.473 . . . . 63.5 110.725 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.7 m -114.37 97.09 45.12 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.605 -0.887 . . . . 71.019999999999996 108.605 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.39 167.24 27.8 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 122.428 2.085 . . . . 72.209999999999994 112.748 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 148.48 93.07 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.466 2.111 . . . . 51.310000000000002 112.194 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 -16.52 55.09 Favored Glycine 0 N--CA 1.474 1.218 0 CA-C-N 116.52 -0.309 . . . . 74.219999999999999 112.752 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 22.32 1.71 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.982 0.913 . . . . 73.450000000000003 111.103 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.97 -5.89 84.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.04 -0.424 . . . . 42.130000000000003 112.04 -166.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 m -99.02 116.78 65.05 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.34 1.056 . . . . 75.319999999999993 109.497 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.26 -20.09 49.56 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.429 2.086 . . . . 44.329999999999998 111.558 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -125.48 145.82 49.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.653 1.181 . . . . 73.030000000000001 110.089 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 m -72.61 115.52 11.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.362 -0.977 . . . . 61.109999999999999 108.362 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -120.08 140.43 51.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.1 0.409 . . . . 72.150000000000006 110.865 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG13 HG23 ' A' ' 29' ' ' ILE . 93.0 t -91.09 120.51 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.923 0.889 . . . . 52.530000000000001 110.145 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 54' ' ' CYS . 57.8 t -91.14 117.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.854 0.861 . . . . 75.420000000000002 108.814 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.12 128.68 44.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.633 -0.506 . . . . 51.439999999999998 109.633 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 50.0 m95 -104.64 116.28 31.78 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.452 -1.684 . . . . 64.329999999999998 106.452 166.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 p -87.19 172.14 10.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.959 0.409 . . . . 64.0 111.273 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.895 0.878 . . . . 55.030000000000001 111.033 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 49' ' ' MET . 1.1 mpt? -83.72 -0.84 52.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.025 0.93 . . . . 71.120000000000005 111.246 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.67 19.37 9.77 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.183 1.393 . . . . 74.310000000000002 111.634 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -72.05 124.96 26.06 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.73 -0.841 . . . . 74.299999999999997 108.73 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.31 113.35 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.222 1.009 . . . . 71.209999999999994 108.32 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.26 154.48 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.895 0.878 . . . . 63.039999999999999 109.398 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 44' ' ' VAL . 24.2 m -116.93 117.95 31.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.385 -0.968 . . . . 72.219999999999999 108.385 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.11 160.33 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.814 0.846 . . . . 75.510000000000005 109.512 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -62.94 133.64 95.4 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.043 0.537 . . . . 64.25 110.273 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 -32.87 59.32 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.825 2.35 . . . . 74.239999999999995 112.414 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -100.82 25.26 8.14 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.577 -0.738 . . . . 73.219999999999999 111.477 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.06 131.86 47.67 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.287 -0.635 . . . . 64.109999999999999 109.287 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -57.65 -34.03 68.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.857 1.263 . . . . 74.310000000000002 112.927 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -78.57 -34.43 46.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.39 0.676 . . . . 71.329999999999998 111.648 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -70.59 -20.62 62.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.661 0.784 . . . . 72.400000000000006 111.457 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -51.99 -37.6 53.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.851 0.86 . . . . 73.299999999999997 111.706 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -72.38 -29.65 63.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 73.409999999999997 111.317 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -73.55 -38.33 65.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 63.119999999999997 109.71 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.63 -29.39 65.75 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.737 0.815 . . . . 71.150000000000006 110.427 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -81.13 -23.43 38.35 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.634 0.774 . . . . 72.329999999999998 110.805 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.13 -37.56 66.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.272 0.629 . . . . 73.099999999999994 111.28 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.79 -29.7 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.562 0.345 . . . . 65.120000000000005 111.919 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.477 0.907 0 C-N-CA 123.114 0.566 . . . . 72.329999999999998 109.527 176.918 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 107.835 -1.172 . . . . 53.329999999999998 107.835 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.5 p -55.31 -28.22 52.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.243 1.017 . . . . 64.140000000000001 111.866 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.16 161.94 15.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.093 -1.203 . . . . 62.039999999999999 110.093 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.2 m -102.81 143.24 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.21 -1.033 . . . . 70.209999999999994 108.21 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.9 pt -99.87 139.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.599 -0.728 . . . . 71.219999999999999 110.439 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m -103.48 7.54 37.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.908 0.883 . . . . 43.219999999999999 111.105 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 m -74.37 137.86 43.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.557 0.743 . . . . 53.219999999999999 110.321 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -73.05 111.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.102 -1.073 . . . . 64.140000000000001 108.102 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -114.27 128.2 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.958 0.903 . . . . 60.109999999999999 109.225 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.99 162.79 16.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.096 -0.502 . . . . 60.030000000000001 112.712 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.33 -21.99 60.61 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.824 0.85 . . . . 71.439999999999998 111.469 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -53.55 -30.72 43.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 73.230000000000004 112.038 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 36.1 pt -119.8 -3.46 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 71.409999999999997 113.044 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.58 135.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 118.749 0.704 . . . . 72.219999999999999 109.704 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.91 -56.86 2.35 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.241 0.616 . . . . 52.0 110.411 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -143.42 147.55 34.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.566 0.746 . . . . 65.230000000000004 109.746 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.8 mt -108.16 112.33 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.928 -1.138 . . . . 71.420000000000002 107.928 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.16 104.42 14.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.097 -0.705 . . . . 73.349999999999994 109.097 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.85 140.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.922 -0.77 . . . . 62.229999999999997 108.922 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -111.99 92.9 19.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.793 -0.818 . . . . 73.329999999999998 108.793 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.74 149.87 38.93 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.365 2.71 . . . . 74.099999999999994 113.089 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 90.0 Cg_endo -74.36 2.26 6.45 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.719 2.28 . . . . 73.430000000000007 114.166 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.72 47.53 3.59 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 112.196 -0.362 . . . . 73.019999999999996 112.196 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -144.21 5.22 1.27 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.597 1.159 . . . . 74.319999999999993 110.683 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.95 44.79 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.675 -0.514 . . . . 73.319999999999993 112.739 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.6 m -82.68 126.61 72.88 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 108.595 -0.891 . . . . 75.420000000000002 108.595 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.61 -42.79 44.08 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.652 2.235 . . . . 62.210000000000001 113.565 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.92 164.56 12.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.22 0.608 . . . . 71.010000000000005 110.238 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 12.7 t -86.1 128.46 34.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.459 -0.941 . . . . 74.010000000000005 108.459 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -108.21 119.07 38.44 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.616 -0.513 . . . . 60.219999999999999 109.616 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.52 102.34 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.696 -0.483 . . . . 75.239999999999995 109.696 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -99.45 107.52 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.0 -1.111 . . . . 74.239999999999995 108.0 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -103.9 133.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.404 -0.591 . . . . 71.409999999999997 109.404 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -102.79 130.0 49.63 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.615 1.166 . . . . 74.219999999999999 108.422 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.5 p -87.07 176.89 7.39 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.388 0.675 . . . . 73.120000000000005 110.52 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 41.4 mtmt -71.58 -24.48 61.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.077 0.551 . . . . 72.329999999999998 110.726 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.76 -2.66 37.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.175 0.99 . . . . 74.099999999999994 110.569 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 68.84 14.64 8.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.462 1.505 . . . . 52.5 110.826 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.17 131.78 39.58 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.856 -1.164 . . . . 75.310000000000002 107.856 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.22 121.28 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.344 -0.844 . . . . 74.519999999999996 109.817 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -119.01 134.0 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.805 -0.813 . . . . 74.030000000000001 108.805 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 44.4 t -110.92 126.24 54.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.862 0.865 . . . . 74.040000000000006 109.568 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG11 ' HE1' ' A' ' 61' ' ' TRP . 19.2 m -137.42 164.29 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.218 1.007 . . . . 73.430000000000007 109.394 172.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.27 161.3 55.03 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 115.137 -0.938 . . . . 64.420000000000002 110.052 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.4 -18.19 63.49 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 112.748 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.07 25.51 7.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.8 0.84 . . . . 75.349999999999994 110.62 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 136.09 36.11 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.85 0.46 . . . . 43.439999999999998 110.363 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.21 -50.52 71.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.008 0.923 . . . . 53.420000000000002 112.748 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.401 ' HE1' HG11 ' A' ' 55' ' ' VAL . 36.4 p-90 -66.86 -28.69 68.54 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.881 0.472 . . . . 71.299999999999997 110.948 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.2 tp -67.25 -30.3 70.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.216 1.006 . . . . 63.119999999999997 111.683 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -54.17 -35.92 62.82 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.764 0.826 . . . . 70.340000000000003 111.63 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.24 -42.22 84.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.103 -0.953 . . . . 73.299999999999997 109.651 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.86 -32.37 72.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.406 1.082 . . . . 63.549999999999997 110.443 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -38.57 79.47 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.444 0.698 . . . . 64.409999999999997 110.178 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -68.96 -37.73 79.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.324 -0.25 . . . . 63.240000000000002 110.324 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.54 -37.98 86.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.012 0.525 . . . . 54.219999999999999 112.15 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.16 -11.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-O 120.927 0.394 . . . . 71.430000000000007 111.117 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.92 -0.771 . . . . 72.439999999999998 108.92 172.498 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.123 -0.325 . . . . 74.030000000000001 110.123 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -57.35 -31.08 65.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.19 0.996 . . . . 72.019999999999996 112.212 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.46 -173.34 15.97 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.46 -0.791 . . . . 75.109999999999999 111.562 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 55' ' ' VAL . 99.5 t -99.68 129.35 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.17 -1.048 . . . . 71.349999999999994 108.17 -175.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 53' ' ' ILE . 37.9 pt -84.15 140.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 123.361 0.413 . . . . 72.0 110.228 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 p -90.39 -4.18 57.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.794 0.838 . . . . 65.019999999999996 111.446 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.9 m -88.41 142.84 27.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.598 0.759 . . . . 62.299999999999997 109.878 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.74 112.38 22.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.839 -1.171 . . . . 70.140000000000001 107.839 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -72.68 143.09 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.186 0.594 . . . . 55.219999999999999 110.556 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 123.27 30.18 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.83 0.706 . . . . 64.439999999999998 112.574 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 64' ' ' ARG . 9.8 mp -67.41 -22.41 65.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.209 0.604 . . . . 71.019999999999996 111.428 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -74.43 -26.08 59.84 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.435 0.694 . . . . 74.519999999999996 111.683 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 47.8 pt -97.65 3.44 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 122.149 -0.344 . . . . 64.329999999999998 111.525 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 65' ' ' LEU . 27.5 mm -72.05 130.18 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 109.566 -0.531 . . . . 74.109999999999999 109.566 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -102.03 -59.43 1.7 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.452 0.701 . . . . 64.200000000000003 110.81 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -146.29 150.18 35.28 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.71 0.404 . . . . 70.439999999999998 110.684 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.24 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.115 0.966 . . . . 73.140000000000001 108.946 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -97.44 147.6 24.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.922 1.289 . . . . 75.25 109.101 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.17 142.9 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.677 -0.49 . . . . 64.209999999999994 109.677 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.2 m -121.78 109.78 33.89 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.992 0.917 . . . . 75.319999999999993 109.098 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.12 155.3 17.11 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.625 2.216 . . . . 53.329999999999998 113.085 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.1 173.66 14.06 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.733 2.289 . . . . 72.340000000000003 112.051 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 -26.13 8.66 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 116.775 -0.193 . . . . 74.420000000000002 113.384 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.8 23.49 3.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.135 0.974 . . . . 63.020000000000003 110.816 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.59 -19.53 44.63 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.905 -0.589 . . . . 51.219999999999999 112.235 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.8 m -80.46 119.3 75.93 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.034 0.417 . . . . 53.219999999999999 109.941 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.81 -22.7 74.92 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.13 2.553 . . . . 75.230000000000004 113.327 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 172.24 17.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.494 0.718 . . . . 75.150000000000006 109.713 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -75.04 133.86 41.53 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.131 -0.692 . . . . 73.219999999999999 109.131 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.84 124.97 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.081 0.467 . . . . 73.109999999999999 110.532 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.27 113.84 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.223 1.009 . . . . 62.140000000000001 109.1 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.76 109.68 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.417 -0.957 . . . . 71.019999999999996 108.417 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.9 mt -98.65 136.35 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.431 -0.581 . . . . 70.340000000000003 109.431 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -114.39 129.03 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.121 1.369 . . . . 72.030000000000001 108.616 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 p -90.46 172.22 8.87 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.777 0.431 . . . . 75.340000000000003 110.758 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 19.5 ptpt -69.16 -31.25 69.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.681 0.793 . . . . 64.239999999999995 111.133 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.1 ptm -78.42 4.62 12.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.89 0.876 . . . . 74.430000000000007 110.729 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 63.36 25.0 14.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.839 1.656 . . . . 73.409999999999997 112.14 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -76.5 128.57 35.02 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.276 -1.379 . . . . 64.329999999999998 107.276 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -100.56 131.0 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.66 1.184 . . . . 54.450000000000003 109.64 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 17' ' ' ILE . 32.2 pt -133.25 156.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.886 0.874 . . . . 63.140000000000001 108.672 171.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.1 p -137.15 122.48 19.4 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.128 -0.693 . . . . 63.43 109.128 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 16' ' ' VAL . 35.6 m -126.4 150.95 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.382 0.673 . . . . 75.439999999999998 109.785 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.57 152.97 67.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.349 -0.611 . . . . 71.310000000000002 109.349 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.53 -4.87 6.11 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.018 2.479 . . . . 73.25 115.259 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -84.07 -11.63 56.38 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.096 0.559 . . . . 72.109999999999999 112.147 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 113.63 3.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.65 -0.87 . . . . 63.240000000000002 108.65 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 17.5 mtpp -77.72 -20.86 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.722 0.638 . . . . 65.439999999999998 112.722 -171.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -75.5 -14.91 60.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.376 0.27 . . . . 62.340000000000003 111.171 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.5 tp -70.52 -29.4 65.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.672 0.389 . . . . 53.140000000000001 110.041 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -64.45 -19.69 65.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.455 0.302 . . . . 72.219999999999999 111.754 175.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 23' ' ' LEU . 1.1 tpm_? -65.76 -44.11 86.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.942 0.497 . . . . 74.310000000000002 109.691 170.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.448 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -66.78 -41.27 87.95 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.826 0.85 . . . . 64.209999999999994 110.28 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.35 -36.63 81.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.425 0.69 . . . . 65.120000000000005 110.759 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.72 -29.08 56.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.399 0.68 . . . . 74.209999999999994 110.956 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -74.26 -51.12 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.373 0.669 . . . . 74.200000000000003 111.072 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.77 -34.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.988 0.515 . . . . 72.040000000000006 110.747 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 108.031 -1.1 . . . . 75.439999999999998 108.031 175.773 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 109.495 -0.557 . . . . 62.43 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 t -100.0 10.7 40.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.218 0.607 . . . . 72.420000000000002 111.01 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 172.3 46.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.3 -0.72 . . . . 33.109999999999999 111.3 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 33.9 m -100.21 140.13 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 117.325 0.562 . . . . 71.409999999999997 109.895 -174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.95 146.24 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.501 0.72 . . . . 60.229999999999997 110.705 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 p -92.87 -2.2 56.08 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.315 -0.857 . . . . 65.129999999999995 111.394 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.6 m -60.47 118.82 6.96 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.49 -0.559 . . . . 73.439999999999998 109.49 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.27 111.19 3.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.822 -0.807 . . . . 53.350000000000001 108.822 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.52 132.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.249 0.62 . . . . 75.200000000000003 109.4 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.51 145.56 27.9 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.998 -0.546 . . . . 71.230000000000004 112.501 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.16 -33.66 72.49 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.103 0.961 . . . . 71.140000000000001 110.513 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.8 -28.71 68.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.834 0.853 . . . . 73.099999999999994 111.62 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -103.92 12.42 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 111.931 0.345 . . . . 71.310000000000002 111.931 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 mm -76.9 122.24 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.196 -1.039 . . . . 64.319999999999993 108.196 169.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -90.06 -58.86 2.36 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.37 -0.604 . . . . 74.439999999999998 109.37 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -146.95 155.67 42.46 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.183 0.593 . . . . 65.310000000000002 109.749 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.8 mt -113.95 108.15 24.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.202 -1.036 . . . . 64.439999999999998 108.202 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -99.47 137.75 37.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.616 0.766 . . . . 73.549999999999997 108.968 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.15 129.24 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.3 -0.63 . . . . 73.430000000000007 109.3 172.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -106.98 115.18 60.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.855 0.862 . . . . 70.310000000000002 108.984 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.35 166.17 29.31 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.724 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.73 84.09 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.434 2.089 . . . . 72.140000000000001 112.191 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.33 -179.48 39.77 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.676 -1.147 . . . . 70.129999999999995 110.677 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 65.42 18.89 11.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.636 1.174 . . . . 74.340000000000003 111.77 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.52 10.71 53.08 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 122.763 0.22 . . . . 34.409999999999997 113.568 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.36 117.43 33.09 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 108.059 -1.089 . . . . 64.540000000000006 108.059 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.4 5.86 5.79 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.566 2.178 . . . . 61.32 113.603 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -153.01 173.32 15.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.191 0.596 . . . . 73.409999999999997 110.776 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -86.8 121.29 29.1 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.55 -0.907 . . . . 65.5 108.55 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.9 134.51 45.78 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.052 0.541 . . . . 64.450000000000003 109.967 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 101.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.788 -0.819 . . . . 70.019999999999996 108.788 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.12 108.96 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.899 0.88 . . . . 74.530000000000001 109.262 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.41 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.5 mt -95.43 130.56 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.197 -0.668 . . . . 75.129999999999995 109.197 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -97.68 125.78 42.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.662 -1.607 . . . . 74.400000000000006 106.662 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.9 p -89.47 169.42 11.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.025 0.375 . . . . 64.420000000000002 110.531 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.9 -25.99 63.96 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.988 0.915 . . . . 71.340000000000003 111.519 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -80.39 1.67 28.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.888 0.875 . . . . 70.319999999999993 110.542 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.03 22.92 11.16 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.151 1.78 . . . . 65.310000000000002 112.162 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -79.95 123.78 28.1 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 106.664 -1.606 . . . . 74.340000000000003 106.664 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.19 124.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.844 -0.799 . . . . 72.120000000000005 108.844 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.2 pt -132.67 158.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.123 0.969 . . . . 64.5 109.265 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 55.6 m -120.37 149.94 41.54 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.107 -1.072 . . . . 73.450000000000003 108.107 167.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.92 163.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.416 0.687 . . . . 62.340000000000003 109.817 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.37 128.24 84.72 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.051 0.54 . . . . 64.25 110.098 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.53 -29.97 80.73 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.55 2.833 . . . . 75.549999999999997 113.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -89.09 16.98 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.424 0.69 . . . . 72.219999999999999 112.702 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 125.9 28.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.587 -0.894 . . . . 63.43 108.587 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.1 -37.36 81.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.675 0.79 . . . . 73.420000000000002 111.772 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 70.5 p-90 -63.49 -34.47 77.84 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.036 0.446 . . . . 74.319999999999993 110.474 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.11 -34.49 73.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.54 -0.754 . . . . 72.310000000000002 110.476 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.05 -38.95 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.708 0.803 . . . . 75.129999999999995 110.779 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -61.59 -48.43 80.99 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.86 -1.064 . . . . 71.310000000000002 110.072 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.44 -36.19 77.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.646 0.778 . . . . 62.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.95 -36.38 67.14 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.485 0.714 . . . . 62.130000000000003 110.637 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -75.36 -23.0 57.1 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.899 0.48 . . . . 74.530000000000001 110.284 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -67.1 -43.91 81.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.062 0.945 . . . . 71.319999999999993 110.716 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.9 m -90.78 -8.05 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 123.619 0.574 . . . . 75.129999999999995 112.045 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 CA--C 1.55 0.973 0 C-N-CA 123.379 0.672 . . . . 65.530000000000001 109.565 177.786 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 44' ' ' VAL . 55.5 m . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -82.81 -153.16 0.12 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.677 -0.692 . . . . 71.209999999999994 109.403 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.72 158.27 36.95 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-O 120.955 0.197 . . . . 54.229999999999997 112.853 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.98 146.8 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.215 -1.032 . . . . 30.41 108.215 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.29 145.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.223 0.535 . . . . 71.129999999999995 110.904 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -128.72 31.1 5.01 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.749 1.22 . . . . 64.340000000000003 108.289 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -140.57 142.21 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.708 1.203 . . . . 40.439999999999998 108.271 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.12 114.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.367 -0.605 . . . . 75.430000000000007 109.367 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.02 139.03 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.233 0.613 . . . . 74.150000000000006 109.583 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.92 131.81 11.0 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.796 0.685 . . . . 14.210000000000001 112.928 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' A' ' 68' ' ' HIS . 7.4 tt -54.46 -31.55 55.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.868 1.267 . . . . 74.099999999999994 110.747 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -58.35 -35.26 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.018 1.327 . . . . 51.549999999999997 112.445 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.4 pt -96.81 -6.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 119.098 -0.477 . . . . 71.409999999999997 111.46 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -75.01 130.26 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.221 -0.659 . . . . 73.400000000000006 109.221 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.86 -53.94 2.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.212 0.605 . . . . 55.200000000000003 109.562 174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -139.11 141.14 38.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.011 0.524 . . . . 73.409999999999997 110.188 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.1 mt -119.22 107.94 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.37 -1.344 . . . . 73.519999999999996 107.37 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -105.3 138.99 40.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.141 -1.059 . . . . 61.100000000000001 108.141 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -116.33 110.97 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.43 -0.952 . . . . 44.350000000000001 108.43 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -89.43 121.09 69.6 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.505 -0.554 . . . . 65.519999999999996 109.505 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.1 148.89 83.38 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.33 2.687 . . . . 53.340000000000003 113.636 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.86 100.57 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.886 2.391 . . . . 72.219999999999999 112.142 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.97 -5.52 4.71 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-N 115.478 -0.783 . . . . 71.129999999999995 112.31 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -89.68 41.08 1.02 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.686 0.795 . . . . 70.510000000000005 111.047 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -19.75 47.92 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.501 -0.772 . . . . 63.100000000000001 112.775 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.37 116.11 39.58 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.125 -1.435 . . . . 74.140000000000001 107.125 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.02 -39.02 40.63 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.932 3.088 . . . . 75.319999999999993 113.48 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -106.58 157.81 17.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.666 0.786 . . . . 70.319999999999993 109.297 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -61.07 115.7 3.96 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.939 0.774 . . . . 75.310000000000002 109.703 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -110.87 110.79 21.54 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.713 -0.847 . . . . 74.409999999999997 108.713 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.34 103.04 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.732 -0.84 . . . . 73.530000000000001 108.732 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 54' ' ' CYS . 44.5 t -90.27 108.12 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.7 -0.852 . . . . 71.349999999999994 108.7 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 53' ' ' ILE . 62.3 mt -106.23 119.97 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.559 0.743 . . . . 73.140000000000001 109.133 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -94.71 124.86 38.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.117 -1.068 . . . . 75.25 108.117 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.8 p -84.81 163.68 18.93 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.906 -0.405 . . . . 52.310000000000002 109.906 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -71.61 -10.98 60.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.228 0.611 . . . . 71.5 111.512 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 ptp -90.81 4.79 50.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.54 0.736 . . . . 61.100000000000001 110.772 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 68.3 22.23 8.13 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.3 1.44 . . . . 74.409999999999997 112.648 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -84.74 128.95 34.86 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.538 -0.912 . . . . 75.120000000000005 108.538 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.45 114.02 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.8 pt -125.16 128.5 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.257 -1.016 . . . . 72.049999999999997 108.257 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 44' ' ' VAL . 94.9 m -120.74 138.0 54.21 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.152 -0.343 . . . . 64.219999999999999 110.469 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' HE1' ' A' ' 61' ' ' TRP . 28.5 m -130.43 167.05 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.913 0.885 . . . . 73.329999999999998 110.958 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -73.75 153.92 89.28 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 114.427 -1.26 . . . . 70.340000000000003 110.329 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.4 -28.54 71.46 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.909 2.406 . . . . 61.020000000000003 113.2 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -107.48 24.71 12.46 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.419 0.687 . . . . 73.430000000000007 111.672 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 62' ' ' LEU . . . -65.24 124.32 21.87 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.398 -0.964 . . . . 42.009999999999998 108.398 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -70.83 -30.7 67.2 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.987 0.515 . . . . 63.32 111.502 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.469 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.4 p-90 -64.34 -32.32 73.88 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.207 -0.664 . . . . 74.019999999999996 109.207 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 59' ' ' ALA . 64.1 tp -73.29 -37.86 66.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.775 . . . . 74.109999999999999 110.555 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.11 -44.16 95.07 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.993 0.517 . . . . 65.129999999999995 111.177 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' TRP . 13.5 ptm180 -67.86 -31.59 71.51 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.917 0.487 . . . . 75.120000000000005 111.2 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.6 mm? -59.71 -47.94 83.63 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.596 0.759 . . . . 61.310000000000002 110.044 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.66 -34.77 78.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.914 0.886 . . . . 71.239999999999995 111.664 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -69.78 -32.61 71.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.632 0.773 . . . . 63.119999999999997 110.641 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' ND1' HD11 ' A' ' 23' ' ' LEU . 29.7 t-80 -74.64 -30.6 61.69 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.03 0.532 . . . . 72.530000000000001 111.545 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 65' ' ' LEU . 80.6 t -64.76 -49.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 109.145 -0.687 . . . . 52.039999999999999 109.145 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 108.319 -0.993 . . . . 72.010000000000005 108.319 173.345 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--O 1.239 0.543 0 CA-C-O 121.008 0.433 . . . . 63.439999999999998 109.851 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 p -104.26 -55.2 2.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.001 0.92 . . . . 71.540000000000006 109.364 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.18 167.96 35.7 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.247 -0.888 . . . . 73.219999999999999 111.186 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.26 156.44 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.257 0.528 . . . . 71.209999999999994 110.314 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.38 149.88 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 65.329999999999998 110.313 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -111.36 12.53 21.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 110.764 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.0 m -93.93 144.44 25.45 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.746 0.818 . . . . 74.109999999999999 109.88 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.26 110.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.701 -1.222 . . . . 73.040000000000006 107.701 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.77 124.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.894 -0.78 . . . . 71.099999999999994 108.894 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 147.57 30.35 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.774 0.671 . . . . 71.219999999999999 113.859 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.45 -33.36 65.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.974 0.909 . . . . 63.119999999999997 110.486 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.25 -34.28 72.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.986 0.914 . . . . 55.450000000000003 112.241 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.9 pt -107.0 13.36 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.693 0.397 . . . . 72.239999999999995 111.776 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.4 129.27 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.627 -0.879 . . . . 73.519999999999996 108.627 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.92 -59.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.822 -0.436 . . . . 63.310000000000002 109.822 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 -143.74 139.65 29.56 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.397 0.679 . . . . 64.209999999999994 109.703 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -107.33 119.48 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.139 0.975 . . . . 71.099999999999994 109.638 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 44' ' ' VAL . 6.3 tp-100 -105.68 135.24 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.321 -1.363 . . . . 74.319999999999993 107.321 170.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.11 127.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.621 -0.511 . . . . 63.210000000000001 109.621 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -118.08 103.6 49.63 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 108.836 -0.802 . . . . 65.120000000000005 108.836 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.75 170.42 12.69 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.438 2.758 . . . . 72.299999999999997 112.063 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.82 99.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.263 1.975 . . . . 64.310000000000002 111.408 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.83 164.52 29.09 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.591 -1.404 . . . . 31.530000000000001 109.591 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 66.09 19.43 11.16 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.307 1.051 . . . . 63.43 110.363 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.32 8.46 87.56 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.205 -0.907 . . . . 73.439999999999998 113.325 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.2 m -84.87 136.87 38.34 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.305 0.642 . . . . 71.439999999999998 109.667 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.31 -52.72 0.77 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.845 2.363 . . . . 73.409999999999997 114.206 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -135.04 177.4 7.84 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.261 1.025 . . . . 63.450000000000003 109.647 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -67.17 110.37 3.44 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.203 -0.666 . . . . 74.25 109.203 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -111.41 112.5 24.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.714 1.206 . . . . 75.219999999999999 108.425 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.67 101.13 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.323 -0.991 . . . . 72.510000000000005 108.323 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 85.9 t -92.21 110.03 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.112 0.965 . . . . 71.519999999999996 108.814 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.57 128.81 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.006 -0.434 . . . . 72.439999999999998 110.557 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -88.76 123.9 33.62 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.448 -1.315 . . . . 75.329999999999998 107.448 168.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -84.87 174.41 9.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.812 0.445 . . . . 71.25 110.463 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.57 -21.88 65.41 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.497 0.719 . . . . 72.140000000000001 111.114 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 50.1 mtm -76.64 -4.4 42.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.438 1.095 . . . . 70.430000000000007 110.51 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 60.58 23.56 13.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.839 1.656 . . . . 75.109999999999999 111.364 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -85.6 124.24 31.92 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 106.758 -1.571 . . . . 63.32 106.758 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -88.62 130.37 38.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.77 -0.826 . . . . 63.399999999999999 108.77 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.0 pt -129.68 157.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 75.120000000000005 109.114 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.3 m -126.8 118.1 23.98 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.246 -1.02 . . . . 52.450000000000003 108.246 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.58 155.26 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.946 0.498 . . . . 55.329999999999998 110.094 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.77 165.54 17.75 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.8 0.84 . . . . 73.349999999999994 109.181 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.88 0.19 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.436 2.091 . . . . 64.219999999999999 114.126 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -70.11 -25.48 63.52 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.523 0.729 . . . . 64.239999999999995 110.963 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.9 112.96 3.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.365 0.666 . . . . 61.130000000000003 110.427 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -70.49 -33.17 70.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.33 0.652 . . . . 73.239999999999995 111.389 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -65.46 -27.42 68.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.661 0.385 . . . . 63.520000000000003 111.132 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.4 tp -67.02 -33.5 75.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.016 0.926 . . . . 71.420000000000002 111.768 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.53 -22.46 66.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.297 0.239 . . . . 72.319999999999993 110.929 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -69.97 -39.25 76.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.389 0.676 . . . . 64.040000000000006 110.206 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.73 -41.88 74.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.138 0.975 . . . . 54.520000000000003 109.74 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.96 -25.63 61.94 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.054 -0.976 . . . . 61.43 111.656 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -29.96 31.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.025 -0.732 . . . . 74.239999999999995 109.025 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.65 -28.64 69.25 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.03 0.532 . . . . 74.540000000000006 111.398 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.89 -3.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.2 0.6 . . . . 53.219999999999999 111.734 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 . . . . . 0 N--CA 1.483 1.21 0 C-N-CA 123.914 0.886 . . . . 72.299999999999997 110.393 175.911 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 t . . . . . 0 C--O 1.24 0.567 0 CA-C-O 120.974 0.416 . . . . 64.530000000000001 111.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -132.44 12.98 4.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.141 0.976 . . . . 64.140000000000001 110.979 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.37 175.99 50.59 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.766 -0.652 . . . . 73.310000000000002 112.996 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.31 170.93 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.447 0.699 . . . . 62.109999999999999 109.957 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.89 137.65 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.274 0.559 . . . . 73.409999999999997 111.639 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -83.54 -38.88 21.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.041 0.937 . . . . 73.430000000000007 110.042 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m -68.12 121.35 15.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.267 1.027 . . . . 75.209999999999994 110.125 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.0 116.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.748 0.655 . . . . 74.409999999999997 110.128 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.24 134.84 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.93 0.892 . . . . 70.450000000000003 109.446 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.7 139.28 22.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 113.987 0.355 . . . . 62.0 113.987 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.6 -37.53 65.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.483 1.113 . . . . 73.209999999999994 110.823 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -65.58 -34.07 77.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.733 0.813 . . . . 71.299999999999997 111.842 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 33.7 pt -90.74 -3.79 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 119.565 -0.255 . . . . 71.340000000000003 111.41 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 39.0 mm -71.97 137.47 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.698 -0.853 . . . . 75.129999999999995 108.698 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -104.95 -55.3 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.275 -0.639 . . . . 61.149999999999999 109.275 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -143.01 142.11 31.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.342 -0.845 . . . . 65.200000000000003 109.342 -171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.24 106.57 21.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.029 -1.471 . . . . 73.439999999999998 107.029 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.02 103.5 15.35 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.05 -1.093 . . . . 71.340000000000003 108.05 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.64 109.44 21.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.616 -1.253 . . . . 71.150000000000006 107.616 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -106.54 114.37 62.08 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.389 0.676 . . . . 73.25 109.216 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 160.33 49.66 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.484 2.123 . . . . 55.340000000000003 111.797 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 150.96 74.99 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.864 . . . . 63.520000000000003 111.095 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.54 -52.61 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 C-N-CA 121.357 -0.449 . . . . 35.409999999999997 112.556 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -146.66 107.9 4.23 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.32 0.648 . . . . 73.409999999999997 109.575 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.28 -17.73 9.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.76 -0.655 . . . . 52.219999999999999 114.578 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.4 m -88.52 115.52 63.6 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.571 -0.9 . . . . 63.229999999999997 108.571 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.79 -68.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.696 2.264 . . . . 73.010000000000005 111.665 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -103.79 179.22 4.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.547 0.739 . . . . 71.329999999999998 109.083 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.3 m -64.89 109.96 2.27 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.157 -0.683 . . . . 65.409999999999997 109.157 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -89.76 111.96 23.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.353 -0.98 . . . . 72.430000000000007 108.353 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.42 101.19 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.512 -0.921 . . . . 63.399999999999999 108.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.1 t -96.49 109.71 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.068 0.947 . . . . 61.409999999999997 108.572 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 58.5 mt -94.71 136.83 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.811 -0.811 . . . . 65.530000000000001 108.811 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -110.31 117.6 34.07 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.07 -1.456 . . . . 70.420000000000002 107.07 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HE1' ' A' ' 49' ' ' MET . 60.0 p -82.31 160.81 22.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.687 -0.486 . . . . 73.150000000000006 109.687 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 59.6 pttt -71.05 -10.95 60.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.76 0.824 . . . . 63.329999999999998 112.972 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.427 ' HE1' ' HB ' ' A' ' 47' ' ' THR . 3.1 mpp? -92.7 10.79 29.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.145 0.578 . . . . 72.239999999999995 110.153 170.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 69.82 15.2 7.97 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.2 1.4 . . . . 74.340000000000003 112.931 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -84.3 123.46 30.19 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.559 -1.275 . . . . 71.129999999999995 107.559 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 t -98.84 139.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.124 0.57 . . . . 71.519999999999996 109.478 -171.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.57 156.21 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.077 0.951 . . . . 71.310000000000002 109.909 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.22 137.27 47.36 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.087 -1.449 . . . . 72.329999999999998 107.087 166.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.5 159.28 41.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.838 -0.801 . . . . 73.450000000000003 108.838 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -91.21 139.87 25.65 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 115.788 -0.642 . . . . 74.310000000000002 110.133 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.06 -12.08 32.98 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.025 2.484 . . . . 74.340000000000003 113.771 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.417 HH22 ' NE2' ' A' ' 63' ' ' GLN . 4.1 mmp_? -97.99 8.88 44.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.612 0.765 . . . . 65.140000000000001 112.357 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.59 122.58 20.0 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.037 -0.727 . . . . 53.420000000000002 109.037 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -63.55 -39.39 94.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.978 0.911 . . . . 73.340000000000003 112.583 -167.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -68.16 -35.19 77.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.477 0.711 . . . . 74.319999999999993 110.64 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 54.6 tp -66.06 -36.22 82.63 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.411 0.684 . . . . 72.430000000000007 110.644 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 57.8 mt-30 -56.97 -42.05 79.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.735 0.647 . . . . 74.510000000000005 109.823 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -63.85 -36.13 82.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.327 0.651 . . . . 73.519999999999996 110.906 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.33 -43.29 99.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.248 0.619 . . . . 73.030000000000001 109.992 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 82.0 mt -71.98 -23.01 61.35 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.171 -0.922 . . . . 60.509999999999998 111.182 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 4.7 mmp_? -88.39 -20.68 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.43 0.692 . . . . 64.549999999999997 111.575 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -78.37 -30.61 48.04 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.192 0.597 . . . . 73.420000000000002 110.911 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 m -80.07 -13.85 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.679 0.276 . . . . 74.530000000000001 110.655 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 123.628 0.771 . . . . 74.310000000000002 109.403 172.472 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 14' ' ' SER . 9.8 t . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 110.125 -0.324 . . . . 55.329999999999998 110.125 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 20.8 m -93.62 -50.08 5.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.59 0.756 . . . . 74.120000000000005 110.738 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.22 -121.54 0.83 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.788 -0.451 . . . . 73.519999999999996 112.682 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.12 162.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.599 1.159 . . . . 65.310000000000002 110.044 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.62 151.26 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.14 0.576 . . . . 72.299999999999997 110.727 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 m -110.56 11.78 22.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.034 0.934 . . . . 73.010000000000005 111.45 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 154.91 43.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.166 0.587 . . . . 72.409999999999997 110.417 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.89 141.93 14.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.197 -0.668 . . . . 74.450000000000003 109.197 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.79 144.34 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.467 1.107 . . . . 70.109999999999999 109.04 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' ILE . . . -62.7 123.39 30.41 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.912 -0.382 . . . . 45.0 113.426 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.54 -34.19 68.88 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.258 1.023 . . . . 71.010000000000005 110.755 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.55 -28.33 63.79 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.886 0.874 . . . . 62.25 111.998 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' GLY . 17.8 pt -90.72 -0.41 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 118.131 0.423 . . . . 74.239999999999995 111.152 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 45' ' ' ILE . 36.4 mm -77.31 111.9 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.372 -0.603 . . . . 50.43 109.372 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.15 -53.71 4.89 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.47 -0.566 . . . . 74.310000000000002 109.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -153.72 147.42 25.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.448 -0.797 . . . . 74.120000000000005 110.105 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -113.34 123.19 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.529 -0.915 . . . . 71.129999999999995 108.529 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -94.54 111.05 22.81 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.342 -0.985 . . . . 63.219999999999999 108.342 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.74 131.69 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.112 0.482 . . . . 72.439999999999998 109.9 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 p -122.49 136.23 26.37 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.1 0.96 . . . . 75.310000000000002 108.978 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -61.21 169.84 5.81 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.156 2.571 . . . . 74.439999999999998 113.814 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.37 170.99 14.84 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 121.805 1.67 . . . . 63.200000000000003 111.589 168.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -177.18 48.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.55 -0.295 . . . . 43.130000000000003 112.523 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 64.17 14.31 8.52 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.743 1.217 . . . . 75.530000000000001 111.317 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.72 -20.27 36.98 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.947 0.784 . . . . 54.229999999999997 112.731 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 m -84.72 124.95 72.36 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 117.639 0.72 . . . . 61.310000000000002 109.073 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.0 -69.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.794 2.329 . . . . 63.030000000000001 113.696 -172.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -100.68 179.97 4.26 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.399 1.08 . . . . 62.140000000000001 108.579 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 m -64.12 109.13 1.73 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.022 -1.473 . . . . 63.43 107.022 162.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -90.54 112.78 24.6 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 72.109999999999999 109.682 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 102.13 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.137 -0.69 . . . . 75.209999999999994 109.137 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.03 111.66 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.962 -1.125 . . . . 62.32 107.962 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 26' ' ' ILE . 54.5 mt -94.39 136.27 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.805 -0.443 . . . . 65.219999999999999 109.805 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -114.71 114.0 25.04 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 124.878 1.271 . . . . 74.340000000000003 108.053 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.2 p -80.29 169.17 18.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.429 0.292 . . . . 53.229999999999997 111.073 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.75 -20.62 64.38 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.002 0.921 . . . . 73.310000000000002 112.0 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.8 ptp -91.49 8.86 34.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.515 0.726 . . . . 55.229999999999997 110.906 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 67.68 21.55 9.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.987 1.315 . . . . 64.450000000000003 111.523 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -81.01 123.06 28.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.011 -1.477 . . . . 74.530000000000001 107.011 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.86 130.19 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.603 -0.888 . . . . 64.219999999999999 108.603 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 45' ' ' ILE . 29.8 pt -134.38 153.96 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.263 0.625 . . . . 71.439999999999998 109.836 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 92.8 m -109.54 128.76 55.43 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.231 -0.895 . . . . 64.209999999999994 108.632 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.14 140.6 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.499 -0.926 . . . . 64.409999999999997 108.499 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -79.66 128.1 75.77 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.19 -21.32 27.8 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.923 3.082 . . . . 74.239999999999995 114.558 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -73.28 -7.48 51.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.202 0.601 . . . . 74.430000000000007 112.459 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.04 123.03 16.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.858 0.863 . . . . 64.519999999999996 110.696 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -66.5 -38.33 87.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.022 -0.99 . . . . 72.040000000000006 111.914 -172.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.846 0.459 . . . . 72.010000000000005 111.425 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.55 -27.0 63.81 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.569 0.747 . . . . 71.310000000000002 110.921 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -59.95 -25.92 65.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.046 0.538 . . . . 72.239999999999995 111.698 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.77 -41.68 97.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.2 0.6 . . . . 75.219999999999999 109.903 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.04 -40.35 82.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.532 0.733 . . . . 43.219999999999999 110.0 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.86 -31.29 72.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.392 0.677 . . . . 74.430000000000007 110.812 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -78.23 -34.14 49.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.125 0.57 . . . . 73.030000000000001 111.058 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.585 0.354 . . . . 73.299999999999997 111.64 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.43 -11.51 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.011 0.375 . . . . 74.319999999999993 112.011 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 124.175 0.99 . . . . 61.219999999999999 111.417 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 109.665 -0.494 . . . . 74.540000000000006 109.665 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 t -51.97 -31.98 31.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.67 1.188 . . . . 63.0 112.125 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.73 -169.86 34.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.323 -0.711 . . . . 70.439999999999998 111.323 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.68 129.95 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 55' ' ' VAL . 2.2 pp -114.26 144.69 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.162 0.585 . . . . 70.140000000000001 109.584 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.0 m -133.95 34.2 3.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.91 0.884 . . . . 62.130000000000003 109.429 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 m -126.53 138.89 53.54 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.964 -1.016 . . . . 44.200000000000003 108.906 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -74.25 110.85 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.406 -1.331 . . . . 64.329999999999998 107.406 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.75 139.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.478 -0.564 . . . . 73.450000000000003 109.478 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.36 128.58 33.37 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.756 0.66 . . . . 45.43 113.28 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.65 -30.17 63.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.057 0.943 . . . . 61.229999999999997 109.943 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -54.77 -35.49 63.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 73.010000000000005 112.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.0 pt -104.49 -3.88 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 119.266 -0.397 . . . . 74.329999999999998 112.013 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 45' ' ' ILE . 41.1 mm -71.13 110.97 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.684 -0.858 . . . . 72.519999999999996 108.684 172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB2' ' HD2' ' A' ' 48' ' ' LYS . 24.0 t70 -85.75 -56.6 3.41 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.198 0.599 . . . . 75.150000000000006 110.712 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -160.69 143.88 13.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.209 -0.663 . . . . 75.430000000000007 109.209 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.12 123.99 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.215 -0.661 . . . . 64.140000000000001 109.215 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -103.98 116.82 32.94 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.864 0.866 . . . . 71.239999999999995 109.012 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.36 112.83 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.294 0.638 . . . . 52.409999999999997 110.165 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 11.0 m -89.84 116.65 66.88 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 108.935 -0.765 . . . . 75.540000000000006 108.935 169.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.81 157.73 36.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.812 2.341 . . . . 64.540000000000006 112.535 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.38 122.08 10.76 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.607 2.204 . . . . 74.25 111.294 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.64 -159.59 23.49 Favored Glycine 0 C--O 1.241 0.546 0 N-CA-C 110.221 -1.152 . . . . 72.230000000000004 110.221 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 63.82 30.09 14.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 72.430000000000007 111.641 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.87 20.5 61.17 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.423 -0.353 . . . . 11.44 112.914 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 53.4 t -138.32 133.34 17.1 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.888 0.875 . . . . 71.540000000000006 109.965 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.72 -9.31 13.35 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.336 2.024 . . . . 63.509999999999998 112.616 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 16.5 tppt? -101.29 155.09 18.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.806 1.242 . . . . 64.200000000000003 110.163 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -86.43 115.23 23.8 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.183 -1.043 . . . . 74.140000000000001 108.183 164.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 42.7 tt0 -83.21 112.97 20.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.014 -0.735 . . . . 75.120000000000005 109.014 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.04 102.15 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.539 -1.282 . . . . 63.539999999999999 107.539 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.11 135.27 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.934 0.894 . . . . 51.109999999999999 109.061 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.601 HG21 HD12 ' A' ' 26' ' ' ILE . 60.9 mt -110.29 121.78 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.624 0.37 . . . . 73.450000000000003 110.083 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.15 127.04 32.74 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.998 -1.112 . . . . 71.010000000000005 107.998 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.7 p -84.66 178.42 7.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.408 0.683 . . . . 75.439999999999998 110.359 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 27' ' ' ASP . 14.4 mmmm -66.02 -23.52 66.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.277 0.56 . . . . 73.230000000000004 110.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.3 mtm -79.8 -1.45 38.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.458 1.103 . . . . 73.230000000000004 110.434 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 65.2 14.51 9.44 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.986 1.714 . . . . 65.25 111.919 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -79.77 125.97 30.35 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.248 -1.019 . . . . 72.319999999999993 108.248 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.92 122.65 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 41.020000000000003 109.386 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.1 pt -108.11 149.93 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.147 -1.057 . . . . 74.5 108.147 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.97 118.68 37.42 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.515 0.726 . . . . 63.109999999999999 109.355 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 HD11 ' A' ' 17' ' ' ILE . 32.8 m -124.69 156.06 32.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 123.524 0.73 . . . . 70.340000000000003 109.55 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.55 152.95 78.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.558 -0.904 . . . . 73.430000000000007 108.558 168.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.54 -27.0 69.69 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.839 1.693 . . . . 65.140000000000001 111.261 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.89 12.67 36.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.313 1.045 . . . . 72.329999999999998 112.208 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.97 56.58 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.041 0.536 . . . . 74.400000000000006 109.985 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.96 -40.99 97.67 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.973 0.731 . . . . 73.219999999999999 112.973 -166.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -77.84 -17.48 57.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.073 0.397 . . . . 63.43 112.073 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.49 -21.59 66.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 52.119999999999997 110.712 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -56.4 -23.97 41.66 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.092 0.957 . . . . 62.310000000000002 113.139 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.99 -46.94 82.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.927 0.491 . . . . 74.219999999999999 110.274 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.52 -37.96 55.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.369 -0.832 . . . . 73.409999999999997 110.472 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.05 -35.62 78.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 74.340000000000003 110.547 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -75.03 -41.38 59.34 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.309 0.243 . . . . 65.450000000000003 110.682 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -68.66 -36.11 78.14 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.27 0.47 . . . . 64.349999999999994 112.27 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.0 -28.81 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.025 0.44 . . . . 70.329999999999998 110.137 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 123.834 0.853 . . . . 53.43 111.049 176.861 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 16' ' ' VAL . 52.9 t . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.236 -0.653 . . . . 74.140000000000001 109.236 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.9 m -114.54 123.88 50.47 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.185 0.994 . . . . 71.439999999999998 109.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.33 90.24 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 O-C-N 123.773 0.671 . . . . 50.149999999999999 111.736 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.662 HG22 ' SG ' ' A' ' 13' ' ' CYS . 22.7 t -100.5 128.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.808 -0.812 . . . . 64.329999999999998 108.808 -173.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 55' ' ' VAL . 2.7 pp -124.74 147.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.082 0.553 . . . . 62.130000000000003 109.986 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.4 m -117.76 22.68 12.17 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.489 1.115 . . . . 72.5 109.122 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.5 m -93.72 146.57 23.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.753 1.221 . . . . 74.299999999999997 109.994 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.63 112.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.359 -0.978 . . . . 45.299999999999997 108.359 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -90.5 143.33 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.664 0.786 . . . . 74.25 109.548 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 118.09 13.73 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.881 0.738 . . . . 72.120000000000005 112.011 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.3 -30.81 52.22 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.767 1.227 . . . . 72.439999999999998 110.995 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.47 -35.79 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.399 0.679 . . . . 71.150000000000006 111.942 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt -86.19 -6.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 111.957 0.354 . . . . 73.109999999999999 111.957 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD12 HG21 ' A' ' 45' ' ' ILE . 44.5 mm -72.9 129.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.364 -0.976 . . . . 70.420000000000002 108.364 176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -117.16 -58.64 2.04 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.633 0.373 . . . . 63.450000000000003 111.055 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -144.81 127.47 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.849 0.46 . . . . 62.43 109.906 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -110.79 140.66 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.359 1.064 . . . . 51.030000000000001 109.71 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.37 127.17 25.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.979 1.312 . . . . 73.25 108.082 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.52 139.43 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 122.576 0.35 . . . . 55.329999999999998 111.253 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 28.5 m -111.06 118.36 48.16 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.06 0.944 . . . . 71.099999999999994 109.099 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.44 147.18 36.19 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.025 1.816 . . . . 55.219999999999999 111.156 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.75 144.7 92.75 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.61 2.207 . . . . 63.310000000000002 112.59 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.02 -32.8 7.1 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.066 -0.516 . . . . 72.400000000000006 112.534 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -80.59 77.76 7.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.636 0.774 . . . . 72.530000000000001 110.426 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.37 -2.92 18.12 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 115.808 -0.633 . . . . 62.32 114.501 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.08 138.26 17.72 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 74.439999999999998 109.139 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.71 16.61 1.78 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.868 2.379 . . . . 73.209999999999994 114.034 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -152.16 173.21 15.23 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.277 0.631 . . . . 75.439999999999998 110.572 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 m -81.2 131.32 35.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.402 0.681 . . . . 73.510000000000005 110.114 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 19.9 tt0 -115.05 126.33 54.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.915 -1.143 . . . . 74.099999999999994 107.915 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.08 102.68 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.283 -1.006 . . . . 64.400000000000006 108.283 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.91 130.56 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 109.083 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 26' ' ' ILE . 52.3 mt -121.16 129.85 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.256 -0.646 . . . . 75.129999999999995 109.256 173.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -99.53 124.56 44.81 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.969 1.307 . . . . 75.140000000000001 107.523 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.8 p -84.9 170.64 12.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.883 0.473 . . . . 73.120000000000005 110.792 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 18.6 ptpt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 75.510000000000005 110.845 170.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.96 -8.29 56.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.186 0.994 . . . . 73.519999999999996 110.647 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.09 21.17 7.41 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.074 1.349 . . . . 73.239999999999995 109.246 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -100.43 133.09 45.38 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.25 1.02 . . . . 65.519999999999996 108.364 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.42 124.04 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.128 0.971 . . . . 71.230000000000004 110.397 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.6 pt -120.61 139.04 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.901 -1.148 . . . . 54.409999999999997 107.901 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.62 117.02 32.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.228 -1.397 . . . . 51.409999999999997 107.228 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 17' ' ' ILE . 7.2 m -117.55 166.35 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.176 0.59 . . . . 75.510000000000005 111.073 -168.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.18 139.09 56.21 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 115.299 -0.864 . . . . 72.329999999999998 109.512 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.1 -43.57 28.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.422 2.081 . . . . 72.510000000000005 112.721 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -85.08 21.96 1.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.93 0.492 . . . . 73.530000000000001 111.461 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.84 124.65 21.33 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.145 -0.687 . . . . 71.409999999999997 109.145 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.92 -32.89 74.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.252 1.021 . . . . 74.439999999999998 112.316 -169.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -74.12 -29.96 62.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.05 0.54 . . . . 73.430000000000007 111.154 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.7 tp -67.44 -23.55 65.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.674 0.79 . . . . 74.430000000000007 110.869 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -57.77 -38.04 74.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.753 0.821 . . . . 62.5 111.171 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -69.7 -31.39 69.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.119 0.568 . . . . 75.129999999999995 110.74 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.9 -35.58 69.75 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.454 -0.572 . . . . 61.420000000000002 109.454 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -66.04 -40.33 90.9 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.342 0.657 . . . . 74.430000000000007 110.129 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -70.33 -35.84 73.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.31 0.644 . . . . 71.409999999999997 111.05 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.78 -44.84 92.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.736 0.414 . . . . 54.399999999999999 110.412 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 m -82.37 -20.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.85 -0.614 . . . . 55.350000000000001 111.534 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 . . . . . 0 N--CA 1.478 0.961 0 C-N-CA 123.024 0.529 . . . . 73.129999999999995 109.96 178.858 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.24 0.6 0 N-CA-C 109.125 -0.695 . . . . 62.020000000000003 109.125 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 p -64.01 -49.58 71.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.745 0.818 . . . . 75.010000000000005 110.539 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.61 172.03 32.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.027 -0.988 . . . . 74.230000000000004 111.236 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.56 148.2 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.024 0.53 . . . . 64.209999999999994 109.788 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.8 pt -83.53 133.06 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.582 -0.735 . . . . 74.430000000000007 111.566 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.0 m -85.07 -41.04 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.374 -0.83 . . . . 74.219999999999999 109.354 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.8 m -92.45 129.29 38.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.007 . . . . 74.239999999999995 108.806 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.52 129.68 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.739 0.649 . . . . 64.120000000000005 109.627 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.596 HG21 HG21 ' A' ' 53' ' ' ILE . 71.1 t -84.23 130.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.508 0.723 . . . . 72.409999999999997 110.236 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.22 134.2 42.67 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.284 0.99 . . . . 63.119999999999997 113.602 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.63 -33.81 66.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.432 1.093 . . . . 63.509999999999998 110.474 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.05 -34.54 77.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.225 1.01 . . . . 54.149999999999999 111.913 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 25.4 pt -97.59 -5.78 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 118.925 -0.559 . . . . 64.510000000000005 112.096 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 45' ' ' ILE . 38.9 mm -65.58 103.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.215 -1.031 . . . . 71.349999999999994 108.215 171.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -85.72 -55.07 4.15 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.31 0.644 . . . . 63.149999999999999 109.618 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -148.99 143.4 26.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.987 -0.551 . . . . 72.120000000000005 110.526 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.65 118.46 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.332 1.053 . . . . 71.319999999999993 108.647 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -106.62 143.88 34.09 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.036 -1.098 . . . . 74.099999999999994 108.036 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.5 t -120.1 124.95 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.167 -1.049 . . . . 62.310000000000002 108.167 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -88.48 111.37 43.3 Favored Pre-proline 0 C--O 1.251 1.156 0 N-CA-C 108.143 -1.058 . . . . 24.120000000000001 108.143 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.2 151.39 49.09 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.862 2.375 . . . . 74.239999999999995 112.266 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.76 158.07 43.35 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.342 2.028 . . . . 61.210000000000001 112.164 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.99 -19.1 44.17 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.738 -0.479 . . . . 73.109999999999999 113.734 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -83.45 66.17 8.75 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.736 0.814 . . . . 73.340000000000003 109.844 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.6 -18.12 6.04 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 115.422 -0.808 . . . . 41.299999999999997 113.839 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -139.67 129.44 14.01 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.629 1.172 . . . . 70.409999999999997 108.563 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.25 32.91 0.45 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.003 2.469 . . . . 62.119999999999997 112.676 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.31 126.78 50.35 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.565 0.746 . . . . 63.420000000000002 110.773 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -88.61 121.35 30.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.714 0.805 . . . . 75.120000000000005 108.914 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -144.3 163.6 33.22 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.29 0.567 . . . . 65.340000000000003 110.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.4 t -121.41 104.16 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.576 1.15 . . . . 75.420000000000002 108.277 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.54 108.98 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.616 1.166 . . . . 71.530000000000001 108.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.419 ' HB ' HG12 ' A' ' 53' ' ' ILE . 69.7 mt -107.91 134.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.562 -0.712 . . . . 75.019999999999996 110.391 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.17 124.89 48.55 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.831 1.252 . . . . 75.400000000000006 107.749 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -80.23 179.06 7.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.508 0.323 . . . . 35.039999999999999 110.302 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 52.5 mtmt -62.35 -28.63 69.89 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.264 0.554 . . . . 62.100000000000001 110.617 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 49' ' ' MET . 0.9 OUTLIER -86.28 7.05 26.89 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.748 1.219 . . . . 72.109999999999999 111.028 177.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 63.74 15.61 9.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.305 1.442 . . . . 74.129999999999995 111.793 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -72.68 128.46 35.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.789 -1.189 . . . . 63.530000000000001 107.789 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.83 118.5 35.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.033 -0.985 . . . . 73.230000000000004 109.051 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 21' ' ' VAL . 7.2 pt -110.98 157.11 11.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.626 -1.25 . . . . 74.400000000000006 107.626 167.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.9 t -139.83 116.61 10.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.482 -0.933 . . . . 73.230000000000004 108.482 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 158.12 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 75.109999999999999 109.434 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.22 151.35 78.27 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.425 -0.583 . . . . 61.310000000000002 109.425 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.74 -16.41 37.18 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.262 2.641 . . . . 73.400000000000006 114.053 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -91.29 18.99 6.34 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.13 0.972 . . . . 62.310000000000002 112.386 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 128.07 34.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.152 -0.684 . . . . 63.509999999999998 109.152 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 11.1 mmpt? -66.99 -38.5 86.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.703 0.801 . . . . 64.510000000000005 112.584 -172.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -63.55 -33.24 75.15 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.131 0.491 . . . . 74.540000000000006 110.156 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.15 -31.15 43.91 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.057 -0.974 . . . . 74.310000000000002 110.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -31.95 73.14 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 110.143 -0.318 . . . . 72.120000000000005 110.143 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.7 -42.12 92.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.289 0.635 . . . . 70.120000000000005 110.199 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.5 mm? -64.1 -42.7 96.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.444 0.698 . . . . 61.420000000000002 110.269 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.77 -31.64 72.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.241 0.617 . . . . 70.230000000000004 111.072 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -78.77 -27.04 44.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.1 0.96 . . . . 73.439999999999998 110.804 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -83.69 -29.27 27.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.252 0.621 . . . . 73.430000000000007 112.067 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 65' ' ' LEU . 24.4 m -70.45 -24.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 110.104 -0.332 . . . . 71.230000000000004 110.104 176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.555 1.157 0 N-CA-C 107.441 -1.318 . . . . 44.420000000000002 107.441 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.04 0.448 . . . . 73.230000000000004 110.166 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' A' ' 54' ' ' CYS . 23.1 t -87.34 31.29 0.74 Allowed 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 125.092 1.357 . . . . 75.109999999999999 111.212 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.06 -142.23 20.52 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.365 -0.294 . . . . 54.109999999999999 112.365 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.03 133.38 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.644 -1.243 . . . . 73.329999999999998 107.644 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.402 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.7 pp -125.52 150.43 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 122.862 0.465 . . . . 73.540000000000006 111.424 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -97.32 2.21 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.285 1.034 . . . . 62.210000000000001 110.982 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 m -74.9 98.08 3.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.251 0.62 . . . . 51.219999999999999 109.523 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.66 109.69 6.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.124 -1.436 . . . . 55.439999999999998 107.124 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.1 t -100.39 139.41 21.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.429 0.691 . . . . 72.200000000000003 109.987 -173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.77 136.8 38.65 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 124.015 0.822 . . . . 75.239999999999995 112.565 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 64' ' ' ARG . 10.8 mp -60.89 -29.41 69.55 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.936 0.894 . . . . 71.510000000000005 110.542 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.61 -33.19 67.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.327 1.451 . . . . 74.420000000000002 112.794 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.572 HG22 ' HE2' ' A' ' 48' ' ' LYS . 43.4 pt -110.21 7.46 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.519 0.328 . . . . 73.239999999999995 111.869 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.472 HD12 HG21 ' A' ' 45' ' ' ILE . 39.5 mm -73.86 111.48 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.393 -0.966 . . . . 64.319999999999993 108.393 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.2 -56.66 3.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.484 0.713 . . . . 74.510000000000005 110.652 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -153.58 138.26 16.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.200000000000003 109.856 -174.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.7 128.8 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.122 -1.066 . . . . 73.310000000000002 108.122 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' VAL . 72.1 mt-30 -116.88 138.99 51.15 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.632 -0.877 . . . . 74.129999999999995 108.632 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.69 119.24 49.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.683 -0.858 . . . . 71.230000000000004 108.683 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.7 p -101.37 112.76 65.54 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.423 -0.954 . . . . 72.540000000000006 108.423 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.63 161.05 47.43 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.373 2.715 . . . . 73.219999999999999 112.677 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 119.72 6.14 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.526 2.151 . . . . 62.43 111.453 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.74 -39.08 1.24 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 116.131 -0.486 . . . . 74.540000000000006 112.231 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -77.22 77.99 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.219 0.607 . . . . 50.119999999999997 110.144 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.68 14.51 55.22 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.17 -0.468 . . . . 60.539999999999999 113.872 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 31.9 p -139.89 133.79 15.59 Favored Pre-proline 0 C--N 1.356 0.881 0 C-N-CA 123.422 0.689 . . . . 72.409999999999997 110.161 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 17.2 Cg_exo -68.94 -38.19 10.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.132 2.554 . . . . 45.030000000000001 112.914 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -118.43 159.24 23.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.769 0.828 . . . . 64.030000000000001 110.491 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -62.96 120.86 12.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.102 0.961 . . . . 64.230000000000004 109.9 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -108.55 117.55 34.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.501 0.72 . . . . 55.119999999999997 109.299 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.35 106.49 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.816 0.846 . . . . 75.319999999999993 109.423 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 30' ' ' GLN . 5.8 m -104.71 125.33 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.046 0.539 . . . . 63.539999999999999 109.789 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 26' ' ' ILE . 46.3 mt -114.37 120.11 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 108.978 -175.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -86.57 128.25 34.97 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.236 1.014 . . . . 75.400000000000006 108.484 174.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.6 p -83.62 179.68 7.55 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.328 0.651 . . . . 74.409999999999997 110.17 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE2' HG22 ' A' ' 25' ' ' ILE . 41.8 mtmt -66.2 -29.67 69.98 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.394 0.278 . . . . 54.149999999999999 111.065 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -77.09 -7.3 55.5 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.501 0.72 . . . . 64.230000000000004 110.294 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 70.04 23.51 5.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 125.934 1.694 . . . . 75.150000000000006 111.408 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.01 123.69 25.62 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.19 126.58 43.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.342 0.657 . . . . 72.219999999999999 109.422 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HB ' HG12 ' A' ' 17' ' ' ILE . 46.6 pt -117.64 157.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.479 -1.304 . . . . 71.430000000000007 107.479 170.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.612 ' HB2' ' H ' ' A' ' 14' ' ' SER . 13.4 t -133.93 134.15 42.27 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.203 0.456 . . . . 52.140000000000001 109.939 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.7 HG11 ' HE1' ' A' ' 61' ' ' TRP . 31.0 m -133.95 164.94 33.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 C-N-CA 124.344 1.058 . . . . 73.150000000000006 109.598 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -81.57 159.16 67.46 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.367 -1.288 . . . . 65.0 109.846 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.68 -12.95 37.97 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.928 2.419 . . . . 74.209999999999994 112.028 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -83.52 -8.65 59.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.811 0.844 . . . . 54.219999999999999 111.432 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.87 132.37 49.23 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.735 0.814 . . . . 62.210000000000001 112.161 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.2 -36.45 69.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 74.099999999999994 112.491 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.7 ' HE1' HG11 ' A' ' 55' ' ' VAL . 7.7 p-90 -74.75 -23.15 58.51 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.565 0.346 . . . . 74.420000000000002 110.368 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.81 -28.5 69.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.097 0.959 . . . . 71.349999999999994 110.59 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.77 -34.78 73.44 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.632 0.773 . . . . 74.540000000000006 110.571 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 23' ' ' LEU . 95.5 mtt180 -66.95 -39.49 87.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.572 0.749 . . . . 72.230000000000004 111.009 176.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.1 -38.08 72.36 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.544 0.738 . . . . 65.5 110.858 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.53 -49.66 57.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.611 -0.722 . . . . 70.310000000000002 109.682 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -67.62 -24.03 65.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.315 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.658 0.783 . . . . 63.549999999999997 111.119 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.89 -29.78 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 122.723 0.409 . . . . 62.149999999999999 111.039 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 123.467 0.707 . . . . 70.239999999999995 110.45 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 110.056 -0.35 . . . . 73.299999999999997 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.9 m -99.18 -6.91 27.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.288 0.635 . . . . 64.409999999999997 111.255 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.92 165.23 10.18 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 111.521 -0.632 . . . . 72.510000000000005 111.521 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.228 -1.026 . . . . 75.349999999999994 108.228 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.87 143.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.062 0.458 . . . . 74.400000000000006 110.581 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -100.5 -57.1 2.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.016 0.926 . . . . 52.340000000000003 108.733 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -67.32 127.54 33.04 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.814 0.846 . . . . 71.549999999999997 110.45 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.89 139.47 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 124.007 0.817 . . . . 62.149999999999999 110.668 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.97 144.66 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.361 1.064 . . . . 73.540000000000006 109.949 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.64 135.62 25.22 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.561 0.538 . . . . 72.219999999999999 114.253 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.71 -18.76 63.05 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.176 0.99 . . . . 63.109999999999999 111.578 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -59.52 -35.79 74.86 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.413 1.085 . . . . 72.150000000000006 111.746 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.85 -1.92 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 119.324 -0.37 . . . . 75.420000000000002 111.793 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 45' ' ' ILE . 50.2 mm -78.37 124.62 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.963 -0.755 . . . . 62.409999999999997 108.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.13 -57.15 2.08 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.172 0.589 . . . . 71.219999999999999 110.26 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -142.99 153.81 43.37 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.142 0.977 . . . . 74.219999999999999 109.519 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.03 113.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.747 0.819 . . . . 63.109999999999999 109.103 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -96.93 106.66 19.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.652 0.781 . . . . 61.219999999999999 109.139 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.89 117.73 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.033 -0.729 . . . . 65.530000000000001 109.033 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.4 m -89.47 112.68 53.02 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.701 0.8 . . . . 72.340000000000003 108.949 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.63 152.48 64.83 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.08 1.853 . . . . 60.340000000000003 111.999 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.79 109.38 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.828 2.352 . . . . 62.539999999999999 111.928 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.53 -27.79 0.96 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.868 -0.606 . . . . 41.229999999999997 112.181 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.36 68.88 10.62 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.748 0.819 . . . . 54.450000000000003 110.515 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.62 -3.79 40.02 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.338 -0.846 . . . . 62.530000000000001 114.145 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -132.89 125.55 19.28 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 124.233 1.013 . . . . 74.120000000000005 109.443 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.45 -17.79 30.1 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.498 2.132 . . . . 52.009999999999998 112.941 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -110.77 173.75 6.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.787 0.835 . . . . 72.120000000000005 110.165 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -85.43 113.82 22.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.867 -0.79 . . . . 75.040000000000006 108.867 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -101.74 111.13 23.27 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.21 -0.663 . . . . 74.200000000000003 109.21 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.3 t -92.63 99.81 10.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.328 -0.99 . . . . 71.109999999999999 108.328 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.11 107.02 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.093 -1.077 . . . . 73.439999999999998 108.093 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 53' ' ' ILE . 58.5 mt -98.1 128.74 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.507 0.723 . . . . 63.43 109.493 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -102.91 121.45 42.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.137 0.975 . . . . 73.409999999999997 108.712 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -80.95 170.66 15.98 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.695 0.398 . . . . 74.310000000000002 111.106 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -69.31 -12.32 61.56 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.89 0.876 . . . . 75.109999999999999 111.605 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 ptp -101.94 18.28 21.03 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.921 0.888 . . . . 71.329999999999998 110.302 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 61.6 7.48 1.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.381 1.473 . . . . 31.530000000000001 113.902 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -73.14 128.52 35.71 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.281 -1.007 . . . . 72.040000000000006 108.281 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.95 119.21 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.867 -1.06 . . . . 73.319999999999993 109.791 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.604 HG13 ' HB ' ' A' ' 45' ' ' ILE . 23.9 pt -127.71 145.12 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.06 -1.089 . . . . 72.129999999999995 108.06 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.9 m -120.44 142.51 49.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.708 -0.479 . . . . 62.310000000000002 109.708 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG11 ' HE1' ' A' ' 61' ' ' TRP . 29.9 m -126.37 159.67 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 122.969 0.508 . . . . 70.530000000000001 109.712 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -74.96 146.32 82.42 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.085 -0.962 . . . . 74.349999999999994 109.476 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.87 -23.72 76.33 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.981 2.454 . . . . 60.310000000000002 113.1 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -106.23 22.91 14.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.714 0.806 . . . . 63.310000000000002 111.405 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.82 135.03 49.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.136 -0.69 . . . . 53.109999999999999 109.136 171.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.81 -39.53 90.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 71.510000000000005 111.703 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.546 ' HE1' HG11 ' A' ' 55' ' ' VAL . 2.4 p-90 -69.36 -30.16 68.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.77 0.428 . . . . 71.310000000000002 110.035 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.5 tp -68.27 -34.22 75.79 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.247 0.619 . . . . 55.32 110.838 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -57.19 -32.69 66.72 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.128 0.49 . . . . 72.409999999999997 110.976 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.31 -45.48 80.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.105 -0.952 . . . . 73.310000000000002 109.582 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.73 -42.99 97.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.834 . . . . 63.43 110.599 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.62 -49.16 74.37 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.963 0.79 . . . . 55.439999999999998 110.506 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -72.34 -27.11 62.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.308 0.485 . . . . 64.420000000000002 112.308 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.18 -42.12 47.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.361 0.664 . . . . 62.520000000000003 110.995 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.32 -28.24 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 116.389 -0.369 . . . . 73.420000000000002 110.493 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 N--CA 1.48 1.063 0 C-N-CA 123.187 0.595 . . . . 71.340000000000003 110.02 176.476 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.267 -0.642 . . . . 73.219999999999999 109.267 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 t -93.37 99.6 12.08 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.247 0.619 . . . . 60.549999999999997 109.43 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.03 -148.11 50.83 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.516 0.51 . . . . 13.039999999999999 113.152 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.21 129.12 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.365 -0.976 . . . . 71.140000000000001 108.365 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.8 pt -102.03 119.01 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.368 -0.604 . . . . 71.430000000000007 109.368 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 p -97.49 5.98 48.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.609 0.764 . . . . 74.439999999999998 110.833 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.9 m -77.69 127.67 32.82 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.882 0.873 . . . . 64.310000000000002 109.798 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.78 111.12 10.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 107.274 -1.38 . . . . 71.519999999999996 107.274 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.43 139.06 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 109.022 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 124.63 36.9 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.005 0.816 . . . . 54.439999999999998 112.496 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.32 -34.29 70.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.508 0.723 . . . . 72.040000000000006 109.491 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.84 -34.13 77.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.781 0.832 . . . . 74.140000000000001 111.681 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.4 pt -92.06 3.61 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.049 -0.407 . . . . 70.420000000000002 112.067 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 35.3 mm -78.96 132.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 108.546 -0.909 . . . . 65.329999999999998 108.546 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.15 -56.03 2.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.218 0.607 . . . . 72.329999999999998 109.893 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -144.83 155.88 43.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.328 0.651 . . . . 72.040000000000006 110.974 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.73 112.05 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.759 1.223 . . . . 74.409999999999997 108.058 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -103.69 127.36 51.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.799 -0.815 . . . . 72.040000000000006 108.799 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.26 120.6 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.371 0.668 . . . . 62.43 109.406 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.1 m -95.12 110.35 49.65 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.549 -0.908 . . . . 71.109999999999999 108.549 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.49 156.44 64.03 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.871 2.38 . . . . 71.319999999999993 112.638 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.11 165.3 21.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.383 2.055 . . . . 75.510000000000005 112.026 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.43 -51.9 4.63 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.496 -0.32 . . . . 64.150000000000006 112.425 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -76.55 80.68 3.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.946 0.898 . . . . 75.120000000000005 110.856 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.3 -15.14 9.49 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.657 -0.701 . . . . 43.0 114.66 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.91 132.96 23.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.097 -0.705 . . . . 23.34 109.097 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.89 5.74 6.13 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.665 2.243 . . . . 74.099999999999994 112.912 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.2 159.61 42.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.404 1.082 . . . . 71.230000000000004 109.52 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -80.78 114.31 19.58 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.267 -1.012 . . . . 70.019999999999996 108.267 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.27 117.22 33.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 64.209999999999994 109.733 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.67 102.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.706 -0.85 . . . . 72.150000000000006 108.706 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.1 t -92.05 108.53 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.874 -1.158 . . . . 74.510000000000005 107.874 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 60.2 mt -94.56 138.02 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.155 -0.683 . . . . 70.420000000000002 109.155 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -104.58 119.91 40.09 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.268 -1.382 . . . . 70.319999999999993 107.268 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.3 p -77.09 168.63 19.76 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.331 0.395 . . . . 74.439999999999998 110.215 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -73.47 -10.87 60.17 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.114 0.566 . . . . 54.43 111.226 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.72 -5.34 58.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.584 1.154 . . . . 53.539999999999999 110.127 168.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.97 18.91 10.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.16 1.784 . . . . 62.530000000000001 112.234 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -79.03 133.74 36.8 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.755 -0.657 . . . . 74.450000000000003 109.913 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.01 117.77 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.47 -1.241 . . . . 75.540000000000006 108.46 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.4 pt -126.64 148.05 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.258 0.623 . . . . 62.450000000000003 109.478 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -111.85 130.96 55.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.171 -1.048 . . . . 43.530000000000001 108.171 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.03 165.6 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.31 0.644 . . . . 72.200000000000003 110.25 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -74.35 135.55 75.85 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.274 0.629 . . . . 74.010000000000005 109.885 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.69 -29.07 69.1 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 112.831 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -88.76 4.57 47.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.698 0.799 . . . . 64.109999999999999 112.313 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.1 120.31 8.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.837 -0.431 . . . . 72.409999999999997 109.837 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.49 -36.73 74.22 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.241 1.016 . . . . 54.210000000000001 113.078 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -68.46 -31.59 70.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.234 0.614 . . . . 74.230000000000004 111.106 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.72 -37.75 65.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.095 0.958 . . . . 73.430000000000007 110.84 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -42.69 82.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.891 0.877 . . . . 70.420000000000002 112.565 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -71.4 -27.69 63.5 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 116.112 -0.495 . . . . 72.140000000000001 111.464 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.28 -25.83 46.85 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.494 0.718 . . . . 73.019999999999996 110.097 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.09 -28.61 54.58 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.73 0.812 . . . . 75.209999999999994 109.99 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -74.49 -31.12 62.09 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.591 0.356 . . . . 73.109999999999999 110.544 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.57 -37.36 85.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.237 0.615 . . . . 70.439999999999998 111.514 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.39 -12.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 116.096 -0.502 . . . . 60.350000000000001 111.104 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 CA--C 1.548 0.9 0 C-N-CA 123.678 0.791 . . . . 71.329999999999998 109.881 178.007 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.242 0.683 0 N-CA-C 107.732 -1.21 . . . . 75.530000000000001 107.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -81.46 73.4 8.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 60.549999999999997 110.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.71 -142.53 48.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 113.181 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.87 153.74 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.75 0.82 . . . . 45.350000000000001 109.264 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.401 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.3 pp -128.69 131.28 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.249 0.547 . . . . 72.310000000000002 109.875 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -89.93 -10.16 46.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.726 0.811 . . . . 44.240000000000002 111.596 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 m -64.19 127.21 30.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.709 0.803 . . . . 72.319999999999993 111.247 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.65 114.26 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 108.276 -1.009 . . . . 75.329999999999998 108.276 172.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.53 127.0 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.468 0.707 . . . . 74.420000000000002 109.63 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.0 160.67 17.7 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.777 -0.647 . . . . 52.399999999999999 113.378 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.6 -33.82 68.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.012 1.325 . . . . 63.130000000000003 111.215 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -58.97 -32.22 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.044 0.938 . . . . 73.340000000000003 111.865 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.11 5.83 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 112.435 0.532 . . . . 72.120000000000005 112.435 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.548 HG13 HD11 ' A' ' 65' ' ' LEU . 21.7 mm -77.42 113.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.786 -0.82 . . . . 71.530000000000001 108.786 170.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.58 -55.97 3.73 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.697 -0.482 . . . . 62.210000000000001 109.697 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -157.34 143.62 17.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.673 0.789 . . . . 71.040000000000006 109.891 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 45' ' ' ILE . 65.7 mt -120.88 139.73 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.276 1.03 . . . . 54.32 109.493 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.41 143.09 47.39 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.682 -0.858 . . . . 71.239999999999995 108.682 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.2 138.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 109.229 -0.656 . . . . 72.209999999999994 109.229 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.8 p -119.9 143.2 34.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 123.626 0.77 . . . . 71.239999999999995 109.279 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.77 163.45 26.27 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.077 2.518 . . . . 75.510000000000005 113.652 -170.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.94 130.04 14.01 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 110.878 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.68 -162.01 30.03 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.356 -0.698 . . . . 74.310000000000002 111.356 -170.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.35 17.48 11.0 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.03 0.932 . . . . 72.239999999999995 111.451 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.44 41.21 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.674 -0.694 . . . . 73.310000000000002 112.828 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.5 m -85.06 135.75 39.15 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.763 0.825 . . . . 61.43 109.398 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.55 -63.34 0.19 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.994 2.463 . . . . 75.219999999999999 113.333 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.66 -177.27 4.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.323 -0.991 . . . . 74.430000000000007 108.323 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' THR . 24.2 m -57.59 110.13 0.83 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.806 -0.813 . . . . 61.109999999999999 108.806 166.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -104.33 119.39 38.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.959 -0.756 . . . . 71.109999999999999 108.959 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.45 102.48 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.885 -0.783 . . . . 55.130000000000003 108.885 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.61 134.35 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.553 -0.906 . . . . 72.439999999999998 108.553 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 29' ' ' ILE . 61.8 mt -133.01 125.54 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.329 -0.619 . . . . 72.120000000000005 109.329 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.82 123.43 36.08 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.064 -1.087 . . . . 73.420000000000002 108.064 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.0 p -84.58 179.46 7.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.247 0.619 . . . . 74.030000000000001 110.87 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.93 -24.41 64.28 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.119 0.568 . . . . 71.219999999999999 111.809 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.549 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 25.0 ptp -90.93 12.4 19.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.271 0.628 . . . . 61.130000000000003 110.766 172.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.56 22.44 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.839 1.656 . . . . 65.409999999999997 112.461 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 49' ' ' MET . 2.0 tmtp? -74.75 123.77 25.56 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.622 -1.622 . . . . 72.329999999999998 106.622 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.34 121.53 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.301 1.041 . . . . 72.030000000000001 108.523 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HB ' HG12 ' A' ' 17' ' ' ILE . 30.0 pt -125.56 147.51 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 108.522 -0.918 . . . . 71.019999999999996 108.522 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.35 118.42 25.02 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.813 -1.18 . . . . 74.129999999999995 107.813 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.88 164.57 21.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.582 0.753 . . . . 72.510000000000005 109.911 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.45 147.56 92.74 Favored Pre-proline 0 N--CA 1.474 0.744 0 O-C-N 123.936 0.773 . . . . 72.439999999999998 110.186 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.42 -9.19 19.26 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.981 2.454 . . . . 74.109999999999999 113.582 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -111.44 26.15 10.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.989 0.916 . . . . 73.349999999999994 111.952 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 131.46 44.06 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 108.643 -0.873 . . . . 50.310000000000002 108.643 168.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.23 -47.94 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 71.329999999999998 112.844 -167.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.9 -24.47 64.31 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.673 0.389 . . . . 74.230000000000004 111.849 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.02 -32.13 72.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.033 0.533 . . . . 75.510000000000005 110.237 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.72 -23.63 67.44 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.172 0.589 . . . . 71.549999999999997 111.476 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -69.58 -40.55 76.67 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.415 0.686 . . . . 73.140000000000001 110.3 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -71.33 -34.73 70.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.499 0.72 . . . . 73.109999999999999 110.26 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.15 -37.81 72.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.539 0.736 . . . . 70.329999999999998 110.012 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.85 -40.82 97.47 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.755 0.822 . . . . 75.230000000000004 109.96 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -59.12 -40.65 86.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.565 1.146 . . . . 64.310000000000002 112.056 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -85.93 -14.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 115.9 -0.591 . . . . 73.129999999999995 112.346 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 122.716 0.406 . . . . 70.209999999999994 111.783 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.237 0.446 0 CA-C-O 120.899 0.38 . . . . 63.43 110.431 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 t -83.8 -28.18 28.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.995 0.918 . . . . 65.230000000000004 110.611 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.63 174.89 15.73 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 109.849 -1.3 . . . . 71.129999999999995 109.849 -173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.3 m -101.76 147.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 117.273 0.537 . . . . 71.120000000000005 110.468 -173.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.95 131.98 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.853 -0.612 . . . . 74.219999999999999 109.531 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -85.73 -47.94 9.3 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.524 0.73 . . . . 72.430000000000007 110.017 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 122.26 28.2 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.011 0.924 . . . . 74.230000000000004 108.822 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -54.54 113.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.688 0.795 . . . . 54.030000000000001 111.502 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.77 141.6 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.691 -0.686 . . . . 75.219999999999999 109.98 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.19 131.23 32.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.674 0.609 . . . . 70.150000000000006 112.569 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.1 -33.13 68.77 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.159 0.984 . . . . 40.229999999999997 109.716 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.06 -34.48 77.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.203 1.001 . . . . 73.129999999999995 111.815 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -95.4 16.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 122.222 -0.299 . . . . 71.5 111.395 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 45' ' ' ILE . 50.4 mm -79.94 129.22 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.006 -0.738 . . . . 71.010000000000005 109.006 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -94.89 -56.13 2.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 64.239999999999995 110.535 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -156.03 142.47 18.52 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.737 -0.665 . . . . 71.010000000000005 109.414 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -108.82 138.13 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.392 1.077 . . . . 75.140000000000001 108.821 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 3.1 pt20 -136.66 111.55 8.86 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.687 -0.857 . . . . 72.439999999999998 108.687 171.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.9 123.15 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.102 -0.703 . . . . 74.030000000000001 109.102 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.3 m -87.28 110.88 37.2 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 109.241 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.41 154.14 55.75 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.911 2.407 . . . . 74.349999999999994 112.877 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.25 164.81 33.35 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.353 2.035 . . . . 63.43 112.235 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.49 4.8 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 112.712 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.51 88.94 0.35 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.271 1.028 . . . . 55.32 110.451 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.9 -18.54 3.87 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.067 0.841 . . . . 32.520000000000003 114.625 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.2 m -139.19 132.62 15.8 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 63.299999999999997 109.43 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.5 -9.97 20.25 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.734 2.289 . . . . 53.539999999999999 112.088 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -116.1 137.64 51.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.165 0.986 . . . . 71.129999999999995 110.248 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.5 m -69.19 138.48 54.11 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.725 0.81 . . . . 70.230000000000004 109.423 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.23 145.99 49.68 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.274 -1.01 . . . . 64.230000000000004 108.274 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.19 103.32 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.067 -1.086 . . . . 74.549999999999997 108.067 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 30' ' ' GLN . 61.6 t -94.04 124.05 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.235 -1.024 . . . . 73.230000000000004 108.235 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.574 HG21 HD12 ' A' ' 26' ' ' ILE . 66.8 mt -119.39 137.22 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 123.271 0.628 . . . . 55.43 110.002 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -91.62 131.93 36.68 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.923 -1.14 . . . . 75.010000000000005 107.923 166.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.5 p -86.43 172.07 10.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.368 0.667 . . . . 74.310000000000002 109.895 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -75.61 -7.61 54.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.372 0.669 . . . . 72.510000000000005 111.328 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.5 mtm -83.61 -7.09 59.58 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.942 0.897 . . . . 75.530000000000001 109.435 167.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 65.18 24.6 12.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.207 1.803 . . . . 74.329999999999998 110.536 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.46 125.97 32.84 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.737 -1.579 . . . . 73.140000000000001 106.737 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.53 122.85 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.101 -1.074 . . . . 75.319999999999993 108.101 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -127.19 155.89 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.648 -0.871 . . . . 72.129999999999995 108.648 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 39.6 m -111.63 151.19 29.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.91 -1.515 . . . . 64.450000000000003 106.91 165.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.06 129.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.602 -1.259 . . . . 71.310000000000002 107.602 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -54.07 129.08 57.96 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.493 0.717 . . . . 64.25 109.734 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.02 -14.45 41.6 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.511 2.141 . . . . 61.450000000000003 113.59 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -85.91 3.89 39.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.081 0.552 . . . . 74.109999999999999 111.947 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 120.85 10.53 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 123.414 0.686 . . . . 61.130000000000003 109.747 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.23 -31.54 71.97 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.762 1.225 . . . . 74.219999999999999 112.082 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -79.51 -23.51 42.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.25 1.02 . . . . 73.319999999999993 111.418 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.96 -27.58 68.35 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.892 0.877 . . . . 71.329999999999998 111.347 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.1 -35.86 69.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.817 0.847 . . . . 74.420000000000002 111.545 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -69.0 -34.06 74.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.405 0.682 . . . . 73.530000000000001 110.57 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.4 mp -70.22 -41.7 73.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.248 -0.649 . . . . 61.009999999999998 109.248 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.77 -38.35 88.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.749 0.82 . . . . 74.329999999999998 110.516 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -63.72 -34.16 77.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.863 0.865 . . . . 74.310000000000002 110.785 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -71.98 -33.71 68.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.922 0.489 . . . . 60.310000000000002 110.619 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' LEU . 97.4 t -71.99 -30.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.348 0.659 . . . . 62.509999999999998 109.414 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 107.854 -1.165 . . . . 61.399999999999999 107.854 171.64 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 107.501 -1.296 . . . . 74.349999999999994 107.501 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 t -72.36 94.18 1.59 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.277 0.631 . . . . 61.420000000000002 111.08 -170.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.1 67.6 0.24 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.708 -0.557 . . . . 42.340000000000003 111.708 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.62 170.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.541 0.737 . . . . 71.030000000000001 110.882 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.53 147.42 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.37 0.668 . . . . 71.030000000000001 110.822 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.9 p -108.76 17.71 21.57 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.974 0.909 . . . . 64.120000000000005 110.679 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t -143.9 150.09 37.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.909 0.884 . . . . 73.310000000000002 109.176 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.02 130.49 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 108.99 -0.745 . . . . 74.310000000000002 108.99 168.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.34 147.22 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.525 -0.916 . . . . 62.43 108.525 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.44 118.99 10.42 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.568 0.543 . . . . 72.540000000000006 112.836 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.32 -34.49 73.89 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.686 0.794 . . . . 75.439999999999998 110.216 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.67 -32.36 73.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.831 0.852 . . . . 75.549999999999997 111.765 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.11 15.03 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 111.733 0.271 . . . . 61.109999999999999 111.733 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.72 122.88 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.989 -0.745 . . . . 54.009999999999998 108.989 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.69 -56.24 3.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.101 -0.703 . . . . 74.200000000000003 109.101 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -160.86 137.06 8.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.327 -0.851 . . . . 74.109999999999999 110.44 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.69 108.54 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 108.68 -0.859 . . . . 74.439999999999998 108.68 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -101.63 115.28 30.16 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.425 -0.954 . . . . 72.219999999999999 108.425 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -85.94 121.88 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 107.96 -1.126 . . . . 74.019999999999996 107.96 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 m -105.68 126.3 31.11 Favored Pre-proline 0 C--O 1.247 0.973 0 C-N-CA 123.572 0.749 . . . . 73.329999999999998 109.777 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.02 153.3 58.87 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.541 2.16 . . . . 73.519999999999996 112.219 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' A' ' 40' ' ' LYS . 11.1 Cg_endo -52.76 92.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.419 2.746 . . . . 73.150000000000006 114.109 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.4 14.52 10.07 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.334 -0.848 . . . . 75.430000000000007 111.487 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -73.23 -14.53 61.36 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.427 1.091 . . . . 74.430000000000007 111.124 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.03 -14.66 48.55 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.834 0.73 . . . . 52.229999999999997 111.289 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -131.54 156.73 79.73 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.335 1.454 . . . . 75.510000000000005 109.002 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.52 81.96 0.55 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.085 2.523 . . . . 74.310000000000002 112.325 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 34' ' ' PRO . 27.8 mmmt -142.77 121.26 12.44 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.946 0.898 . . . . 72.239999999999995 110.087 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 m -79.23 114.74 18.41 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.995 -1.113 . . . . 73.129999999999995 107.995 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -94.56 108.29 20.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.526 -0.916 . . . . 75.510000000000005 108.526 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.8 101.57 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.3 -1.0 . . . . 64.040000000000006 108.3 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.2 t -96.2 108.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.359 -0.837 . . . . 64.319999999999993 109.057 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.447 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.0 mt -104.75 121.92 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.925 -0.769 . . . . 64.109999999999999 108.925 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -95.23 131.71 40.99 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 124.175 0.99 . . . . 75.200000000000003 108.899 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.8 p -90.46 169.75 10.79 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 123.214 0.606 . . . . 73.129999999999995 110.278 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -73.37 -17.13 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.637 0.775 . . . . 51.140000000000001 110.891 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.7 mtt -79.86 6.72 10.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.482 0.713 . . . . 45.329999999999998 110.837 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 65.7 17.21 10.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.486 1.114 . . . . 65.120000000000005 111.877 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -91.8 130.28 37.6 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.357 -0.979 . . . . 75.340000000000003 108.357 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -85.92 128.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.207 -0.906 . . . . 63.130000000000003 109.84 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 45' ' ' ILE . 42.8 pt -128.53 156.08 40.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 108.013 -1.106 . . . . 72.120000000000005 108.013 167.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -133.07 136.02 45.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.962 -0.755 . . . . 70.319999999999993 108.962 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.43 163.57 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.507 0.723 . . . . 64.140000000000001 109.728 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -86.0 146.18 42.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.78 -1.1 . . . . 72.420000000000002 108.391 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.16 -10.06 24.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.074 2.516 . . . . 75.230000000000004 113.522 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -75.2 -12.54 60.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.139 0.576 . . . . 70.239999999999995 111.712 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.96 115.36 2.36 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.09 0.956 . . . . 72.239999999999995 110.573 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -66.32 -32.6 74.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.209999999999994 112.278 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.3 p-90 -70.92 -26.23 63.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.933 0.493 . . . . 75.340000000000003 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.4 -30.17 70.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 73.230000000000004 110.761 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -59.26 -27.07 65.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 63.130000000000003 111.399 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -62.63 -47.54 83.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.863 0.727 . . . . 75.400000000000006 110.037 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.3 mm? -69.84 -46.52 65.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.15 -0.932 . . . . 73.450000000000003 110.189 -177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.22 -46.16 90.72 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.1 0.875 . . . . 74.129999999999995 111.222 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -79.03 -18.35 53.71 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.715 -0.675 . . . . 72.120000000000005 110.965 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.26 -30.43 64.85 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.469 0.308 . . . . 75.219999999999999 110.473 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' LEU . 49.0 t -68.65 -23.62 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 109.805 -0.443 . . . . 72.420000000000002 109.805 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.901 0.858 . . . . 70.120000000000005 109.553 173.641 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.662 -0.495 . . . . 71.129999999999995 109.662 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 t -102.98 39.02 1.62 Allowed 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.343 -0.984 . . . . 50.140000000000001 108.343 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.18 -149.07 24.77 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.211 -0.904 . . . . 31.109999999999999 111.037 -171.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.56 170.08 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.911 0.884 . . . . 62.439999999999998 109.76 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 ' O ' ' A' ' 19' ' ' THR . 2.6 pp -81.82 150.64 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.283 0.563 . . . . 60.32 110.524 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.5 p -113.65 8.18 17.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.037 0.935 . . . . 62.240000000000002 111.435 171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.417 ' O ' HD13 ' A' ' 17' ' ' ILE . 41.0 m -136.71 129.7 30.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.913 0.885 . . . . 70.430000000000007 109.251 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.3 t -65.85 113.3 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.658 -0.867 . . . . 63.340000000000003 108.658 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -77.01 126.59 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.186 -0.915 . . . . 72.340000000000003 110.554 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.03 137.4 38.39 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.924 0.765 . . . . 24.420000000000002 113.596 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.3 -36.53 71.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.022 0.929 . . . . 73.209999999999994 110.39 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -61.82 -34.18 75.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.852 0.861 . . . . 72.239999999999995 111.98 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.52 -4.82 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 119.278 -0.392 . . . . 70.310000000000002 111.742 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.3 mm -68.51 114.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.832 -0.803 . . . . 73.340000000000003 108.832 171.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -89.81 -52.85 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.412 -0.588 . . . . 74.319999999999993 109.412 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 6.2 ptp180 -152.05 145.63 24.93 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.3 -0.409 . . . . 62.030000000000001 110.3 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.51 108.63 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.838 -1.171 . . . . 73.150000000000006 107.838 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -103.0 121.93 43.57 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.772 -0.825 . . . . 64.319999999999993 108.772 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.53 113.54 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.837 -1.171 . . . . 70.129999999999995 107.837 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -96.4 106.91 32.42 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 109.59 -0.522 . . . . 73.340000000000003 109.59 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.41 163.82 37.45 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.104 1.869 . . . . 74.329999999999998 111.522 174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 97.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.468 2.778 . . . . 74.519999999999996 112.98 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -92.22 0.09 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.413 -0.358 . . . . 63.140000000000001 113.164 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.77 79.34 6.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.384 0.673 . . . . 72.439999999999998 111.692 -170.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.32 -20.85 3.82 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.105 -0.952 . . . . 73.230000000000004 114.638 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.7 m -89.73 114.54 61.03 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 108.503 -0.925 . . . . 64.329999999999998 108.503 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.41 -6.54 10.93 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.614 2.209 . . . . 44.039999999999999 113.504 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 172.09 12.05 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.084 0.954 . . . . 64.239999999999995 109.209 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.3 m -73.05 115.61 12.58 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.679 -0.692 . . . . 64.319999999999993 110.183 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -124.04 114.44 19.74 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.223 1.009 . . . . 53.409999999999997 108.479 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.43 104.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.923 0.489 . . . . 60.399999999999999 110.063 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.575 HG12 ' SG ' ' A' ' 54' ' ' CYS . 35.3 m -92.37 111.69 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.814 0.816 . . . . 64.319999999999993 109.238 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.71 134.53 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.264 0.626 . . . . 74.230000000000004 109.565 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 66.4 m95 -96.34 130.03 43.54 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 78.3 p -84.13 169.02 15.28 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.477 0.486 . . . . 73.040000000000006 109.704 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -21.47 66.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.178 0.591 . . . . 74.5 110.533 172.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.0 mtm -85.02 2.35 43.55 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.829 1.252 . . . . 71.530000000000001 110.915 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.86 38.57 11.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.895 1.678 . . . . 70.040000000000006 112.704 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -90.73 135.65 33.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.472 -1.24 . . . . 63.420000000000002 109.467 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -98.1 115.8 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.429 -0.952 . . . . 73.450000000000003 108.429 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 46.4 pt -119.16 149.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.291 0.636 . . . . 70.030000000000001 109.478 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.575 ' SG ' HG12 ' A' ' 44' ' ' VAL . 92.6 m -115.07 117.83 31.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.391 0.676 . . . . 70.439999999999998 109.532 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.55 154.29 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.274 1.03 . . . . 72.340000000000003 108.877 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -77.21 148.26 77.66 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.874 0.47 . . . . 71.519999999999996 110.477 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -64.47 -13.67 39.86 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.879 2.386 . . . . 64.310000000000002 113.078 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -107.42 18.41 21.59 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.716 0.806 . . . . 71.530000000000001 111.871 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.84 123.21 19.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.851 -1.166 . . . . 55.329999999999998 107.851 167.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -56.25 -44.52 79.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.219 1.008 . . . . 54.329999999999998 112.19 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.0 p-90 -64.24 -38.16 90.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.814 0.445 . . . . 74.140000000000001 111.135 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.93 -33.65 76.06 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.559 0.744 . . . . 63.149999999999999 110.99 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -54.26 -38.61 66.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 72.030000000000001 111.132 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.48 -37.95 86.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.643 . . . . 73.040000000000006 110.372 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.81 -41.93 91.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.767 0.827 . . . . 73.439999999999998 109.924 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 -24.97 62.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.231 1.012 . . . . 73.299999999999997 110.984 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -83.46 -35.64 24.78 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.951 0.5 . . . . 55.310000000000002 109.844 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -75.88 -23.13 55.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.957 0.503 . . . . 73.150000000000006 111.626 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 p -77.22 -17.86 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 110.032 -0.359 . . . . 71.329999999999998 110.032 174.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.35 -0.982 . . . . 73.129999999999995 108.35 168.457 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.237 0.409 0 N-CA-C 107.91 -1.145 . . . . 44.409999999999997 107.91 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -86.71 40.51 0.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.138 0.975 . . . . 53.109999999999999 111.188 -174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' CYS . . . 74.21 165.65 12.82 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.826 -0.624 . . . . 74.420000000000002 112.284 -174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -100.0 168.61 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 109.282 -0.636 . . . . 72.430000000000007 109.282 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.92 138.15 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.129 0.572 . . . . 71.409999999999997 110.086 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -98.18 7.04 46.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.796 0.839 . . . . 73.230000000000004 109.638 172.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -118.28 128.61 54.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.293 1.037 . . . . 55.149999999999999 109.283 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.44 126.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 109.156 -0.683 . . . . 74.200000000000003 109.156 170.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.65 142.21 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 122.803 0.441 . . . . 71.5 110.167 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.66 135.82 15.95 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.268 -0.424 . . . . 41.009999999999998 112.35 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.35 -34.25 70.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.45 0.7 . . . . 72.019999999999996 109.962 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -62.25 -32.64 73.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.295 1.038 . . . . 54.299999999999997 112.309 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -98.42 4.18 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 111.905 0.335 . . . . 71.010000000000005 111.905 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 32.7 mm -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.371 -0.603 . . . . 74.349999999999994 109.371 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.32 -57.95 2.1 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.796 -0.446 . . . . 53.509999999999998 109.796 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -145.9 144.37 30.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.043 0.937 . . . . 75.230000000000004 109.364 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -107.9 109.33 27.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.226 -1.027 . . . . 73.140000000000001 108.226 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -93.06 127.2 38.51 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.535 -0.913 . . . . 74.329999999999998 108.535 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.6 111.51 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 107.956 -1.127 . . . . 74.299999999999997 107.956 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 m -113.74 127.28 27.0 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 109.143 -0.688 . . . . 72.109999999999999 109.143 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.24 154.44 5.78 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.574 3.516 . . . . 74.409999999999997 114.159 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.97 -177.05 2.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.224 2.616 . . . . 71.319999999999993 113.63 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.13 76.55 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.018 -0.537 . . . . 52.530000000000001 113.288 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -90.51 72.35 6.91 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.465 -0.939 . . . . 52.310000000000002 108.465 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.42 -13.45 11.12 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.384 -0.676 . . . . 73.310000000000002 114.601 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.53 146.39 47.84 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.915 0.886 . . . . 70.230000000000004 109.874 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.04 -7.56 19.23 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.239 2.626 . . . . 73.319999999999993 113.915 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -100.13 150.45 22.49 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.095 0.558 . . . . 71.409999999999997 109.994 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.9 m -67.57 134.16 50.74 Favored 'General case' 0 C--O 1.242 0.666 0 O-C-N 123.93 0.768 . . . . 63.020000000000003 109.757 170.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.88 119.79 28.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.099 -0.704 . . . . 74.109999999999999 109.099 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.77 103.5 15.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.265 -1.013 . . . . 54.43 108.265 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.22 114.56 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.779 -0.823 . . . . 53.109999999999999 108.779 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 54.7 mt -95.06 121.61 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.351 -0.611 . . . . 74.209999999999994 109.351 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -86.95 123.67 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.912 -1.144 . . . . 72.450000000000003 107.912 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.3 p -87.78 179.22 6.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.015 0.526 . . . . 71.5 111.016 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.76 -14.08 60.67 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.374 0.67 . . . . 72.209999999999994 111.737 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -94.5 0.94 55.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.551 0.74 . . . . 74.109999999999999 110.33 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.18 23.6 10.9 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.879 1.671 . . . . 73.510000000000005 112.909 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -71.52 123.81 23.25 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.877 -1.157 . . . . 63.219999999999999 107.877 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t -96.01 111.26 25.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.468 -1.308 . . . . 61.520000000000003 107.468 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.19 136.89 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.515 -0.92 . . . . 73.219999999999999 108.515 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 42.3 t -107.61 117.55 34.4 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.003 -1.11 . . . . 64.420000000000002 108.003 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.81 164.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 54.119999999999997 109.812 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.44 141.43 73.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.324 -0.621 . . . . 73.209999999999994 109.324 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.06 -23.95 78.44 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.782 2.321 . . . . 64.030000000000001 112.765 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.71 31.48 5.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.591 0.757 . . . . 71.109999999999999 110.663 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 126.06 27.39 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -68.68 -30.17 68.79 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.614 0.766 . . . . 73.0 112.936 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -74.1 -23.36 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.986 0.514 . . . . 65.140000000000001 111.603 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.97 -21.81 65.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.841 0.856 . . . . 74.200000000000003 110.631 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -58.18 -30.8 66.7 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.105 0.962 . . . . 75.400000000000006 111.522 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -65.59 -36.93 85.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.408 0.683 . . . . 61.399999999999999 110.708 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.62 -37.28 65.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.272 0.629 . . . . 42.219999999999999 109.687 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -67.55 -33.27 74.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.776 0.83 . . . . 64.310000000000002 110.51 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -74.65 -36.96 62.85 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.899 1.28 . . . . 75.299999999999997 110.552 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -69.32 -35.43 75.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.441 0.697 . . . . 74.430000000000007 111.038 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.98 -7.81 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.233 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.05 -0.722 . . . . 45.049999999999997 109.05 175.183 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.451 -0.574 . . . . 70.129999999999995 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -110.28 10.14 23.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.907 0.883 . . . . 54.200000000000003 109.915 174.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.69 -82.5 1.07 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.778 0.704 . . . . 71.040000000000006 111.415 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.85 168.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.536 1.134 . . . . 72.310000000000002 109.955 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 HD11 ' HZ2' ' A' ' 61' ' ' TRP . 43.9 pt -123.75 144.07 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.805 -0.813 . . . . 75.340000000000003 108.805 167.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -77.24 -41.05 42.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.535 0.734 . . . . 54.219999999999999 111.328 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.5 p -81.85 144.71 30.82 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.223 1.009 . . . . 75.5 111.632 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.7 t -85.4 115.42 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.499 -0.926 . . . . 73.519999999999996 108.499 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.6 134.17 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.625 0.77 . . . . 65.140000000000001 109.523 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.13 140.07 30.51 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.762 0.664 . . . . 54.340000000000003 114.23 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.22 -37.15 71.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.996 0.918 . . . . 70.540000000000006 110.907 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.14 -21.63 60.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.404 0.682 . . . . 74.409999999999997 112.099 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.38 4.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 122.173 -0.329 . . . . 73.209999999999994 111.276 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 47.2 mm -74.23 123.4 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.842 0.857 . . . . 74.120000000000005 108.94 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.28 -55.92 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.999 0.52 . . . . 74.109999999999999 110.604 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -149.4 136.21 19.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.912 0.485 . . . . 54.210000000000001 110.165 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.94 145.01 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.476 1.11 . . . . 74.030000000000001 109.296 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -136.55 126.11 25.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.182 0.993 . . . . 70.420000000000002 108.543 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.87 112.54 40.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.445 0.698 . . . . 73.329999999999998 109.293 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 22.4 m -87.59 123.63 69.1 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.515 0.726 . . . . 64.219999999999999 109.489 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 27.4 Cg_exo -64.35 139.94 67.82 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.28 2.653 . . . . 73.5 113.789 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.78 99.99 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.292 2.662 . . . . 72.030000000000001 112.544 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.52 -45.74 0.26 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.985 -0.552 . . . . 41.32 112.207 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.03 75.01 9.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.578 0.751 . . . . 62.520000000000003 110.582 -173.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.67 26.7 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.709 0.643 . . . . 41.049999999999997 114.709 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -122.42 130.82 24.52 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.749 0.82 . . . . 73.230000000000004 108.957 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.48 -4.83 13.18 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.73 2.287 . . . . 73.549999999999997 113.352 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -123.06 161.56 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.83 0.852 . . . . 75.120000000000005 110.392 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.4 m -69.31 113.78 6.96 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.961 -0.755 . . . . 72.010000000000005 108.961 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 40.8 tt0 -96.49 130.44 43.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.351 0.66 . . . . 73.510000000000005 109.518 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.88 101.36 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.159 -1.052 . . . . 70.310000000000002 108.159 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -108.1 125.13 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.802 0.841 . . . . 64.230000000000004 109.037 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 63.2 mt -118.72 129.66 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.405 0.682 . . . . 61.409999999999997 109.829 -175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -86.96 124.73 33.48 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.751 -1.203 . . . . 73.340000000000003 107.751 167.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.5 p -81.96 173.53 12.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.228 0.611 . . . . 62.219999999999999 109.573 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.66 -12.0 60.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.943 0.402 . . . . 72.099999999999994 110.919 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -85.98 1.91 48.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.939 0.896 . . . . 74.420000000000002 110.773 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 67.72 11.69 8.49 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.589 1.556 . . . . 62.009999999999998 111.618 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -73.45 126.02 29.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.991 -0.744 . . . . 62.109999999999999 108.991 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.07 102.51 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.476 -1.305 . . . . 61.310000000000002 107.476 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.6 pt -98.92 154.01 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.361 -0.978 . . . . 74.319999999999993 108.361 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 t -135.46 128.79 32.11 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.948 -1.13 . . . . 63.210000000000001 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.3 160.11 29.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 123.919 0.888 . . . . 75.340000000000003 109.51 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.6 148.32 65.51 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.109 -1.071 . . . . 74.200000000000003 108.109 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.59 -28.19 64.02 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.76 2.306 . . . . 74.239999999999995 113.997 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -90.5 2.58 55.59 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.42 0.526 . . . . 72.510000000000005 112.42 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.31 30.84 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.796 0.839 . . . . 64.150000000000006 112.277 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -50.64 37.87 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.391 1.476 . . . . 65.010000000000005 112.334 -162.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.42 ' HZ2' HD11 ' A' ' 17' ' ' ILE . 51.9 p-90 -76.2 -20.19 57.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.046 0.139 . . . . 73.129999999999995 111.182 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.82 -28.67 69.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.461 0.705 . . . . 61.340000000000003 110.174 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -61.7 -19.05 61.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.708 . . . . 54.310000000000002 112.428 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -71.8 -38.02 70.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.994 0.517 . . . . 74.219999999999999 109.75 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.55 -37.05 65.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.764 0.826 . . . . 71.510000000000005 109.124 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -71.35 -29.54 65.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.233 -0.894 . . . . 64.099999999999994 110.875 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -81.47 -34.54 31.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.055 0.542 . . . . 73.040000000000006 110.794 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -67.83 -31.99 72.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.186 0.594 . . . . 75.129999999999995 111.001 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.99 -6.28 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.091 0.472 . . . . 73.439999999999998 110.873 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 N--CA 1.474 0.765 0 C-N-CA 124.015 0.926 . . . . 63.100000000000001 110.884 176.146 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.6 pt . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 121.479 0.657 . . . . 75.400000000000006 110.55 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.32 142.33 50.45 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.963 -0.562 . . . . 60.25 109.678 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 170.43 8.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.01 0.924 . . . . 73.049999999999997 109.146 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.63 99.35 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.666 0.787 . . . . 23.109999999999999 111.203 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -82.52 127.38 33.27 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.424 -0.807 . . . . 74.420000000000002 109.81 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -75.54 143.59 42.36 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.255 -1.017 . . . . 75.219999999999999 108.255 168.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -141.55 163.41 32.99 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.766 0.826 . . . . 73.040000000000006 109.562 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -67.76 136.97 55.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.052 -0.722 . . . . 72.129999999999995 109.052 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -152.0 163.85 38.41 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.759 -0.83 . . . . 72.219999999999999 108.759 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -141.62 -179.6 6.26 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.571 0.748 . . . . 72.040000000000006 110.403 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.1 p -64.65 114.96 4.77 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.319 -0.855 . . . . 60.43 109.642 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -73.27 120.53 19.02 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.394 -0.595 . . . . 71.329999999999998 109.394 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 14' ' ' SER . 47.1 t -81.03 168.13 19.01 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.626 0.77 . . . . 71.510000000000005 110.143 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 p -53.83 -47.14 71.21 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.427 -0.806 . . . . 73.019999999999996 110.235 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.34 168.1 40.71 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 115.835 -0.62 . . . . 73.049999999999997 113.298 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 172.41 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.688 1.195 . . . . 64.5 109.403 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -124.05 147.65 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.24 0.543 . . . . 72.25 111.496 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 p -97.52 -14.55 21.02 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.219 168.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.3 m -99.24 143.28 29.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.89 0.876 . . . . 73.310000000000002 109.753 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.22 122.96 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.82 136.82 24.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 115.993 -0.549 . . . . 52.240000000000002 109.577 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 121.88 27.21 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.659 0.6 . . . . 72.319999999999993 112.477 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.49 -31.03 61.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.713 1.205 . . . . 73.409999999999997 110.777 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.58 -31.9 53.37 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.67 0.788 . . . . 73.439999999999998 111.373 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 pt -90.59 8.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 111.579 0.215 . . . . 71.239999999999995 111.579 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.451 HG13 HD11 ' A' ' 65' ' ' LEU . 29.8 mm -75.64 136.81 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.422 -0.955 . . . . 71.219999999999999 108.422 173.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.76 -55.44 2.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.948 0.499 . . . . 62.340000000000003 109.966 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 24.4 ptt180 -147.6 159.15 44.09 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.489 0.662 . . . . 73.439999999999998 110.769 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 43' ' ' VAL . 76.7 mt -111.53 110.76 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.23 -1.35 . . . . 74.099999999999994 108.741 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 26.7 tt0 -100.98 142.58 32.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.482 1.113 . . . . 54.240000000000002 108.125 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -112.74 136.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 122.882 0.473 . . . . 63.5 110.725 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.7 m -114.37 97.09 45.12 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.605 -0.887 . . . . 71.019999999999996 108.605 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.39 167.24 27.8 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 122.428 2.085 . . . . 72.209999999999994 112.748 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 148.48 93.07 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.466 2.111 . . . . 51.310000000000002 112.194 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 -16.52 55.09 Favored Glycine 0 N--CA 1.474 1.218 0 CA-C-N 116.52 -0.309 . . . . 74.219999999999999 112.752 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 22.32 1.71 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.982 0.913 . . . . 73.450000000000003 111.103 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.97 -5.89 84.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.04 -0.424 . . . . 42.130000000000003 112.04 -166.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 m -99.02 116.78 65.05 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.34 1.056 . . . . 75.319999999999993 109.497 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.26 -20.09 49.56 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.429 2.086 . . . . 44.329999999999998 111.558 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -125.48 145.82 49.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.653 1.181 . . . . 73.030000000000001 110.089 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 m -72.61 115.52 11.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.362 -0.977 . . . . 61.109999999999999 108.362 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -120.08 140.43 51.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.1 0.409 . . . . 72.150000000000006 110.865 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG13 HG23 ' A' ' 29' ' ' ILE . 93.0 t -91.09 120.51 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.923 0.889 . . . . 52.530000000000001 110.145 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 54' ' ' CYS . 57.8 t -91.14 117.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.854 0.861 . . . . 75.420000000000002 108.814 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.12 128.68 44.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.633 -0.506 . . . . 51.439999999999998 109.633 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 50.0 m95 -104.64 116.28 31.78 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.452 -1.684 . . . . 64.329999999999998 106.452 166.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 p -87.19 172.14 10.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.959 0.409 . . . . 64.0 111.273 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.895 0.878 . . . . 55.030000000000001 111.033 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 49' ' ' MET . 1.1 mpt? -83.72 -0.84 52.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.025 0.93 . . . . 71.120000000000005 111.246 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.67 19.37 9.77 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.183 1.393 . . . . 74.310000000000002 111.634 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -72.05 124.96 26.06 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.73 -0.841 . . . . 74.299999999999997 108.73 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.31 113.35 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.222 1.009 . . . . 71.209999999999994 108.32 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.26 154.48 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.895 0.878 . . . . 63.039999999999999 109.398 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 44' ' ' VAL . 24.2 m -116.93 117.95 31.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.385 -0.968 . . . . 72.219999999999999 108.385 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.11 160.33 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.814 0.846 . . . . 75.510000000000005 109.512 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -62.94 133.64 95.4 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.043 0.537 . . . . 64.25 110.273 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 -32.87 59.32 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.825 2.35 . . . . 74.239999999999995 112.414 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -100.82 25.26 8.14 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.577 -0.738 . . . . 73.219999999999999 111.477 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.06 131.86 47.67 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.287 -0.635 . . . . 64.109999999999999 109.287 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -57.65 -34.03 68.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.857 1.263 . . . . 74.310000000000002 112.927 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -78.57 -34.43 46.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.39 0.676 . . . . 71.329999999999998 111.648 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -70.59 -20.62 62.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.661 0.784 . . . . 72.400000000000006 111.457 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -51.99 -37.6 53.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.851 0.86 . . . . 73.299999999999997 111.706 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -72.38 -29.65 63.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 73.409999999999997 111.317 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -73.55 -38.33 65.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 63.119999999999997 109.71 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.63 -29.39 65.75 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.737 0.815 . . . . 71.150000000000006 110.427 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -81.13 -23.43 38.35 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.634 0.774 . . . . 72.329999999999998 110.805 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.13 -37.56 66.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.272 0.629 . . . . 73.099999999999994 111.28 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.79 -29.7 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.562 0.345 . . . . 65.120000000000005 111.919 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -95.26 159.46 15.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.114 0.566 . . . . 72.329999999999998 109.527 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.5 t -74.25 139.89 44.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.127 -0.488 . . . . 71.430000000000007 110.012 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.3 -55.4 3.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.069 -0.715 . . . . 72.140000000000001 109.069 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.1 t -167.74 -172.09 1.78 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.07 0.948 . . . . 53.420000000000002 109.021 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 tt -153.51 135.24 14.49 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.978 -0.749 . . . . 51.420000000000002 108.978 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 t -148.2 148.03 30.08 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.443 0.697 . . . . 54.43 109.545 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.9 p -153.21 148.1 26.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.61 0.764 . . . . 70.430000000000007 109.71 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -112.64 92.02 18.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.858 0.863 . . . . 75.040000000000006 110.615 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.35 110.21 2.2 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.539 2.159 . . . . 72.530000000000001 111.317 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -148.98 135.52 19.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.423 0.689 . . . . 61.009999999999998 109.315 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.99 134.29 78.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.289 -0.862 . . . . 72.319999999999993 109.222 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.85 103.51 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.276 1.984 . . . . 64.150000000000006 111.813 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.7 85.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 122.706 1.241 . . . . 73.25 110.044 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 t -93.74 88.16 5.71 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.541 -1.209 . . . . 74.319999999999993 108.218 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -79.73 73.0 6.46 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.427 0.691 . . . . 63.149999999999999 109.904 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -65.17 118.13 8.78 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.966 -0.753 . . . . 73.150000000000006 108.966 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -158.9 96.67 1.36 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.828 -0.624 . . . . 74.310000000000002 109.393 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.12 -39.78 15.24 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.694 -0.685 . . . . 41.5 109.488 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.979 0 C-N-CA 125.395 1.478 . . . . 64.219999999999999 108.172 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.359 -0.608 . . . . 52.130000000000003 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.0 149.91 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.346 1.058 . . . . 61.299999999999997 108.697 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 136.94 33.83 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.897 -0.779 . . . . 70.400000000000006 108.897 175.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.31 114.15 8.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.187 -0.671 . . . . 73.099999999999994 109.187 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.92 97.41 6.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.944 0.498 . . . . 43.109999999999999 110.088 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -75.84 96.54 3.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.44 -0.8 . . . . 60.32 109.212 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -64.31 101.36 0.42 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.977 0.911 . . . . 43.140000000000001 111.636 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -99.0 93.68 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.069 -0.715 . . . . 63.039999999999999 109.069 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.98 97.87 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.747 -0.661 . . . . 73.319999999999993 110.659 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -156.95 -178.23 7.21 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.216 -1.031 . . . . 72.129999999999995 108.216 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.9 m -69.96 114.42 8.12 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.637 -0.875 . . . . 73.549999999999997 108.637 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -79.39 118.85 21.66 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.909 -0.774 . . . . 64.030000000000001 108.909 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.17 110.76 23.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.835 -1.172 . . . . 53.329999999999998 107.835 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.5 p -55.31 -28.22 52.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.243 1.017 . . . . 64.140000000000001 111.866 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.16 161.94 15.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.093 -1.203 . . . . 62.039999999999999 110.093 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.2 m -102.81 143.24 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.21 -1.033 . . . . 70.209999999999994 108.21 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.9 pt -99.87 139.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.599 -0.728 . . . . 71.219999999999999 110.439 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m -103.48 7.54 37.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.908 0.883 . . . . 43.219999999999999 111.105 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 m -74.37 137.86 43.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.557 0.743 . . . . 53.219999999999999 110.321 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -73.05 111.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.102 -1.073 . . . . 64.140000000000001 108.102 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -114.27 128.2 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.958 0.903 . . . . 60.109999999999999 109.225 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.99 162.79 16.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.096 -0.502 . . . . 60.030000000000001 112.712 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.33 -21.99 60.61 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.824 0.85 . . . . 71.439999999999998 111.469 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -53.55 -30.72 43.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 73.230000000000004 112.038 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 36.1 pt -119.8 -3.46 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 71.409999999999997 113.044 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.58 135.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 118.749 0.704 . . . . 72.219999999999999 109.704 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.91 -56.86 2.35 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.241 0.616 . . . . 52.0 110.411 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -143.42 147.55 34.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.566 0.746 . . . . 65.230000000000004 109.746 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.8 mt -108.16 112.33 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.928 -1.138 . . . . 71.420000000000002 107.928 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.16 104.42 14.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.097 -0.705 . . . . 73.349999999999994 109.097 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.85 140.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.922 -0.77 . . . . 62.229999999999997 108.922 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -111.99 92.9 19.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.793 -0.818 . . . . 73.329999999999998 108.793 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.74 149.87 38.93 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.365 2.71 . . . . 74.099999999999994 113.089 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 90.0 Cg_endo -74.36 2.26 6.45 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.719 2.28 . . . . 73.430000000000007 114.166 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.72 47.53 3.59 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 112.196 -0.362 . . . . 73.019999999999996 112.196 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -144.21 5.22 1.27 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.597 1.159 . . . . 74.319999999999993 110.683 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.95 44.79 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.675 -0.514 . . . . 73.319999999999993 112.739 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 28.6 m -82.68 126.61 72.88 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 108.595 -0.891 . . . . 75.420000000000002 108.595 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.61 -42.79 44.08 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.652 2.235 . . . . 62.210000000000001 113.565 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.92 164.56 12.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.22 0.608 . . . . 71.010000000000005 110.238 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 12.7 t -86.1 128.46 34.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.459 -0.941 . . . . 74.010000000000005 108.459 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 mm-40 -108.21 119.07 38.44 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.616 -0.513 . . . . 60.219999999999999 109.616 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.52 102.34 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.696 -0.483 . . . . 75.239999999999995 109.696 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -99.45 107.52 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.0 -1.111 . . . . 74.239999999999995 108.0 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -103.9 133.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.404 -0.591 . . . . 71.409999999999997 109.404 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -102.79 130.0 49.63 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.615 1.166 . . . . 74.219999999999999 108.422 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.5 p -87.07 176.89 7.39 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.388 0.675 . . . . 73.120000000000005 110.52 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 41.4 mtmt -71.58 -24.48 61.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.077 0.551 . . . . 72.329999999999998 110.726 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.76 -2.66 37.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.175 0.99 . . . . 74.099999999999994 110.569 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 68.84 14.64 8.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.462 1.505 . . . . 52.5 110.826 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.17 131.78 39.58 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.856 -1.164 . . . . 75.310000000000002 107.856 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.22 121.28 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.344 -0.844 . . . . 74.519999999999996 109.817 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -119.01 134.0 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.805 -0.813 . . . . 74.030000000000001 108.805 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 44.4 t -110.92 126.24 54.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.862 0.865 . . . . 74.040000000000006 109.568 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG11 ' HE1' ' A' ' 61' ' ' TRP . 19.2 m -137.42 164.29 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.218 1.007 . . . . 73.430000000000007 109.394 172.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.27 161.3 55.03 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 115.137 -0.938 . . . . 64.420000000000002 110.052 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.4 -18.19 63.49 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 112.748 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.07 25.51 7.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.8 0.84 . . . . 75.349999999999994 110.62 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 136.09 36.11 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.85 0.46 . . . . 43.439999999999998 110.363 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.21 -50.52 71.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.008 0.923 . . . . 53.420000000000002 112.748 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.401 ' HE1' HG11 ' A' ' 55' ' ' VAL . 36.4 p-90 -66.86 -28.69 68.54 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.881 0.472 . . . . 71.299999999999997 110.948 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.2 tp -67.25 -30.3 70.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.216 1.006 . . . . 63.119999999999997 111.683 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -54.17 -35.92 62.82 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.764 0.826 . . . . 70.340000000000003 111.63 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.24 -42.22 84.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.103 -0.953 . . . . 73.299999999999997 109.651 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.86 -32.37 72.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.406 1.082 . . . . 63.549999999999997 110.443 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -38.57 79.47 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.444 0.698 . . . . 64.409999999999997 110.178 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -68.96 -37.73 79.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.324 -0.25 . . . . 63.240000000000002 110.324 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.54 -37.98 86.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.012 0.525 . . . . 54.219999999999999 112.15 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.16 -11.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-O 120.927 0.394 . . . . 71.430000000000007 111.117 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 72' ' ' LYS . 26.8 tp60 -80.14 124.84 29.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.92 -0.771 . . . . 72.439999999999998 108.92 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.7 p -68.99 -2.66 10.43 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.128 0.971 . . . . 64.349999999999994 113.175 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' A' ' 70' ' ' GLN . 24.0 tptp -71.86 -34.57 69.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.435 0.694 . . . . 72.129999999999995 109.928 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.7 m -85.39 147.28 26.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.868 0.867 . . . . 73.439999999999998 110.878 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.0 tp -77.14 89.15 3.63 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.054 -0.721 . . . . 25.219999999999999 109.054 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.8 m -148.11 -158.84 0.95 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.461 -1.311 . . . . 75.530000000000001 107.461 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.7 t -70.38 92.39 0.8 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.305 -0.998 . . . . 65.319999999999993 108.305 167.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.3 p -73.35 119.08 73.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.703 0.801 . . . . 71.329999999999998 110.614 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -91.51 110.51 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.444 2.096 . . . . 72.420000000000002 110.826 165.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -49.0 129.55 17.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.873 0.869 . . . . 55.350000000000001 111.302 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -112.86 93.25 23.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.057 0.943 . . . . 71.239999999999995 108.905 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 80.37 0.88 Allowed 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.55 2.166 . . . . 64.040000000000006 111.26 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.8 p -152.06 162.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.468 1.107 . . . . 73.019999999999996 108.779 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.3 p -62.48 97.96 0.11 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 109.063 -0.718 . . . . 74.540000000000006 109.063 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -131.37 156.81 44.89 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.093 0.957 . . . . 72.420000000000002 108.955 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -75.42 93.9 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.843 -0.799 . . . . 75.140000000000001 108.843 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -60.18 140.16 57.12 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.932 -1.031 . . . . 62.310000000000002 109.758 171.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.82 26.72 14.43 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.962 0.905 . . . . 75.319999999999993 112.331 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.673 -0.679 . . . . 65.549999999999997 110.578 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 110.369 -0.234 . . . . 75.409999999999997 110.369 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.03 116.84 23.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.225 -1.028 . . . . 74.140000000000001 108.225 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -71.06 91.23 0.88 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 75.209999999999994 110.978 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.71 94.89 1.41 Allowed 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.612 -0.885 . . . . 61.340000000000003 108.612 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -66.96 117.61 9.28 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.973 0.909 . . . . 74.420000000000002 111.713 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -70.75 -9.73 57.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.092 0.957 . . . . 74.319999999999993 111.46 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 t -107.28 145.65 32.48 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.543 -0.91 . . . . 62.119999999999997 108.543 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -74.15 135.4 42.86 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 122.613 0.365 . . . . 40.310000000000002 110.059 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.79 89.14 1.8 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.343 -0.984 . . . . 74.209999999999994 108.343 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.71 160.74 31.1 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.835 -1.075 . . . . 73.239999999999995 110.744 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 m -71.65 107.14 4.35 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.062 -0.718 . . . . 74.450000000000003 109.062 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.73 121.05 37.04 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.514 -1.291 . . . . 73.310000000000002 107.514 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -118.4 166.16 13.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.025 0.53 . . . . 74.030000000000001 110.123 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -57.35 -31.08 65.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.19 0.996 . . . . 72.019999999999996 112.212 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.46 -173.34 15.97 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.46 -0.791 . . . . 75.109999999999999 111.562 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 55' ' ' VAL . 99.5 t -99.68 129.35 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.17 -1.048 . . . . 71.349999999999994 108.17 -175.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 53' ' ' ILE . 37.9 pt -84.15 140.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 123.361 0.413 . . . . 72.0 110.228 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 p -90.39 -4.18 57.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.794 0.838 . . . . 65.019999999999996 111.446 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.9 m -88.41 142.84 27.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.598 0.759 . . . . 62.299999999999997 109.878 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.74 112.38 22.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.839 -1.171 . . . . 70.140000000000001 107.839 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -72.68 143.09 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.186 0.594 . . . . 55.219999999999999 110.556 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 123.27 30.18 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.83 0.706 . . . . 64.439999999999998 112.574 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 64' ' ' ARG . 9.8 mp -67.41 -22.41 65.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.209 0.604 . . . . 71.019999999999996 111.428 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -74.43 -26.08 59.84 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.435 0.694 . . . . 74.519999999999996 111.683 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 47.8 pt -97.65 3.44 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 122.149 -0.344 . . . . 64.329999999999998 111.525 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 65' ' ' LEU . 27.5 mm -72.05 130.18 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 109.566 -0.531 . . . . 74.109999999999999 109.566 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -102.03 -59.43 1.7 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.452 0.701 . . . . 64.200000000000003 110.81 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -146.29 150.18 35.28 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.71 0.404 . . . . 70.439999999999998 110.684 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.24 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.115 0.966 . . . . 73.140000000000001 108.946 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -97.44 147.6 24.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.922 1.289 . . . . 75.25 109.101 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.17 142.9 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.677 -0.49 . . . . 64.209999999999994 109.677 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.2 m -121.78 109.78 33.89 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.992 0.917 . . . . 75.319999999999993 109.098 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.12 155.3 17.11 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.625 2.216 . . . . 53.329999999999998 113.085 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.1 173.66 14.06 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.733 2.289 . . . . 72.340000000000003 112.051 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 -26.13 8.66 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 116.775 -0.193 . . . . 74.420000000000002 113.384 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.8 23.49 3.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.135 0.974 . . . . 63.020000000000003 110.816 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.59 -19.53 44.63 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.905 -0.589 . . . . 51.219999999999999 112.235 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.8 m -80.46 119.3 75.93 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.034 0.417 . . . . 53.219999999999999 109.941 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.81 -22.7 74.92 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.13 2.553 . . . . 75.230000000000004 113.327 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 172.24 17.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.494 0.718 . . . . 75.150000000000006 109.713 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -75.04 133.86 41.53 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.131 -0.692 . . . . 73.219999999999999 109.131 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.84 124.97 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.081 0.467 . . . . 73.109999999999999 110.532 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.27 113.84 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.223 1.009 . . . . 62.140000000000001 109.1 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.76 109.68 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.417 -0.957 . . . . 71.019999999999996 108.417 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.9 mt -98.65 136.35 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.431 -0.581 . . . . 70.340000000000003 109.431 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -114.39 129.03 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.121 1.369 . . . . 72.030000000000001 108.616 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 p -90.46 172.22 8.87 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.777 0.431 . . . . 75.340000000000003 110.758 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 19.5 ptpt -69.16 -31.25 69.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.681 0.793 . . . . 64.239999999999995 111.133 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.1 ptm -78.42 4.62 12.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.89 0.876 . . . . 74.430000000000007 110.729 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 63.36 25.0 14.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.839 1.656 . . . . 73.409999999999997 112.14 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -76.5 128.57 35.02 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.276 -1.379 . . . . 64.329999999999998 107.276 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -100.56 131.0 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.66 1.184 . . . . 54.450000000000003 109.64 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 17' ' ' ILE . 32.2 pt -133.25 156.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.886 0.874 . . . . 63.140000000000001 108.672 171.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.1 p -137.15 122.48 19.4 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.128 -0.693 . . . . 63.43 109.128 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 16' ' ' VAL . 35.6 m -126.4 150.95 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.382 0.673 . . . . 75.439999999999998 109.785 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.57 152.97 67.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.349 -0.611 . . . . 71.310000000000002 109.349 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.53 -4.87 6.11 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.018 2.479 . . . . 73.25 115.259 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -84.07 -11.63 56.38 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.096 0.559 . . . . 72.109999999999999 112.147 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 113.63 3.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.65 -0.87 . . . . 63.240000000000002 108.65 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 17.5 mtpp -77.72 -20.86 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.722 0.638 . . . . 65.439999999999998 112.722 -171.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -75.5 -14.91 60.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.376 0.27 . . . . 62.340000000000003 111.171 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.5 tp -70.52 -29.4 65.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.672 0.389 . . . . 53.140000000000001 110.041 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -64.45 -19.69 65.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.455 0.302 . . . . 72.219999999999999 111.754 175.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 23' ' ' LEU . 1.1 tpm_? -65.76 -44.11 86.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.942 0.497 . . . . 74.310000000000002 109.691 170.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.448 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -66.78 -41.27 87.95 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.826 0.85 . . . . 64.209999999999994 110.28 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.35 -36.63 81.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.425 0.69 . . . . 65.120000000000005 110.759 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.72 -29.08 56.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.399 0.68 . . . . 74.209999999999994 110.956 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -74.26 -51.12 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.373 0.669 . . . . 74.200000000000003 111.072 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.77 -34.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.988 0.515 . . . . 72.040000000000006 110.747 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -102.92 96.87 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.031 -1.1 . . . . 75.439999999999998 108.031 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 t -157.85 108.56 2.2 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.495 -1.298 . . . . 54.350000000000001 107.495 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -76.76 -17.97 58.74 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.001 0.92 . . . . 74.329999999999998 110.719 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.0 p -117.97 74.06 0.93 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.965 0.906 . . . . 62.039999999999999 109.758 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 tt -140.56 104.79 4.82 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.287 -1.005 . . . . 72.120000000000005 108.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.8 p -96.5 128.1 43.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.679 -0.859 . . . . 63.210000000000001 108.679 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 m -82.77 115.51 21.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.486 0.714 . . . . 60.32 110.36 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 p -63.28 135.84 96.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.407 0.683 . . . . 72.0 110.466 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.54 94.87 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.732 2.288 . . . . 54.140000000000001 112.338 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -103.83 136.4 43.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.523 -1.217 . . . . 74.319999999999993 108.427 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -136.69 100.55 10.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.191 0.596 . . . . 43.399999999999999 110.145 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.48 -174.64 2.07 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.131 1.887 . . . . 72.340000000000003 111.438 169.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.79 78.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.526 -1.287 . . . . 75.209999999999994 107.526 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 p -84.01 75.71 10.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.822 0.82 . . . . 64.120000000000005 110.453 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -151.43 148.8 28.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.745 -1.116 . . . . 62.409999999999997 108.52 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -130.13 171.53 12.75 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.135 0.974 . . . . 73.340000000000003 109.341 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -17.58 61.16 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 121.97 0.108 . . . . 74.319999999999993 110.807 173.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -50.56 20.78 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.092 0.557 . . . . 72.409999999999997 109.743 169.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 124.324 1.05 . . . . 37.380000000000003 108.79 178.658 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.858 -0.423 . . . . 62.420000000000002 109.858 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.7 tp -130.36 151.64 50.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.495 1.118 . . . . 75.340000000000003 108.362 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -115.18 140.42 49.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.688 . . . . 61.210000000000001 109.676 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.27 105.02 17.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.932 0.893 . . . . 64.400000000000006 109.006 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -76.49 82.37 3.19 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 74.109999999999999 110.062 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.5 151.96 51.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.94 0.896 . . . . 74.409999999999997 109.787 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -75.48 85.96 2.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.464 -0.939 . . . . 44.25 108.464 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -87.65 107.32 18.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.473 -0.785 . . . . 72.549999999999997 109.266 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.82 -12.4 58.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.259 1.024 . . . . 52.219999999999999 110.913 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -82.24 174.59 11.02 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.565 0.746 . . . . 74.109999999999999 110.25 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 p -79.14 114.88 18.44 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.334 -0.988 . . . . 53.109999999999999 108.334 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -78.17 135.49 37.64 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.031 0.443 . . . . 73.450000000000003 110.049 -177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.44 149.47 32.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.125 0.97 . . . . 62.43 109.495 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 t -100.0 10.7 40.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.218 0.607 . . . . 72.420000000000002 111.01 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 172.3 46.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.3 -0.72 . . . . 33.109999999999999 111.3 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 33.9 m -100.21 140.13 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 117.325 0.562 . . . . 71.409999999999997 109.895 -174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.95 146.24 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.501 0.72 . . . . 60.229999999999997 110.705 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 p -92.87 -2.2 56.08 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.315 -0.857 . . . . 65.129999999999995 111.394 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.6 m -60.47 118.82 6.96 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.49 -0.559 . . . . 73.439999999999998 109.49 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.27 111.19 3.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.822 -0.807 . . . . 53.350000000000001 108.822 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.52 132.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.249 0.62 . . . . 75.200000000000003 109.4 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.51 145.56 27.9 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.998 -0.546 . . . . 71.230000000000004 112.501 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.16 -33.66 72.49 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.103 0.961 . . . . 71.140000000000001 110.513 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.8 -28.71 68.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.834 0.853 . . . . 73.099999999999994 111.62 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -103.92 12.42 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 111.931 0.345 . . . . 71.310000000000002 111.931 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 mm -76.9 122.24 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.196 -1.039 . . . . 64.319999999999993 108.196 169.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -90.06 -58.86 2.36 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.37 -0.604 . . . . 74.439999999999998 109.37 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -146.95 155.67 42.46 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.183 0.593 . . . . 65.310000000000002 109.749 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.8 mt -113.95 108.15 24.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.202 -1.036 . . . . 64.439999999999998 108.202 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -99.47 137.75 37.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.616 0.766 . . . . 73.549999999999997 108.968 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.15 129.24 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.3 -0.63 . . . . 73.430000000000007 109.3 172.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -106.98 115.18 60.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.855 0.862 . . . . 70.310000000000002 108.984 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.35 166.17 29.31 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.724 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.73 84.09 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.434 2.089 . . . . 72.140000000000001 112.191 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.33 -179.48 39.77 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.676 -1.147 . . . . 70.129999999999995 110.677 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 65.42 18.89 11.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.636 1.174 . . . . 74.340000000000003 111.77 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.52 10.71 53.08 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 122.763 0.22 . . . . 34.409999999999997 113.568 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.36 117.43 33.09 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 108.059 -1.089 . . . . 64.540000000000006 108.059 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.4 5.86 5.79 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.566 2.178 . . . . 61.32 113.603 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -153.01 173.32 15.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.191 0.596 . . . . 73.409999999999997 110.776 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -86.8 121.29 29.1 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.55 -0.907 . . . . 65.5 108.55 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.9 134.51 45.78 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.052 0.541 . . . . 64.450000000000003 109.967 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 101.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.788 -0.819 . . . . 70.019999999999996 108.788 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.12 108.96 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.899 0.88 . . . . 74.530000000000001 109.262 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.41 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.5 mt -95.43 130.56 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.197 -0.668 . . . . 75.129999999999995 109.197 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -97.68 125.78 42.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.662 -1.607 . . . . 74.400000000000006 106.662 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.9 p -89.47 169.42 11.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.025 0.375 . . . . 64.420000000000002 110.531 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.9 -25.99 63.96 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.988 0.915 . . . . 71.340000000000003 111.519 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -80.39 1.67 28.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.888 0.875 . . . . 70.319999999999993 110.542 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.03 22.92 11.16 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.151 1.78 . . . . 65.310000000000002 112.162 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -79.95 123.78 28.1 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 106.664 -1.606 . . . . 74.340000000000003 106.664 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.19 124.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.844 -0.799 . . . . 72.120000000000005 108.844 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.2 pt -132.67 158.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.123 0.969 . . . . 64.5 109.265 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 55.6 m -120.37 149.94 41.54 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.107 -1.072 . . . . 73.450000000000003 108.107 167.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.92 163.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.416 0.687 . . . . 62.340000000000003 109.817 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.37 128.24 84.72 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.051 0.54 . . . . 64.25 110.098 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.53 -29.97 80.73 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.55 2.833 . . . . 75.549999999999997 113.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -89.09 16.98 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.424 0.69 . . . . 72.219999999999999 112.702 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 125.9 28.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.587 -0.894 . . . . 63.43 108.587 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.1 -37.36 81.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.675 0.79 . . . . 73.420000000000002 111.772 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 70.5 p-90 -63.49 -34.47 77.84 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.036 0.446 . . . . 74.319999999999993 110.474 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.11 -34.49 73.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.54 -0.754 . . . . 72.310000000000002 110.476 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.05 -38.95 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.708 0.803 . . . . 75.129999999999995 110.779 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -61.59 -48.43 80.99 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.86 -1.064 . . . . 71.310000000000002 110.072 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.44 -36.19 77.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.646 0.778 . . . . 62.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.95 -36.38 67.14 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.485 0.714 . . . . 62.130000000000003 110.637 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -75.36 -23.0 57.1 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.899 0.48 . . . . 74.530000000000001 110.284 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -67.1 -43.91 81.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.062 0.945 . . . . 71.319999999999993 110.716 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.9 m -90.78 -8.05 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 123.619 0.574 . . . . 75.129999999999995 112.045 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -79.11 167.46 21.0 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.379 0.672 . . . . 65.530000000000001 109.565 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -66.31 169.49 7.21 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.68 0.792 . . . . 54.329999999999998 111.203 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mttp 56.22 37.53 28.92 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.111 0.964 . . . . 71.439999999999998 110.929 -170.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 t -154.59 -161.47 1.22 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.558 1.143 . . . . 61.340000000000003 108.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 91.5 0.11 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.937 0.895 . . . . 71.420000000000002 110.055 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 p -101.83 129.5 48.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.328 -0.851 . . . . 60.219999999999999 109.394 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.0 p -79.0 -75.84 0.22 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.184 0.594 . . . . 61.219999999999999 110.858 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.7 p -90.57 120.25 68.95 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.381 0.672 . . . . 70.109999999999999 110.648 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.58 96.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.748 2.299 . . . . 73.239999999999995 111.334 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 50.5 tt0 -123.5 162.59 22.6 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.503 1.121 . . . . 73.129999999999995 108.646 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.11 98.13 5.23 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.081 0.953 . . . . 63.299999999999997 109.906 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 93.3 Cg_endo -87.05 142.65 6.51 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.857 2.371 . . . . 74.540000000000006 111.676 175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.91 -19.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 123.442 0.697 . . . . 55.049999999999997 111.133 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 116.38 8.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.731 0.813 . . . . 64.129999999999995 109.803 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 10.4 mmpt? -67.74 133.29 49.02 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.745 0.818 . . . . 74.230000000000004 110.432 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -66.45 108.98 2.57 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.197 0.936 . . . . 53.329999999999998 109.795 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -65.6 103.51 0.87 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.066 -0.716 . . . . 75.400000000000006 109.066 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.63 71.73 10.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.711 0.804 . . . . 74.219999999999999 108.838 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 124.128 0.971 . . . . 64.450000000000003 108.738 -178.515 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.4 mt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 121.007 0.432 . . . . 71.019999999999996 109.875 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.66 106.45 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.757 -0.831 . . . . 73.219999999999999 108.757 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -88.04 97.66 11.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 53.200000000000003 110.087 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.94 10.09 2.06 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.411 1.084 . . . . 73.019999999999996 112.418 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -129.82 113.06 14.21 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.631 1.173 . . . . 62.219999999999999 108.963 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -84.59 103.2 13.5 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.406 -0.961 . . . . 72.319999999999993 108.406 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -71.83 90.27 1.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.705 0.764 . . . . 75.340000000000003 109.26 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -89.66 137.1 32.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.805 -1.089 . . . . 65.150000000000006 111.408 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -84.54 -32.08 24.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 75.230000000000004 109.561 169.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -66.01 153.69 41.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.469 0.708 . . . . 74.439999999999998 111.822 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.638 ' SG ' HG21 ' A' ' 32' ' ' THR . 32.4 m -78.04 116.06 18.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.246 -1.02 . . . . 74.25 108.246 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -84.44 125.1 32.04 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.775 0.321 . . . . 72.319999999999993 110.838 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 44' ' ' VAL . 55.5 m -142.32 150.72 41.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.21 1.004 . . . . 74.430000000000007 110.202 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -82.81 -153.16 0.12 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.677 -0.692 . . . . 71.209999999999994 109.403 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.72 158.27 36.95 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-O 120.955 0.197 . . . . 54.229999999999997 112.853 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.98 146.8 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.215 -1.032 . . . . 30.41 108.215 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.29 145.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.223 0.535 . . . . 71.129999999999995 110.904 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -128.72 31.1 5.01 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.749 1.22 . . . . 64.340000000000003 108.289 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -140.57 142.21 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.708 1.203 . . . . 40.439999999999998 108.271 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.12 114.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.367 -0.605 . . . . 75.430000000000007 109.367 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.02 139.03 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.233 0.613 . . . . 74.150000000000006 109.583 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.92 131.81 11.0 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.796 0.685 . . . . 14.210000000000001 112.928 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' A' ' 68' ' ' HIS . 7.4 tt -54.46 -31.55 55.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.868 1.267 . . . . 74.099999999999994 110.747 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -58.35 -35.26 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.018 1.327 . . . . 51.549999999999997 112.445 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.4 pt -96.81 -6.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 119.098 -0.477 . . . . 71.409999999999997 111.46 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -75.01 130.26 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.221 -0.659 . . . . 73.400000000000006 109.221 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.86 -53.94 2.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.212 0.605 . . . . 55.200000000000003 109.562 174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -139.11 141.14 38.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.011 0.524 . . . . 73.409999999999997 110.188 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 90.1 mt -119.22 107.94 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.37 -1.344 . . . . 73.519999999999996 107.37 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -105.3 138.99 40.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.141 -1.059 . . . . 61.100000000000001 108.141 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -116.33 110.97 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.43 -0.952 . . . . 44.350000000000001 108.43 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.638 HG21 ' SG ' ' A' ' 11' ' ' CYS . 9.6 m -89.43 121.09 69.6 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.505 -0.554 . . . . 65.519999999999996 109.505 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.1 148.89 83.38 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.33 2.687 . . . . 53.340000000000003 113.636 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.86 100.57 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.886 2.391 . . . . 72.219999999999999 112.142 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.97 -5.52 4.71 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-N 115.478 -0.783 . . . . 71.129999999999995 112.31 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -89.68 41.08 1.02 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.686 0.795 . . . . 70.510000000000005 111.047 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -19.75 47.92 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.501 -0.772 . . . . 63.100000000000001 112.775 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.37 116.11 39.58 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.125 -1.435 . . . . 74.140000000000001 107.125 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.02 -39.02 40.63 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.932 3.088 . . . . 75.319999999999993 113.48 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -106.58 157.81 17.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.666 0.786 . . . . 70.319999999999993 109.297 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -61.07 115.7 3.96 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.939 0.774 . . . . 75.310000000000002 109.703 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -110.87 110.79 21.54 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.713 -0.847 . . . . 74.409999999999997 108.713 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.34 103.04 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.732 -0.84 . . . . 73.530000000000001 108.732 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 54' ' ' CYS . 44.5 t -90.27 108.12 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.7 -0.852 . . . . 71.349999999999994 108.7 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 53' ' ' ILE . 62.3 mt -106.23 119.97 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.559 0.743 . . . . 73.140000000000001 109.133 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -94.71 124.86 38.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.117 -1.068 . . . . 75.25 108.117 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.8 p -84.81 163.68 18.93 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.906 -0.405 . . . . 52.310000000000002 109.906 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -71.61 -10.98 60.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.228 0.611 . . . . 71.5 111.512 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 ptp -90.81 4.79 50.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.54 0.736 . . . . 61.100000000000001 110.772 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 68.3 22.23 8.13 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.3 1.44 . . . . 74.409999999999997 112.648 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -84.74 128.95 34.86 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.538 -0.912 . . . . 75.120000000000005 108.538 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.45 114.02 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.8 pt -125.16 128.5 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.257 -1.016 . . . . 72.049999999999997 108.257 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 44' ' ' VAL . 94.9 m -120.74 138.0 54.21 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.152 -0.343 . . . . 64.219999999999999 110.469 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' HE1' ' A' ' 61' ' ' TRP . 28.5 m -130.43 167.05 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.913 0.885 . . . . 73.329999999999998 110.958 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -73.75 153.92 89.28 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 114.427 -1.26 . . . . 70.340000000000003 110.329 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.4 -28.54 71.46 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.909 2.406 . . . . 61.020000000000003 113.2 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -107.48 24.71 12.46 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.419 0.687 . . . . 73.430000000000007 111.672 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 62' ' ' LEU . . . -65.24 124.32 21.87 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.398 -0.964 . . . . 42.009999999999998 108.398 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -70.83 -30.7 67.2 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.987 0.515 . . . . 63.32 111.502 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.469 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.4 p-90 -64.34 -32.32 73.88 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.207 -0.664 . . . . 74.019999999999996 109.207 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 59' ' ' ALA . 64.1 tp -73.29 -37.86 66.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.775 . . . . 74.109999999999999 110.555 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.11 -44.16 95.07 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.993 0.517 . . . . 65.129999999999995 111.177 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' TRP . 13.5 ptm180 -67.86 -31.59 71.51 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.917 0.487 . . . . 75.120000000000005 111.2 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.6 mm? -59.71 -47.94 83.63 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.596 0.759 . . . . 61.310000000000002 110.044 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.66 -34.77 78.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.914 0.886 . . . . 71.239999999999995 111.664 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -69.78 -32.61 71.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.632 0.773 . . . . 63.119999999999997 110.641 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' ND1' HD11 ' A' ' 23' ' ' LEU . 29.7 t-80 -74.64 -30.6 61.69 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.03 0.532 . . . . 72.530000000000001 111.545 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 65' ' ' LEU . 80.6 t -64.76 -49.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 109.145 -0.687 . . . . 52.039999999999999 109.145 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -95.91 61.63 2.18 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.319 -0.993 . . . . 72.010000000000005 108.319 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -72.57 -27.72 62.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.209 -0.905 . . . . 72.400000000000006 109.43 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -86.16 117.87 25.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.949 . . . . 74.420000000000002 109.025 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.0 m -68.25 130.88 44.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.595 0.758 . . . . 63.409999999999997 110.887 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.8 tp 67.32 28.96 7.75 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.865 1.266 . . . . 72.010000000000005 111.107 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 t -86.72 121.56 29.4 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.945 -0.472 . . . . 64.040000000000006 110.299 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -114.57 25.79 10.73 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.28 1.032 . . . . 72.329999999999998 110.12 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 p -127.39 64.13 61.21 Favored Pre-proline 0 CA--C 1.56 1.345 0 C-N-CA 123.267 0.627 . . . . 64.400000000000006 110.997 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -86.31 145.01 8.23 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.188 1.925 . . . . 71.439999999999998 111.939 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -82.79 74.81 9.73 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.23 -1.026 . . . . 63.329999999999998 108.23 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.78 144.05 51.4 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.394 -1.275 . . . . 72.400000000000006 109.908 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HG3' ' O ' ' A' ' 29' ' ' ILE . 65.4 Cg_endo -65.98 87.87 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.967 2.445 . . . . 73.329999999999998 112.493 -175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.1 m -81.43 -15.89 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 115.244 -0.889 . . . . 53.520000000000003 110.944 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -68.82 91.74 0.47 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.583 0.706 . . . . 73.439999999999998 109.99 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -85.75 75.49 10.06 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.491 -1.3 . . . . 73.209999999999994 107.491 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -122.22 98.53 5.97 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.307 -0.861 . . . . 74.530000000000001 110.276 -170.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -97.0 74.86 2.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.525 -0.761 . . . . 75.219999999999999 109.477 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.7 154.92 33.74 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.543 -0.753 . . . . 75.319999999999993 109.467 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 109.233 -0.655 . . . . 71.040000000000006 109.233 178.689 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.977 -0.379 . . . . 74.239999999999995 109.977 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.74 128.41 34.79 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.557 -0.534 . . . . 70.219999999999999 109.557 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.26 155.12 21.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 65.0 109.198 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.74 121.98 45.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.207 0.603 . . . . 55.539999999999999 110.102 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.35 84.4 5.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.084 0.553 . . . . 73.239999999999995 110.044 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -61.93 143.42 56.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.833 -1.076 . . . . 72.219999999999999 111.225 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.4 m -141.93 123.0 14.6 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.888 0.875 . . . . 70.329999999999998 109.16 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.87 150.22 47.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.35 0.66 . . . . 50.119999999999997 110.018 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.36 90.19 0.94 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.485 0.714 . . . . 70.230000000000004 111.358 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.64 171.67 9.85 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.648 0.779 . . . . 73.540000000000006 109.101 168.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.69 113.03 12.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.411 -1.329 . . . . 73.409999999999997 107.411 168.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -71.77 120.87 17.98 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 120.953 0.406 . . . . 74.329999999999998 110.596 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.9 t -118.54 158.94 24.44 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.194 0.998 . . . . 63.439999999999998 109.851 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 p -104.26 -55.2 2.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.001 0.92 . . . . 71.540000000000006 109.364 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.18 167.96 35.7 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.247 -0.888 . . . . 73.219999999999999 111.186 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.26 156.44 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.257 0.528 . . . . 71.209999999999994 110.314 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.38 149.88 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 65.329999999999998 110.313 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -111.36 12.53 21.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 110.764 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.0 m -93.93 144.44 25.45 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.746 0.818 . . . . 74.109999999999999 109.88 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.26 110.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.701 -1.222 . . . . 73.040000000000006 107.701 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.77 124.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.894 -0.78 . . . . 71.099999999999994 108.894 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 147.57 30.35 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.774 0.671 . . . . 71.219999999999999 113.859 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.45 -33.36 65.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.974 0.909 . . . . 63.119999999999997 110.486 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.25 -34.28 72.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.986 0.914 . . . . 55.450000000000003 112.241 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.9 pt -107.0 13.36 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.693 0.397 . . . . 72.239999999999995 111.776 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.4 129.27 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.627 -0.879 . . . . 73.519999999999996 108.627 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.92 -59.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.822 -0.436 . . . . 63.310000000000002 109.822 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 -143.74 139.65 29.56 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.397 0.679 . . . . 64.209999999999994 109.703 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -107.33 119.48 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.139 0.975 . . . . 71.099999999999994 109.638 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 44' ' ' VAL . 6.3 tp-100 -105.68 135.24 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.321 -1.363 . . . . 74.319999999999993 107.321 170.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.11 127.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.621 -0.511 . . . . 63.210000000000001 109.621 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -118.08 103.6 49.63 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 108.836 -0.802 . . . . 65.120000000000005 108.836 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.75 170.42 12.69 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.438 2.758 . . . . 72.299999999999997 112.063 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.82 99.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.263 1.975 . . . . 64.310000000000002 111.408 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.83 164.52 29.09 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.591 -1.404 . . . . 31.530000000000001 109.591 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 66.09 19.43 11.16 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.307 1.051 . . . . 63.43 110.363 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.32 8.46 87.56 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.205 -0.907 . . . . 73.439999999999998 113.325 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.2 m -84.87 136.87 38.34 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.305 0.642 . . . . 71.439999999999998 109.667 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.31 -52.72 0.77 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.845 2.363 . . . . 73.409999999999997 114.206 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -135.04 177.4 7.84 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.261 1.025 . . . . 63.450000000000003 109.647 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -67.17 110.37 3.44 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.203 -0.666 . . . . 74.25 109.203 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -111.41 112.5 24.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.714 1.206 . . . . 75.219999999999999 108.425 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.67 101.13 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.323 -0.991 . . . . 72.510000000000005 108.323 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 85.9 t -92.21 110.03 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.112 0.965 . . . . 71.519999999999996 108.814 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.57 128.81 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.006 -0.434 . . . . 72.439999999999998 110.557 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -88.76 123.9 33.62 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.448 -1.315 . . . . 75.329999999999998 107.448 168.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -84.87 174.41 9.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.812 0.445 . . . . 71.25 110.463 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.57 -21.88 65.41 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.497 0.719 . . . . 72.140000000000001 111.114 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 50.1 mtm -76.64 -4.4 42.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.438 1.095 . . . . 70.430000000000007 110.51 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 60.58 23.56 13.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.839 1.656 . . . . 75.109999999999999 111.364 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -85.6 124.24 31.92 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 106.758 -1.571 . . . . 63.32 106.758 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -88.62 130.37 38.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.77 -0.826 . . . . 63.399999999999999 108.77 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.0 pt -129.68 157.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 75.120000000000005 109.114 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.3 m -126.8 118.1 23.98 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.246 -1.02 . . . . 52.450000000000003 108.246 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.58 155.26 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.946 0.498 . . . . 55.329999999999998 110.094 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.77 165.54 17.75 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.8 0.84 . . . . 73.349999999999994 109.181 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.88 0.19 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.436 2.091 . . . . 64.219999999999999 114.126 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -70.11 -25.48 63.52 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.523 0.729 . . . . 64.239999999999995 110.963 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.9 112.96 3.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.365 0.666 . . . . 61.130000000000003 110.427 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -70.49 -33.17 70.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.33 0.652 . . . . 73.239999999999995 111.389 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -65.46 -27.42 68.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.661 0.385 . . . . 63.520000000000003 111.132 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.4 tp -67.02 -33.5 75.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.016 0.926 . . . . 71.420000000000002 111.768 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.53 -22.46 66.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.297 0.239 . . . . 72.319999999999993 110.929 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -69.97 -39.25 76.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.389 0.676 . . . . 64.040000000000006 110.206 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.73 -41.88 74.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.138 0.975 . . . . 54.520000000000003 109.74 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.96 -25.63 61.94 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.054 -0.976 . . . . 61.43 111.656 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -29.96 31.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.025 -0.732 . . . . 74.239999999999995 109.025 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.65 -28.64 69.25 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.03 0.532 . . . . 74.540000000000006 111.398 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.89 -3.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.2 0.6 . . . . 53.219999999999999 111.734 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -91.42 157.67 16.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.914 0.886 . . . . 72.299999999999997 110.393 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -60.8 132.99 55.62 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.201 1.0 . . . . 61.240000000000002 112.586 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -111.16 4.45 19.3 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.566 0.747 . . . . 62.32 111.034 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -75.23 90.78 2.6 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.091 0.472 . . . . 65.150000000000006 110.495 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.65 147.5 23.23 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.307 -0.627 . . . . 74.430000000000007 109.307 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.8 p -80.86 145.94 31.11 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.97 0.908 . . . . 54.130000000000003 110.196 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.4 p -65.35 109.47 2.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.395 0.678 . . . . 72.230000000000004 110.495 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.6 m -68.75 115.57 32.15 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.356 0.662 . . . . 73.519999999999996 109.336 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.48 174.13 13.1 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.571 2.181 . . . . 75.319999999999993 112.084 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -62.75 135.07 57.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.076 -0.511 . . . . 74.25 110.679 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.7 140.56 40.99 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.297 -0.865 . . . . 62.420000000000002 110.033 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 102.83 0.46 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.231 1.954 . . . . 73.230000000000004 110.915 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.99 109.22 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.067 0.947 . . . . 62.25 110.36 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.5 t -130.51 127.81 39.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.542 -0.91 . . . . 74.430000000000007 108.542 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -66.85 133.07 49.34 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.347 0.404 . . . . 62.219999999999999 110.124 177.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -109.52 102.83 11.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.342 0.657 . . . . 74.430000000000007 109.48 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -82.32 108.24 15.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.678 -0.86 . . . . 72.329999999999998 108.678 170.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.78 161.37 24.54 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.748 -0.66 . . . . 32.049999999999997 110.187 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 C-N-CA 123.765 0.826 . . . . 73.519999999999996 109.221 179.46 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.9 pt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.979 0.419 . . . . 64.109999999999999 110.645 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.21 107.17 3.06 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.257 -1.757 . . . . 73.140000000000001 106.257 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -71.54 169.91 14.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.157 0.583 . . . . 74.140000000000001 111.97 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.18 30.5 1.27 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.685 1.194 . . . . 75.219999999999999 108.972 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -66.64 158.5 29.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.244 0.618 . . . . 74.209999999999994 111.674 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -64.83 92.33 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.269 1.027 . . . . 74.349999999999994 110.779 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -124.24 113.28 18.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.864 0.865 . . . . 53.450000000000003 110.228 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -167.61 148.79 5.45 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.172 1.389 . . . . 61.43 108.475 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp 62.87 24.44 14.55 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.159 0.984 . . . . 71.0 110.082 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -155.97 177.25 11.62 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.875 0.87 . . . . 75.430000000000007 110.636 -173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 61.7 m -71.79 115.85 11.48 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.195 0.998 . . . . 30.350000000000001 109.52 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.99 144.56 56.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.401 0.68 . . . . 75.540000000000006 110.765 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.5 166.59 22.85 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.255 0.622 . . . . 64.530000000000001 111.026 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -132.44 12.98 4.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.141 0.976 . . . . 64.140000000000001 110.979 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.37 175.99 50.59 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.766 -0.652 . . . . 73.310000000000002 112.996 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.31 170.93 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.447 0.699 . . . . 62.109999999999999 109.957 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.89 137.65 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.274 0.559 . . . . 73.409999999999997 111.639 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -83.54 -38.88 21.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.041 0.937 . . . . 73.430000000000007 110.042 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m -68.12 121.35 15.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.267 1.027 . . . . 75.209999999999994 110.125 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.0 116.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.748 0.655 . . . . 74.409999999999997 110.128 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.24 134.84 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.93 0.892 . . . . 70.450000000000003 109.446 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.7 139.28 22.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 113.987 0.355 . . . . 62.0 113.987 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.6 -37.53 65.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.483 1.113 . . . . 73.209999999999994 110.823 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -65.58 -34.07 77.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.733 0.813 . . . . 71.299999999999997 111.842 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 33.7 pt -90.74 -3.79 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 119.565 -0.255 . . . . 71.340000000000003 111.41 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 39.0 mm -71.97 137.47 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.698 -0.853 . . . . 75.129999999999995 108.698 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -104.95 -55.3 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.275 -0.639 . . . . 61.149999999999999 109.275 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -143.01 142.11 31.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.342 -0.845 . . . . 65.200000000000003 109.342 -171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.24 106.57 21.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.029 -1.471 . . . . 73.439999999999998 107.029 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.02 103.5 15.35 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.05 -1.093 . . . . 71.340000000000003 108.05 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.64 109.44 21.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.616 -1.253 . . . . 71.150000000000006 107.616 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -106.54 114.37 62.08 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.389 0.676 . . . . 73.25 109.216 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 160.33 49.66 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.484 2.123 . . . . 55.340000000000003 111.797 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 150.96 74.99 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.864 . . . . 63.520000000000003 111.095 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.54 -52.61 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 C-N-CA 121.357 -0.449 . . . . 35.409999999999997 112.556 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -146.66 107.9 4.23 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.32 0.648 . . . . 73.409999999999997 109.575 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.28 -17.73 9.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.76 -0.655 . . . . 52.219999999999999 114.578 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 21.4 m -88.52 115.52 63.6 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.571 -0.9 . . . . 63.229999999999997 108.571 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.79 -68.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.696 2.264 . . . . 73.010000000000005 111.665 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -103.79 179.22 4.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.547 0.739 . . . . 71.329999999999998 109.083 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.3 m -64.89 109.96 2.27 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.157 -0.683 . . . . 65.409999999999997 109.157 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -89.76 111.96 23.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.353 -0.98 . . . . 72.430000000000007 108.353 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.42 101.19 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.512 -0.921 . . . . 63.399999999999999 108.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.1 t -96.49 109.71 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.068 0.947 . . . . 61.409999999999997 108.572 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 58.5 mt -94.71 136.83 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.811 -0.811 . . . . 65.530000000000001 108.811 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -110.31 117.6 34.07 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.07 -1.456 . . . . 70.420000000000002 107.07 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HE1' ' A' ' 49' ' ' MET . 60.0 p -82.31 160.81 22.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.687 -0.486 . . . . 73.150000000000006 109.687 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 59.6 pttt -71.05 -10.95 60.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.76 0.824 . . . . 63.329999999999998 112.972 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.427 ' HE1' ' HB ' ' A' ' 47' ' ' THR . 3.1 mpp? -92.7 10.79 29.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.145 0.578 . . . . 72.239999999999995 110.153 170.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 69.82 15.2 7.97 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.2 1.4 . . . . 74.340000000000003 112.931 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -84.3 123.46 30.19 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.559 -1.275 . . . . 71.129999999999995 107.559 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 t -98.84 139.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.124 0.57 . . . . 71.519999999999996 109.478 -171.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.57 156.21 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.077 0.951 . . . . 71.310000000000002 109.909 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.22 137.27 47.36 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.087 -1.449 . . . . 72.329999999999998 107.087 166.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.5 159.28 41.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.838 -0.801 . . . . 73.450000000000003 108.838 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -91.21 139.87 25.65 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 115.788 -0.642 . . . . 74.310000000000002 110.133 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.06 -12.08 32.98 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.025 2.484 . . . . 74.340000000000003 113.771 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.417 HH22 ' NE2' ' A' ' 63' ' ' GLN . 4.1 mmp_? -97.99 8.88 44.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.612 0.765 . . . . 65.140000000000001 112.357 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.59 122.58 20.0 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.037 -0.727 . . . . 53.420000000000002 109.037 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -63.55 -39.39 94.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.978 0.911 . . . . 73.340000000000003 112.583 -167.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -68.16 -35.19 77.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.477 0.711 . . . . 74.319999999999993 110.64 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 54.6 tp -66.06 -36.22 82.63 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.411 0.684 . . . . 72.430000000000007 110.644 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 57.8 mt-30 -56.97 -42.05 79.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.735 0.647 . . . . 74.510000000000005 109.823 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -63.85 -36.13 82.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.327 0.651 . . . . 73.519999999999996 110.906 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.33 -43.29 99.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.248 0.619 . . . . 73.030000000000001 109.992 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 82.0 mt -71.98 -23.01 61.35 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.171 -0.922 . . . . 60.509999999999998 111.182 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 4.7 mmp_? -88.39 -20.68 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.43 0.692 . . . . 64.549999999999997 111.575 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -78.37 -30.61 48.04 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.192 0.597 . . . . 73.420000000000002 110.911 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 m -80.07 -13.85 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.679 0.276 . . . . 74.530000000000001 110.655 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.84 142.99 58.24 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.628 0.771 . . . . 74.310000000000002 109.403 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.98 94.22 0.13 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.543 0.687 . . . . 75.310000000000002 110.792 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -80.86 145.26 31.46 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.863 1.265 . . . . 65.5 110.287 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.3 t -69.67 82.82 0.43 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.855 0.836 . . . . 74.129999999999995 108.996 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -142.72 143.72 32.38 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.449 1.5 . . . . 64.099999999999994 107.704 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -58.23 101.12 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.585 0.754 . . . . 72.040000000000006 111.898 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -87.14 167.95 13.7 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.661 -0.7 . . . . 71.420000000000002 110.292 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 t -153.06 154.4 30.91 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.989 0.916 . . . . 74.310000000000002 108.777 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.61 103.95 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 121.967 1.778 . . . . 60.350000000000001 111.717 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -80.98 133.52 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.115 -0.698 . . . . 72.230000000000004 109.115 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.5 125.8 91.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.433 0.693 . . . . 73.549999999999997 109.611 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.83 144.08 94.37 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 121.911 1.74 . . . . 74.120000000000005 111.161 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.36 104.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.589 -0.893 . . . . 73.019999999999996 108.589 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.0 t -65.23 90.99 0.1 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.988 0.805 . . . . 53.439999999999998 109.509 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -91.41 128.82 37.39 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.325 -0.991 . . . . 70.150000000000006 108.325 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -61.35 164.18 5.82 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.809 0.844 . . . . 73.030000000000001 112.648 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -77.53 87.58 3.86 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.773 -0.825 . . . . 72.140000000000001 108.773 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.53 88.7 7.02 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.57 -0.741 . . . . 71.340000000000003 109.356 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.442 0 CA-C-N 115.135 -0.939 . . . . 61.130000000000003 110.563 -176.563 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.297 0.094 . . . . 63.43 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 pp -166.34 11.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.385 0.513 . . . . 71.219999999999999 112.385 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.39 139.64 24.17 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.647 1.179 . . . . 72.519999999999996 112.222 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.04 124.73 25.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.585 0.754 . . . . 64.420000000000002 110.435 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -78.38 -29.14 47.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.426 0.691 . . . . 52.530000000000001 109.645 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -119.72 150.06 41.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.371 0.668 . . . . 74.340000000000003 109.698 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -152.32 -179.69 7.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.966 0.906 . . . . 75.120000000000005 109.639 -176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -138.76 126.46 22.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 109.548 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -99.56 100.59 11.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.197 0.599 . . . . 71.129999999999995 109.493 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.91 166.35 13.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.956 0.902 . . . . 64.25 108.932 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.3 m -70.93 113.99 8.54 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.108 -0.701 . . . . 53.25 109.108 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -90.08 143.87 26.39 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.635 0.774 . . . . 75.340000000000003 111.55 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 14' ' ' SER . 9.8 t -146.56 163.91 34.27 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.533 1.133 . . . . 55.329999999999998 110.125 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 20.8 m -93.62 -50.08 5.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.59 0.756 . . . . 74.120000000000005 110.738 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.22 -121.54 0.83 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.788 -0.451 . . . . 73.519999999999996 112.682 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.12 162.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.599 1.159 . . . . 65.310000000000002 110.044 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.62 151.26 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.14 0.576 . . . . 72.299999999999997 110.727 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 m -110.56 11.78 22.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.034 0.934 . . . . 73.010000000000005 111.45 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 154.91 43.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.166 0.587 . . . . 72.409999999999997 110.417 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.89 141.93 14.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.197 -0.668 . . . . 74.450000000000003 109.197 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.79 144.34 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.467 1.107 . . . . 70.109999999999999 109.04 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' ILE . . . -62.7 123.39 30.41 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.912 -0.382 . . . . 45.0 113.426 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.54 -34.19 68.88 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.258 1.023 . . . . 71.010000000000005 110.755 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.55 -28.33 63.79 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.886 0.874 . . . . 62.25 111.998 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' GLY . 17.8 pt -90.72 -0.41 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 118.131 0.423 . . . . 74.239999999999995 111.152 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 45' ' ' ILE . 36.4 mm -77.31 111.9 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.372 -0.603 . . . . 50.43 109.372 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.15 -53.71 4.89 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.47 -0.566 . . . . 74.310000000000002 109.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -153.72 147.42 25.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.448 -0.797 . . . . 74.120000000000005 110.105 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -113.34 123.19 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.529 -0.915 . . . . 71.129999999999995 108.529 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -94.54 111.05 22.81 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.342 -0.985 . . . . 63.219999999999999 108.342 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.74 131.69 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.112 0.482 . . . . 72.439999999999998 109.9 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 p -122.49 136.23 26.37 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.1 0.96 . . . . 75.310000000000002 108.978 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -61.21 169.84 5.81 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.156 2.571 . . . . 74.439999999999998 113.814 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.37 170.99 14.84 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 121.805 1.67 . . . . 63.200000000000003 111.589 168.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -177.18 48.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.55 -0.295 . . . . 43.130000000000003 112.523 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 64.17 14.31 8.52 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.743 1.217 . . . . 75.530000000000001 111.317 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.72 -20.27 36.98 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.947 0.784 . . . . 54.229999999999997 112.731 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 m -84.72 124.95 72.36 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 117.639 0.72 . . . . 61.310000000000002 109.073 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.0 -69.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.794 2.329 . . . . 63.030000000000001 113.696 -172.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -100.68 179.97 4.26 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.399 1.08 . . . . 62.140000000000001 108.579 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 m -64.12 109.13 1.73 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.022 -1.473 . . . . 63.43 107.022 162.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -90.54 112.78 24.6 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 72.109999999999999 109.682 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 102.13 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.137 -0.69 . . . . 75.209999999999994 109.137 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.03 111.66 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.962 -1.125 . . . . 62.32 107.962 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 26' ' ' ILE . 54.5 mt -94.39 136.27 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.805 -0.443 . . . . 65.219999999999999 109.805 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -114.71 114.0 25.04 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 124.878 1.271 . . . . 74.340000000000003 108.053 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.2 p -80.29 169.17 18.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.429 0.292 . . . . 53.229999999999997 111.073 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.75 -20.62 64.38 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.002 0.921 . . . . 73.310000000000002 112.0 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.8 ptp -91.49 8.86 34.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.515 0.726 . . . . 55.229999999999997 110.906 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 67.68 21.55 9.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.987 1.315 . . . . 64.450000000000003 111.523 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -81.01 123.06 28.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.011 -1.477 . . . . 74.530000000000001 107.011 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.86 130.19 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.603 -0.888 . . . . 64.219999999999999 108.603 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 45' ' ' ILE . 29.8 pt -134.38 153.96 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.263 0.625 . . . . 71.439999999999998 109.836 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 92.8 m -109.54 128.76 55.43 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.231 -0.895 . . . . 64.209999999999994 108.632 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.14 140.6 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.499 -0.926 . . . . 64.409999999999997 108.499 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -79.66 128.1 75.77 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.19 -21.32 27.8 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.923 3.082 . . . . 74.239999999999995 114.558 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -73.28 -7.48 51.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.202 0.601 . . . . 74.430000000000007 112.459 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.04 123.03 16.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.858 0.863 . . . . 64.519999999999996 110.696 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -66.5 -38.33 87.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.022 -0.99 . . . . 72.040000000000006 111.914 -172.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.846 0.459 . . . . 72.010000000000005 111.425 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.55 -27.0 63.81 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.569 0.747 . . . . 71.310000000000002 110.921 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -59.95 -25.92 65.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.046 0.538 . . . . 72.239999999999995 111.698 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.77 -41.68 97.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.2 0.6 . . . . 75.219999999999999 109.903 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.04 -40.35 82.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.532 0.733 . . . . 43.219999999999999 110.0 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.86 -31.29 72.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.392 0.677 . . . . 74.430000000000007 110.812 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -78.23 -34.14 49.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.125 0.57 . . . . 73.030000000000001 111.058 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.585 0.354 . . . . 73.299999999999997 111.64 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.43 -11.51 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.011 0.375 . . . . 74.319999999999993 112.011 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -65.84 157.57 30.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.175 0.99 . . . . 61.219999999999999 111.417 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.9 m -55.51 149.46 13.58 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.927 0.891 . . . . 63.140000000000001 111.549 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? 78.98 -2.98 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.07 1.748 . . . . 55.439999999999998 112.374 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -78.04 150.1 33.88 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.543 -0.723 . . . . 72.230000000000004 110.156 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.606 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -87.82 20.66 2.94 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.873 0.469 . . . . 72.25 111.287 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.4 p -79.79 170.35 16.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.719 0.808 . . . . 74.450000000000003 110.087 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 m -82.27 90.33 6.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.173 -0.677 . . . . 65.109999999999999 109.173 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.8 p -93.29 156.4 40.09 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.86 0.864 . . . . 64.430000000000007 109.284 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.03 -171.21 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.317 2.012 . . . . 63.049999999999997 111.224 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -67.33 106.77 2.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.493 -0.929 . . . . 75.310000000000002 108.493 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 112.27 11.19 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 109.482 -0.562 . . . . 74.420000000000002 109.482 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.22 -172.9 1.49 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.848 2.366 . . . . 43.520000000000003 111.642 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.48 91.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-O 122.241 1.019 . . . . 72.239999999999995 110.141 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 p -75.51 131.19 39.91 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.512 -1.222 . . . . 45.119999999999997 108.831 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.56 110.75 0.6 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.168 0.987 . . . . 54.119999999999997 110.632 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 -62.2 97.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.044 1.338 . . . . 73.310000000000002 111.929 -167.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.71 12.82 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.745 1.618 . . . . 63.409999999999997 112.613 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.95 167.34 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.192 0.997 . . . . 63.25 110.463 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.447 0.699 . . . . 37.5 110.085 179.407 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.723 -0.473 . . . . 63.039999999999999 109.723 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.89 19.89 3.85 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.542 0.737 . . . . 62.240000000000002 112.786 -174.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.7 166.5 12.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.677 0.791 . . . . 72.040000000000006 112.128 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 71.35 10.18 6.61 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.009 1.323 . . . . 65.109999999999999 112.133 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -100.86 129.71 46.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.923 0.889 . . . . 72.510000000000005 109.53 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -132.94 137.1 46.48 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.454 1.101 . . . . 72.540000000000006 109.001 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 p -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.121 0.568 . . . . 72.530000000000001 110.801 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -69.28 105.01 2.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.11 -0.7 . . . . 74.329999999999998 109.11 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.66 112.52 3.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.796 -0.816 . . . . 54.329999999999998 108.796 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -139.49 -164.46 1.68 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.219 1.008 . . . . 65.120000000000005 108.355 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.38 110.46 3.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.316 0.507 . . . . 72.519999999999996 109.986 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -91.95 120.78 32.92 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.392 -0.595 . . . . 73.409999999999997 109.392 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.1 t -92.96 115.27 27.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.74 -0.663 . . . . 74.540000000000006 109.665 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 t -51.97 -31.98 31.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.67 1.188 . . . . 63.0 112.125 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.73 -169.86 34.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.323 -0.711 . . . . 70.439999999999998 111.323 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.68 129.95 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 55' ' ' VAL . 2.2 pp -114.26 144.69 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.162 0.585 . . . . 70.140000000000001 109.584 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.0 m -133.95 34.2 3.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.91 0.884 . . . . 62.130000000000003 109.429 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 m -126.53 138.89 53.54 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.964 -1.016 . . . . 44.200000000000003 108.906 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -74.25 110.85 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.406 -1.331 . . . . 64.329999999999998 107.406 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.75 139.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.478 -0.564 . . . . 73.450000000000003 109.478 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.36 128.58 33.37 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.756 0.66 . . . . 45.43 113.28 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.65 -30.17 63.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.057 0.943 . . . . 61.229999999999997 109.943 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -54.77 -35.49 63.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 73.010000000000005 112.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.0 pt -104.49 -3.88 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 119.266 -0.397 . . . . 74.329999999999998 112.013 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 45' ' ' ILE . 41.1 mm -71.13 110.97 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.684 -0.858 . . . . 72.519999999999996 108.684 172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB2' ' HD2' ' A' ' 48' ' ' LYS . 24.0 t70 -85.75 -56.6 3.41 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.198 0.599 . . . . 75.150000000000006 110.712 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -160.69 143.88 13.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.209 -0.663 . . . . 75.430000000000007 109.209 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.12 123.99 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.215 -0.661 . . . . 64.140000000000001 109.215 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -103.98 116.82 32.94 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.864 0.866 . . . . 71.239999999999995 109.012 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.36 112.83 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.294 0.638 . . . . 52.409999999999997 110.165 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 11.0 m -89.84 116.65 66.88 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 108.935 -0.765 . . . . 75.540000000000006 108.935 169.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.81 157.73 36.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.812 2.341 . . . . 64.540000000000006 112.535 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.38 122.08 10.76 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.607 2.204 . . . . 74.25 111.294 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.64 -159.59 23.49 Favored Glycine 0 C--O 1.241 0.546 0 N-CA-C 110.221 -1.152 . . . . 72.230000000000004 110.221 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 63.82 30.09 14.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 72.430000000000007 111.641 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.87 20.5 61.17 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.423 -0.353 . . . . 11.44 112.914 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 53.4 t -138.32 133.34 17.1 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.888 0.875 . . . . 71.540000000000006 109.965 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.72 -9.31 13.35 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.336 2.024 . . . . 63.509999999999998 112.616 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 16.5 tppt? -101.29 155.09 18.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.806 1.242 . . . . 64.200000000000003 110.163 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -86.43 115.23 23.8 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.183 -1.043 . . . . 74.140000000000001 108.183 164.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 42.7 tt0 -83.21 112.97 20.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.014 -0.735 . . . . 75.120000000000005 109.014 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.04 102.15 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.539 -1.282 . . . . 63.539999999999999 107.539 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.11 135.27 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.934 0.894 . . . . 51.109999999999999 109.061 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.601 HG21 HD12 ' A' ' 26' ' ' ILE . 60.9 mt -110.29 121.78 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.624 0.37 . . . . 73.450000000000003 110.083 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.15 127.04 32.74 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.998 -1.112 . . . . 71.010000000000005 107.998 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.7 p -84.66 178.42 7.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.408 0.683 . . . . 75.439999999999998 110.359 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 27' ' ' ASP . 14.4 mmmm -66.02 -23.52 66.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.277 0.56 . . . . 73.230000000000004 110.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.3 mtm -79.8 -1.45 38.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.458 1.103 . . . . 73.230000000000004 110.434 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 65.2 14.51 9.44 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.986 1.714 . . . . 65.25 111.919 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -79.77 125.97 30.35 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.248 -1.019 . . . . 72.319999999999993 108.248 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.92 122.65 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 41.020000000000003 109.386 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.1 pt -108.11 149.93 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.147 -1.057 . . . . 74.5 108.147 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.97 118.68 37.42 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.515 0.726 . . . . 63.109999999999999 109.355 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 HD11 ' A' ' 17' ' ' ILE . 32.8 m -124.69 156.06 32.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 123.524 0.73 . . . . 70.340000000000003 109.55 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.55 152.95 78.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.558 -0.904 . . . . 73.430000000000007 108.558 168.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.54 -27.0 69.69 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.839 1.693 . . . . 65.140000000000001 111.261 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.89 12.67 36.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.313 1.045 . . . . 72.329999999999998 112.208 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.97 56.58 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.041 0.536 . . . . 74.400000000000006 109.985 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.96 -40.99 97.67 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.973 0.731 . . . . 73.219999999999999 112.973 -166.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -77.84 -17.48 57.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.073 0.397 . . . . 63.43 112.073 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.49 -21.59 66.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 52.119999999999997 110.712 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -56.4 -23.97 41.66 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.092 0.957 . . . . 62.310000000000002 113.139 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.99 -46.94 82.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.927 0.491 . . . . 74.219999999999999 110.274 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.52 -37.96 55.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.369 -0.832 . . . . 73.409999999999997 110.472 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.05 -35.62 78.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 74.340000000000003 110.547 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -75.03 -41.38 59.34 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.309 0.243 . . . . 65.450000000000003 110.682 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -68.66 -36.11 78.14 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.27 0.47 . . . . 64.349999999999994 112.27 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.0 -28.81 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.025 0.44 . . . . 70.329999999999998 110.137 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -78.97 -18.68 53.3 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.834 0.853 . . . . 53.43 111.049 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -66.84 161.71 23.25 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.063 0.545 . . . . 71.019999999999996 111.343 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -63.54 101.29 0.32 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.166 0.586 . . . . 71.019999999999996 110.184 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 p -120.98 165.6 15.02 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.326 1.05 . . . . 74.209999999999994 110.492 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.0 79.43 2.19 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.609 0.719 . . . . 62.409999999999997 109.547 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.2 p -88.55 146.7 25.0 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.059 0.944 . . . . 71.150000000000006 110.584 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 p -65.7 -17.21 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.984 0.914 . . . . 74.049999999999997 111.9 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.4 m -124.93 106.33 28.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.016 0.926 . . . . 61.43 109.663 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.42 160.87 37.23 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.769 2.313 . . . . 74.030000000000001 111.674 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.55 128.91 50.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.784 -0.45 . . . . 74.109999999999999 109.784 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.65 129.56 93.4 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 108.999 -0.741 . . . . 62.240000000000002 108.999 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.07 140.7 95.03 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.998 1.798 . . . . 64.140000000000001 111.181 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.75 138.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.616 0.766 . . . . 73.439999999999998 112.015 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -77.76 71.04 4.22 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.632 0.729 . . . . 72.420000000000002 109.483 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.29 166.98 22.15 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.992 -1.004 . . . . 74.420000000000002 110.048 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.06 142.28 51.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.825 0.45 . . . . 72.010000000000005 110.431 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -86.63 96.51 10.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.324 1.05 . . . . 74.510000000000005 109.423 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.07 88.65 0.29 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.303 -0.628 . . . . 71.019999999999996 109.303 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.013 0.925 . . . . 70.400000000000006 110.302 -175.446 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.712 -0.477 . . . . 53.210000000000001 109.712 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.14 120.62 33.64 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.682 -0.859 . . . . 75.439999999999998 108.682 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.45 143.45 40.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.915 0.886 . . . . 63.340000000000003 110.932 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.98 137.74 25.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 43.130000000000003 110.197 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.14 151.03 33.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.304 0.642 . . . . 73.230000000000004 109.53 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.98 10.68 34.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.497 0.719 . . . . 72.120000000000005 111.583 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -63.92 93.03 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.079 0.952 . . . . 75.0 110.253 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.8 83.15 0.14 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.92 1.288 . . . . 64.430000000000007 110.659 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.4 134.29 34.89 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.458 0.647 . . . . 72.349999999999994 109.549 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -85.99 -170.28 3.03 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.678 -0.86 . . . . 53.539999999999999 108.678 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 42' ' ' GLU . 73.0 m -52.08 114.06 1.21 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.567 0.347 . . . . 51.409999999999997 110.99 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -86.46 120.61 27.97 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.216 -1.402 . . . . 75.420000000000002 107.216 173.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 16' ' ' VAL . 52.9 t -143.04 102.99 4.1 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.236 -0.653 . . . . 74.140000000000001 109.236 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.9 m -114.54 123.88 50.47 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.185 0.994 . . . . 71.439999999999998 109.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.33 90.24 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 O-C-N 123.773 0.671 . . . . 50.149999999999999 111.736 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.662 HG22 ' SG ' ' A' ' 13' ' ' CYS . 22.7 t -100.5 128.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.808 -0.812 . . . . 64.329999999999998 108.808 -173.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 55' ' ' VAL . 2.7 pp -124.74 147.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.082 0.553 . . . . 62.130000000000003 109.986 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.4 m -117.76 22.68 12.17 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.489 1.115 . . . . 72.5 109.122 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.5 m -93.72 146.57 23.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.753 1.221 . . . . 74.299999999999997 109.994 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.63 112.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.359 -0.978 . . . . 45.299999999999997 108.359 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -90.5 143.33 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.664 0.786 . . . . 74.25 109.548 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 118.09 13.73 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.881 0.738 . . . . 72.120000000000005 112.011 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.3 -30.81 52.22 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.767 1.227 . . . . 72.439999999999998 110.995 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.47 -35.79 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.399 0.679 . . . . 71.150000000000006 111.942 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt -86.19 -6.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 111.957 0.354 . . . . 73.109999999999999 111.957 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD12 HG21 ' A' ' 45' ' ' ILE . 44.5 mm -72.9 129.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.364 -0.976 . . . . 70.420000000000002 108.364 176.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -117.16 -58.64 2.04 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.633 0.373 . . . . 63.450000000000003 111.055 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -144.81 127.47 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.849 0.46 . . . . 62.43 109.906 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -110.79 140.66 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.359 1.064 . . . . 51.030000000000001 109.71 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.37 127.17 25.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.979 1.312 . . . . 73.25 108.082 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.52 139.43 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 122.576 0.35 . . . . 55.329999999999998 111.253 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 28.5 m -111.06 118.36 48.16 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.06 0.944 . . . . 71.099999999999994 109.099 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.44 147.18 36.19 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.025 1.816 . . . . 55.219999999999999 111.156 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.75 144.7 92.75 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.61 2.207 . . . . 63.310000000000002 112.59 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.02 -32.8 7.1 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.066 -0.516 . . . . 72.400000000000006 112.534 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -80.59 77.76 7.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.636 0.774 . . . . 72.530000000000001 110.426 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.37 -2.92 18.12 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 115.808 -0.633 . . . . 62.32 114.501 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.08 138.26 17.72 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 74.439999999999998 109.139 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.71 16.61 1.78 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.868 2.379 . . . . 73.209999999999994 114.034 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -152.16 173.21 15.23 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.277 0.631 . . . . 75.439999999999998 110.572 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 m -81.2 131.32 35.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.402 0.681 . . . . 73.510000000000005 110.114 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 19.9 tt0 -115.05 126.33 54.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.915 -1.143 . . . . 74.099999999999994 107.915 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.08 102.68 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.283 -1.006 . . . . 64.400000000000006 108.283 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.91 130.56 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 109.083 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 26' ' ' ILE . 52.3 mt -121.16 129.85 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.256 -0.646 . . . . 75.129999999999995 109.256 173.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -99.53 124.56 44.81 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.969 1.307 . . . . 75.140000000000001 107.523 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.8 p -84.9 170.64 12.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.883 0.473 . . . . 73.120000000000005 110.792 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 18.6 ptpt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 75.510000000000005 110.845 170.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.96 -8.29 56.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.186 0.994 . . . . 73.519999999999996 110.647 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.09 21.17 7.41 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.074 1.349 . . . . 73.239999999999995 109.246 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -100.43 133.09 45.38 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.25 1.02 . . . . 65.519999999999996 108.364 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.42 124.04 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.128 0.971 . . . . 71.230000000000004 110.397 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.6 pt -120.61 139.04 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.901 -1.148 . . . . 54.409999999999997 107.901 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.62 117.02 32.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.228 -1.397 . . . . 51.409999999999997 107.228 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 17' ' ' ILE . 7.2 m -117.55 166.35 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.176 0.59 . . . . 75.510000000000005 111.073 -168.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.18 139.09 56.21 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 115.299 -0.864 . . . . 72.329999999999998 109.512 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.1 -43.57 28.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.422 2.081 . . . . 72.510000000000005 112.721 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -85.08 21.96 1.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.93 0.492 . . . . 73.530000000000001 111.461 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.84 124.65 21.33 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.145 -0.687 . . . . 71.409999999999997 109.145 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.92 -32.89 74.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.252 1.021 . . . . 74.439999999999998 112.316 -169.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -74.12 -29.96 62.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.05 0.54 . . . . 73.430000000000007 111.154 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.7 tp -67.44 -23.55 65.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.674 0.79 . . . . 74.430000000000007 110.869 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -57.77 -38.04 74.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.753 0.821 . . . . 62.5 111.171 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -69.7 -31.39 69.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.119 0.568 . . . . 75.129999999999995 110.74 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.9 -35.58 69.75 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.454 -0.572 . . . . 61.420000000000002 109.454 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -66.04 -40.33 90.9 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.342 0.657 . . . . 74.430000000000007 110.129 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -70.33 -35.84 73.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.31 0.644 . . . . 71.409999999999997 111.05 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.78 -44.84 92.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.736 0.414 . . . . 54.399999999999999 110.412 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 m -82.37 -20.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.85 -0.614 . . . . 55.350000000000001 111.534 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.99 153.25 38.61 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.024 0.529 . . . . 73.129999999999995 109.96 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -60.32 148.3 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.401 1.081 . . . . 74.120000000000005 111.205 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER 69.48 67.62 0.25 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.384 1.474 . . . . 63.25 109.177 -175.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.7 p -139.52 -176.22 4.47 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.84 -1.073 . . . . 64.049999999999997 109.566 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.33 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.574 0.75 . . . . 72.420000000000002 110.275 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.1 t -168.58 148.48 4.49 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.925 1.29 . . . . 54.520000000000003 108.704 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 p -97.02 77.59 2.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.245 0.618 . . . . 43.310000000000002 111.055 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 m -89.66 118.33 68.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.788 -0.819 . . . . 44.100000000000001 108.788 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.13 89.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.622 2.215 . . . . 70.349999999999994 111.205 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -136.18 130.43 33.19 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.494 1.118 . . . . 64.230000000000004 108.595 -170.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.11 134.54 90.46 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.41 0.684 . . . . 71.530000000000001 110.708 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.54 94.07 0.43 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.271 1.981 . . . . 73.239999999999995 111.687 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.44 146.86 12.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 116.074 -0.512 . . . . 71.099999999999994 110.49 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 t -66.42 152.39 45.2 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.394 -0.821 . . . . 63.119999999999997 110.327 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.63 114.93 26.73 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.332 -0.988 . . . . 72.140000000000001 108.332 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -61.36 115.86 4.19 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 123.674 0.609 . . . . 63.25 109.857 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -83.93 158.23 21.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.164 0.585 . . . . 72.319999999999993 109.897 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.04 105.25 9.13 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.193 -1.04 . . . . 73.439999999999998 108.193 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 123.721 0.808 . . . . 72.519999999999996 110.768 -175.104 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.15 -0.685 . . . . 70.109999999999999 109.15 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.92 159.02 34.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.127 0.971 . . . . 74.099999999999994 111.02 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -120.91 166.83 13.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.576 0.75 . . . . 70.099999999999994 110.762 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.99 -25.01 10.94 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.569 0.748 . . . . 72.420000000000002 111.824 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -144.69 95.37 2.69 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.325 0.65 . . . . 72.450000000000003 110.646 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.48 -27.87 60.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.158 0.583 . . . . 52.109999999999999 109.464 164.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 m -69.12 123.41 21.0 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.873 -1.058 . . . . 61.140000000000001 110.902 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -101.71 129.83 47.96 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.376 -0.972 . . . . 53.420000000000002 108.376 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.91 98.43 0.28 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.688 0.795 . . . . 75.129999999999995 110.541 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 99.3 mttt -110.07 -107.85 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.3 1.04 . . . . 65.239999999999995 109.196 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -88.61 113.66 24.41 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.948 -1.13 . . . . 74.310000000000002 107.948 171.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -85.12 118.33 24.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.614 0.766 . . . . 71.230000000000004 109.15 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.3 t -144.57 105.24 4.14 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.125 -0.695 . . . . 62.020000000000003 109.125 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 p -64.01 -49.58 71.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.745 0.818 . . . . 75.010000000000005 110.539 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.61 172.03 32.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.027 -0.988 . . . . 74.230000000000004 111.236 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.56 148.2 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.024 0.53 . . . . 64.209999999999994 109.788 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.8 pt -83.53 133.06 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.582 -0.735 . . . . 74.430000000000007 111.566 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.0 m -85.07 -41.04 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.374 -0.83 . . . . 74.219999999999999 109.354 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.8 m -92.45 129.29 38.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.007 . . . . 74.239999999999995 108.806 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.52 129.68 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.739 0.649 . . . . 64.120000000000005 109.627 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.596 HG21 HG21 ' A' ' 53' ' ' ILE . 71.1 t -84.23 130.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.508 0.723 . . . . 72.409999999999997 110.236 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.22 134.2 42.67 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.284 0.99 . . . . 63.119999999999997 113.602 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.63 -33.81 66.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.432 1.093 . . . . 63.509999999999998 110.474 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.05 -34.54 77.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.225 1.01 . . . . 54.149999999999999 111.913 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 25.4 pt -97.59 -5.78 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 118.925 -0.559 . . . . 64.510000000000005 112.096 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 45' ' ' ILE . 38.9 mm -65.58 103.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.215 -1.031 . . . . 71.349999999999994 108.215 171.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -85.72 -55.07 4.15 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.31 0.644 . . . . 63.149999999999999 109.618 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -148.99 143.4 26.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.987 -0.551 . . . . 72.120000000000005 110.526 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.65 118.46 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.332 1.053 . . . . 71.319999999999993 108.647 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -106.62 143.88 34.09 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.036 -1.098 . . . . 74.099999999999994 108.036 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.5 t -120.1 124.95 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.167 -1.049 . . . . 62.310000000000002 108.167 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -88.48 111.37 43.3 Favored Pre-proline 0 C--O 1.251 1.156 0 N-CA-C 108.143 -1.058 . . . . 24.120000000000001 108.143 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.2 151.39 49.09 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.862 2.375 . . . . 74.239999999999995 112.266 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.76 158.07 43.35 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.342 2.028 . . . . 61.210000000000001 112.164 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.99 -19.1 44.17 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.738 -0.479 . . . . 73.109999999999999 113.734 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -83.45 66.17 8.75 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.736 0.814 . . . . 73.340000000000003 109.844 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.6 -18.12 6.04 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 115.422 -0.808 . . . . 41.299999999999997 113.839 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 10' ' ' LYS . 49.4 t -139.67 129.44 14.01 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.629 1.172 . . . . 70.409999999999997 108.563 -175.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.25 32.91 0.45 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.003 2.469 . . . . 62.119999999999997 112.676 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.31 126.78 50.35 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.565 0.746 . . . . 63.420000000000002 110.773 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -88.61 121.35 30.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.714 0.805 . . . . 75.120000000000005 108.914 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -144.3 163.6 33.22 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.29 0.567 . . . . 65.340000000000003 110.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.4 t -121.41 104.16 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.576 1.15 . . . . 75.420000000000002 108.277 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.54 108.98 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.616 1.166 . . . . 71.530000000000001 108.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.419 ' HB ' HG12 ' A' ' 53' ' ' ILE . 69.7 mt -107.91 134.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.562 -0.712 . . . . 75.019999999999996 110.391 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.17 124.89 48.55 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.831 1.252 . . . . 75.400000000000006 107.749 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -80.23 179.06 7.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.508 0.323 . . . . 35.039999999999999 110.302 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 52.5 mtmt -62.35 -28.63 69.89 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.264 0.554 . . . . 62.100000000000001 110.617 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 49' ' ' MET . 0.9 OUTLIER -86.28 7.05 26.89 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.748 1.219 . . . . 72.109999999999999 111.028 177.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 63.74 15.61 9.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.305 1.442 . . . . 74.129999999999995 111.793 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -72.68 128.46 35.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.789 -1.189 . . . . 63.530000000000001 107.789 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.83 118.5 35.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.033 -0.985 . . . . 73.230000000000004 109.051 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 21' ' ' VAL . 7.2 pt -110.98 157.11 11.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.626 -1.25 . . . . 74.400000000000006 107.626 167.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.9 t -139.83 116.61 10.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.482 -0.933 . . . . 73.230000000000004 108.482 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 158.12 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 75.109999999999999 109.434 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.22 151.35 78.27 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.425 -0.583 . . . . 61.310000000000002 109.425 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.74 -16.41 37.18 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.262 2.641 . . . . 73.400000000000006 114.053 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -91.29 18.99 6.34 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.13 0.972 . . . . 62.310000000000002 112.386 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 128.07 34.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.152 -0.684 . . . . 63.509999999999998 109.152 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 11.1 mmpt? -66.99 -38.5 86.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.703 0.801 . . . . 64.510000000000005 112.584 -172.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -63.55 -33.24 75.15 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.131 0.491 . . . . 74.540000000000006 110.156 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.15 -31.15 43.91 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.057 -0.974 . . . . 74.310000000000002 110.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -31.95 73.14 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 110.143 -0.318 . . . . 72.120000000000005 110.143 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.7 -42.12 92.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.289 0.635 . . . . 70.120000000000005 110.199 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.5 mm? -64.1 -42.7 96.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.444 0.698 . . . . 61.420000000000002 110.269 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.77 -31.64 72.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.241 0.617 . . . . 70.230000000000004 111.072 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -78.77 -27.04 44.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.1 0.96 . . . . 73.439999999999998 110.804 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -83.69 -29.27 27.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.252 0.621 . . . . 73.430000000000007 112.067 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 65' ' ' LEU . 24.4 m -70.45 -24.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 110.104 -0.332 . . . . 71.230000000000004 110.104 176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.03 122.12 14.16 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.441 -1.318 . . . . 44.420000000000002 107.441 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -55.68 142.96 32.1 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.486 1.114 . . . . 53.43 112.055 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? 62.54 52.81 2.81 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.111 0.965 . . . . 70.340000000000003 111.212 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.1 p -91.76 169.32 10.8 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.956 -1.02 . . . . 62.149999999999999 109.825 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -53.88 103.08 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.656 0.782 . . . . 72.239999999999995 112.025 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 m -141.97 9.35 1.92 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.753 1.221 . . . . 62.100000000000001 110.348 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -98.15 111.48 23.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.093 0.957 . . . . 45.240000000000002 110.76 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -96.76 104.65 19.1 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.157 0.983 . . . . 45.210000000000001 109.299 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -55.76 95.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.448 2.765 . . . . 74.140000000000001 113.89 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -85.38 94.34 8.94 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.187 -1.042 . . . . 55.049999999999997 108.187 170.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.73 33.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 73.200000000000003 110.013 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.66 111.52 0.75 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.019 2.479 . . . . 65.129999999999995 111.896 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.15 121.36 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.814 0.696 . . . . 70.409999999999997 109.492 -171.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.9 p -99.55 30.84 3.4 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 73.209999999999994 111.492 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -84.65 80.59 9.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.422 0.629 . . . . 75.549999999999997 110.508 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.25 140.79 1.18 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.375 1.47 . . . . 64.219999999999999 107.8 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -62.63 1.57 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.7 -1.222 . . . . 75.239999999999995 107.7 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.94 73.65 6.71 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 63.299999999999997 110.444 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.913 0.885 . . . . 52.109999999999999 109.061 -178.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.567 -0.16 . . . . 53.439999999999998 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 pp -103.56 171.39 7.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.895 -0.78 . . . . 65.430000000000007 108.895 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 169.39 17.74 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.316 0.579 . . . . 72.450000000000003 111.119 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.28 139.02 37.24 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.43 -1.322 . . . . 65.030000000000001 107.43 169.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -74.65 91.72 2.37 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.258 -0.645 . . . . 72.510000000000005 109.258 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -73.75 89.9 1.82 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 115.69 -0.687 . . . . 71.439999999999998 109.346 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 t -66.54 2.57 1.25 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.841 1.256 . . . . 62.200000000000003 112.747 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -45.29 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.086 1.354 . . . . 72.439999999999998 110.588 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.35 77.37 8.23 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.895 0.855 . . . . 74.200000000000003 109.417 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.34 155.56 45.18 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.437 -1.256 . . . . 65.430000000000007 109.568 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 85.2 m -66.43 133.41 50.39 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.593 -0.891 . . . . 74.310000000000002 108.593 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -83.55 128.18 34.31 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.248 -0.649 . . . . 72.420000000000002 109.248 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.2 t -144.73 133.74 22.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.357 0.663 . . . . 73.230000000000004 110.166 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' A' ' 54' ' ' CYS . 23.1 t -87.34 31.29 0.74 Allowed 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 125.092 1.357 . . . . 75.109999999999999 111.212 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.06 -142.23 20.52 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.365 -0.294 . . . . 54.109999999999999 112.365 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.03 133.38 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.644 -1.243 . . . . 73.329999999999998 107.644 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.402 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.7 pp -125.52 150.43 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 122.862 0.465 . . . . 73.540000000000006 111.424 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -97.32 2.21 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.285 1.034 . . . . 62.210000000000001 110.982 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 m -74.9 98.08 3.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.251 0.62 . . . . 51.219999999999999 109.523 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.66 109.69 6.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.124 -1.436 . . . . 55.439999999999998 107.124 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.1 t -100.39 139.41 21.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.429 0.691 . . . . 72.200000000000003 109.987 -173.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.77 136.8 38.65 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 124.015 0.822 . . . . 75.239999999999995 112.565 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 64' ' ' ARG . 10.8 mp -60.89 -29.41 69.55 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.936 0.894 . . . . 71.510000000000005 110.542 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.61 -33.19 67.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.327 1.451 . . . . 74.420000000000002 112.794 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.572 HG22 ' HE2' ' A' ' 48' ' ' LYS . 43.4 pt -110.21 7.46 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.519 0.328 . . . . 73.239999999999995 111.869 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.472 HD12 HG21 ' A' ' 45' ' ' ILE . 39.5 mm -73.86 111.48 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.393 -0.966 . . . . 64.319999999999993 108.393 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.2 -56.66 3.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.484 0.713 . . . . 74.510000000000005 110.652 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -153.58 138.26 16.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.200000000000003 109.856 -174.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.7 128.8 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.122 -1.066 . . . . 73.310000000000002 108.122 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' VAL . 72.1 mt-30 -116.88 138.99 51.15 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.632 -0.877 . . . . 74.129999999999995 108.632 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.69 119.24 49.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.683 -0.858 . . . . 71.230000000000004 108.683 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.7 p -101.37 112.76 65.54 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.423 -0.954 . . . . 72.540000000000006 108.423 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.63 161.05 47.43 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.373 2.715 . . . . 73.219999999999999 112.677 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 119.72 6.14 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.526 2.151 . . . . 62.43 111.453 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.74 -39.08 1.24 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 116.131 -0.486 . . . . 74.540000000000006 112.231 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -77.22 77.99 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.219 0.607 . . . . 50.119999999999997 110.144 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.68 14.51 55.22 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.17 -0.468 . . . . 60.539999999999999 113.872 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 31.9 p -139.89 133.79 15.59 Favored Pre-proline 0 C--N 1.356 0.881 0 C-N-CA 123.422 0.689 . . . . 72.409999999999997 110.161 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 17.2 Cg_exo -68.94 -38.19 10.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.132 2.554 . . . . 45.030000000000001 112.914 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -118.43 159.24 23.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.769 0.828 . . . . 64.030000000000001 110.491 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -62.96 120.86 12.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.102 0.961 . . . . 64.230000000000004 109.9 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -108.55 117.55 34.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.501 0.72 . . . . 55.119999999999997 109.299 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.35 106.49 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.816 0.846 . . . . 75.319999999999993 109.423 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 30' ' ' GLN . 5.8 m -104.71 125.33 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.046 0.539 . . . . 63.539999999999999 109.789 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 26' ' ' ILE . 46.3 mt -114.37 120.11 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 108.978 -175.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -86.57 128.25 34.97 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.236 1.014 . . . . 75.400000000000006 108.484 174.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.6 p -83.62 179.68 7.55 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.328 0.651 . . . . 74.409999999999997 110.17 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE2' HG22 ' A' ' 25' ' ' ILE . 41.8 mtmt -66.2 -29.67 69.98 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.394 0.278 . . . . 54.149999999999999 111.065 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -77.09 -7.3 55.5 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.501 0.72 . . . . 64.230000000000004 110.294 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 70.04 23.51 5.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 125.934 1.694 . . . . 75.150000000000006 111.408 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.01 123.69 25.62 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.19 126.58 43.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.342 0.657 . . . . 72.219999999999999 109.422 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HB ' HG12 ' A' ' 17' ' ' ILE . 46.6 pt -117.64 157.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.479 -1.304 . . . . 71.430000000000007 107.479 170.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.612 ' HB2' ' H ' ' A' ' 14' ' ' SER . 13.4 t -133.93 134.15 42.27 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.203 0.456 . . . . 52.140000000000001 109.939 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.7 HG11 ' HE1' ' A' ' 61' ' ' TRP . 31.0 m -133.95 164.94 33.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 C-N-CA 124.344 1.058 . . . . 73.150000000000006 109.598 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -81.57 159.16 67.46 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.367 -1.288 . . . . 65.0 109.846 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.68 -12.95 37.97 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.928 2.419 . . . . 74.209999999999994 112.028 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -83.52 -8.65 59.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.811 0.844 . . . . 54.219999999999999 111.432 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.87 132.37 49.23 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.735 0.814 . . . . 62.210000000000001 112.161 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.2 -36.45 69.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 74.099999999999994 112.491 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.7 ' HE1' HG11 ' A' ' 55' ' ' VAL . 7.7 p-90 -74.75 -23.15 58.51 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.565 0.346 . . . . 74.420000000000002 110.368 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.81 -28.5 69.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.097 0.959 . . . . 71.349999999999994 110.59 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.77 -34.78 73.44 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.632 0.773 . . . . 74.540000000000006 110.571 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 23' ' ' LEU . 95.5 mtt180 -66.95 -39.49 87.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.572 0.749 . . . . 72.230000000000004 111.009 176.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.1 -38.08 72.36 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.544 0.738 . . . . 65.5 110.858 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.53 -49.66 57.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.611 -0.722 . . . . 70.310000000000002 109.682 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -67.62 -24.03 65.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.315 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.658 0.783 . . . . 63.549999999999997 111.119 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.89 -29.78 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 122.723 0.409 . . . . 62.149999999999999 111.039 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -88.55 154.7 20.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.467 0.707 . . . . 70.239999999999995 110.45 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -65.86 125.5 25.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.336 -0.616 . . . . 54.340000000000003 109.336 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -90.0 -73.4 0.52 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.975 -0.75 . . . . 71.230000000000004 108.975 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m -156.62 100.2 1.92 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.166 0.986 . . . . 63.210000000000001 108.78 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tt -69.34 93.21 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.206 -1.035 . . . . 71.430000000000007 108.206 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -107.66 176.59 5.1 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.974 -1.012 . . . . 70.349999999999994 108.983 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.1 p -75.04 127.69 33.82 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.056 -0.72 . . . . 61.340000000000003 109.056 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.6 t -72.7 123.53 89.66 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.171 -0.678 . . . . 42.530000000000001 109.171 176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 122.78 12.28 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.295 1.997 . . . . 73.530000000000001 112.269 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.37 141.76 58.16 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.945 0.498 . . . . 71.239999999999995 111.084 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.52 123.76 20.59 Favored Pre-proline 0 C--O 1.244 0.791 0 C-N-CA 123.843 0.857 . . . . 74.310000000000002 108.795 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.79 101.73 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.143 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.12 146.89 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 75.25 110.973 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -78.15 73.58 4.71 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.759 0.79 . . . . 75.319999999999993 109.829 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -163.61 111.31 1.18 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.633 -1.988 . . . . 73.510000000000005 105.633 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.65 162.31 14.87 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.026 0.93 . . . . 72.540000000000006 108.666 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -67.14 -34.27 77.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.734 0.813 . . . . 72.310000000000002 110.552 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.8 -0.3 37.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.773 0.829 . . . . 71.510000000000005 111.947 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.143 0 C-N-CA 122.804 0.441 . . . . 71.540000000000006 110.161 -177.448 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 75.510000000000005 108.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.04 92.1 3.79 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.574 0.75 . . . . 71.510000000000005 109.348 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.28 84.11 6.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.53 0.732 . . . . 70.420000000000002 109.349 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.93 16.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.662 0.385 . . . . 53.329999999999998 110.524 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -84.07 88.2 7.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.409 0.684 . . . . 62.299999999999997 110.135 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -100.45 141.76 32.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.041 -0.726 . . . . 74.230000000000004 109.041 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 m -69.28 86.6 0.41 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.883 0.849 . . . . 62.399999999999999 109.725 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -122.49 138.28 54.61 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.738 -1.119 . . . . 71.209999999999994 108.828 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.77 95.73 2.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.377 -0.971 . . . . 74.519999999999996 108.377 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.55 173.76 11.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.914 1.286 . . . . 74.040000000000006 108.208 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' SG ' HG21 ' A' ' 32' ' ' THR . 14.0 m -77.42 117.07 18.54 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.956 0.502 . . . . 72.120000000000005 110.066 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -67.37 132.79 48.38 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.176 0.591 . . . . 73.129999999999995 110.081 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 41.8 t -146.57 155.61 42.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.526 0.73 . . . . 73.299999999999997 110.056 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.9 m -99.18 -6.91 27.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.288 0.635 . . . . 64.409999999999997 111.255 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.92 165.23 10.18 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 111.521 -0.632 . . . . 72.510000000000005 111.521 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.228 -1.026 . . . . 75.349999999999994 108.228 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.87 143.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.062 0.458 . . . . 74.400000000000006 110.581 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -100.5 -57.1 2.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.016 0.926 . . . . 52.340000000000003 108.733 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -67.32 127.54 33.04 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.814 0.846 . . . . 71.549999999999997 110.45 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.89 139.47 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 124.007 0.817 . . . . 62.149999999999999 110.668 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.97 144.66 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.361 1.064 . . . . 73.540000000000006 109.949 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.64 135.62 25.22 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.561 0.538 . . . . 72.219999999999999 114.253 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.71 -18.76 63.05 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.176 0.99 . . . . 63.109999999999999 111.578 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -59.52 -35.79 74.86 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.413 1.085 . . . . 72.150000000000006 111.746 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.85 -1.92 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 119.324 -0.37 . . . . 75.420000000000002 111.793 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 45' ' ' ILE . 50.2 mm -78.37 124.62 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.963 -0.755 . . . . 62.409999999999997 108.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.13 -57.15 2.08 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.172 0.589 . . . . 71.219999999999999 110.26 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -142.99 153.81 43.37 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.142 0.977 . . . . 74.219999999999999 109.519 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.03 113.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.747 0.819 . . . . 63.109999999999999 109.103 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -96.93 106.66 19.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.652 0.781 . . . . 61.219999999999999 109.139 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.89 117.73 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.033 -0.729 . . . . 65.530000000000001 109.033 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.577 HG21 ' SG ' ' A' ' 11' ' ' CYS . 8.4 m -89.47 112.68 53.02 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.701 0.8 . . . . 72.340000000000003 108.949 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.63 152.48 64.83 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.08 1.853 . . . . 60.340000000000003 111.999 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.79 109.38 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.828 2.352 . . . . 62.539999999999999 111.928 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.53 -27.79 0.96 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.868 -0.606 . . . . 41.229999999999997 112.181 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.36 68.88 10.62 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.748 0.819 . . . . 54.450000000000003 110.515 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.62 -3.79 40.02 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.338 -0.846 . . . . 62.530000000000001 114.145 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -132.89 125.55 19.28 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 124.233 1.013 . . . . 74.120000000000005 109.443 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.45 -17.79 30.1 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.498 2.132 . . . . 52.009999999999998 112.941 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -110.77 173.75 6.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.787 0.835 . . . . 72.120000000000005 110.165 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -85.43 113.82 22.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.867 -0.79 . . . . 75.040000000000006 108.867 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -101.74 111.13 23.27 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.21 -0.663 . . . . 74.200000000000003 109.21 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.3 t -92.63 99.81 10.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.328 -0.99 . . . . 71.109999999999999 108.328 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.11 107.02 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.093 -1.077 . . . . 73.439999999999998 108.093 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 53' ' ' ILE . 58.5 mt -98.1 128.74 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.507 0.723 . . . . 63.43 109.493 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -102.91 121.45 42.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.137 0.975 . . . . 73.409999999999997 108.712 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -80.95 170.66 15.98 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.695 0.398 . . . . 74.310000000000002 111.106 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -69.31 -12.32 61.56 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.89 0.876 . . . . 75.109999999999999 111.605 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 ptp -101.94 18.28 21.03 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.921 0.888 . . . . 71.329999999999998 110.302 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 61.6 7.48 1.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.381 1.473 . . . . 31.530000000000001 113.902 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -73.14 128.52 35.71 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.281 -1.007 . . . . 72.040000000000006 108.281 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.95 119.21 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.867 -1.06 . . . . 73.319999999999993 109.791 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.604 HG13 ' HB ' ' A' ' 45' ' ' ILE . 23.9 pt -127.71 145.12 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.06 -1.089 . . . . 72.129999999999995 108.06 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.9 m -120.44 142.51 49.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.708 -0.479 . . . . 62.310000000000002 109.708 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG11 ' HE1' ' A' ' 61' ' ' TRP . 29.9 m -126.37 159.67 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 122.969 0.508 . . . . 70.530000000000001 109.712 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -74.96 146.32 82.42 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.085 -0.962 . . . . 74.349999999999994 109.476 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.87 -23.72 76.33 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.981 2.454 . . . . 60.310000000000002 113.1 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -106.23 22.91 14.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.714 0.806 . . . . 63.310000000000002 111.405 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.82 135.03 49.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.136 -0.69 . . . . 53.109999999999999 109.136 171.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.81 -39.53 90.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 71.510000000000005 111.703 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.546 ' HE1' HG11 ' A' ' 55' ' ' VAL . 2.4 p-90 -69.36 -30.16 68.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.77 0.428 . . . . 71.310000000000002 110.035 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.5 tp -68.27 -34.22 75.79 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.247 0.619 . . . . 55.32 110.838 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -57.19 -32.69 66.72 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.128 0.49 . . . . 72.409999999999997 110.976 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.31 -45.48 80.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.105 -0.952 . . . . 73.310000000000002 109.582 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.73 -42.99 97.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.834 . . . . 63.43 110.599 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.62 -49.16 74.37 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.963 0.79 . . . . 55.439999999999998 110.506 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -72.34 -27.11 62.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.308 0.485 . . . . 64.420000000000002 112.308 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.18 -42.12 47.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.361 0.664 . . . . 62.520000000000003 110.995 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.32 -28.24 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 116.389 -0.369 . . . . 73.420000000000002 110.493 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -81.3 149.58 28.89 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.187 0.595 . . . . 71.340000000000003 110.02 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m 71.31 16.44 6.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.42 1.488 . . . . 71.239999999999995 110.945 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -109.34 103.1 11.97 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.664 0.786 . . . . 74.209999999999994 109.107 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 t -85.78 64.01 8.37 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.705 0.802 . . . . 72.420000000000002 109.406 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.23 113.3 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.046 -1.094 . . . . 63.219999999999999 108.046 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.2 m -76.87 81.42 3.44 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.397 0.617 . . . . 71.239999999999995 110.373 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.4 t -81.07 116.31 20.95 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.965 -0.754 . . . . 73.129999999999995 108.965 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 p -95.24 137.49 22.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.605 0.762 . . . . 62.43 110.611 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.95 170.29 20.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.512 2.142 . . . . 74.430000000000007 113.064 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.35 147.43 41.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.133 0.973 . . . . 75.430000000000007 109.349 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.16 111.17 12.45 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.666 0.787 . . . . 62.039999999999999 111.359 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 150.25 26.83 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.153 1.902 . . . . 52.119999999999997 112.511 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p 40.45 82.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 126.274 1.83 . . . . 65.030000000000001 114.125 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 t -85.93 95.0 9.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 74.439999999999998 108.871 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -165.18 150.02 9.13 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.956 0.502 . . . . 74.420000000000002 111.265 -171.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -136.47 158.35 44.63 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.985 1.314 . . . . 60.43 108.897 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -80.66 87.83 5.77 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.65 -0.87 . . . . 63.119999999999997 108.65 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 65.68 9.3 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.573 0.749 . . . . 73.230000000000004 110.16 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.898 -1.046 . . . . 65.25 109.513 -176.002 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.735 -0.839 . . . . 62.219999999999999 108.735 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.19 156.96 45.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.033 0.933 . . . . 74.129999999999995 108.979 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.43 139.3 35.28 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.82 0.848 . . . . 44.310000000000002 109.337 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.99 116.22 21.51 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.123 0.569 . . . . 73.25 109.62 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -72.73 100.75 2.92 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.249 -0.649 . . . . 74.019999999999996 109.249 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -76.65 126.75 31.52 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.551 -0.749 . . . . 74.420000000000002 109.973 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 140.37 38.11 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.002 0.921 . . . . 71.319999999999993 109.041 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.87 42.81 1.12 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.192 0.597 . . . . 73.099999999999994 110.265 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tt -61.03 -39.79 91.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 74.510000000000005 110.215 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -132.05 175.59 9.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 122.989 0.515 . . . . 73.239999999999995 111.477 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.0 p -62.0 115.73 4.32 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.287 -0.869 . . . . 51.119999999999997 110.137 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -90.13 122.02 32.71 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.221 0.608 . . . . 73.239999999999995 110.682 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 t -143.4 126.07 15.98 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.838 0.855 . . . . 73.219999999999999 109.267 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 t -93.37 99.6 12.08 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.247 0.619 . . . . 60.549999999999997 109.43 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.03 -148.11 50.83 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.516 0.51 . . . . 13.039999999999999 113.152 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.21 129.12 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.365 -0.976 . . . . 71.140000000000001 108.365 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.8 pt -102.03 119.01 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.368 -0.604 . . . . 71.430000000000007 109.368 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 p -97.49 5.98 48.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.609 0.764 . . . . 74.439999999999998 110.833 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.9 m -77.69 127.67 32.82 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.882 0.873 . . . . 64.310000000000002 109.798 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.78 111.12 10.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 107.274 -1.38 . . . . 71.519999999999996 107.274 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.43 139.06 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 109.022 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 124.63 36.9 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.005 0.816 . . . . 54.439999999999998 112.496 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.32 -34.29 70.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.508 0.723 . . . . 72.040000000000006 109.491 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.84 -34.13 77.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.781 0.832 . . . . 74.140000000000001 111.681 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.4 pt -92.06 3.61 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.049 -0.407 . . . . 70.420000000000002 112.067 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 35.3 mm -78.96 132.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 108.546 -0.909 . . . . 65.329999999999998 108.546 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.15 -56.03 2.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.218 0.607 . . . . 72.329999999999998 109.893 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -144.83 155.88 43.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.328 0.651 . . . . 72.040000000000006 110.974 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.73 112.05 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.759 1.223 . . . . 74.409999999999997 108.058 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -103.69 127.36 51.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.799 -0.815 . . . . 72.040000000000006 108.799 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.26 120.6 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.371 0.668 . . . . 62.43 109.406 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.1 m -95.12 110.35 49.65 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.549 -0.908 . . . . 71.109999999999999 108.549 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.49 156.44 64.03 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.871 2.38 . . . . 71.319999999999993 112.638 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.11 165.3 21.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.383 2.055 . . . . 75.510000000000005 112.026 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.43 -51.9 4.63 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.496 -0.32 . . . . 64.150000000000006 112.425 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -76.55 80.68 3.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.946 0.898 . . . . 75.120000000000005 110.856 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.3 -15.14 9.49 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.657 -0.701 . . . . 43.0 114.66 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.91 132.96 23.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.097 -0.705 . . . . 23.34 109.097 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.89 5.74 6.13 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.665 2.243 . . . . 74.099999999999994 112.912 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.2 159.61 42.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.404 1.082 . . . . 71.230000000000004 109.52 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -80.78 114.31 19.58 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.267 -1.012 . . . . 70.019999999999996 108.267 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.27 117.22 33.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 64.209999999999994 109.733 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.67 102.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.706 -0.85 . . . . 72.150000000000006 108.706 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.1 t -92.05 108.53 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.874 -1.158 . . . . 74.510000000000005 107.874 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 60.2 mt -94.56 138.02 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.155 -0.683 . . . . 70.420000000000002 109.155 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -104.58 119.91 40.09 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.268 -1.382 . . . . 70.319999999999993 107.268 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.3 p -77.09 168.63 19.76 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.331 0.395 . . . . 74.439999999999998 110.215 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -73.47 -10.87 60.17 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.114 0.566 . . . . 54.43 111.226 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.72 -5.34 58.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.584 1.154 . . . . 53.539999999999999 110.127 168.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.97 18.91 10.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.16 1.784 . . . . 62.530000000000001 112.234 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -79.03 133.74 36.8 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.755 -0.657 . . . . 74.450000000000003 109.913 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.01 117.77 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.47 -1.241 . . . . 75.540000000000006 108.46 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.4 pt -126.64 148.05 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.258 0.623 . . . . 62.450000000000003 109.478 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -111.85 130.96 55.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.171 -1.048 . . . . 43.530000000000001 108.171 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.03 165.6 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.31 0.644 . . . . 72.200000000000003 110.25 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -74.35 135.55 75.85 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.274 0.629 . . . . 74.010000000000005 109.885 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.69 -29.07 69.1 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 112.831 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -88.76 4.57 47.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.698 0.799 . . . . 64.109999999999999 112.313 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.1 120.31 8.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.837 -0.431 . . . . 72.409999999999997 109.837 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.49 -36.73 74.22 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.241 1.016 . . . . 54.210000000000001 113.078 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -68.46 -31.59 70.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.234 0.614 . . . . 74.230000000000004 111.106 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.72 -37.75 65.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.095 0.958 . . . . 73.430000000000007 110.84 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -42.69 82.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.891 0.877 . . . . 70.420000000000002 112.565 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -71.4 -27.69 63.5 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 116.112 -0.495 . . . . 72.140000000000001 111.464 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.28 -25.83 46.85 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.494 0.718 . . . . 73.019999999999996 110.097 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.09 -28.61 54.58 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.73 0.812 . . . . 75.209999999999994 109.99 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -74.49 -31.12 62.09 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.591 0.356 . . . . 73.109999999999999 110.544 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.57 -37.36 85.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.237 0.615 . . . . 70.439999999999998 111.514 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.39 -12.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 116.096 -0.502 . . . . 60.350000000000001 111.104 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.16 111.07 21.76 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.678 0.791 . . . . 71.329999999999998 109.881 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 p -89.73 130.14 36.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.449 0.699 . . . . 74.329999999999998 110.336 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -74.04 93.16 2.22 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.813 -0.81 . . . . 54.030000000000001 108.813 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 p -145.77 19.64 1.47 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.37 1.068 . . . . 73.310000000000002 109.965 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.37 73.58 0.41 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.88 1.272 . . . . 50.25 108.561 -168.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.8 m -70.97 106.88 3.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.622 -1.172 . . . . 71.420000000000002 109.631 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -80.05 154.32 28.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.144 0.578 . . . . 71.409999999999997 110.299 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.0 p -62.49 136.67 96.01 Favored Pre-proline 0 CA--C 1.556 1.192 0 O-C-N 123.959 0.787 . . . . 72.420000000000002 110.492 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.52 127.09 7.44 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.661 2.907 . . . . 60.539999999999999 114.153 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -82.39 13.31 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.911 0.884 . . . . 72.409999999999997 111.641 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.67 83.06 20.38 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.227 1.011 . . . . 74.409999999999997 108.301 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.17 160.5 47.14 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.301 2.001 . . . . 55.530000000000001 110.757 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.78 109.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.34 -0.985 . . . . 63.409999999999997 108.34 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.1 m -75.16 73.13 2.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.91 0.884 . . . . 61.439999999999998 111.128 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.25 104.35 13.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.077 -1.453 . . . . 52.119999999999997 107.077 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -114.97 150.33 35.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.415 0.686 . . . . 72.209999999999994 109.441 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -129.08 122.81 30.73 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.903 -1.147 . . . . 75.010000000000005 107.903 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -115.58 145.05 43.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.57 0.748 . . . . 65.230000000000004 109.403 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.445 0.698 . . . . 72.409999999999997 110.945 -179.452 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.617 -0.512 . . . . 61.140000000000001 109.617 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.97 103.06 9.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.737 -1.579 . . . . 51.350000000000001 106.737 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.95 90.13 2.98 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.44 -0.578 . . . . 63.130000000000003 109.44 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.64 142.78 58.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.231 0.613 . . . . 72.409999999999997 109.937 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -63.86 112.11 2.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.282 0.633 . . . . 71.450000000000003 109.304 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.16 137.45 54.89 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.109 0.963 . . . . 74.329999999999998 110.921 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -60.09 161.22 7.08 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.857 1.263 . . . . 74.239999999999995 112.386 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -102.01 174.71 5.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.689 0.796 . . . . 74.329999999999998 109.997 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp 65.67 26.12 11.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.886 1.274 . . . . 73.200000000000003 110.172 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -96.54 174.27 6.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.887 -1.051 . . . . 73.099999999999994 110.73 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 32' ' ' THR . 72.7 m -76.23 125.28 28.87 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.784 0.833 . . . . 75.439999999999998 110.109 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -76.33 117.38 17.95 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.68 -0.859 . . . . 75.120000000000005 108.68 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.48 109.84 20.78 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.732 -1.21 . . . . 75.530000000000001 107.732 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -81.46 73.4 8.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 60.549999999999997 110.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.71 -142.53 48.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 113.181 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.87 153.74 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.75 0.82 . . . . 45.350000000000001 109.264 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.401 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.3 pp -128.69 131.28 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.249 0.547 . . . . 72.310000000000002 109.875 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -89.93 -10.16 46.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.726 0.811 . . . . 44.240000000000002 111.596 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 m -64.19 127.21 30.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.709 0.803 . . . . 72.319999999999993 111.247 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.65 114.26 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 108.276 -1.009 . . . . 75.329999999999998 108.276 172.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.53 127.0 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.468 0.707 . . . . 74.420000000000002 109.63 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.0 160.67 17.7 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.777 -0.647 . . . . 52.399999999999999 113.378 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.6 -33.82 68.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.012 1.325 . . . . 63.130000000000003 111.215 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -58.97 -32.22 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.044 0.938 . . . . 73.340000000000003 111.865 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.11 5.83 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 112.435 0.532 . . . . 72.120000000000005 112.435 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.548 HG13 HD11 ' A' ' 65' ' ' LEU . 21.7 mm -77.42 113.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.786 -0.82 . . . . 71.530000000000001 108.786 170.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.58 -55.97 3.73 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.697 -0.482 . . . . 62.210000000000001 109.697 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -157.34 143.62 17.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.673 0.789 . . . . 71.040000000000006 109.891 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 45' ' ' ILE . 65.7 mt -120.88 139.73 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.276 1.03 . . . . 54.32 109.493 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.41 143.09 47.39 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.682 -0.858 . . . . 71.239999999999995 108.682 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.2 138.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 109.229 -0.656 . . . . 72.209999999999994 109.229 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 71.8 p -119.9 143.2 34.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 123.626 0.77 . . . . 71.239999999999995 109.279 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.77 163.45 26.27 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.077 2.518 . . . . 75.510000000000005 113.652 -170.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.94 130.04 14.01 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 110.878 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.68 -162.01 30.03 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.356 -0.698 . . . . 74.310000000000002 111.356 -170.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.35 17.48 11.0 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.03 0.932 . . . . 72.239999999999995 111.451 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.44 41.21 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.674 -0.694 . . . . 73.310000000000002 112.828 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.5 m -85.06 135.75 39.15 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.763 0.825 . . . . 61.43 109.398 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.55 -63.34 0.19 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.994 2.463 . . . . 75.219999999999999 113.333 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.66 -177.27 4.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.323 -0.991 . . . . 74.430000000000007 108.323 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' THR . 24.2 m -57.59 110.13 0.83 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.806 -0.813 . . . . 61.109999999999999 108.806 166.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -104.33 119.39 38.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.959 -0.756 . . . . 71.109999999999999 108.959 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.45 102.48 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.885 -0.783 . . . . 55.130000000000003 108.885 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.61 134.35 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.553 -0.906 . . . . 72.439999999999998 108.553 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 29' ' ' ILE . 61.8 mt -133.01 125.54 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.329 -0.619 . . . . 72.120000000000005 109.329 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.82 123.43 36.08 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.064 -1.087 . . . . 73.420000000000002 108.064 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.0 p -84.58 179.46 7.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.247 0.619 . . . . 74.030000000000001 110.87 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.93 -24.41 64.28 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.119 0.568 . . . . 71.219999999999999 111.809 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.549 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 25.0 ptp -90.93 12.4 19.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.271 0.628 . . . . 61.130000000000003 110.766 172.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.56 22.44 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.839 1.656 . . . . 65.409999999999997 112.461 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 49' ' ' MET . 2.0 tmtp? -74.75 123.77 25.56 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.622 -1.622 . . . . 72.329999999999998 106.622 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.34 121.53 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.301 1.041 . . . . 72.030000000000001 108.523 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HB ' HG12 ' A' ' 17' ' ' ILE . 30.0 pt -125.56 147.51 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 108.522 -0.918 . . . . 71.019999999999996 108.522 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.35 118.42 25.02 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.813 -1.18 . . . . 74.129999999999995 107.813 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.88 164.57 21.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.582 0.753 . . . . 72.510000000000005 109.911 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.45 147.56 92.74 Favored Pre-proline 0 N--CA 1.474 0.744 0 O-C-N 123.936 0.773 . . . . 72.439999999999998 110.186 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.42 -9.19 19.26 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.981 2.454 . . . . 74.109999999999999 113.582 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -111.44 26.15 10.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.989 0.916 . . . . 73.349999999999994 111.952 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 131.46 44.06 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 108.643 -0.873 . . . . 50.310000000000002 108.643 168.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.23 -47.94 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 71.329999999999998 112.844 -167.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.9 -24.47 64.31 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.673 0.389 . . . . 74.230000000000004 111.849 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.02 -32.13 72.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.033 0.533 . . . . 75.510000000000005 110.237 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.72 -23.63 67.44 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.172 0.589 . . . . 71.549999999999997 111.476 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -69.58 -40.55 76.67 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.415 0.686 . . . . 73.140000000000001 110.3 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -71.33 -34.73 70.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.499 0.72 . . . . 73.109999999999999 110.26 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.15 -37.81 72.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.539 0.736 . . . . 70.329999999999998 110.012 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.85 -40.82 97.47 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.755 0.822 . . . . 75.230000000000004 109.96 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -59.12 -40.65 86.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.565 1.146 . . . . 64.310000000000002 112.056 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -85.93 -14.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 115.9 -0.591 . . . . 73.129999999999995 112.346 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -25.42 11.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.716 0.406 . . . . 70.209999999999994 111.783 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.5 p -127.36 -159.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.176 0.591 . . . . 61.219999999999999 110.282 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -59.5 162.36 5.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.133 0.973 . . . . 65.299999999999997 112.276 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.0 t -144.77 153.82 42.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.586 -0.733 . . . . 64.239999999999995 110.923 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.74 104.0 14.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.907 -0.775 . . . . 61.350000000000001 108.907 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -72.02 113.99 9.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.996 0.919 . . . . 61.509999999999998 109.822 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -76.02 160.59 29.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.368 0.667 . . . . 74.109999999999999 110.19 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.8 p -61.17 132.05 92.31 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.499 1.12 . . . . 61.130000000000003 110.923 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.29 104.88 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.339 2.692 . . . . 74.530000000000001 112.297 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.09 127.06 37.42 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.673 -1.149 . . . . 74.129999999999995 110.229 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -118.69 107.01 43.2 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.912 0.885 . . . . 53.420000000000002 109.092 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.25 151.64 58.5 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.663 2.242 . . . . 53.32 112.317 171.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.63 123.94 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.291 -0.633 . . . . 73.109999999999999 109.291 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -78.0 157.79 29.52 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.034 0.533 . . . . 64.349999999999994 109.684 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -60.19 122.31 14.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.585 0.754 . . . . 72.310000000000002 109.729 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 123.39 11.4 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.316 1.01 . . . . 75.549999999999997 110.986 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -111.01 111.91 23.36 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.512 0.725 . . . . 73.420000000000002 109.147 -171.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.03 81.71 0.67 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.85 -0.796 . . . . 50.25 108.85 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 C-N-CA 124.389 1.076 . . . . 65.219999999999999 110.283 -169.554 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 110.22 -0.289 . . . . 64.129999999999995 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -155.8 130.86 9.33 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.03 0.932 . . . . 61.130000000000003 108.546 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.78 157.74 27.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.212 0.605 . . . . 62.140000000000001 109.871 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.97 68.1 9.33 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.47 0.708 . . . . 32.340000000000003 110.469 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.79 121.77 41.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.062 -1.088 . . . . 74.239999999999995 108.062 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -97.97 -37.71 9.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.337 0.655 . . . . 74.310000000000002 109.955 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 t -149.39 144.1 26.17 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.608 -0.724 . . . . 75.140000000000001 110.366 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -127.04 115.48 19.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.646 1.178 . . . . 72.439999999999998 107.833 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.59 135.75 50.07 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.767 0.427 . . . . 73.239999999999995 111.013 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 pttt 179.74 174.25 0.85 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.918 1.687 . . . . 71.329999999999998 108.145 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' SG ' HG21 ' A' ' 32' ' ' THR . 11.2 m -81.59 121.21 26.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.564 0.746 . . . . 23.539999999999999 109.638 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -78.99 138.14 37.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.916 -0.772 . . . . 74.049999999999997 108.916 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.76 148.3 33.96 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.546 0.739 . . . . 63.43 110.431 -170.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 t -83.8 -28.18 28.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.995 0.918 . . . . 65.230000000000004 110.611 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.63 174.89 15.73 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 109.849 -1.3 . . . . 71.129999999999995 109.849 -173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.3 m -101.76 147.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 117.273 0.537 . . . . 71.120000000000005 110.468 -173.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.95 131.98 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.853 -0.612 . . . . 74.219999999999999 109.531 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -85.73 -47.94 9.3 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.524 0.73 . . . . 72.430000000000007 110.017 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 122.26 28.2 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.011 0.924 . . . . 74.230000000000004 108.822 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -54.54 113.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.688 0.795 . . . . 54.030000000000001 111.502 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.77 141.6 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.691 -0.686 . . . . 75.219999999999999 109.98 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.19 131.23 32.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.674 0.609 . . . . 70.150000000000006 112.569 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.1 -33.13 68.77 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.159 0.984 . . . . 40.229999999999997 109.716 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.06 -34.48 77.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.203 1.001 . . . . 73.129999999999995 111.815 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -95.4 16.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 122.222 -0.299 . . . . 71.5 111.395 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 45' ' ' ILE . 50.4 mm -79.94 129.22 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.006 -0.738 . . . . 71.010000000000005 109.006 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -94.89 -56.13 2.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 64.239999999999995 110.535 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -156.03 142.47 18.52 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.737 -0.665 . . . . 71.010000000000005 109.414 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -108.82 138.13 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.392 1.077 . . . . 75.140000000000001 108.821 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 3.1 pt20 -136.66 111.55 8.86 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.687 -0.857 . . . . 72.439999999999998 108.687 171.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.9 123.15 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.102 -0.703 . . . . 74.030000000000001 109.102 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.474 HG21 ' SG ' ' A' ' 11' ' ' CYS . 22.3 m -87.28 110.88 37.2 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 109.241 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.41 154.14 55.75 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.911 2.407 . . . . 74.349999999999994 112.877 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.25 164.81 33.35 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.353 2.035 . . . . 63.43 112.235 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.49 4.8 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 112.712 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.51 88.94 0.35 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.271 1.028 . . . . 55.32 110.451 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.9 -18.54 3.87 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.067 0.841 . . . . 32.520000000000003 114.625 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.2 m -139.19 132.62 15.8 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 63.299999999999997 109.43 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.5 -9.97 20.25 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.734 2.289 . . . . 53.539999999999999 112.088 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -116.1 137.64 51.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.165 0.986 . . . . 71.129999999999995 110.248 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.5 m -69.19 138.48 54.11 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.725 0.81 . . . . 70.230000000000004 109.423 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.23 145.99 49.68 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.274 -1.01 . . . . 64.230000000000004 108.274 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.19 103.32 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.067 -1.086 . . . . 74.549999999999997 108.067 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 30' ' ' GLN . 61.6 t -94.04 124.05 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.235 -1.024 . . . . 73.230000000000004 108.235 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.574 HG21 HD12 ' A' ' 26' ' ' ILE . 66.8 mt -119.39 137.22 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 123.271 0.628 . . . . 55.43 110.002 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -91.62 131.93 36.68 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.923 -1.14 . . . . 75.010000000000005 107.923 166.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.5 p -86.43 172.07 10.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.368 0.667 . . . . 74.310000000000002 109.895 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -75.61 -7.61 54.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.372 0.669 . . . . 72.510000000000005 111.328 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.5 mtm -83.61 -7.09 59.58 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.942 0.897 . . . . 75.530000000000001 109.435 167.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 65.18 24.6 12.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.207 1.803 . . . . 74.329999999999998 110.536 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.46 125.97 32.84 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.737 -1.579 . . . . 73.140000000000001 106.737 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.53 122.85 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.101 -1.074 . . . . 75.319999999999993 108.101 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -127.19 155.89 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.648 -0.871 . . . . 72.129999999999995 108.648 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 39.6 m -111.63 151.19 29.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.91 -1.515 . . . . 64.450000000000003 106.91 165.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.06 129.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.602 -1.259 . . . . 71.310000000000002 107.602 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -54.07 129.08 57.96 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.493 0.717 . . . . 64.25 109.734 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.02 -14.45 41.6 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.511 2.141 . . . . 61.450000000000003 113.59 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -85.91 3.89 39.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.081 0.552 . . . . 74.109999999999999 111.947 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 120.85 10.53 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 123.414 0.686 . . . . 61.130000000000003 109.747 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.23 -31.54 71.97 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.762 1.225 . . . . 74.219999999999999 112.082 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -79.51 -23.51 42.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.25 1.02 . . . . 73.319999999999993 111.418 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.96 -27.58 68.35 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.892 0.877 . . . . 71.329999999999998 111.347 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.1 -35.86 69.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.817 0.847 . . . . 74.420000000000002 111.545 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -69.0 -34.06 74.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.405 0.682 . . . . 73.530000000000001 110.57 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.4 mp -70.22 -41.7 73.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.248 -0.649 . . . . 61.009999999999998 109.248 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.77 -38.35 88.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.749 0.82 . . . . 74.329999999999998 110.516 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -63.72 -34.16 77.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.863 0.865 . . . . 74.310000000000002 110.785 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -71.98 -33.71 68.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.922 0.489 . . . . 60.310000000000002 110.619 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' LEU . 97.4 t -71.99 -30.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.348 0.659 . . . . 62.509999999999998 109.414 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -71.88 90.19 1.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.854 -1.165 . . . . 61.399999999999999 107.854 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.3 p -108.86 177.86 4.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.776 1.231 . . . . 71.319999999999993 110.886 -170.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.94 151.22 40.42 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.517 0.727 . . . . 74.109999999999999 109.298 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 p -69.14 76.1 0.34 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.724 1.21 . . . . 72.230000000000004 111.753 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.69 131.47 40.9 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.63 1.172 . . . . 50.340000000000003 108.065 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.0 p -66.43 90.37 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.302 0.641 . . . . 72.5 110.167 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.4 t -63.26 113.45 3.2 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.491 1.116 . . . . 73.239999999999995 110.28 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.0 t -79.02 141.2 58.28 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 118.421 -0.799 . . . . 73.510000000000005 109.142 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.76 83.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.723 2.282 . . . . 75.400000000000006 112.425 171.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.2 -20.78 54.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.514 -0.766 . . . . 72.299999999999997 111.014 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.08 84.33 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.233 0.613 . . . . 50.109999999999999 109.621 174.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.03 150.67 38.38 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.269 1.979 . . . . 75.120000000000005 112.007 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.91 110.64 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.67 -1.233 . . . . 72.439999999999998 107.67 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.0 t -137.22 168.34 19.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.044 0.938 . . . . 64.010000000000005 109.992 -171.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -66.36 129.08 38.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.463 0.705 . . . . 73.239999999999995 111.828 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -120.93 98.41 5.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.714 1.205 . . . . 72.109999999999999 107.845 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -72.58 -40.02 66.93 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.692 -0.855 . . . . 71.430000000000007 108.692 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.94 164.5 15.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.845 -1.07 . . . . 51.310000000000002 110.215 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.893 0 C-N-CA 124.385 1.074 . . . . 61.25 108.954 177.09 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.164 -1.05 . . . . 51.340000000000003 108.164 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.0 mt -102.53 124.5 48.19 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.498 -0.927 . . . . 73.540000000000006 108.498 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.9 134.99 35.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.119 0.567 . . . . 65.109999999999999 110.631 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.96 97.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.037 0.935 . . . . 72.400000000000006 111.565 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -66.49 123.4 19.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.284 -0.636 . . . . 65.25 109.284 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.59 138.91 41.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.44 -0.578 . . . . 70.420000000000002 109.44 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -82.74 155.13 24.44 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 123.886 0.741 . . . . 62.310000000000002 110.346 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -74.69 -3.97 34.57 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.632 0.773 . . . . 64.420000000000002 111.481 175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.28 149.71 44.97 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.114 0.965 . . . . 73.219999999999999 111.358 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -53.87 131.48 40.0 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.048 -0.978 . . . . 73.099999999999994 110.618 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.526 ' SG ' ' HG3' ' A' ' 40' ' ' LYS . 26.3 p -67.32 135.57 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.222 1.009 . . . . 65.140000000000001 112.02 -169.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -91.79 161.55 14.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.126 . . . . 74.319999999999993 109.635 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 t -94.76 119.96 34.21 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.501 -1.296 . . . . 74.349999999999994 107.501 165.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 t -72.36 94.18 1.59 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.277 0.631 . . . . 61.420000000000002 111.08 -170.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.1 67.6 0.24 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.708 -0.557 . . . . 42.340000000000003 111.708 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.62 170.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.541 0.737 . . . . 71.030000000000001 110.882 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.53 147.42 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.37 0.668 . . . . 71.030000000000001 110.822 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.9 p -108.76 17.71 21.57 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.974 0.909 . . . . 64.120000000000005 110.679 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t -143.9 150.09 37.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.909 0.884 . . . . 73.310000000000002 109.176 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.02 130.49 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 108.99 -0.745 . . . . 74.310000000000002 108.99 168.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.34 147.22 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.525 -0.916 . . . . 62.43 108.525 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.44 118.99 10.42 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.568 0.543 . . . . 72.540000000000006 112.836 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.32 -34.49 73.89 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.686 0.794 . . . . 75.439999999999998 110.216 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.67 -32.36 73.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.831 0.852 . . . . 75.549999999999997 111.765 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.11 15.03 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 111.733 0.271 . . . . 61.109999999999999 111.733 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.72 122.88 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.989 -0.745 . . . . 54.009999999999998 108.989 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.69 -56.24 3.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.101 -0.703 . . . . 74.200000000000003 109.101 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -160.86 137.06 8.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.327 -0.851 . . . . 74.109999999999999 110.44 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.69 108.54 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 108.68 -0.859 . . . . 74.439999999999998 108.68 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -101.63 115.28 30.16 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.425 -0.954 . . . . 72.219999999999999 108.425 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -85.94 121.88 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 107.96 -1.126 . . . . 74.019999999999996 107.96 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 m -105.68 126.3 31.11 Favored Pre-proline 0 C--O 1.247 0.973 0 C-N-CA 123.572 0.749 . . . . 73.329999999999998 109.777 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.02 153.3 58.87 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.541 2.16 . . . . 73.519999999999996 112.219 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' A' ' 40' ' ' LYS . 11.1 Cg_endo -52.76 92.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.419 2.746 . . . . 73.150000000000006 114.109 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.4 14.52 10.07 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.334 -0.848 . . . . 75.430000000000007 111.487 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -73.23 -14.53 61.36 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.427 1.091 . . . . 74.430000000000007 111.124 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.03 -14.66 48.55 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.834 0.73 . . . . 52.229999999999997 111.289 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -131.54 156.73 79.73 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.335 1.454 . . . . 75.510000000000005 109.002 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.52 81.96 0.55 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.085 2.523 . . . . 74.310000000000002 112.325 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 27.8 mmmt -142.77 121.26 12.44 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.946 0.898 . . . . 72.239999999999995 110.087 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 m -79.23 114.74 18.41 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.995 -1.113 . . . . 73.129999999999995 107.995 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -94.56 108.29 20.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.526 -0.916 . . . . 75.510000000000005 108.526 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.8 101.57 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.3 -1.0 . . . . 64.040000000000006 108.3 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.2 t -96.2 108.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.359 -0.837 . . . . 64.319999999999993 109.057 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.447 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.0 mt -104.75 121.92 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.925 -0.769 . . . . 64.109999999999999 108.925 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -95.23 131.71 40.99 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 124.175 0.99 . . . . 75.200000000000003 108.899 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.8 p -90.46 169.75 10.79 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 123.214 0.606 . . . . 73.129999999999995 110.278 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -73.37 -17.13 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.637 0.775 . . . . 51.140000000000001 110.891 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.7 mtt -79.86 6.72 10.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.482 0.713 . . . . 45.329999999999998 110.837 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 65.7 17.21 10.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.486 1.114 . . . . 65.120000000000005 111.877 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -91.8 130.28 37.6 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.357 -0.979 . . . . 75.340000000000003 108.357 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -85.92 128.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.207 -0.906 . . . . 63.130000000000003 109.84 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 45' ' ' ILE . 42.8 pt -128.53 156.08 40.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 108.013 -1.106 . . . . 72.120000000000005 108.013 167.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -133.07 136.02 45.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.962 -0.755 . . . . 70.319999999999993 108.962 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.43 163.57 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.507 0.723 . . . . 64.140000000000001 109.728 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -86.0 146.18 42.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.78 -1.1 . . . . 72.420000000000002 108.391 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.16 -10.06 24.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.074 2.516 . . . . 75.230000000000004 113.522 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -75.2 -12.54 60.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.139 0.576 . . . . 70.239999999999995 111.712 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.96 115.36 2.36 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.09 0.956 . . . . 72.239999999999995 110.573 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -66.32 -32.6 74.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.209999999999994 112.278 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.3 p-90 -70.92 -26.23 63.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.933 0.493 . . . . 75.340000000000003 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.4 -30.17 70.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 73.230000000000004 110.761 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -59.26 -27.07 65.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 63.130000000000003 111.399 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -62.63 -47.54 83.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.863 0.727 . . . . 75.400000000000006 110.037 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.3 mm? -69.84 -46.52 65.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.15 -0.932 . . . . 73.450000000000003 110.189 -177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.22 -46.16 90.72 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.1 0.875 . . . . 74.129999999999995 111.222 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -79.03 -18.35 53.71 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.715 -0.675 . . . . 72.120000000000005 110.965 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.26 -30.43 64.85 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.469 0.308 . . . . 75.219999999999999 110.473 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' LEU . 49.0 t -68.65 -23.62 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 109.805 -0.443 . . . . 72.420000000000002 109.805 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.71 85.12 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.901 0.858 . . . . 70.120000000000005 109.553 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 t -117.77 174.62 6.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.565 -1.198 . . . . 74.400000000000006 109.303 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -76.99 172.29 13.42 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.919 0.488 . . . . 71.409999999999997 110.901 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.5 m -68.14 85.66 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.386 0.675 . . . . 64.430000000000007 110.586 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 mt -82.24 83.7 7.32 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.674 -1.232 . . . . 64.099999999999994 107.674 175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.4 t -65.76 98.54 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.969 -1.014 . . . . 64.120000000000005 110.204 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 p -75.28 161.16 29.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.061 -0.972 . . . . 74.549999999999997 110.19 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -77.04 151.6 81.87 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.158 0.583 . . . . 74.140000000000001 110.041 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.18 148.47 49.38 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 72.230000000000004 112.498 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -140.91 130.52 24.06 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.399 0.68 . . . . 74.219999999999999 109.948 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.57 123.48 66.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.643 0.777 . . . . 42.130000000000003 109.744 175.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.09 107.84 0.29 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.622 2.215 . . . . 74.319999999999993 112.202 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.95 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.789 -0.641 . . . . 55.210000000000001 110.328 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.0 p -166.89 84.26 0.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.315 0.646 . . . . 63.299999999999997 110.387 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -86.15 107.58 17.93 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.058 0.543 . . . . 71.409999999999997 110.045 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -73.03 99.0 2.64 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.032 -0.729 . . . . 73.239999999999995 109.032 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.29 115.94 11.04 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.413 -0.958 . . . . 73.129999999999995 108.413 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.55 105.58 1.54 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.106 -1.072 . . . . 70.109999999999999 108.106 169.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 O-C-N 124.35 1.031 . . . . 72.519999999999996 111.014 -173.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.573 -0.529 . . . . 75.340000000000003 109.573 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -76.43 -12.46 60.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.01 0.524 . . . . 64.510000000000005 111.42 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.12 145.29 46.53 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.101 -0.703 . . . . 64.439999999999998 109.101 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.63 -178.25 6.15 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.462 0.705 . . . . 73.540000000000006 110.348 -172.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -68.54 127.8 34.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.482 0.713 . . . . 73.409999999999997 110.85 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -110.78 128.97 55.95 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.804 1.242 . . . . 73.230000000000004 109.575 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -89.43 112.8 24.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.592 0.757 . . . . 70.420000000000002 110.188 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.74 -60.48 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.777 -0.453 . . . . 62.409999999999997 109.777 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 53.4 65.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.066 1.346 . . . . 74.140000000000001 112.662 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -163.99 -173.72 3.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.23 1.012 . . . . 75.310000000000002 109.257 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.493 ' SG ' HG21 ' A' ' 32' ' ' THR . 2.6 m -53.02 137.57 32.7 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.092 0.957 . . . . 71.420000000000002 109.699 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -65.32 118.34 9.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.999 -0.741 . . . . 73.439999999999998 108.999 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.3 m -143.7 132.04 22.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 71.129999999999995 109.662 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 t -102.98 39.02 1.62 Allowed 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.343 -0.984 . . . . 50.140000000000001 108.343 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.18 -149.07 24.77 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.211 -0.904 . . . . 31.109999999999999 111.037 -171.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.56 170.08 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.911 0.884 . . . . 62.439999999999998 109.76 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 ' O ' ' A' ' 19' ' ' THR . 2.6 pp -81.82 150.64 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.283 0.563 . . . . 60.32 110.524 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.5 p -113.65 8.18 17.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.037 0.935 . . . . 62.240000000000002 111.435 171.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.417 ' O ' HD13 ' A' ' 17' ' ' ILE . 41.0 m -136.71 129.7 30.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.913 0.885 . . . . 70.430000000000007 109.251 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.3 t -65.85 113.3 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.658 -0.867 . . . . 63.340000000000003 108.658 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -77.01 126.59 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.186 -0.915 . . . . 72.340000000000003 110.554 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.03 137.4 38.39 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.924 0.765 . . . . 24.420000000000002 113.596 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.3 -36.53 71.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.022 0.929 . . . . 73.209999999999994 110.39 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -61.82 -34.18 75.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.852 0.861 . . . . 72.239999999999995 111.98 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.52 -4.82 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 119.278 -0.392 . . . . 70.310000000000002 111.742 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.3 mm -68.51 114.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.832 -0.803 . . . . 73.340000000000003 108.832 171.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -89.81 -52.85 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.412 -0.588 . . . . 74.319999999999993 109.412 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 6.2 ptp180 -152.05 145.63 24.93 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.3 -0.409 . . . . 62.030000000000001 110.3 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.51 108.63 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.838 -1.171 . . . . 73.150000000000006 107.838 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -103.0 121.93 43.57 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.772 -0.825 . . . . 64.319999999999993 108.772 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.53 113.54 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.837 -1.171 . . . . 70.129999999999995 107.837 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' SG ' ' A' ' 11' ' ' CYS . 7.2 m -96.4 106.91 32.42 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 109.59 -0.522 . . . . 73.340000000000003 109.59 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.41 163.82 37.45 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.104 1.869 . . . . 74.329999999999998 111.522 174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 97.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.468 2.778 . . . . 74.519999999999996 112.98 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -92.22 0.09 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.413 -0.358 . . . . 63.140000000000001 113.164 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.77 79.34 6.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.384 0.673 . . . . 72.439999999999998 111.692 -170.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.32 -20.85 3.82 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.105 -0.952 . . . . 73.230000000000004 114.638 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.7 m -89.73 114.54 61.03 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 108.503 -0.925 . . . . 64.329999999999998 108.503 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.41 -6.54 10.93 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.614 2.209 . . . . 44.039999999999999 113.504 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 172.09 12.05 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.084 0.954 . . . . 64.239999999999995 109.209 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.3 m -73.05 115.61 12.58 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.679 -0.692 . . . . 64.319999999999993 110.183 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -124.04 114.44 19.74 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.223 1.009 . . . . 53.409999999999997 108.479 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.43 104.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.923 0.489 . . . . 60.399999999999999 110.063 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG12 ' SG ' ' A' ' 54' ' ' CYS . 35.3 m -92.37 111.69 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.814 0.816 . . . . 64.319999999999993 109.238 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.71 134.53 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.264 0.626 . . . . 74.230000000000004 109.565 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 66.4 m95 -96.34 130.03 43.54 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 78.3 p -84.13 169.02 15.28 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.477 0.486 . . . . 73.040000000000006 109.704 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -21.47 66.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.178 0.591 . . . . 74.5 110.533 172.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.0 mtm -85.02 2.35 43.55 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.829 1.252 . . . . 71.530000000000001 110.915 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.86 38.57 11.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.895 1.678 . . . . 70.040000000000006 112.704 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -90.73 135.65 33.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.472 -1.24 . . . . 63.420000000000002 109.467 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -98.1 115.8 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.429 -0.952 . . . . 73.450000000000003 108.429 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 46.4 pt -119.16 149.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.291 0.636 . . . . 70.030000000000001 109.478 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.575 ' SG ' HG12 ' A' ' 44' ' ' VAL . 92.6 m -115.07 117.83 31.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.391 0.676 . . . . 70.439999999999998 109.532 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.55 154.29 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.274 1.03 . . . . 72.340000000000003 108.877 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -77.21 148.26 77.66 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.874 0.47 . . . . 71.519999999999996 110.477 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -64.47 -13.67 39.86 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.879 2.386 . . . . 64.310000000000002 113.078 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -107.42 18.41 21.59 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.716 0.806 . . . . 71.530000000000001 111.871 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.84 123.21 19.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.851 -1.166 . . . . 55.329999999999998 107.851 167.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -56.25 -44.52 79.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.219 1.008 . . . . 54.329999999999998 112.19 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.0 p-90 -64.24 -38.16 90.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.814 0.445 . . . . 74.140000000000001 111.135 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.93 -33.65 76.06 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.559 0.744 . . . . 63.149999999999999 110.99 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -54.26 -38.61 66.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 72.030000000000001 111.132 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.48 -37.95 86.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.643 . . . . 73.040000000000006 110.372 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.81 -41.93 91.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.767 0.827 . . . . 73.439999999999998 109.924 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 -24.97 62.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.231 1.012 . . . . 73.299999999999997 110.984 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -83.46 -35.64 24.78 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.951 0.5 . . . . 55.310000000000002 109.844 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -75.88 -23.13 55.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.957 0.503 . . . . 73.150000000000006 111.626 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 5.4 p -77.22 -17.86 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 110.032 -0.359 . . . . 71.329999999999998 110.032 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.68 138.41 40.01 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.35 -0.982 . . . . 73.129999999999995 108.35 168.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t 63.65 37.97 9.78 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.484 1.114 . . . . 73.319999999999993 109.23 -174.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 59.3 tttm -59.64 -36.95 77.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.72 1.608 . . . . 62.0 112.337 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.8 p -121.87 73.2 1.06 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.777 0.831 . . . . 75.010000000000005 109.19 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.8 tp -95.12 142.85 27.09 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.942 -1.026 . . . . 65.010000000000005 108.471 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.5 p -60.65 107.74 0.73 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.592 -0.522 . . . . 71.109999999999999 109.592 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.4 t -69.82 151.46 45.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.927 -0.579 . . . . 62.539999999999999 109.915 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.0 p -78.18 156.71 78.98 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.406 0.682 . . . . 63.009999999999998 110.018 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 -171.12 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.127 1.885 . . . . 53.420000000000002 112.942 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -139.08 28.67 2.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.784 0.834 . . . . 65.310000000000002 110.101 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 72.03 134.86 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 125.48 1.512 . . . . 53.409999999999997 111.604 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.85 177.78 2.71 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 123.043 2.495 . . . . 72.439999999999998 112.376 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG13 ' HE3' ' A' ' 84' ' ' LYS . 9.5 p -48.76 107.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.573 0 CA-C-O 122.018 0.913 . . . . 72.420000000000002 112.855 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -78.03 111.89 14.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.555 -1.202 . . . . 72.129999999999995 109.274 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.43 ' HE3' HG13 ' A' ' 82' ' ' VAL . 34.5 mmtp -74.93 100.25 4.07 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.109 0.564 . . . . 71.219999999999999 109.959 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -69.04 147.26 51.79 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.343 -0.844 . . . . 74.019999999999996 109.8 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -65.83 100.87 0.59 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.792 0.683 . . . . 60.420000000000002 110.078 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.7 175.97 8.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.918 0.887 . . . . 51.329999999999998 109.84 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.422 0.689 . . . . 75.519999999999996 109.53 -178.062 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 112.286 0.476 . . . . 74.510000000000005 112.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -69.68 102.71 1.94 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.438 0.695 . . . . 62.210000000000001 110.387 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.92 131.63 36.1 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.317 1.047 . . . . 65.409999999999997 111.438 172.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.54 133.93 35.19 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.352 0.661 . . . . 75.209999999999994 111.154 -173.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.1 -60.07 1.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.393 1.077 . . . . 72.230000000000004 109.71 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -66.75 -46.94 73.79 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.708 0.63 . . . . 72.439999999999998 110.293 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -83.34 137.31 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.636 -0.875 . . . . 41.0 108.636 168.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -93.71 107.3 19.19 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.978 -1.119 . . . . 75.450000000000003 107.978 169.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.31 -46.17 81.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.679 -0.86 . . . . 72.230000000000004 108.679 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.45 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 14.0 ptmm? -98.8 171.67 7.94 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.597 -0.728 . . . . 74.420000000000002 110.478 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 5.5 p -59.99 149.98 30.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.705 1.202 . . . . 60.210000000000001 111.485 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' NH2' HE22 ' A' ' 30' ' ' GLN . 24.6 ttp180 -64.78 118.81 9.51 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.878 0.736 . . . . 64.530000000000001 110.411 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t -146.32 107.17 4.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.611 -1.177 . . . . 44.409999999999997 107.91 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -86.71 40.51 0.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.138 0.975 . . . . 53.109999999999999 111.188 -174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' CYS . . . 74.21 165.65 12.82 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.826 -0.624 . . . . 74.420000000000002 112.284 -174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -100.0 168.61 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 109.282 -0.636 . . . . 72.430000000000007 109.282 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.92 138.15 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.129 0.572 . . . . 71.409999999999997 110.086 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -98.18 7.04 46.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.796 0.839 . . . . 73.230000000000004 109.638 172.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -118.28 128.61 54.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.293 1.037 . . . . 55.149999999999999 109.283 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.44 126.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 109.156 -0.683 . . . . 74.200000000000003 109.156 170.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.65 142.21 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 122.803 0.441 . . . . 71.5 110.167 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.66 135.82 15.95 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.268 -0.424 . . . . 41.009999999999998 112.35 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.35 -34.25 70.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.45 0.7 . . . . 72.019999999999996 109.962 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -62.25 -32.64 73.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.295 1.038 . . . . 54.299999999999997 112.309 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -98.42 4.18 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 111.905 0.335 . . . . 71.010000000000005 111.905 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 32.7 mm -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.371 -0.603 . . . . 74.349999999999994 109.371 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.32 -57.95 2.1 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.796 -0.446 . . . . 53.509999999999998 109.796 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -145.9 144.37 30.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.043 0.937 . . . . 75.230000000000004 109.364 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -107.9 109.33 27.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.226 -1.027 . . . . 73.140000000000001 108.226 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.52 HE22 ' NH2' ' A' ' 12' ' ' ARG . 31.7 tt0 -93.06 127.2 38.51 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.535 -0.913 . . . . 74.329999999999998 108.535 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.6 111.51 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 107.956 -1.127 . . . . 74.299999999999997 107.956 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 m -113.74 127.28 27.0 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 109.143 -0.688 . . . . 72.109999999999999 109.143 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.24 154.44 5.78 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.574 3.516 . . . . 74.409999999999997 114.159 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.97 -177.05 2.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.224 2.616 . . . . 71.319999999999993 113.63 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.13 76.55 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.018 -0.537 . . . . 52.530000000000001 113.288 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -90.51 72.35 6.91 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.465 -0.939 . . . . 52.310000000000002 108.465 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 10' ' ' LYS . . . 77.42 -13.45 11.12 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.384 -0.676 . . . . 73.310000000000002 114.601 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.53 146.39 47.84 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.915 0.886 . . . . 70.230000000000004 109.874 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.04 -7.56 19.23 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.239 2.626 . . . . 73.319999999999993 113.915 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -100.13 150.45 22.49 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.095 0.558 . . . . 71.409999999999997 109.994 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.9 m -67.57 134.16 50.74 Favored 'General case' 0 C--O 1.242 0.666 0 O-C-N 123.93 0.768 . . . . 63.020000000000003 109.757 170.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 6.4 pt-20 -87.88 119.79 28.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.099 -0.704 . . . . 74.109999999999999 109.099 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.77 103.5 15.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.265 -1.013 . . . . 54.43 108.265 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.22 114.56 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.779 -0.823 . . . . 53.109999999999999 108.779 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 54.7 mt -95.06 121.61 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.351 -0.611 . . . . 74.209999999999994 109.351 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -86.95 123.67 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.912 -1.144 . . . . 72.450000000000003 107.912 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.3 p -87.78 179.22 6.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.015 0.526 . . . . 71.5 111.016 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.76 -14.08 60.67 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.374 0.67 . . . . 72.209999999999994 111.737 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -94.5 0.94 55.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.551 0.74 . . . . 74.109999999999999 110.33 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.18 23.6 10.9 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.879 1.671 . . . . 73.510000000000005 112.909 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -71.52 123.81 23.25 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.877 -1.157 . . . . 63.219999999999999 107.877 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t -96.01 111.26 25.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.468 -1.308 . . . . 61.520000000000003 107.468 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.19 136.89 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.515 -0.92 . . . . 73.219999999999999 108.515 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 42.3 t -107.61 117.55 34.4 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.003 -1.11 . . . . 64.420000000000002 108.003 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.81 164.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 54.119999999999997 109.812 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.44 141.43 73.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.324 -0.621 . . . . 73.209999999999994 109.324 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.06 -23.95 78.44 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.782 2.321 . . . . 64.030000000000001 112.765 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.71 31.48 5.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.591 0.757 . . . . 71.109999999999999 110.663 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 126.06 27.39 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -68.68 -30.17 68.79 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.614 0.766 . . . . 73.0 112.936 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -74.1 -23.36 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.986 0.514 . . . . 65.140000000000001 111.603 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.97 -21.81 65.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.841 0.856 . . . . 74.200000000000003 110.631 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -58.18 -30.8 66.7 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.105 0.962 . . . . 75.400000000000006 111.522 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -65.59 -36.93 85.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.408 0.683 . . . . 61.399999999999999 110.708 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.62 -37.28 65.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.272 0.629 . . . . 42.219999999999999 109.687 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -67.55 -33.27 74.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.776 0.83 . . . . 64.310000000000002 110.51 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -74.65 -36.96 62.85 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.899 1.28 . . . . 75.299999999999997 110.552 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -69.32 -35.43 75.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.441 0.697 . . . . 74.430000000000007 111.038 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.98 -7.81 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.233 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.18 124.97 34.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.05 -0.722 . . . . 45.049999999999997 109.05 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.7 t -108.51 147.58 31.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.908 0.483 . . . . 63.299999999999997 110.303 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -146.55 119.02 8.45 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.66 1.184 . . . . 71.030000000000001 108.057 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -67.04 134.17 51.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.544 -0.909 . . . . 65.140000000000001 108.544 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.48 97.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.743 0.817 . . . . 73.420000000000002 110.287 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 m -116.02 178.96 4.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.858 0.863 . . . . 71.109999999999999 111.226 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -70.5 92.72 0.84 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.461 0.704 . . . . 71.140000000000001 109.601 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 t -101.89 107.08 50.74 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.82 0.848 . . . . 73.129999999999995 110.505 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.57 126.67 19.67 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.894 2.396 . . . . 72.150000000000006 113.118 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.0 145.73 29.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.507 0.723 . . . . 72.329999999999998 110.261 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.35 148.32 88.27 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.539 0.736 . . . . 60.109999999999999 109.515 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -55.51 137.97 79.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.935 2.424 . . . . 55.109999999999999 112.098 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.79 92.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 122.168 0.985 . . . . 73.239999999999995 110.905 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 p -68.72 141.62 55.22 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.282 -1.326 . . . . 64.230000000000004 109.571 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.01 148.11 44.82 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.298 0.639 . . . . 52.299999999999997 110.182 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -75.1 102.84 5.05 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.094 -1.447 . . . . 65.200000000000003 107.094 170.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -56.61 101.85 0.07 Allowed 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.35 1.06 . . . . 64.510000000000005 110.512 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.37 147.99 35.8 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.392 0.677 . . . . 74.430000000000007 110.491 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 C-N-CA 123.491 0.716 . . . . 64.439999999999998 110.054 179.116 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.643 -0.502 . . . . 65.530000000000001 109.643 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.49 162.8 13.49 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.43 0.692 . . . . 73.140000000000001 110.292 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.11 85.49 2.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.687 0.756 . . . . 64.010000000000005 109.934 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.37 119.8 8.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.078 -0.964 . . . . 55.399999999999999 110.104 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -59.79 -24.9 64.5 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.66 0.784 . . . . 63.039999999999999 111.737 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 t80 61.07 59.48 2.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.587 1.155 . . . . 74.340000000000003 110.688 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -76.06 84.32 2.93 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 123.17 1.462 . . . . 55.219999999999999 110.786 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -118.96 18.87 13.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.198 -1.364 . . . . 64.25 110.737 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.93 -18.7 65.46 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.294 0.638 . . . . 55.229999999999997 111.025 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.743 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -88.05 127.43 35.4 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.351 -0.981 . . . . 55.399999999999999 108.351 172.041 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 39.8 m -58.28 124.52 19.77 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.864 0.865 . . . . 64.0 111.611 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -90.68 120.15 31.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.203 0.601 . . . . 75.219999999999999 110.558 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.3 t -140.34 167.8 21.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.928 0.891 . . . . 70.129999999999995 109.451 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -110.28 10.14 23.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.907 0.883 . . . . 54.200000000000003 109.915 174.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.69 -82.5 1.07 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.778 0.704 . . . . 71.040000000000006 111.415 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.85 168.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.536 1.134 . . . . 72.310000000000002 109.955 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 HD11 ' HZ2' ' A' ' 61' ' ' TRP . 43.9 pt -123.75 144.07 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.805 -0.813 . . . . 75.340000000000003 108.805 167.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -77.24 -41.05 42.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.535 0.734 . . . . 54.219999999999999 111.328 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.5 p -81.85 144.71 30.82 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.223 1.009 . . . . 75.5 111.632 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.7 t -85.4 115.42 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.499 -0.926 . . . . 73.519999999999996 108.499 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.6 134.17 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.625 0.77 . . . . 65.140000000000001 109.523 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.13 140.07 30.51 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.762 0.664 . . . . 54.340000000000003 114.23 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.22 -37.15 71.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.996 0.918 . . . . 70.540000000000006 110.907 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.14 -21.63 60.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.404 0.682 . . . . 74.409999999999997 112.099 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.38 4.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 122.173 -0.329 . . . . 73.209999999999994 111.276 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 47.2 mm -74.23 123.4 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.842 0.857 . . . . 74.120000000000005 108.94 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.28 -55.92 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.999 0.52 . . . . 74.109999999999999 110.604 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -149.4 136.21 19.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.912 0.485 . . . . 54.210000000000001 110.165 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.94 145.01 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.476 1.11 . . . . 74.030000000000001 109.296 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -136.55 126.11 25.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.182 0.993 . . . . 70.420000000000002 108.543 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.87 112.54 40.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.445 0.698 . . . . 73.329999999999998 109.293 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 22.4 m -87.59 123.63 69.1 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.515 0.726 . . . . 64.219999999999999 109.489 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 27.4 Cg_exo -64.35 139.94 67.82 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.28 2.653 . . . . 73.5 113.789 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.78 99.99 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.292 2.662 . . . . 72.030000000000001 112.544 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.52 -45.74 0.26 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.985 -0.552 . . . . 41.32 112.207 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.482 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.5 t30 -83.03 75.01 9.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.578 0.751 . . . . 62.520000000000003 110.582 -173.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 10' ' ' LYS . . . 85.18 -18.67 26.7 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.709 0.643 . . . . 41.049999999999997 114.709 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.9 p -122.42 130.82 24.52 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.749 0.82 . . . . 73.230000000000004 108.957 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.48 -4.83 13.18 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.73 2.287 . . . . 73.549999999999997 113.352 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -123.06 161.56 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.83 0.852 . . . . 75.120000000000005 110.392 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.4 m -69.31 113.78 6.96 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.961 -0.755 . . . . 72.010000000000005 108.961 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 40.8 tt0 -96.49 130.44 43.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.351 0.66 . . . . 73.510000000000005 109.518 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.88 101.36 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.159 -1.052 . . . . 70.310000000000002 108.159 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -108.1 125.13 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.802 0.841 . . . . 64.230000000000004 109.037 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 63.2 mt -118.72 129.66 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.405 0.682 . . . . 61.409999999999997 109.829 -175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -86.96 124.73 33.48 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.751 -1.203 . . . . 73.340000000000003 107.751 167.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.5 p -81.96 173.53 12.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.228 0.611 . . . . 62.219999999999999 109.573 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.66 -12.0 60.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.943 0.402 . . . . 72.099999999999994 110.919 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -85.98 1.91 48.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.939 0.896 . . . . 74.420000000000002 110.773 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 67.72 11.69 8.49 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.589 1.556 . . . . 62.009999999999998 111.618 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -73.45 126.02 29.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.991 -0.744 . . . . 62.109999999999999 108.991 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.07 102.51 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.476 -1.305 . . . . 61.310000000000002 107.476 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.6 pt -98.92 154.01 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.361 -0.978 . . . . 74.319999999999993 108.361 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 t -135.46 128.79 32.11 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.948 -1.13 . . . . 63.210000000000001 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.3 160.11 29.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 123.919 0.888 . . . . 75.340000000000003 109.51 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.6 148.32 65.51 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.109 -1.071 . . . . 74.200000000000003 108.109 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.59 -28.19 64.02 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.76 2.306 . . . . 74.239999999999995 113.997 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -90.5 2.58 55.59 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.42 0.526 . . . . 72.510000000000005 112.42 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.31 30.84 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.796 0.839 . . . . 64.150000000000006 112.277 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -50.64 37.87 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.391 1.476 . . . . 65.010000000000005 112.334 -162.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.42 ' HZ2' HD11 ' A' ' 17' ' ' ILE . 51.9 p-90 -76.2 -20.19 57.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.046 0.139 . . . . 73.129999999999995 111.182 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.82 -28.67 69.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.461 0.705 . . . . 61.340000000000003 110.174 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -61.7 -19.05 61.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.708 . . . . 54.310000000000002 112.428 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -71.8 -38.02 70.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.994 0.517 . . . . 74.219999999999999 109.75 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.55 -37.05 65.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.764 0.826 . . . . 71.510000000000005 109.124 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -71.35 -29.54 65.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.233 -0.894 . . . . 64.099999999999994 110.875 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -81.47 -34.54 31.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.055 0.542 . . . . 73.040000000000006 110.794 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -67.83 -31.99 72.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.186 0.594 . . . . 75.129999999999995 111.001 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.99 -6.28 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.091 0.472 . . . . 73.439999999999998 110.873 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.15 19.36 20.64 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.015 0.926 . . . . 63.100000000000001 110.884 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.8 m -66.24 137.29 56.86 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.441 -0.578 . . . . 65.150000000000006 109.441 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -56.91 151.83 13.93 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.226 0.611 . . . . 65.099999999999994 110.929 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t -81.54 25.46 0.52 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.445 0.698 . . . . 71.510000000000005 111.025 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.71 97.1 0.2 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.92 1.288 . . . . 74.120000000000005 108.837 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 m -81.86 71.16 8.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.742 0.817 . . . . 41.039999999999999 109.62 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.9 p -74.45 116.03 14.66 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.679 -1.146 . . . . 72.219999999999999 109.965 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.4 m -73.31 111.92 13.75 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.814 0.846 . . . . 74.109999999999999 110.247 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.28 111.95 3.37 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 121.824 1.683 . . . . 74.439999999999998 111.407 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.59 143.08 27.18 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.948 -0.76 . . . . 75.540000000000006 108.948 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.42 43.04 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.762 0.825 . . . . 53.32 109.033 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.33 154.32 53.64 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.044 1.83 . . . . 73.400000000000006 112.222 167.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.0 t 71.1 4.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.853 1.261 . . . . 74.450000000000003 111.655 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -72.93 146.28 46.2 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 121.585 -0.697 . . . . 72.140000000000001 109.748 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.43 109.6 2.8 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.836 0.854 . . . . 75.420000000000002 109.993 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -73.16 98.86 2.69 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.95 0.5 . . . . 71.319999999999993 110.579 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -71.99 122.56 21.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.878 0.871 . . . . 55.530000000000001 109.165 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.82 73.76 4.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.726 0.774 . . . . 71.019999999999996 109.843 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-N 115.06 -0.973 . . . . 52.399999999999999 108.827 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 14' ' ' SER . 47.1 t . . . . . 0 C--O 1.244 0.79 0 N-CA-C 110.143 -0.317 . . . . 71.510000000000005 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 p -53.83 -47.14 71.21 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.427 -0.806 . . . . 73.019999999999996 110.235 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.34 168.1 40.71 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 115.835 -0.62 . . . . 73.049999999999997 113.298 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 172.41 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.688 1.195 . . . . 64.5 109.403 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -124.05 147.65 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.24 0.543 . . . . 72.25 111.496 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 p -97.52 -14.55 21.02 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.219 168.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.3 m -99.24 143.28 29.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.89 0.876 . . . . 73.310000000000002 109.753 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.22 122.96 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.82 136.82 24.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 115.993 -0.549 . . . . 52.240000000000002 109.577 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 121.88 27.21 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.659 0.6 . . . . 72.319999999999993 112.477 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.49 -31.03 61.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.713 1.205 . . . . 73.409999999999997 110.777 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.58 -31.9 53.37 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.67 0.788 . . . . 73.439999999999998 111.373 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 pt -90.59 8.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 111.579 0.215 . . . . 71.239999999999995 111.579 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.451 HG13 HD11 ' A' ' 65' ' ' LEU . 29.8 mm -75.64 136.81 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.422 -0.955 . . . . 71.219999999999999 108.422 173.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.76 -55.44 2.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.948 0.499 . . . . 62.340000000000003 109.966 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 24.4 ptt180 -147.6 159.15 44.09 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.489 0.662 . . . . 73.439999999999998 110.769 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 43' ' ' VAL . 76.7 mt -111.53 110.76 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.23 -1.35 . . . . 74.099999999999994 108.741 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 26.7 tt0 -100.98 142.58 32.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.482 1.113 . . . . 54.240000000000002 108.125 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -112.74 136.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 122.882 0.473 . . . . 63.5 110.725 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.7 m -114.37 97.09 45.12 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.605 -0.887 . . . . 71.019999999999996 108.605 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.39 167.24 27.8 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 122.428 2.085 . . . . 72.209999999999994 112.748 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 148.48 93.07 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.466 2.111 . . . . 51.310000000000002 112.194 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 -16.52 55.09 Favored Glycine 0 N--CA 1.474 1.218 0 CA-C-N 116.52 -0.309 . . . . 74.219999999999999 112.752 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 22.32 1.71 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.982 0.913 . . . . 73.450000000000003 111.103 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.97 -5.89 84.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.04 -0.424 . . . . 42.130000000000003 112.04 -166.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 m -99.02 116.78 65.05 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.34 1.056 . . . . 75.319999999999993 109.497 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.26 -20.09 49.56 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.429 2.086 . . . . 44.329999999999998 111.558 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -125.48 145.82 49.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.653 1.181 . . . . 73.030000000000001 110.089 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 m -72.61 115.52 11.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.362 -0.977 . . . . 61.109999999999999 108.362 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -120.08 140.43 51.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.1 0.409 . . . . 72.150000000000006 110.865 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG13 HG23 ' A' ' 29' ' ' ILE . 93.0 t -91.09 120.51 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.923 0.889 . . . . 52.530000000000001 110.145 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 54' ' ' CYS . 57.8 t -91.14 117.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.854 0.861 . . . . 75.420000000000002 108.814 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.12 128.68 44.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.633 -0.506 . . . . 51.439999999999998 109.633 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 50.0 m95 -104.64 116.28 31.78 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.452 -1.684 . . . . 64.329999999999998 106.452 166.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 p -87.19 172.14 10.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.959 0.409 . . . . 64.0 111.273 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.895 0.878 . . . . 55.030000000000001 111.033 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 49' ' ' MET . 1.1 mpt? -83.72 -0.84 52.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.025 0.93 . . . . 71.120000000000005 111.246 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.67 19.37 9.77 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.183 1.393 . . . . 74.310000000000002 111.634 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -72.05 124.96 26.06 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.73 -0.841 . . . . 74.299999999999997 108.73 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.31 113.35 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.222 1.009 . . . . 71.209999999999994 108.32 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.26 154.48 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.895 0.878 . . . . 63.039999999999999 109.398 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 44' ' ' VAL . 24.2 m -116.93 117.95 31.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.385 -0.968 . . . . 72.219999999999999 108.385 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.11 160.33 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.814 0.846 . . . . 75.510000000000005 109.512 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.8 OUTLIER -62.94 133.64 95.4 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.043 0.537 . . . . 64.25 110.273 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 -32.87 59.32 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.825 2.35 . . . . 74.239999999999995 112.414 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -100.82 25.26 8.14 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.577 -0.738 . . . . 73.219999999999999 111.477 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.06 131.86 47.67 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.287 -0.635 . . . . 64.109999999999999 109.287 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -57.65 -34.03 68.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.857 1.263 . . . . 74.310000000000002 112.927 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -78.57 -34.43 46.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.39 0.676 . . . . 71.329999999999998 111.648 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -70.59 -20.62 62.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.661 0.784 . . . . 72.400000000000006 111.457 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -51.99 -37.6 53.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.851 0.86 . . . . 73.299999999999997 111.706 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -72.38 -29.65 63.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 73.409999999999997 111.317 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -73.55 -38.33 65.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 63.119999999999997 109.71 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.63 -29.39 65.75 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.737 0.815 . . . . 71.150000000000006 110.427 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -81.13 -23.43 38.35 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.634 0.774 . . . . 72.329999999999998 110.805 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.13 -37.56 66.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.272 0.629 . . . . 73.099999999999994 111.28 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.79 -29.7 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.562 0.345 . . . . 65.120000000000005 111.919 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.477 0.907 0 C-N-CA 123.114 0.566 . . . . 72.329999999999998 109.527 176.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 107.835 -1.172 . . . . 53.329999999999998 107.835 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.5 p -55.31 -28.22 52.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.243 1.017 . . . . 64.140000000000001 111.866 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.16 161.94 15.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.093 -1.203 . . . . 62.039999999999999 110.093 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.2 m -102.81 143.24 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.21 -1.033 . . . . 70.209999999999994 108.21 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.9 pt -99.87 139.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.599 -0.728 . . . . 71.219999999999999 110.439 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m -103.48 7.54 37.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.908 0.883 . . . . 43.219999999999999 111.105 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 m -74.37 137.86 43.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.557 0.743 . . . . 53.219999999999999 110.321 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -73.05 111.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.102 -1.073 . . . . 64.140000000000001 108.102 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -114.27 128.2 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.958 0.903 . . . . 60.109999999999999 109.225 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.99 162.79 16.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.096 -0.502 . . . . 60.030000000000001 112.712 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.33 -21.99 60.61 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.824 0.85 . . . . 71.439999999999998 111.469 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -53.55 -30.72 43.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 73.230000000000004 112.038 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 36.1 pt -119.8 -3.46 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 71.409999999999997 113.044 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.58 135.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 118.749 0.704 . . . . 72.219999999999999 109.704 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.91 -56.86 2.35 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.241 0.616 . . . . 52.0 110.411 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -143.42 147.55 34.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.566 0.746 . . . . 65.230000000000004 109.746 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.8 mt -108.16 112.33 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.928 -1.138 . . . . 71.420000000000002 107.928 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.16 104.42 14.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.097 -0.705 . . . . 73.349999999999994 109.097 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.85 140.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.922 -0.77 . . . . 62.229999999999997 108.922 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -111.99 92.9 19.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.793 -0.818 . . . . 73.329999999999998 108.793 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.74 149.87 38.93 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.365 2.71 . . . . 74.099999999999994 113.089 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 90.0 Cg_endo -74.36 2.26 6.45 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.719 2.28 . . . . 73.430000000000007 114.166 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.72 47.53 3.59 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 112.196 -0.362 . . . . 73.019999999999996 112.196 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -144.21 5.22 1.27 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.597 1.159 . . . . 74.319999999999993 110.683 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.95 44.79 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.675 -0.514 . . . . 73.319999999999993 112.739 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.6 m -82.68 126.61 72.88 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 108.595 -0.891 . . . . 75.420000000000002 108.595 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.61 -42.79 44.08 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.652 2.235 . . . . 62.210000000000001 113.565 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.92 164.56 12.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.22 0.608 . . . . 71.010000000000005 110.238 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 12.7 t -86.1 128.46 34.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.459 -0.941 . . . . 74.010000000000005 108.459 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -108.21 119.07 38.44 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.616 -0.513 . . . . 60.219999999999999 109.616 -171.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.52 102.34 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.696 -0.483 . . . . 75.239999999999995 109.696 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -99.45 107.52 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.0 -1.111 . . . . 74.239999999999995 108.0 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -103.9 133.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.404 -0.591 . . . . 71.409999999999997 109.404 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -102.79 130.0 49.63 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.615 1.166 . . . . 74.219999999999999 108.422 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.5 p -87.07 176.89 7.39 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.388 0.675 . . . . 73.120000000000005 110.52 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 41.4 mtmt -71.58 -24.48 61.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.077 0.551 . . . . 72.329999999999998 110.726 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.76 -2.66 37.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.175 0.99 . . . . 74.099999999999994 110.569 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 68.84 14.64 8.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.462 1.505 . . . . 52.5 110.826 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.17 131.78 39.58 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.856 -1.164 . . . . 75.310000000000002 107.856 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.22 121.28 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.344 -0.844 . . . . 74.519999999999996 109.817 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -119.01 134.0 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.805 -0.813 . . . . 74.030000000000001 108.805 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 44.4 t -110.92 126.24 54.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.862 0.865 . . . . 74.040000000000006 109.568 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG11 ' HE1' ' A' ' 61' ' ' TRP . 19.2 m -137.42 164.29 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.218 1.007 . . . . 73.430000000000007 109.394 172.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.27 161.3 55.03 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 115.137 -0.938 . . . . 64.420000000000002 110.052 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.4 -18.19 63.49 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 112.748 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.07 25.51 7.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.8 0.84 . . . . 75.349999999999994 110.62 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 136.09 36.11 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.85 0.46 . . . . 43.439999999999998 110.363 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.21 -50.52 71.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.008 0.923 . . . . 53.420000000000002 112.748 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.401 ' HE1' HG11 ' A' ' 55' ' ' VAL . 36.4 p-90 -66.86 -28.69 68.54 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.881 0.472 . . . . 71.299999999999997 110.948 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.2 tp -67.25 -30.3 70.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.216 1.006 . . . . 63.119999999999997 111.683 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -54.17 -35.92 62.82 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.764 0.826 . . . . 70.340000000000003 111.63 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.24 -42.22 84.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.103 -0.953 . . . . 73.299999999999997 109.651 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.86 -32.37 72.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.406 1.082 . . . . 63.549999999999997 110.443 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -38.57 79.47 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.444 0.698 . . . . 64.409999999999997 110.178 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -68.96 -37.73 79.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.324 -0.25 . . . . 63.240000000000002 110.324 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.54 -37.98 86.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.012 0.525 . . . . 54.219999999999999 112.15 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.16 -11.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-O 120.927 0.394 . . . . 71.430000000000007 111.117 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 108.92 -0.771 . . . . 72.439999999999998 108.92 172.498 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.123 -0.325 . . . . 74.030000000000001 110.123 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -57.35 -31.08 65.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.19 0.996 . . . . 72.019999999999996 112.212 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.46 -173.34 15.97 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.46 -0.791 . . . . 75.109999999999999 111.562 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 55' ' ' VAL . 99.5 t -99.68 129.35 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.17 -1.048 . . . . 71.349999999999994 108.17 -175.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 53' ' ' ILE . 37.9 pt -84.15 140.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 123.361 0.413 . . . . 72.0 110.228 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 p -90.39 -4.18 57.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.794 0.838 . . . . 65.019999999999996 111.446 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.9 m -88.41 142.84 27.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.598 0.759 . . . . 62.299999999999997 109.878 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.74 112.38 22.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.839 -1.171 . . . . 70.140000000000001 107.839 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -72.68 143.09 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.186 0.594 . . . . 55.219999999999999 110.556 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 123.27 30.18 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.83 0.706 . . . . 64.439999999999998 112.574 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 64' ' ' ARG . 9.8 mp -67.41 -22.41 65.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.209 0.604 . . . . 71.019999999999996 111.428 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -74.43 -26.08 59.84 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.435 0.694 . . . . 74.519999999999996 111.683 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 47.8 pt -97.65 3.44 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 122.149 -0.344 . . . . 64.329999999999998 111.525 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 65' ' ' LEU . 27.5 mm -72.05 130.18 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 109.566 -0.531 . . . . 74.109999999999999 109.566 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -102.03 -59.43 1.7 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.452 0.701 . . . . 64.200000000000003 110.81 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -146.29 150.18 35.28 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.71 0.404 . . . . 70.439999999999998 110.684 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.24 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.115 0.966 . . . . 73.140000000000001 108.946 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -97.44 147.6 24.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.922 1.289 . . . . 75.25 109.101 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.17 142.9 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.677 -0.49 . . . . 64.209999999999994 109.677 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.2 m -121.78 109.78 33.89 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.992 0.917 . . . . 75.319999999999993 109.098 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.12 155.3 17.11 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.625 2.216 . . . . 53.329999999999998 113.085 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.1 173.66 14.06 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.733 2.289 . . . . 72.340000000000003 112.051 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 -26.13 8.66 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 116.775 -0.193 . . . . 74.420000000000002 113.384 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.8 23.49 3.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.135 0.974 . . . . 63.020000000000003 110.816 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.59 -19.53 44.63 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.905 -0.589 . . . . 51.219999999999999 112.235 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.8 m -80.46 119.3 75.93 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.034 0.417 . . . . 53.219999999999999 109.941 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.81 -22.7 74.92 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.13 2.553 . . . . 75.230000000000004 113.327 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 172.24 17.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.494 0.718 . . . . 75.150000000000006 109.713 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -75.04 133.86 41.53 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.131 -0.692 . . . . 73.219999999999999 109.131 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.84 124.97 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.081 0.467 . . . . 73.109999999999999 110.532 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.27 113.84 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.223 1.009 . . . . 62.140000000000001 109.1 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.76 109.68 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.417 -0.957 . . . . 71.019999999999996 108.417 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.9 mt -98.65 136.35 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.431 -0.581 . . . . 70.340000000000003 109.431 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -114.39 129.03 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.121 1.369 . . . . 72.030000000000001 108.616 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 p -90.46 172.22 8.87 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.777 0.431 . . . . 75.340000000000003 110.758 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 19.5 ptpt -69.16 -31.25 69.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.681 0.793 . . . . 64.239999999999995 111.133 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.1 ptm -78.42 4.62 12.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.89 0.876 . . . . 74.430000000000007 110.729 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 63.36 25.0 14.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.839 1.656 . . . . 73.409999999999997 112.14 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -76.5 128.57 35.02 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.276 -1.379 . . . . 64.329999999999998 107.276 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -100.56 131.0 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.66 1.184 . . . . 54.450000000000003 109.64 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 17' ' ' ILE . 32.2 pt -133.25 156.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.886 0.874 . . . . 63.140000000000001 108.672 171.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.1 p -137.15 122.48 19.4 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.128 -0.693 . . . . 63.43 109.128 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 16' ' ' VAL . 35.6 m -126.4 150.95 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.382 0.673 . . . . 75.439999999999998 109.785 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.57 152.97 67.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.349 -0.611 . . . . 71.310000000000002 109.349 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.53 -4.87 6.11 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.018 2.479 . . . . 73.25 115.259 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -84.07 -11.63 56.38 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.096 0.559 . . . . 72.109999999999999 112.147 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 113.63 3.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.65 -0.87 . . . . 63.240000000000002 108.65 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 17.5 mtpp -77.72 -20.86 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.722 0.638 . . . . 65.439999999999998 112.722 -171.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -75.5 -14.91 60.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.376 0.27 . . . . 62.340000000000003 111.171 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.5 tp -70.52 -29.4 65.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.672 0.389 . . . . 53.140000000000001 110.041 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -64.45 -19.69 65.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.455 0.302 . . . . 72.219999999999999 111.754 175.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 23' ' ' LEU . 1.1 tpm_? -65.76 -44.11 86.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.942 0.497 . . . . 74.310000000000002 109.691 170.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.448 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -66.78 -41.27 87.95 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.826 0.85 . . . . 64.209999999999994 110.28 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.35 -36.63 81.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.425 0.69 . . . . 65.120000000000005 110.759 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.72 -29.08 56.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.399 0.68 . . . . 74.209999999999994 110.956 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -74.26 -51.12 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.373 0.669 . . . . 74.200000000000003 111.072 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.77 -34.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.988 0.515 . . . . 72.040000000000006 110.747 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 108.031 -1.1 . . . . 75.439999999999998 108.031 175.773 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 109.495 -0.557 . . . . 62.43 109.495 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 t -100.0 10.7 40.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.218 0.607 . . . . 72.420000000000002 111.01 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 172.3 46.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.3 -0.72 . . . . 33.109999999999999 111.3 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 33.9 m -100.21 140.13 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 117.325 0.562 . . . . 71.409999999999997 109.895 -174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.95 146.24 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.501 0.72 . . . . 60.229999999999997 110.705 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 p -92.87 -2.2 56.08 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.315 -0.857 . . . . 65.129999999999995 111.394 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.6 m -60.47 118.82 6.96 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.49 -0.559 . . . . 73.439999999999998 109.49 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.27 111.19 3.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.822 -0.807 . . . . 53.350000000000001 108.822 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.52 132.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.249 0.62 . . . . 75.200000000000003 109.4 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.51 145.56 27.9 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.998 -0.546 . . . . 71.230000000000004 112.501 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.16 -33.66 72.49 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.103 0.961 . . . . 71.140000000000001 110.513 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.8 -28.71 68.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.834 0.853 . . . . 73.099999999999994 111.62 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -103.92 12.42 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 111.931 0.345 . . . . 71.310000000000002 111.931 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 mm -76.9 122.24 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.196 -1.039 . . . . 64.319999999999993 108.196 169.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -90.06 -58.86 2.36 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.37 -0.604 . . . . 74.439999999999998 109.37 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -146.95 155.67 42.46 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.183 0.593 . . . . 65.310000000000002 109.749 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.8 mt -113.95 108.15 24.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.202 -1.036 . . . . 64.439999999999998 108.202 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -99.47 137.75 37.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.616 0.766 . . . . 73.549999999999997 108.968 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.15 129.24 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.3 -0.63 . . . . 73.430000000000007 109.3 172.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -106.98 115.18 60.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.855 0.862 . . . . 70.310000000000002 108.984 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.35 166.17 29.31 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.724 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.73 84.09 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.434 2.089 . . . . 72.140000000000001 112.191 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.33 -179.48 39.77 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.676 -1.147 . . . . 70.129999999999995 110.677 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 65.42 18.89 11.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.636 1.174 . . . . 74.340000000000003 111.77 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.52 10.71 53.08 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 122.763 0.22 . . . . 34.409999999999997 113.568 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.36 117.43 33.09 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 108.059 -1.089 . . . . 64.540000000000006 108.059 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.4 5.86 5.79 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.566 2.178 . . . . 61.32 113.603 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -153.01 173.32 15.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.191 0.596 . . . . 73.409999999999997 110.776 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -86.8 121.29 29.1 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.55 -0.907 . . . . 65.5 108.55 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.9 134.51 45.78 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.052 0.541 . . . . 64.450000000000003 109.967 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 101.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.788 -0.819 . . . . 70.019999999999996 108.788 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.12 108.96 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.899 0.88 . . . . 74.530000000000001 109.262 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.41 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.5 mt -95.43 130.56 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.197 -0.668 . . . . 75.129999999999995 109.197 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -97.68 125.78 42.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.662 -1.607 . . . . 74.400000000000006 106.662 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.9 p -89.47 169.42 11.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.025 0.375 . . . . 64.420000000000002 110.531 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.9 -25.99 63.96 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.988 0.915 . . . . 71.340000000000003 111.519 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -80.39 1.67 28.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.888 0.875 . . . . 70.319999999999993 110.542 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.03 22.92 11.16 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.151 1.78 . . . . 65.310000000000002 112.162 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -79.95 123.78 28.1 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 106.664 -1.606 . . . . 74.340000000000003 106.664 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.19 124.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.844 -0.799 . . . . 72.120000000000005 108.844 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.2 pt -132.67 158.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.123 0.969 . . . . 64.5 109.265 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 55.6 m -120.37 149.94 41.54 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.107 -1.072 . . . . 73.450000000000003 108.107 167.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.92 163.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.416 0.687 . . . . 62.340000000000003 109.817 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.37 128.24 84.72 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.051 0.54 . . . . 64.25 110.098 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.53 -29.97 80.73 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.55 2.833 . . . . 75.549999999999997 113.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -89.09 16.98 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.424 0.69 . . . . 72.219999999999999 112.702 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 125.9 28.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.587 -0.894 . . . . 63.43 108.587 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.1 -37.36 81.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.675 0.79 . . . . 73.420000000000002 111.772 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 70.5 p-90 -63.49 -34.47 77.84 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.036 0.446 . . . . 74.319999999999993 110.474 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.11 -34.49 73.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.54 -0.754 . . . . 72.310000000000002 110.476 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.05 -38.95 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.708 0.803 . . . . 75.129999999999995 110.779 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -61.59 -48.43 80.99 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.86 -1.064 . . . . 71.310000000000002 110.072 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.44 -36.19 77.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.646 0.778 . . . . 62.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.95 -36.38 67.14 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.485 0.714 . . . . 62.130000000000003 110.637 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -75.36 -23.0 57.1 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.899 0.48 . . . . 74.530000000000001 110.284 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -67.1 -43.91 81.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.062 0.945 . . . . 71.319999999999993 110.716 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.9 m -90.78 -8.05 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 123.619 0.574 . . . . 75.129999999999995 112.045 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 CA--C 1.55 0.973 0 C-N-CA 123.379 0.672 . . . . 65.530000000000001 109.565 177.786 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 44' ' ' VAL . 55.5 m . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 110.202 -0.296 . . . . 74.430000000000007 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -82.81 -153.16 0.12 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.677 -0.692 . . . . 71.209999999999994 109.403 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.72 158.27 36.95 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-O 120.955 0.197 . . . . 54.229999999999997 112.853 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.98 146.8 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.215 -1.032 . . . . 30.41 108.215 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.29 145.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.223 0.535 . . . . 71.129999999999995 110.904 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -128.72 31.1 5.01 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.749 1.22 . . . . 64.340000000000003 108.289 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -140.57 142.21 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.708 1.203 . . . . 40.439999999999998 108.271 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.12 114.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.367 -0.605 . . . . 75.430000000000007 109.367 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.02 139.03 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.233 0.613 . . . . 74.150000000000006 109.583 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.92 131.81 11.0 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.796 0.685 . . . . 14.210000000000001 112.928 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' A' ' 68' ' ' HIS . 7.4 tt -54.46 -31.55 55.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.868 1.267 . . . . 74.099999999999994 110.747 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -58.35 -35.26 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.018 1.327 . . . . 51.549999999999997 112.445 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.4 pt -96.81 -6.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 119.098 -0.477 . . . . 71.409999999999997 111.46 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -75.01 130.26 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.221 -0.659 . . . . 73.400000000000006 109.221 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.86 -53.94 2.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.212 0.605 . . . . 55.200000000000003 109.562 174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -139.11 141.14 38.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.011 0.524 . . . . 73.409999999999997 110.188 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.1 mt -119.22 107.94 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.37 -1.344 . . . . 73.519999999999996 107.37 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -105.3 138.99 40.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.141 -1.059 . . . . 61.100000000000001 108.141 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -116.33 110.97 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.43 -0.952 . . . . 44.350000000000001 108.43 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 m -89.43 121.09 69.6 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.505 -0.554 . . . . 65.519999999999996 109.505 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.1 148.89 83.38 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.33 2.687 . . . . 53.340000000000003 113.636 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.86 100.57 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.886 2.391 . . . . 72.219999999999999 112.142 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.97 -5.52 4.71 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-N 115.478 -0.783 . . . . 71.129999999999995 112.31 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -89.68 41.08 1.02 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.686 0.795 . . . . 70.510000000000005 111.047 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -19.75 47.92 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.501 -0.772 . . . . 63.100000000000001 112.775 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.37 116.11 39.58 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.125 -1.435 . . . . 74.140000000000001 107.125 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.02 -39.02 40.63 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.932 3.088 . . . . 75.319999999999993 113.48 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -106.58 157.81 17.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.666 0.786 . . . . 70.319999999999993 109.297 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -61.07 115.7 3.96 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.939 0.774 . . . . 75.310000000000002 109.703 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -110.87 110.79 21.54 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.713 -0.847 . . . . 74.409999999999997 108.713 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.34 103.04 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.732 -0.84 . . . . 73.530000000000001 108.732 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 54' ' ' CYS . 44.5 t -90.27 108.12 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.7 -0.852 . . . . 71.349999999999994 108.7 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 53' ' ' ILE . 62.3 mt -106.23 119.97 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.559 0.743 . . . . 73.140000000000001 109.133 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -94.71 124.86 38.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.117 -1.068 . . . . 75.25 108.117 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.8 p -84.81 163.68 18.93 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.906 -0.405 . . . . 52.310000000000002 109.906 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -71.61 -10.98 60.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.228 0.611 . . . . 71.5 111.512 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 ptp -90.81 4.79 50.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.54 0.736 . . . . 61.100000000000001 110.772 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 68.3 22.23 8.13 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.3 1.44 . . . . 74.409999999999997 112.648 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -84.74 128.95 34.86 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.538 -0.912 . . . . 75.120000000000005 108.538 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.45 114.02 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.8 pt -125.16 128.5 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.257 -1.016 . . . . 72.049999999999997 108.257 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 44' ' ' VAL . 94.9 m -120.74 138.0 54.21 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.152 -0.343 . . . . 64.219999999999999 110.469 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' HE1' ' A' ' 61' ' ' TRP . 28.5 m -130.43 167.05 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.913 0.885 . . . . 73.329999999999998 110.958 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -73.75 153.92 89.28 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 114.427 -1.26 . . . . 70.340000000000003 110.329 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.4 -28.54 71.46 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.909 2.406 . . . . 61.020000000000003 113.2 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -107.48 24.71 12.46 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.419 0.687 . . . . 73.430000000000007 111.672 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 62' ' ' LEU . . . -65.24 124.32 21.87 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.398 -0.964 . . . . 42.009999999999998 108.398 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -70.83 -30.7 67.2 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.987 0.515 . . . . 63.32 111.502 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.469 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.4 p-90 -64.34 -32.32 73.88 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.207 -0.664 . . . . 74.019999999999996 109.207 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 59' ' ' ALA . 64.1 tp -73.29 -37.86 66.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.775 . . . . 74.109999999999999 110.555 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.11 -44.16 95.07 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.993 0.517 . . . . 65.129999999999995 111.177 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' TRP . 13.5 ptm180 -67.86 -31.59 71.51 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.917 0.487 . . . . 75.120000000000005 111.2 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.6 mm? -59.71 -47.94 83.63 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.596 0.759 . . . . 61.310000000000002 110.044 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.66 -34.77 78.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.914 0.886 . . . . 71.239999999999995 111.664 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -69.78 -32.61 71.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.632 0.773 . . . . 63.119999999999997 110.641 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' ND1' HD11 ' A' ' 23' ' ' LEU . 29.7 t-80 -74.64 -30.6 61.69 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.03 0.532 . . . . 72.530000000000001 111.545 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 65' ' ' LEU . 80.6 t -64.76 -49.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 109.145 -0.687 . . . . 52.039999999999999 109.145 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 108.319 -0.993 . . . . 72.010000000000005 108.319 173.345 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--O 1.239 0.543 0 CA-C-O 121.008 0.433 . . . . 63.439999999999998 109.851 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 p -104.26 -55.2 2.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.001 0.92 . . . . 71.540000000000006 109.364 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.18 167.96 35.7 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.247 -0.888 . . . . 73.219999999999999 111.186 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.26 156.44 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.257 0.528 . . . . 71.209999999999994 110.314 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.38 149.88 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 65.329999999999998 110.313 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -111.36 12.53 21.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 110.764 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.0 m -93.93 144.44 25.45 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.746 0.818 . . . . 74.109999999999999 109.88 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.26 110.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.701 -1.222 . . . . 73.040000000000006 107.701 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.77 124.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.894 -0.78 . . . . 71.099999999999994 108.894 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 147.57 30.35 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.774 0.671 . . . . 71.219999999999999 113.859 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.45 -33.36 65.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.974 0.909 . . . . 63.119999999999997 110.486 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.25 -34.28 72.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.986 0.914 . . . . 55.450000000000003 112.241 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.9 pt -107.0 13.36 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.693 0.397 . . . . 72.239999999999995 111.776 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.4 129.27 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.627 -0.879 . . . . 73.519999999999996 108.627 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.92 -59.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.822 -0.436 . . . . 63.310000000000002 109.822 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 -143.74 139.65 29.56 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.397 0.679 . . . . 64.209999999999994 109.703 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -107.33 119.48 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.139 0.975 . . . . 71.099999999999994 109.638 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 44' ' ' VAL . 24.4 tp60 -105.68 135.24 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.321 -1.363 . . . . 74.319999999999993 107.321 170.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.4 ' N ' HE21 ' A' ' 30' ' ' GLN . 7.3 p -128.11 127.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.621 -0.511 . . . . 63.210000000000001 109.621 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -118.08 103.6 49.63 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 108.836 -0.802 . . . . 65.120000000000005 108.836 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.75 170.42 12.69 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.438 2.758 . . . . 72.299999999999997 112.063 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.82 99.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.263 1.975 . . . . 64.310000000000002 111.408 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.83 164.52 29.09 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.591 -1.404 . . . . 31.530000000000001 109.591 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 66.09 19.43 11.16 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.307 1.051 . . . . 63.43 110.363 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.32 8.46 87.56 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.205 -0.907 . . . . 73.439999999999998 113.325 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.2 m -84.87 136.87 38.34 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.305 0.642 . . . . 71.439999999999998 109.667 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.31 -52.72 0.77 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.845 2.363 . . . . 73.409999999999997 114.206 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -135.04 177.4 7.84 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.261 1.025 . . . . 63.450000000000003 109.647 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -67.17 110.37 3.44 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.203 -0.666 . . . . 74.25 109.203 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -111.41 112.5 24.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.714 1.206 . . . . 75.219999999999999 108.425 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.67 101.13 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.323 -0.991 . . . . 72.510000000000005 108.323 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 85.9 t -92.21 110.03 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.112 0.965 . . . . 71.519999999999996 108.814 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.57 128.81 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.006 -0.434 . . . . 72.439999999999998 110.557 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -88.76 123.9 33.62 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.448 -1.315 . . . . 75.329999999999998 107.448 168.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -84.87 174.41 9.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.812 0.445 . . . . 71.25 110.463 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.57 -21.88 65.41 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.497 0.719 . . . . 72.140000000000001 111.114 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 50.1 mtm -76.64 -4.4 42.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.438 1.095 . . . . 70.430000000000007 110.51 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 60.58 23.56 13.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.839 1.656 . . . . 75.109999999999999 111.364 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -85.6 124.24 31.92 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 106.758 -1.571 . . . . 63.32 106.758 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -88.62 130.37 38.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.77 -0.826 . . . . 63.399999999999999 108.77 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.0 pt -129.68 157.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 75.120000000000005 109.114 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.3 m -126.8 118.1 23.98 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.246 -1.02 . . . . 52.450000000000003 108.246 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.58 155.26 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.946 0.498 . . . . 55.329999999999998 110.094 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.77 165.54 17.75 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.8 0.84 . . . . 73.349999999999994 109.181 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.88 0.19 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.436 2.091 . . . . 64.219999999999999 114.126 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -70.11 -25.48 63.52 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.523 0.729 . . . . 64.239999999999995 110.963 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.9 112.96 3.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.365 0.666 . . . . 61.130000000000003 110.427 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -70.49 -33.17 70.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.33 0.652 . . . . 73.239999999999995 111.389 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -65.46 -27.42 68.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.661 0.385 . . . . 63.520000000000003 111.132 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.4 tp -67.02 -33.5 75.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.016 0.926 . . . . 71.420000000000002 111.768 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.53 -22.46 66.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.297 0.239 . . . . 72.319999999999993 110.929 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -69.97 -39.25 76.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.389 0.676 . . . . 64.040000000000006 110.206 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.73 -41.88 74.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.138 0.975 . . . . 54.520000000000003 109.74 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.96 -25.63 61.94 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.054 -0.976 . . . . 61.43 111.656 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -29.96 31.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.025 -0.732 . . . . 74.239999999999995 109.025 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.65 -28.64 69.25 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.03 0.532 . . . . 74.540000000000006 111.398 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.89 -3.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.2 0.6 . . . . 53.219999999999999 111.734 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 . . . . . 0 N--CA 1.483 1.21 0 C-N-CA 123.914 0.886 . . . . 72.299999999999997 110.393 175.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 t . . . . . 0 C--O 1.24 0.567 0 CA-C-O 120.974 0.416 . . . . 64.530000000000001 111.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -132.44 12.98 4.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.141 0.976 . . . . 64.140000000000001 110.979 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.37 175.99 50.59 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.766 -0.652 . . . . 73.310000000000002 112.996 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.31 170.93 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.447 0.699 . . . . 62.109999999999999 109.957 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.89 137.65 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.274 0.559 . . . . 73.409999999999997 111.639 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -83.54 -38.88 21.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.041 0.937 . . . . 73.430000000000007 110.042 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m -68.12 121.35 15.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.267 1.027 . . . . 75.209999999999994 110.125 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.0 116.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.748 0.655 . . . . 74.409999999999997 110.128 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.24 134.84 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.93 0.892 . . . . 70.450000000000003 109.446 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.7 139.28 22.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 113.987 0.355 . . . . 62.0 113.987 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.6 -37.53 65.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.483 1.113 . . . . 73.209999999999994 110.823 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -65.58 -34.07 77.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.733 0.813 . . . . 71.299999999999997 111.842 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 33.7 pt -90.74 -3.79 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 119.565 -0.255 . . . . 71.340000000000003 111.41 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 39.0 mm -71.97 137.47 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.698 -0.853 . . . . 75.129999999999995 108.698 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -104.95 -55.3 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.275 -0.639 . . . . 61.149999999999999 109.275 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -143.01 142.11 31.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.342 -0.845 . . . . 65.200000000000003 109.342 -171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.24 106.57 21.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.029 -1.471 . . . . 73.439999999999998 107.029 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.02 103.5 15.35 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.05 -1.093 . . . . 71.340000000000003 108.05 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.64 109.44 21.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.616 -1.253 . . . . 71.150000000000006 107.616 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -106.54 114.37 62.08 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.389 0.676 . . . . 73.25 109.216 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 160.33 49.66 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.484 2.123 . . . . 55.340000000000003 111.797 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 150.96 74.99 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.864 . . . . 63.520000000000003 111.095 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.54 -52.61 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 C-N-CA 121.357 -0.449 . . . . 35.409999999999997 112.556 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -146.66 107.9 4.23 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.32 0.648 . . . . 73.409999999999997 109.575 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.28 -17.73 9.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.76 -0.655 . . . . 52.219999999999999 114.578 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.4 m -88.52 115.52 63.6 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.571 -0.9 . . . . 63.229999999999997 108.571 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.79 -68.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.696 2.264 . . . . 73.010000000000005 111.665 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -103.79 179.22 4.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.547 0.739 . . . . 71.329999999999998 109.083 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.3 m -64.89 109.96 2.27 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.157 -0.683 . . . . 65.409999999999997 109.157 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -89.76 111.96 23.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.353 -0.98 . . . . 72.430000000000007 108.353 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.42 101.19 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.512 -0.921 . . . . 63.399999999999999 108.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.1 t -96.49 109.71 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.068 0.947 . . . . 61.409999999999997 108.572 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 58.5 mt -94.71 136.83 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.811 -0.811 . . . . 65.530000000000001 108.811 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -110.31 117.6 34.07 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.07 -1.456 . . . . 70.420000000000002 107.07 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HE1' ' A' ' 49' ' ' MET . 60.0 p -82.31 160.81 22.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.687 -0.486 . . . . 73.150000000000006 109.687 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 59.6 pttt -71.05 -10.95 60.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.76 0.824 . . . . 63.329999999999998 112.972 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.427 ' HE1' ' HB ' ' A' ' 47' ' ' THR . 3.1 mpp? -92.7 10.79 29.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.145 0.578 . . . . 72.239999999999995 110.153 170.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 69.82 15.2 7.97 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.2 1.4 . . . . 74.340000000000003 112.931 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -84.3 123.46 30.19 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.559 -1.275 . . . . 71.129999999999995 107.559 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 t -98.84 139.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.124 0.57 . . . . 71.519999999999996 109.478 -171.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.57 156.21 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.077 0.951 . . . . 71.310000000000002 109.909 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.22 137.27 47.36 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.087 -1.449 . . . . 72.329999999999998 107.087 166.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.5 159.28 41.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.838 -0.801 . . . . 73.450000000000003 108.838 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -91.21 139.87 25.65 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 115.788 -0.642 . . . . 74.310000000000002 110.133 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.06 -12.08 32.98 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.025 2.484 . . . . 74.340000000000003 113.771 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -97.99 8.88 44.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.612 0.765 . . . . 65.140000000000001 112.357 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.59 122.58 20.0 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.037 -0.727 . . . . 53.420000000000002 109.037 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.76 ' HA ' HE21 ' A' ' 63' ' ' GLN . 21.7 ptmt -63.55 -39.39 94.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.978 0.911 . . . . 73.340000000000003 112.583 -167.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -68.16 -35.19 77.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.477 0.711 . . . . 74.319999999999993 110.64 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 54.6 tp -66.06 -36.22 82.63 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.411 0.684 . . . . 72.430000000000007 110.644 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.76 HE21 ' HA ' ' A' ' 60' ' ' LYS . 48.7 mt-30 -56.97 -42.05 79.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.735 0.647 . . . . 74.510000000000005 109.823 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -63.85 -36.13 82.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.327 0.651 . . . . 73.519999999999996 110.906 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.33 -43.29 99.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.248 0.619 . . . . 73.030000000000001 109.992 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 82.0 mt -71.98 -23.01 61.35 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.171 -0.922 . . . . 60.509999999999998 111.182 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 4.7 mmp_? -88.39 -20.68 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.43 0.692 . . . . 64.549999999999997 111.575 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -78.37 -30.61 48.04 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.192 0.597 . . . . 73.420000000000002 110.911 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 m -80.07 -13.85 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.679 0.276 . . . . 74.530000000000001 110.655 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 123.628 0.771 . . . . 74.310000000000002 109.403 172.472 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 14' ' ' SER . 9.8 t . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 110.125 -0.324 . . . . 55.329999999999998 110.125 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 20.8 m -93.62 -50.08 5.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.59 0.756 . . . . 74.120000000000005 110.738 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.22 -121.54 0.83 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.788 -0.451 . . . . 73.519999999999996 112.682 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.12 162.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.599 1.159 . . . . 65.310000000000002 110.044 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.62 151.26 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.14 0.576 . . . . 72.299999999999997 110.727 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 m -110.56 11.78 22.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.034 0.934 . . . . 73.010000000000005 111.45 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 154.91 43.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.166 0.587 . . . . 72.409999999999997 110.417 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.89 141.93 14.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.197 -0.668 . . . . 74.450000000000003 109.197 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.79 144.34 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.467 1.107 . . . . 70.109999999999999 109.04 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' ILE . . . -62.7 123.39 30.41 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.912 -0.382 . . . . 45.0 113.426 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.54 -34.19 68.88 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.258 1.023 . . . . 71.010000000000005 110.755 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.55 -28.33 63.79 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.886 0.874 . . . . 62.25 111.998 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' GLY . 17.8 pt -90.72 -0.41 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 118.131 0.423 . . . . 74.239999999999995 111.152 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 45' ' ' ILE . 36.4 mm -77.31 111.9 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.372 -0.603 . . . . 50.43 109.372 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.15 -53.71 4.89 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.47 -0.566 . . . . 74.310000000000002 109.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -153.72 147.42 25.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.448 -0.797 . . . . 74.120000000000005 110.105 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -113.34 123.19 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.529 -0.915 . . . . 71.129999999999995 108.529 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -94.54 111.05 22.81 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.342 -0.985 . . . . 63.219999999999999 108.342 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.74 131.69 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.112 0.482 . . . . 72.439999999999998 109.9 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 p -122.49 136.23 26.37 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.1 0.96 . . . . 75.310000000000002 108.978 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -61.21 169.84 5.81 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.156 2.571 . . . . 74.439999999999998 113.814 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.37 170.99 14.84 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 121.805 1.67 . . . . 63.200000000000003 111.589 168.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -177.18 48.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.55 -0.295 . . . . 43.130000000000003 112.523 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 64.17 14.31 8.52 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.743 1.217 . . . . 75.530000000000001 111.317 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.72 -20.27 36.98 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.947 0.784 . . . . 54.229999999999997 112.731 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 m -84.72 124.95 72.36 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 117.639 0.72 . . . . 61.310000000000002 109.073 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.0 -69.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.794 2.329 . . . . 63.030000000000001 113.696 -172.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -100.68 179.97 4.26 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.399 1.08 . . . . 62.140000000000001 108.579 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 m -64.12 109.13 1.73 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.022 -1.473 . . . . 63.43 107.022 162.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -90.54 112.78 24.6 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 72.109999999999999 109.682 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 102.13 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.137 -0.69 . . . . 75.209999999999994 109.137 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.03 111.66 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.962 -1.125 . . . . 62.32 107.962 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 26' ' ' ILE . 54.5 mt -94.39 136.27 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.805 -0.443 . . . . 65.219999999999999 109.805 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -114.71 114.0 25.04 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 124.878 1.271 . . . . 74.340000000000003 108.053 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.2 p -80.29 169.17 18.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.429 0.292 . . . . 53.229999999999997 111.073 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.75 -20.62 64.38 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.002 0.921 . . . . 73.310000000000002 112.0 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.8 ptp -91.49 8.86 34.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.515 0.726 . . . . 55.229999999999997 110.906 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 67.68 21.55 9.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.987 1.315 . . . . 64.450000000000003 111.523 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -81.01 123.06 28.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.011 -1.477 . . . . 74.530000000000001 107.011 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.86 130.19 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.603 -0.888 . . . . 64.219999999999999 108.603 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 45' ' ' ILE . 29.8 pt -134.38 153.96 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.263 0.625 . . . . 71.439999999999998 109.836 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 92.8 m -109.54 128.76 55.43 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.231 -0.895 . . . . 64.209999999999994 108.632 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.14 140.6 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.499 -0.926 . . . . 64.409999999999997 108.499 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -79.66 128.1 75.77 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.19 -21.32 27.8 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.923 3.082 . . . . 74.239999999999995 114.558 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -73.28 -7.48 51.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.202 0.601 . . . . 74.430000000000007 112.459 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.04 123.03 16.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.858 0.863 . . . . 64.519999999999996 110.696 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -66.5 -38.33 87.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.022 -0.99 . . . . 72.040000000000006 111.914 -172.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.846 0.459 . . . . 72.010000000000005 111.425 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.55 -27.0 63.81 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.569 0.747 . . . . 71.310000000000002 110.921 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -59.95 -25.92 65.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.046 0.538 . . . . 72.239999999999995 111.698 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.77 -41.68 97.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.2 0.6 . . . . 75.219999999999999 109.903 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.04 -40.35 82.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.532 0.733 . . . . 43.219999999999999 110.0 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.86 -31.29 72.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.392 0.677 . . . . 74.430000000000007 110.812 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -78.23 -34.14 49.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.125 0.57 . . . . 73.030000000000001 111.058 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.585 0.354 . . . . 73.299999999999997 111.64 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.43 -11.51 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.011 0.375 . . . . 74.319999999999993 112.011 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 124.175 0.99 . . . . 61.219999999999999 111.417 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 109.665 -0.494 . . . . 74.540000000000006 109.665 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 t -51.97 -31.98 31.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.67 1.188 . . . . 63.0 112.125 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.73 -169.86 34.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.323 -0.711 . . . . 70.439999999999998 111.323 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.68 129.95 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 55' ' ' VAL . 2.2 pp -114.26 144.69 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.162 0.585 . . . . 70.140000000000001 109.584 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.0 m -133.95 34.2 3.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.91 0.884 . . . . 62.130000000000003 109.429 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 m -126.53 138.89 53.54 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.964 -1.016 . . . . 44.200000000000003 108.906 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -74.25 110.85 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.406 -1.331 . . . . 64.329999999999998 107.406 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.75 139.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.478 -0.564 . . . . 73.450000000000003 109.478 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.36 128.58 33.37 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.756 0.66 . . . . 45.43 113.28 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.65 -30.17 63.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.057 0.943 . . . . 61.229999999999997 109.943 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -54.77 -35.49 63.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 73.010000000000005 112.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.0 pt -104.49 -3.88 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 119.266 -0.397 . . . . 74.329999999999998 112.013 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 45' ' ' ILE . 41.1 mm -71.13 110.97 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.684 -0.858 . . . . 72.519999999999996 108.684 172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB2' ' HD2' ' A' ' 48' ' ' LYS . 24.0 t70 -85.75 -56.6 3.41 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.198 0.599 . . . . 75.150000000000006 110.712 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -160.69 143.88 13.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.209 -0.663 . . . . 75.430000000000007 109.209 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.12 123.99 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.215 -0.661 . . . . 64.140000000000001 109.215 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -103.98 116.82 32.94 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.864 0.866 . . . . 71.239999999999995 109.012 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.36 112.83 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.294 0.638 . . . . 52.409999999999997 110.165 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 11.0 m -89.84 116.65 66.88 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 108.935 -0.765 . . . . 75.540000000000006 108.935 169.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.81 157.73 36.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.812 2.341 . . . . 64.540000000000006 112.535 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.38 122.08 10.76 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.607 2.204 . . . . 74.25 111.294 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.64 -159.59 23.49 Favored Glycine 0 C--O 1.241 0.546 0 N-CA-C 110.221 -1.152 . . . . 72.230000000000004 110.221 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 63.82 30.09 14.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 72.430000000000007 111.641 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.87 20.5 61.17 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.423 -0.353 . . . . 11.44 112.914 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 53.4 t -138.32 133.34 17.1 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.888 0.875 . . . . 71.540000000000006 109.965 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.72 -9.31 13.35 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.336 2.024 . . . . 63.509999999999998 112.616 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 16.5 tppt? -101.29 155.09 18.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.806 1.242 . . . . 64.200000000000003 110.163 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -86.43 115.23 23.8 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.183 -1.043 . . . . 74.140000000000001 108.183 164.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 42.7 tt0 -83.21 112.97 20.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.014 -0.735 . . . . 75.120000000000005 109.014 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.04 102.15 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.539 -1.282 . . . . 63.539999999999999 107.539 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.11 135.27 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.934 0.894 . . . . 51.109999999999999 109.061 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.601 HG21 HD12 ' A' ' 26' ' ' ILE . 60.9 mt -110.29 121.78 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.624 0.37 . . . . 73.450000000000003 110.083 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.15 127.04 32.74 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.998 -1.112 . . . . 71.010000000000005 107.998 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.7 p -84.66 178.42 7.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.408 0.683 . . . . 75.439999999999998 110.359 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 27' ' ' ASP . 14.4 mmmm -66.02 -23.52 66.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.277 0.56 . . . . 73.230000000000004 110.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.3 mtm -79.8 -1.45 38.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.458 1.103 . . . . 73.230000000000004 110.434 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 65.2 14.51 9.44 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.986 1.714 . . . . 65.25 111.919 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -79.77 125.97 30.35 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.248 -1.019 . . . . 72.319999999999993 108.248 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.92 122.65 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 41.020000000000003 109.386 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.1 pt -108.11 149.93 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.147 -1.057 . . . . 74.5 108.147 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.97 118.68 37.42 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.515 0.726 . . . . 63.109999999999999 109.355 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 HD11 ' A' ' 17' ' ' ILE . 32.8 m -124.69 156.06 32.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 123.524 0.73 . . . . 70.340000000000003 109.55 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.55 152.95 78.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.558 -0.904 . . . . 73.430000000000007 108.558 168.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.54 -27.0 69.69 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.839 1.693 . . . . 65.140000000000001 111.261 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.89 12.67 36.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.313 1.045 . . . . 72.329999999999998 112.208 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.97 56.58 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.041 0.536 . . . . 74.400000000000006 109.985 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.96 -40.99 97.67 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.973 0.731 . . . . 73.219999999999999 112.973 -166.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -77.84 -17.48 57.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.073 0.397 . . . . 63.43 112.073 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.49 -21.59 66.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 52.119999999999997 110.712 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -56.4 -23.97 41.66 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.092 0.957 . . . . 62.310000000000002 113.139 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.99 -46.94 82.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.927 0.491 . . . . 74.219999999999999 110.274 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.52 -37.96 55.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.369 -0.832 . . . . 73.409999999999997 110.472 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.05 -35.62 78.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 74.340000000000003 110.547 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -75.03 -41.38 59.34 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.309 0.243 . . . . 65.450000000000003 110.682 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -68.66 -36.11 78.14 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.27 0.47 . . . . 64.349999999999994 112.27 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.0 -28.81 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.025 0.44 . . . . 70.329999999999998 110.137 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 123.834 0.853 . . . . 53.43 111.049 176.861 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 16' ' ' VAL . 52.9 t . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.236 -0.653 . . . . 74.140000000000001 109.236 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.9 m -114.54 123.88 50.47 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.185 0.994 . . . . 71.439999999999998 109.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.33 90.24 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 O-C-N 123.773 0.671 . . . . 50.149999999999999 111.736 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.662 HG22 ' SG ' ' A' ' 13' ' ' CYS . 22.7 t -100.5 128.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.808 -0.812 . . . . 64.329999999999998 108.808 -173.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 55' ' ' VAL . 2.7 pp -124.74 147.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.082 0.553 . . . . 62.130000000000003 109.986 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.4 m -117.76 22.68 12.17 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.489 1.115 . . . . 72.5 109.122 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.5 m -93.72 146.57 23.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.753 1.221 . . . . 74.299999999999997 109.994 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.63 112.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.359 -0.978 . . . . 45.299999999999997 108.359 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -90.5 143.33 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.664 0.786 . . . . 74.25 109.548 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 118.09 13.73 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.881 0.738 . . . . 72.120000000000005 112.011 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.3 -30.81 52.22 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.767 1.227 . . . . 72.439999999999998 110.995 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.47 -35.79 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.399 0.679 . . . . 71.150000000000006 111.942 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt -86.19 -6.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 111.957 0.354 . . . . 73.109999999999999 111.957 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD12 HG21 ' A' ' 45' ' ' ILE . 44.5 mm -72.9 129.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.364 -0.976 . . . . 70.420000000000002 108.364 176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -117.16 -58.64 2.04 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.633 0.373 . . . . 63.450000000000003 111.055 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -144.81 127.47 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.849 0.46 . . . . 62.43 109.906 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -110.79 140.66 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.359 1.064 . . . . 51.030000000000001 109.71 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.37 127.17 25.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.979 1.312 . . . . 73.25 108.082 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.52 139.43 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 122.576 0.35 . . . . 55.329999999999998 111.253 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 28.5 m -111.06 118.36 48.16 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.06 0.944 . . . . 71.099999999999994 109.099 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.44 147.18 36.19 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.025 1.816 . . . . 55.219999999999999 111.156 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.75 144.7 92.75 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.61 2.207 . . . . 63.310000000000002 112.59 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.02 -32.8 7.1 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.066 -0.516 . . . . 72.400000000000006 112.534 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -80.59 77.76 7.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.636 0.774 . . . . 72.530000000000001 110.426 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.37 -2.92 18.12 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 115.808 -0.633 . . . . 62.32 114.501 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.08 138.26 17.72 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 74.439999999999998 109.139 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.71 16.61 1.78 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.868 2.379 . . . . 73.209999999999994 114.034 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -152.16 173.21 15.23 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.277 0.631 . . . . 75.439999999999998 110.572 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 m -81.2 131.32 35.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.402 0.681 . . . . 73.510000000000005 110.114 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 19.9 tt0 -115.05 126.33 54.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.915 -1.143 . . . . 74.099999999999994 107.915 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.08 102.68 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.283 -1.006 . . . . 64.400000000000006 108.283 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.91 130.56 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 109.083 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 26' ' ' ILE . 52.3 mt -121.16 129.85 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.256 -0.646 . . . . 75.129999999999995 109.256 173.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -99.53 124.56 44.81 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.969 1.307 . . . . 75.140000000000001 107.523 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.8 p -84.9 170.64 12.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.883 0.473 . . . . 73.120000000000005 110.792 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 18.6 ptpt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 75.510000000000005 110.845 170.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.96 -8.29 56.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.186 0.994 . . . . 73.519999999999996 110.647 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.09 21.17 7.41 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.074 1.349 . . . . 73.239999999999995 109.246 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -100.43 133.09 45.38 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.25 1.02 . . . . 65.519999999999996 108.364 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.42 124.04 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.128 0.971 . . . . 71.230000000000004 110.397 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.6 pt -120.61 139.04 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.901 -1.148 . . . . 54.409999999999997 107.901 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.62 117.02 32.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.228 -1.397 . . . . 51.409999999999997 107.228 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 17' ' ' ILE . 7.2 m -117.55 166.35 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.176 0.59 . . . . 75.510000000000005 111.073 -168.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.8 OUTLIER -79.18 139.09 56.21 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 115.299 -0.864 . . . . 72.329999999999998 109.512 174.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.1 -43.57 28.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.422 2.081 . . . . 72.510000000000005 112.721 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -85.08 21.96 1.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.93 0.492 . . . . 73.530000000000001 111.461 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.84 124.65 21.33 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.145 -0.687 . . . . 71.409999999999997 109.145 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.92 -32.89 74.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.252 1.021 . . . . 74.439999999999998 112.316 -169.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -74.12 -29.96 62.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.05 0.54 . . . . 73.430000000000007 111.154 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.7 tp -67.44 -23.55 65.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.674 0.79 . . . . 74.430000000000007 110.869 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -57.77 -38.04 74.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.753 0.821 . . . . 62.5 111.171 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -69.7 -31.39 69.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.119 0.568 . . . . 75.129999999999995 110.74 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.9 -35.58 69.75 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.454 -0.572 . . . . 61.420000000000002 109.454 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -66.04 -40.33 90.9 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.342 0.657 . . . . 74.430000000000007 110.129 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -70.33 -35.84 73.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.31 0.644 . . . . 71.409999999999997 111.05 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.78 -44.84 92.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.736 0.414 . . . . 54.399999999999999 110.412 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 m -82.37 -20.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.85 -0.614 . . . . 55.350000000000001 111.534 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 . . . . . 0 N--CA 1.478 0.961 0 C-N-CA 123.024 0.529 . . . . 73.129999999999995 109.96 178.858 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.24 0.6 0 N-CA-C 109.125 -0.695 . . . . 62.020000000000003 109.125 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 p -64.01 -49.58 71.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.745 0.818 . . . . 75.010000000000005 110.539 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.61 172.03 32.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.027 -0.988 . . . . 74.230000000000004 111.236 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.56 148.2 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.024 0.53 . . . . 64.209999999999994 109.788 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.8 pt -83.53 133.06 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.582 -0.735 . . . . 74.430000000000007 111.566 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.0 m -85.07 -41.04 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.374 -0.83 . . . . 74.219999999999999 109.354 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.8 m -92.45 129.29 38.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.007 . . . . 74.239999999999995 108.806 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.52 129.68 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.739 0.649 . . . . 64.120000000000005 109.627 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.596 HG21 HG21 ' A' ' 53' ' ' ILE . 71.1 t -84.23 130.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.508 0.723 . . . . 72.409999999999997 110.236 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.22 134.2 42.67 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.284 0.99 . . . . 63.119999999999997 113.602 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.63 -33.81 66.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.432 1.093 . . . . 63.509999999999998 110.474 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.05 -34.54 77.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.225 1.01 . . . . 54.149999999999999 111.913 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 25.4 pt -97.59 -5.78 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 118.925 -0.559 . . . . 64.510000000000005 112.096 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 45' ' ' ILE . 38.9 mm -65.58 103.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.215 -1.031 . . . . 71.349999999999994 108.215 171.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -85.72 -55.07 4.15 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.31 0.644 . . . . 63.149999999999999 109.618 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -148.99 143.4 26.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.987 -0.551 . . . . 72.120000000000005 110.526 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.65 118.46 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.332 1.053 . . . . 71.319999999999993 108.647 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -106.62 143.88 34.09 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.036 -1.098 . . . . 74.099999999999994 108.036 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.5 t -120.1 124.95 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.167 -1.049 . . . . 62.310000000000002 108.167 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -88.48 111.37 43.3 Favored Pre-proline 0 C--O 1.251 1.156 0 N-CA-C 108.143 -1.058 . . . . 24.120000000000001 108.143 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.2 151.39 49.09 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.862 2.375 . . . . 74.239999999999995 112.266 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.76 158.07 43.35 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.342 2.028 . . . . 61.210000000000001 112.164 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.99 -19.1 44.17 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.738 -0.479 . . . . 73.109999999999999 113.734 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -83.45 66.17 8.75 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.736 0.814 . . . . 73.340000000000003 109.844 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.6 -18.12 6.04 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 115.422 -0.808 . . . . 41.299999999999997 113.839 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -139.67 129.44 14.01 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.629 1.172 . . . . 70.409999999999997 108.563 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.25 32.91 0.45 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.003 2.469 . . . . 62.119999999999997 112.676 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.31 126.78 50.35 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.565 0.746 . . . . 63.420000000000002 110.773 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -88.61 121.35 30.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.714 0.805 . . . . 75.120000000000005 108.914 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -144.3 163.6 33.22 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.29 0.567 . . . . 65.340000000000003 110.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.4 t -121.41 104.16 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.576 1.15 . . . . 75.420000000000002 108.277 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.54 108.98 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.616 1.166 . . . . 71.530000000000001 108.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.419 ' HB ' HG12 ' A' ' 53' ' ' ILE . 69.7 mt -107.91 134.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.562 -0.712 . . . . 75.019999999999996 110.391 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.17 124.89 48.55 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.831 1.252 . . . . 75.400000000000006 107.749 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -80.23 179.06 7.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.508 0.323 . . . . 35.039999999999999 110.302 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 52.5 mtmt -62.35 -28.63 69.89 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.264 0.554 . . . . 62.100000000000001 110.617 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 49' ' ' MET . 0.9 OUTLIER -86.28 7.05 26.89 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.748 1.219 . . . . 72.109999999999999 111.028 177.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 63.74 15.61 9.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.305 1.442 . . . . 74.129999999999995 111.793 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -72.68 128.46 35.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.789 -1.189 . . . . 63.530000000000001 107.789 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.83 118.5 35.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.033 -0.985 . . . . 73.230000000000004 109.051 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 21' ' ' VAL . 7.2 pt -110.98 157.11 11.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.626 -1.25 . . . . 74.400000000000006 107.626 167.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.9 t -139.83 116.61 10.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.482 -0.933 . . . . 73.230000000000004 108.482 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 158.12 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 75.109999999999999 109.434 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.22 151.35 78.27 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.425 -0.583 . . . . 61.310000000000002 109.425 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.74 -16.41 37.18 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.262 2.641 . . . . 73.400000000000006 114.053 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -91.29 18.99 6.34 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.13 0.972 . . . . 62.310000000000002 112.386 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 128.07 34.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.152 -0.684 . . . . 63.509999999999998 109.152 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 11.1 mmpt? -66.99 -38.5 86.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.703 0.801 . . . . 64.510000000000005 112.584 -172.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -63.55 -33.24 75.15 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.131 0.491 . . . . 74.540000000000006 110.156 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.15 -31.15 43.91 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.057 -0.974 . . . . 74.310000000000002 110.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -31.95 73.14 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 110.143 -0.318 . . . . 72.120000000000005 110.143 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.7 -42.12 92.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.289 0.635 . . . . 70.120000000000005 110.199 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.5 mm? -64.1 -42.7 96.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.444 0.698 . . . . 61.420000000000002 110.269 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.77 -31.64 72.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.241 0.617 . . . . 70.230000000000004 111.072 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -78.77 -27.04 44.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.1 0.96 . . . . 73.439999999999998 110.804 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -83.69 -29.27 27.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.252 0.621 . . . . 73.430000000000007 112.067 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 65' ' ' LEU . 24.4 m -70.45 -24.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 110.104 -0.332 . . . . 71.230000000000004 110.104 176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.555 1.157 0 N-CA-C 107.441 -1.318 . . . . 44.420000000000002 107.441 170.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.04 0.448 . . . . 73.230000000000004 110.166 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' A' ' 54' ' ' CYS . 23.1 t -87.34 31.29 0.74 Allowed 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 125.092 1.357 . . . . 75.109999999999999 111.212 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.06 -142.23 20.52 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.365 -0.294 . . . . 54.109999999999999 112.365 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.03 133.38 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.644 -1.243 . . . . 73.329999999999998 107.644 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.402 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.7 pp -125.52 150.43 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 122.862 0.465 . . . . 73.540000000000006 111.424 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -97.32 2.21 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.285 1.034 . . . . 62.210000000000001 110.982 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 m -74.9 98.08 3.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.251 0.62 . . . . 51.219999999999999 109.523 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.66 109.69 6.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.124 -1.436 . . . . 55.439999999999998 107.124 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.1 t -100.39 139.41 21.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.429 0.691 . . . . 72.200000000000003 109.987 -173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.77 136.8 38.65 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 124.015 0.822 . . . . 75.239999999999995 112.565 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 64' ' ' ARG . 10.8 mp -60.89 -29.41 69.55 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.936 0.894 . . . . 71.510000000000005 110.542 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.61 -33.19 67.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.327 1.451 . . . . 74.420000000000002 112.794 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.572 HG22 ' HE2' ' A' ' 48' ' ' LYS . 43.4 pt -110.21 7.46 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.519 0.328 . . . . 73.239999999999995 111.869 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.472 HD12 HG21 ' A' ' 45' ' ' ILE . 39.5 mm -73.86 111.48 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.393 -0.966 . . . . 64.319999999999993 108.393 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.2 -56.66 3.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.484 0.713 . . . . 74.510000000000005 110.652 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -153.58 138.26 16.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.200000000000003 109.856 -174.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.7 128.8 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.122 -1.066 . . . . 73.310000000000002 108.122 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' VAL . 19.4 mt-30 -116.88 138.99 51.15 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.632 -0.877 . . . . 74.129999999999995 108.632 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.69 119.24 49.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.683 -0.858 . . . . 71.230000000000004 108.683 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.7 p -101.37 112.76 65.54 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.423 -0.954 . . . . 72.540000000000006 108.423 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.63 161.05 47.43 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.373 2.715 . . . . 73.219999999999999 112.677 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 119.72 6.14 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.526 2.151 . . . . 62.43 111.453 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.74 -39.08 1.24 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 116.131 -0.486 . . . . 74.540000000000006 112.231 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -77.22 77.99 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.219 0.607 . . . . 50.119999999999997 110.144 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.68 14.51 55.22 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.17 -0.468 . . . . 60.539999999999999 113.872 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 31.9 p -139.89 133.79 15.59 Favored Pre-proline 0 C--N 1.356 0.881 0 C-N-CA 123.422 0.689 . . . . 72.409999999999997 110.161 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 17.2 Cg_exo -68.94 -38.19 10.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.132 2.554 . . . . 45.030000000000001 112.914 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -118.43 159.24 23.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.769 0.828 . . . . 64.030000000000001 110.491 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -62.96 120.86 12.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.102 0.961 . . . . 64.230000000000004 109.9 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -108.55 117.55 34.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.501 0.72 . . . . 55.119999999999997 109.299 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.35 106.49 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.816 0.846 . . . . 75.319999999999993 109.423 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 30' ' ' GLN . 5.8 m -104.71 125.33 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.046 0.539 . . . . 63.539999999999999 109.789 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 26' ' ' ILE . 46.3 mt -114.37 120.11 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 108.978 -175.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.435 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 66.9 m95 -86.57 128.25 34.97 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.236 1.014 . . . . 75.400000000000006 108.484 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.6 p -83.62 179.68 7.55 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.328 0.651 . . . . 74.409999999999997 110.17 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE2' HG22 ' A' ' 25' ' ' ILE . 41.8 mtmt -66.2 -29.67 69.98 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.394 0.278 . . . . 54.149999999999999 111.065 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -77.09 -7.3 55.5 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.501 0.72 . . . . 64.230000000000004 110.294 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 70.04 23.51 5.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 125.934 1.694 . . . . 75.150000000000006 111.408 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.01 123.69 25.62 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.19 126.58 43.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.342 0.657 . . . . 72.219999999999999 109.422 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HB ' HG12 ' A' ' 17' ' ' ILE . 46.6 pt -117.64 157.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.479 -1.304 . . . . 71.430000000000007 107.479 170.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.612 ' HB2' ' H ' ' A' ' 14' ' ' SER . 13.4 t -133.93 134.15 42.27 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.203 0.456 . . . . 52.140000000000001 109.939 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.7 HG11 ' HE1' ' A' ' 61' ' ' TRP . 31.0 m -133.95 164.94 33.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 C-N-CA 124.344 1.058 . . . . 73.150000000000006 109.598 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -81.57 159.16 67.46 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.367 -1.288 . . . . 65.0 109.846 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.68 -12.95 37.97 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.928 2.419 . . . . 74.209999999999994 112.028 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -83.52 -8.65 59.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.811 0.844 . . . . 54.219999999999999 111.432 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.87 132.37 49.23 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.735 0.814 . . . . 62.210000000000001 112.161 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.2 -36.45 69.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 74.099999999999994 112.491 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.7 ' HE1' HG11 ' A' ' 55' ' ' VAL . 7.7 p-90 -74.75 -23.15 58.51 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.565 0.346 . . . . 74.420000000000002 110.368 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.81 -28.5 69.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.097 0.959 . . . . 71.349999999999994 110.59 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.77 -34.78 73.44 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.632 0.773 . . . . 74.540000000000006 110.571 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 23' ' ' LEU . 95.5 mtt180 -66.95 -39.49 87.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.572 0.749 . . . . 72.230000000000004 111.009 176.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.1 -38.08 72.36 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.544 0.738 . . . . 65.5 110.858 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.53 -49.66 57.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.611 -0.722 . . . . 70.310000000000002 109.682 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -67.62 -24.03 65.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.315 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.658 0.783 . . . . 63.549999999999997 111.119 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.89 -29.78 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 122.723 0.409 . . . . 62.149999999999999 111.039 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 123.467 0.707 . . . . 70.239999999999995 110.45 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 110.056 -0.35 . . . . 73.299999999999997 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.9 m -99.18 -6.91 27.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.288 0.635 . . . . 64.409999999999997 111.255 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.92 165.23 10.18 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 111.521 -0.632 . . . . 72.510000000000005 111.521 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.228 -1.026 . . . . 75.349999999999994 108.228 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.87 143.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.062 0.458 . . . . 74.400000000000006 110.581 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -100.5 -57.1 2.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.016 0.926 . . . . 52.340000000000003 108.733 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -67.32 127.54 33.04 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.814 0.846 . . . . 71.549999999999997 110.45 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.89 139.47 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 124.007 0.817 . . . . 62.149999999999999 110.668 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.97 144.66 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.361 1.064 . . . . 73.540000000000006 109.949 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.64 135.62 25.22 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.561 0.538 . . . . 72.219999999999999 114.253 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.71 -18.76 63.05 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.176 0.99 . . . . 63.109999999999999 111.578 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -59.52 -35.79 74.86 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.413 1.085 . . . . 72.150000000000006 111.746 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.85 -1.92 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 119.324 -0.37 . . . . 75.420000000000002 111.793 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 45' ' ' ILE . 50.2 mm -78.37 124.62 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.963 -0.755 . . . . 62.409999999999997 108.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.13 -57.15 2.08 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.172 0.589 . . . . 71.219999999999999 110.26 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -142.99 153.81 43.37 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.142 0.977 . . . . 74.219999999999999 109.519 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.03 113.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.747 0.819 . . . . 63.109999999999999 109.103 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -96.93 106.66 19.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.652 0.781 . . . . 61.219999999999999 109.139 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.89 117.73 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.033 -0.729 . . . . 65.530000000000001 109.033 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.4 m -89.47 112.68 53.02 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.701 0.8 . . . . 72.340000000000003 108.949 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.63 152.48 64.83 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.08 1.853 . . . . 60.340000000000003 111.999 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.79 109.38 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.828 2.352 . . . . 62.539999999999999 111.928 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.53 -27.79 0.96 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.868 -0.606 . . . . 41.229999999999997 112.181 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.36 68.88 10.62 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.748 0.819 . . . . 54.450000000000003 110.515 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.62 -3.79 40.02 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.338 -0.846 . . . . 62.530000000000001 114.145 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -132.89 125.55 19.28 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 124.233 1.013 . . . . 74.120000000000005 109.443 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.45 -17.79 30.1 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.498 2.132 . . . . 52.009999999999998 112.941 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -110.77 173.75 6.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.787 0.835 . . . . 72.120000000000005 110.165 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -85.43 113.82 22.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.867 -0.79 . . . . 75.040000000000006 108.867 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -101.74 111.13 23.27 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.21 -0.663 . . . . 74.200000000000003 109.21 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.3 t -92.63 99.81 10.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.328 -0.99 . . . . 71.109999999999999 108.328 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.11 107.02 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.093 -1.077 . . . . 73.439999999999998 108.093 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 53' ' ' ILE . 58.5 mt -98.1 128.74 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.507 0.723 . . . . 63.43 109.493 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -102.91 121.45 42.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.137 0.975 . . . . 73.409999999999997 108.712 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -80.95 170.66 15.98 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.695 0.398 . . . . 74.310000000000002 111.106 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -69.31 -12.32 61.56 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.89 0.876 . . . . 75.109999999999999 111.605 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 ptp -101.94 18.28 21.03 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.921 0.888 . . . . 71.329999999999998 110.302 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 61.6 7.48 1.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.381 1.473 . . . . 31.530000000000001 113.902 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -73.14 128.52 35.71 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.281 -1.007 . . . . 72.040000000000006 108.281 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.95 119.21 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.867 -1.06 . . . . 73.319999999999993 109.791 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.604 HG13 ' HB ' ' A' ' 45' ' ' ILE . 23.9 pt -127.71 145.12 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.06 -1.089 . . . . 72.129999999999995 108.06 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.9 m -120.44 142.51 49.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.708 -0.479 . . . . 62.310000000000002 109.708 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG11 ' HE1' ' A' ' 61' ' ' TRP . 29.9 m -126.37 159.67 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 122.969 0.508 . . . . 70.530000000000001 109.712 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -74.96 146.32 82.42 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.085 -0.962 . . . . 74.349999999999994 109.476 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.87 -23.72 76.33 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.981 2.454 . . . . 60.310000000000002 113.1 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -106.23 22.91 14.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.714 0.806 . . . . 63.310000000000002 111.405 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.82 135.03 49.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.136 -0.69 . . . . 53.109999999999999 109.136 171.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.81 -39.53 90.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 71.510000000000005 111.703 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.546 ' HE1' HG11 ' A' ' 55' ' ' VAL . 2.4 p-90 -69.36 -30.16 68.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.77 0.428 . . . . 71.310000000000002 110.035 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.5 tp -68.27 -34.22 75.79 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.247 0.619 . . . . 55.32 110.838 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -57.19 -32.69 66.72 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.128 0.49 . . . . 72.409999999999997 110.976 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.31 -45.48 80.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.105 -0.952 . . . . 73.310000000000002 109.582 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.73 -42.99 97.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.834 . . . . 63.43 110.599 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.62 -49.16 74.37 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.963 0.79 . . . . 55.439999999999998 110.506 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -72.34 -27.11 62.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.308 0.485 . . . . 64.420000000000002 112.308 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.18 -42.12 47.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.361 0.664 . . . . 62.520000000000003 110.995 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.32 -28.24 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 116.389 -0.369 . . . . 73.420000000000002 110.493 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 N--CA 1.48 1.063 0 C-N-CA 123.187 0.595 . . . . 71.340000000000003 110.02 176.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.267 -0.642 . . . . 73.219999999999999 109.267 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 t -93.37 99.6 12.08 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.247 0.619 . . . . 60.549999999999997 109.43 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.03 -148.11 50.83 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.516 0.51 . . . . 13.039999999999999 113.152 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.21 129.12 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.365 -0.976 . . . . 71.140000000000001 108.365 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.8 pt -102.03 119.01 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.368 -0.604 . . . . 71.430000000000007 109.368 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 p -97.49 5.98 48.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.609 0.764 . . . . 74.439999999999998 110.833 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.9 m -77.69 127.67 32.82 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.882 0.873 . . . . 64.310000000000002 109.798 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.78 111.12 10.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 107.274 -1.38 . . . . 71.519999999999996 107.274 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.43 139.06 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 109.022 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 124.63 36.9 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.005 0.816 . . . . 54.439999999999998 112.496 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.32 -34.29 70.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.508 0.723 . . . . 72.040000000000006 109.491 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.84 -34.13 77.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.781 0.832 . . . . 74.140000000000001 111.681 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.4 pt -92.06 3.61 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.049 -0.407 . . . . 70.420000000000002 112.067 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 35.3 mm -78.96 132.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 108.546 -0.909 . . . . 65.329999999999998 108.546 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.15 -56.03 2.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.218 0.607 . . . . 72.329999999999998 109.893 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -144.83 155.88 43.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.328 0.651 . . . . 72.040000000000006 110.974 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.73 112.05 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.759 1.223 . . . . 74.409999999999997 108.058 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -103.69 127.36 51.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.799 -0.815 . . . . 72.040000000000006 108.799 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.26 120.6 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.371 0.668 . . . . 62.43 109.406 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.1 m -95.12 110.35 49.65 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.549 -0.908 . . . . 71.109999999999999 108.549 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.49 156.44 64.03 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.871 2.38 . . . . 71.319999999999993 112.638 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.11 165.3 21.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.383 2.055 . . . . 75.510000000000005 112.026 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.43 -51.9 4.63 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.496 -0.32 . . . . 64.150000000000006 112.425 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -76.55 80.68 3.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.946 0.898 . . . . 75.120000000000005 110.856 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.3 -15.14 9.49 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.657 -0.701 . . . . 43.0 114.66 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.91 132.96 23.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.097 -0.705 . . . . 23.34 109.097 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.89 5.74 6.13 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.665 2.243 . . . . 74.099999999999994 112.912 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.2 159.61 42.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.404 1.082 . . . . 71.230000000000004 109.52 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -80.78 114.31 19.58 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.267 -1.012 . . . . 70.019999999999996 108.267 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.27 117.22 33.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 64.209999999999994 109.733 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.67 102.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.706 -0.85 . . . . 72.150000000000006 108.706 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.1 t -92.05 108.53 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.874 -1.158 . . . . 74.510000000000005 107.874 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 60.2 mt -94.56 138.02 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.155 -0.683 . . . . 70.420000000000002 109.155 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -104.58 119.91 40.09 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.268 -1.382 . . . . 70.319999999999993 107.268 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.3 p -77.09 168.63 19.76 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.331 0.395 . . . . 74.439999999999998 110.215 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -73.47 -10.87 60.17 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.114 0.566 . . . . 54.43 111.226 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.72 -5.34 58.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.584 1.154 . . . . 53.539999999999999 110.127 168.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.97 18.91 10.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.16 1.784 . . . . 62.530000000000001 112.234 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -79.03 133.74 36.8 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.755 -0.657 . . . . 74.450000000000003 109.913 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.01 117.77 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.47 -1.241 . . . . 75.540000000000006 108.46 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.4 pt -126.64 148.05 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.258 0.623 . . . . 62.450000000000003 109.478 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -111.85 130.96 55.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.171 -1.048 . . . . 43.530000000000001 108.171 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.03 165.6 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.31 0.644 . . . . 72.200000000000003 110.25 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -74.35 135.55 75.85 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.274 0.629 . . . . 74.010000000000005 109.885 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.69 -29.07 69.1 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 112.831 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -88.76 4.57 47.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.698 0.799 . . . . 64.109999999999999 112.313 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.1 120.31 8.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.837 -0.431 . . . . 72.409999999999997 109.837 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.49 -36.73 74.22 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.241 1.016 . . . . 54.210000000000001 113.078 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -68.46 -31.59 70.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.234 0.614 . . . . 74.230000000000004 111.106 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.72 -37.75 65.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.095 0.958 . . . . 73.430000000000007 110.84 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -42.69 82.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.891 0.877 . . . . 70.420000000000002 112.565 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -71.4 -27.69 63.5 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 116.112 -0.495 . . . . 72.140000000000001 111.464 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.28 -25.83 46.85 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.494 0.718 . . . . 73.019999999999996 110.097 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.09 -28.61 54.58 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.73 0.812 . . . . 75.209999999999994 109.99 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -74.49 -31.12 62.09 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.591 0.356 . . . . 73.109999999999999 110.544 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.57 -37.36 85.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.237 0.615 . . . . 70.439999999999998 111.514 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.39 -12.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 116.096 -0.502 . . . . 60.350000000000001 111.104 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 CA--C 1.548 0.9 0 C-N-CA 123.678 0.791 . . . . 71.329999999999998 109.881 178.007 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.242 0.683 0 N-CA-C 107.732 -1.21 . . . . 75.530000000000001 107.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -81.46 73.4 8.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 60.549999999999997 110.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.71 -142.53 48.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 113.181 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.87 153.74 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.75 0.82 . . . . 45.350000000000001 109.264 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.401 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.3 pp -128.69 131.28 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.249 0.547 . . . . 72.310000000000002 109.875 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -89.93 -10.16 46.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.726 0.811 . . . . 44.240000000000002 111.596 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 m -64.19 127.21 30.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.709 0.803 . . . . 72.319999999999993 111.247 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.65 114.26 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 108.276 -1.009 . . . . 75.329999999999998 108.276 172.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.53 127.0 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.468 0.707 . . . . 74.420000000000002 109.63 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.0 160.67 17.7 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.777 -0.647 . . . . 52.399999999999999 113.378 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.6 -33.82 68.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.012 1.325 . . . . 63.130000000000003 111.215 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -58.97 -32.22 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.044 0.938 . . . . 73.340000000000003 111.865 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.11 5.83 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 112.435 0.532 . . . . 72.120000000000005 112.435 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.548 HG13 HD11 ' A' ' 65' ' ' LEU . 21.7 mm -77.42 113.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.786 -0.82 . . . . 71.530000000000001 108.786 170.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.58 -55.97 3.73 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.697 -0.482 . . . . 62.210000000000001 109.697 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -157.34 143.62 17.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.673 0.789 . . . . 71.040000000000006 109.891 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 45' ' ' ILE . 65.7 mt -120.88 139.73 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.276 1.03 . . . . 54.32 109.493 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.41 143.09 47.39 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.682 -0.858 . . . . 71.239999999999995 108.682 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.2 138.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 109.229 -0.656 . . . . 72.209999999999994 109.229 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 41' ' ' THR . 71.8 p -119.9 143.2 34.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 123.626 0.77 . . . . 71.239999999999995 109.279 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.77 163.45 26.27 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.077 2.518 . . . . 75.510000000000005 113.652 -170.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.94 130.04 14.01 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 110.878 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.68 -162.01 30.03 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.356 -0.698 . . . . 74.310000000000002 111.356 -170.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.35 17.48 11.0 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.03 0.932 . . . . 72.239999999999995 111.451 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.44 41.21 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.674 -0.694 . . . . 73.310000000000002 112.828 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.5 m -85.06 135.75 39.15 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.763 0.825 . . . . 61.43 109.398 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.55 -63.34 0.19 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.994 2.463 . . . . 75.219999999999999 113.333 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.66 -177.27 4.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.323 -0.991 . . . . 74.430000000000007 108.323 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' THR . 24.2 m -57.59 110.13 0.83 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.806 -0.813 . . . . 61.109999999999999 108.806 166.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -104.33 119.39 38.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.959 -0.756 . . . . 71.109999999999999 108.959 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.45 102.48 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.885 -0.783 . . . . 55.130000000000003 108.885 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.61 134.35 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.553 -0.906 . . . . 72.439999999999998 108.553 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 29' ' ' ILE . 61.8 mt -133.01 125.54 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.329 -0.619 . . . . 72.120000000000005 109.329 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.82 123.43 36.08 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.064 -1.087 . . . . 73.420000000000002 108.064 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.0 p -84.58 179.46 7.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.247 0.619 . . . . 74.030000000000001 110.87 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.93 -24.41 64.28 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.119 0.568 . . . . 71.219999999999999 111.809 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.549 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 25.0 ptp -90.93 12.4 19.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.271 0.628 . . . . 61.130000000000003 110.766 172.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.56 22.44 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.839 1.656 . . . . 65.409999999999997 112.461 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 49' ' ' MET . 2.0 tmtp? -74.75 123.77 25.56 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.622 -1.622 . . . . 72.329999999999998 106.622 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.34 121.53 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.301 1.041 . . . . 72.030000000000001 108.523 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HB ' HG12 ' A' ' 17' ' ' ILE . 30.0 pt -125.56 147.51 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 108.522 -0.918 . . . . 71.019999999999996 108.522 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.35 118.42 25.02 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.813 -1.18 . . . . 74.129999999999995 107.813 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.88 164.57 21.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.582 0.753 . . . . 72.510000000000005 109.911 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.45 147.56 92.74 Favored Pre-proline 0 N--CA 1.474 0.744 0 O-C-N 123.936 0.773 . . . . 72.439999999999998 110.186 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.42 -9.19 19.26 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.981 2.454 . . . . 74.109999999999999 113.582 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -111.44 26.15 10.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.989 0.916 . . . . 73.349999999999994 111.952 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 131.46 44.06 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 108.643 -0.873 . . . . 50.310000000000002 108.643 168.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.23 -47.94 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 71.329999999999998 112.844 -167.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.9 -24.47 64.31 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.673 0.389 . . . . 74.230000000000004 111.849 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.02 -32.13 72.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.033 0.533 . . . . 75.510000000000005 110.237 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.72 -23.63 67.44 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.172 0.589 . . . . 71.549999999999997 111.476 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -69.58 -40.55 76.67 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.415 0.686 . . . . 73.140000000000001 110.3 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -71.33 -34.73 70.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.499 0.72 . . . . 73.109999999999999 110.26 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.15 -37.81 72.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.539 0.736 . . . . 70.329999999999998 110.012 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.85 -40.82 97.47 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.755 0.822 . . . . 75.230000000000004 109.96 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -59.12 -40.65 86.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.565 1.146 . . . . 64.310000000000002 112.056 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -85.93 -14.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 115.9 -0.591 . . . . 73.129999999999995 112.346 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 122.716 0.406 . . . . 70.209999999999994 111.783 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.237 0.446 0 CA-C-O 120.899 0.38 . . . . 63.43 110.431 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 t -83.8 -28.18 28.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.995 0.918 . . . . 65.230000000000004 110.611 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.63 174.89 15.73 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 109.849 -1.3 . . . . 71.129999999999995 109.849 -173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.3 m -101.76 147.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 117.273 0.537 . . . . 71.120000000000005 110.468 -173.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.95 131.98 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.853 -0.612 . . . . 74.219999999999999 109.531 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -85.73 -47.94 9.3 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.524 0.73 . . . . 72.430000000000007 110.017 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 122.26 28.2 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.011 0.924 . . . . 74.230000000000004 108.822 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -54.54 113.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.688 0.795 . . . . 54.030000000000001 111.502 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.77 141.6 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.691 -0.686 . . . . 75.219999999999999 109.98 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.19 131.23 32.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.674 0.609 . . . . 70.150000000000006 112.569 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.1 -33.13 68.77 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.159 0.984 . . . . 40.229999999999997 109.716 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.06 -34.48 77.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.203 1.001 . . . . 73.129999999999995 111.815 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -95.4 16.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 122.222 -0.299 . . . . 71.5 111.395 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 45' ' ' ILE . 50.4 mm -79.94 129.22 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.006 -0.738 . . . . 71.010000000000005 109.006 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -94.89 -56.13 2.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 64.239999999999995 110.535 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -156.03 142.47 18.52 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.737 -0.665 . . . . 71.010000000000005 109.414 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -108.82 138.13 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.392 1.077 . . . . 75.140000000000001 108.821 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 26.6 pt20 -136.66 111.55 8.86 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.687 -0.857 . . . . 72.439999999999998 108.687 171.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.9 123.15 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.102 -0.703 . . . . 74.030000000000001 109.102 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.3 m -87.28 110.88 37.2 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 109.241 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.41 154.14 55.75 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.911 2.407 . . . . 74.349999999999994 112.877 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.25 164.81 33.35 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.353 2.035 . . . . 63.43 112.235 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.49 4.8 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 112.712 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.51 88.94 0.35 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.271 1.028 . . . . 55.32 110.451 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.9 -18.54 3.87 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.067 0.841 . . . . 32.520000000000003 114.625 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.2 m -139.19 132.62 15.8 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 63.299999999999997 109.43 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.5 -9.97 20.25 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.734 2.289 . . . . 53.539999999999999 112.088 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -116.1 137.64 51.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.165 0.986 . . . . 71.129999999999995 110.248 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.5 m -69.19 138.48 54.11 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.725 0.81 . . . . 70.230000000000004 109.423 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.23 145.99 49.68 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.274 -1.01 . . . . 64.230000000000004 108.274 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.19 103.32 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.067 -1.086 . . . . 74.549999999999997 108.067 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 30' ' ' GLN . 61.6 t -94.04 124.05 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.235 -1.024 . . . . 73.230000000000004 108.235 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.574 HG21 HD12 ' A' ' 26' ' ' ILE . 66.8 mt -119.39 137.22 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 123.271 0.628 . . . . 55.43 110.002 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -91.62 131.93 36.68 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.923 -1.14 . . . . 75.010000000000005 107.923 166.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.5 p -86.43 172.07 10.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.368 0.667 . . . . 74.310000000000002 109.895 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -75.61 -7.61 54.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.372 0.669 . . . . 72.510000000000005 111.328 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.5 mtm -83.61 -7.09 59.58 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.942 0.897 . . . . 75.530000000000001 109.435 167.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 65.18 24.6 12.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.207 1.803 . . . . 74.329999999999998 110.536 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.46 125.97 32.84 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.737 -1.579 . . . . 73.140000000000001 106.737 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.53 122.85 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.101 -1.074 . . . . 75.319999999999993 108.101 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -127.19 155.89 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.648 -0.871 . . . . 72.129999999999995 108.648 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 39.6 m -111.63 151.19 29.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.91 -1.515 . . . . 64.450000000000003 106.91 165.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.06 129.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.602 -1.259 . . . . 71.310000000000002 107.602 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -54.07 129.08 57.96 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.493 0.717 . . . . 64.25 109.734 176.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.02 -14.45 41.6 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.511 2.141 . . . . 61.450000000000003 113.59 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -85.91 3.89 39.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.081 0.552 . . . . 74.109999999999999 111.947 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 120.85 10.53 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 123.414 0.686 . . . . 61.130000000000003 109.747 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.23 -31.54 71.97 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.762 1.225 . . . . 74.219999999999999 112.082 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -79.51 -23.51 42.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.25 1.02 . . . . 73.319999999999993 111.418 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.96 -27.58 68.35 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.892 0.877 . . . . 71.329999999999998 111.347 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.1 -35.86 69.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.817 0.847 . . . . 74.420000000000002 111.545 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -69.0 -34.06 74.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.405 0.682 . . . . 73.530000000000001 110.57 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.4 mp -70.22 -41.7 73.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.248 -0.649 . . . . 61.009999999999998 109.248 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.77 -38.35 88.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.749 0.82 . . . . 74.329999999999998 110.516 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -63.72 -34.16 77.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.863 0.865 . . . . 74.310000000000002 110.785 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -71.98 -33.71 68.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.922 0.489 . . . . 60.310000000000002 110.619 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' LEU . 97.4 t -71.99 -30.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.348 0.659 . . . . 62.509999999999998 109.414 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 107.854 -1.165 . . . . 61.399999999999999 107.854 171.64 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 107.501 -1.296 . . . . 74.349999999999994 107.501 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 t -72.36 94.18 1.59 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.277 0.631 . . . . 61.420000000000002 111.08 -170.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.1 67.6 0.24 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.708 -0.557 . . . . 42.340000000000003 111.708 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.62 170.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.541 0.737 . . . . 71.030000000000001 110.882 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.53 147.42 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.37 0.668 . . . . 71.030000000000001 110.822 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.9 p -108.76 17.71 21.57 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.974 0.909 . . . . 64.120000000000005 110.679 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t -143.9 150.09 37.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.909 0.884 . . . . 73.310000000000002 109.176 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.02 130.49 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 108.99 -0.745 . . . . 74.310000000000002 108.99 168.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.34 147.22 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.525 -0.916 . . . . 62.43 108.525 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.44 118.99 10.42 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.568 0.543 . . . . 72.540000000000006 112.836 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.32 -34.49 73.89 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.686 0.794 . . . . 75.439999999999998 110.216 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.67 -32.36 73.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.831 0.852 . . . . 75.549999999999997 111.765 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.11 15.03 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 111.733 0.271 . . . . 61.109999999999999 111.733 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.72 122.88 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.989 -0.745 . . . . 54.009999999999998 108.989 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.69 -56.24 3.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.101 -0.703 . . . . 74.200000000000003 109.101 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -160.86 137.06 8.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.327 -0.851 . . . . 74.109999999999999 110.44 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.69 108.54 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 108.68 -0.859 . . . . 74.439999999999998 108.68 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -101.63 115.28 30.16 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.425 -0.954 . . . . 72.219999999999999 108.425 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -85.94 121.88 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 107.96 -1.126 . . . . 74.019999999999996 107.96 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 m -105.68 126.3 31.11 Favored Pre-proline 0 C--O 1.247 0.973 0 C-N-CA 123.572 0.749 . . . . 73.329999999999998 109.777 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.02 153.3 58.87 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.541 2.16 . . . . 73.519999999999996 112.219 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' A' ' 40' ' ' LYS . 11.1 Cg_endo -52.76 92.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.419 2.746 . . . . 73.150000000000006 114.109 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.4 14.52 10.07 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.334 -0.848 . . . . 75.430000000000007 111.487 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -73.23 -14.53 61.36 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.427 1.091 . . . . 74.430000000000007 111.124 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.03 -14.66 48.55 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.834 0.73 . . . . 52.229999999999997 111.289 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -131.54 156.73 79.73 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.335 1.454 . . . . 75.510000000000005 109.002 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.52 81.96 0.55 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.085 2.523 . . . . 74.310000000000002 112.325 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 34' ' ' PRO . 27.8 mmmt -142.77 121.26 12.44 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.946 0.898 . . . . 72.239999999999995 110.087 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 m -79.23 114.74 18.41 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.995 -1.113 . . . . 73.129999999999995 107.995 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -94.56 108.29 20.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.526 -0.916 . . . . 75.510000000000005 108.526 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.8 101.57 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.3 -1.0 . . . . 64.040000000000006 108.3 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.2 t -96.2 108.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.359 -0.837 . . . . 64.319999999999993 109.057 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.447 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.0 mt -104.75 121.92 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.925 -0.769 . . . . 64.109999999999999 108.925 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -95.23 131.71 40.99 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 124.175 0.99 . . . . 75.200000000000003 108.899 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.8 p -90.46 169.75 10.79 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 123.214 0.606 . . . . 73.129999999999995 110.278 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -73.37 -17.13 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.637 0.775 . . . . 51.140000000000001 110.891 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.7 mtt -79.86 6.72 10.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.482 0.713 . . . . 45.329999999999998 110.837 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 65.7 17.21 10.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.486 1.114 . . . . 65.120000000000005 111.877 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -91.8 130.28 37.6 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.357 -0.979 . . . . 75.340000000000003 108.357 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -85.92 128.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.207 -0.906 . . . . 63.130000000000003 109.84 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 45' ' ' ILE . 42.8 pt -128.53 156.08 40.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 108.013 -1.106 . . . . 72.120000000000005 108.013 167.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -133.07 136.02 45.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.962 -0.755 . . . . 70.319999999999993 108.962 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.43 163.57 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.507 0.723 . . . . 64.140000000000001 109.728 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -86.0 146.18 42.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.78 -1.1 . . . . 72.420000000000002 108.391 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.16 -10.06 24.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.074 2.516 . . . . 75.230000000000004 113.522 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -75.2 -12.54 60.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.139 0.576 . . . . 70.239999999999995 111.712 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.96 115.36 2.36 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.09 0.956 . . . . 72.239999999999995 110.573 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HA ' HE21 ' A' ' 63' ' ' GLN . 50.6 mtpt -66.32 -32.6 74.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.209999999999994 112.278 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.3 p-90 -70.92 -26.23 63.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.933 0.493 . . . . 75.340000000000003 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.4 -30.17 70.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 73.230000000000004 110.761 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 60' ' ' LYS . 47.3 mt-30 -59.26 -27.07 65.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 63.130000000000003 111.399 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -62.63 -47.54 83.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.863 0.727 . . . . 75.400000000000006 110.037 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.3 mm? -69.84 -46.52 65.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.15 -0.932 . . . . 73.450000000000003 110.189 -177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.22 -46.16 90.72 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.1 0.875 . . . . 74.129999999999995 111.222 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -79.03 -18.35 53.71 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.715 -0.675 . . . . 72.120000000000005 110.965 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.26 -30.43 64.85 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.469 0.308 . . . . 75.219999999999999 110.473 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' LEU . 49.0 t -68.65 -23.62 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 109.805 -0.443 . . . . 72.420000000000002 109.805 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.901 0.858 . . . . 70.120000000000005 109.553 173.641 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.662 -0.495 . . . . 71.129999999999995 109.662 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 t -102.98 39.02 1.62 Allowed 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.343 -0.984 . . . . 50.140000000000001 108.343 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.18 -149.07 24.77 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.211 -0.904 . . . . 31.109999999999999 111.037 -171.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.56 170.08 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.911 0.884 . . . . 62.439999999999998 109.76 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 ' O ' ' A' ' 19' ' ' THR . 2.6 pp -81.82 150.64 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.283 0.563 . . . . 60.32 110.524 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.5 p -113.65 8.18 17.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.037 0.935 . . . . 62.240000000000002 111.435 171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.417 ' O ' HD13 ' A' ' 17' ' ' ILE . 41.0 m -136.71 129.7 30.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.913 0.885 . . . . 70.430000000000007 109.251 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.3 t -65.85 113.3 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.658 -0.867 . . . . 63.340000000000003 108.658 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -77.01 126.59 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.186 -0.915 . . . . 72.340000000000003 110.554 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.03 137.4 38.39 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.924 0.765 . . . . 24.420000000000002 113.596 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.3 -36.53 71.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.022 0.929 . . . . 73.209999999999994 110.39 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -61.82 -34.18 75.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.852 0.861 . . . . 72.239999999999995 111.98 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.52 -4.82 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 119.278 -0.392 . . . . 70.310000000000002 111.742 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.3 mm -68.51 114.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.832 -0.803 . . . . 73.340000000000003 108.832 171.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -89.81 -52.85 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.412 -0.588 . . . . 74.319999999999993 109.412 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 6.2 ptp180 -152.05 145.63 24.93 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.3 -0.409 . . . . 62.030000000000001 110.3 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.51 108.63 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.838 -1.171 . . . . 73.150000000000006 107.838 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -103.0 121.93 43.57 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.772 -0.825 . . . . 64.319999999999993 108.772 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.53 113.54 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.837 -1.171 . . . . 70.129999999999995 107.837 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -96.4 106.91 32.42 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 109.59 -0.522 . . . . 73.340000000000003 109.59 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.41 163.82 37.45 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.104 1.869 . . . . 74.329999999999998 111.522 174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 97.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.468 2.778 . . . . 74.519999999999996 112.98 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -92.22 0.09 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.413 -0.358 . . . . 63.140000000000001 113.164 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.77 79.34 6.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.384 0.673 . . . . 72.439999999999998 111.692 -170.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.32 -20.85 3.82 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.105 -0.952 . . . . 73.230000000000004 114.638 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.7 m -89.73 114.54 61.03 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 108.503 -0.925 . . . . 64.329999999999998 108.503 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.41 -6.54 10.93 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.614 2.209 . . . . 44.039999999999999 113.504 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 172.09 12.05 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.084 0.954 . . . . 64.239999999999995 109.209 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.3 m -73.05 115.61 12.58 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.679 -0.692 . . . . 64.319999999999993 110.183 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -124.04 114.44 19.74 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.223 1.009 . . . . 53.409999999999997 108.479 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.43 104.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.923 0.489 . . . . 60.399999999999999 110.063 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.575 HG12 ' SG ' ' A' ' 54' ' ' CYS . 35.3 m -92.37 111.69 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.814 0.816 . . . . 64.319999999999993 109.238 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.71 134.53 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.264 0.626 . . . . 74.230000000000004 109.565 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 66.4 m95 -96.34 130.03 43.54 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 78.3 p -84.13 169.02 15.28 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.477 0.486 . . . . 73.040000000000006 109.704 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -21.47 66.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.178 0.591 . . . . 74.5 110.533 172.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.0 mtm -85.02 2.35 43.55 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.829 1.252 . . . . 71.530000000000001 110.915 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.86 38.57 11.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.895 1.678 . . . . 70.040000000000006 112.704 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -90.73 135.65 33.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.472 -1.24 . . . . 63.420000000000002 109.467 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -98.1 115.8 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.429 -0.952 . . . . 73.450000000000003 108.429 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 46.4 pt -119.16 149.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.291 0.636 . . . . 70.030000000000001 109.478 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.575 ' SG ' HG12 ' A' ' 44' ' ' VAL . 92.6 m -115.07 117.83 31.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.391 0.676 . . . . 70.439999999999998 109.532 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.55 154.29 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.274 1.03 . . . . 72.340000000000003 108.877 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -77.21 148.26 77.66 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.874 0.47 . . . . 71.519999999999996 110.477 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -64.47 -13.67 39.86 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.879 2.386 . . . . 64.310000000000002 113.078 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -107.42 18.41 21.59 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.716 0.806 . . . . 71.530000000000001 111.871 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.84 123.21 19.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.851 -1.166 . . . . 55.329999999999998 107.851 167.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -56.25 -44.52 79.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.219 1.008 . . . . 54.329999999999998 112.19 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.0 p-90 -64.24 -38.16 90.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.814 0.445 . . . . 74.140000000000001 111.135 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.93 -33.65 76.06 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.559 0.744 . . . . 63.149999999999999 110.99 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -54.26 -38.61 66.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 72.030000000000001 111.132 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.48 -37.95 86.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.643 . . . . 73.040000000000006 110.372 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.81 -41.93 91.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.767 0.827 . . . . 73.439999999999998 109.924 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 -24.97 62.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.231 1.012 . . . . 73.299999999999997 110.984 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -83.46 -35.64 24.78 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.951 0.5 . . . . 55.310000000000002 109.844 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -75.88 -23.13 55.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.957 0.503 . . . . 73.150000000000006 111.626 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 p -77.22 -17.86 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 110.032 -0.359 . . . . 71.329999999999998 110.032 174.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.35 -0.982 . . . . 73.129999999999995 108.35 168.457 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.237 0.409 0 N-CA-C 107.91 -1.145 . . . . 44.409999999999997 107.91 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -86.71 40.51 0.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.138 0.975 . . . . 53.109999999999999 111.188 -174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' CYS . . . 74.21 165.65 12.82 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.826 -0.624 . . . . 74.420000000000002 112.284 -174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -100.0 168.61 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 109.282 -0.636 . . . . 72.430000000000007 109.282 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.92 138.15 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.129 0.572 . . . . 71.409999999999997 110.086 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -98.18 7.04 46.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.796 0.839 . . . . 73.230000000000004 109.638 172.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -118.28 128.61 54.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.293 1.037 . . . . 55.149999999999999 109.283 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.44 126.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 109.156 -0.683 . . . . 74.200000000000003 109.156 170.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.65 142.21 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 122.803 0.441 . . . . 71.5 110.167 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.66 135.82 15.95 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.268 -0.424 . . . . 41.009999999999998 112.35 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.35 -34.25 70.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.45 0.7 . . . . 72.019999999999996 109.962 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -62.25 -32.64 73.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.295 1.038 . . . . 54.299999999999997 112.309 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -98.42 4.18 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 111.905 0.335 . . . . 71.010000000000005 111.905 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 32.7 mm -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.371 -0.603 . . . . 74.349999999999994 109.371 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.32 -57.95 2.1 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.796 -0.446 . . . . 53.509999999999998 109.796 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -145.9 144.37 30.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.043 0.937 . . . . 75.230000000000004 109.364 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -107.9 109.33 27.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.226 -1.027 . . . . 73.140000000000001 108.226 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -93.06 127.2 38.51 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.535 -0.913 . . . . 74.329999999999998 108.535 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.6 111.51 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 107.956 -1.127 . . . . 74.299999999999997 107.956 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 m -113.74 127.28 27.0 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 109.143 -0.688 . . . . 72.109999999999999 109.143 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.24 154.44 5.78 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.574 3.516 . . . . 74.409999999999997 114.159 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.97 -177.05 2.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.224 2.616 . . . . 71.319999999999993 113.63 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.13 76.55 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.018 -0.537 . . . . 52.530000000000001 113.288 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -90.51 72.35 6.91 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.465 -0.939 . . . . 52.310000000000002 108.465 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.42 -13.45 11.12 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.384 -0.676 . . . . 73.310000000000002 114.601 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.53 146.39 47.84 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.915 0.886 . . . . 70.230000000000004 109.874 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.04 -7.56 19.23 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.239 2.626 . . . . 73.319999999999993 113.915 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -100.13 150.45 22.49 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.095 0.558 . . . . 71.409999999999997 109.994 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.9 m -67.57 134.16 50.74 Favored 'General case' 0 C--O 1.242 0.666 0 O-C-N 123.93 0.768 . . . . 63.020000000000003 109.757 170.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.88 119.79 28.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.099 -0.704 . . . . 74.109999999999999 109.099 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.77 103.5 15.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.265 -1.013 . . . . 54.43 108.265 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.22 114.56 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.779 -0.823 . . . . 53.109999999999999 108.779 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 54.7 mt -95.06 121.61 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.351 -0.611 . . . . 74.209999999999994 109.351 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -86.95 123.67 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.912 -1.144 . . . . 72.450000000000003 107.912 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.3 p -87.78 179.22 6.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.015 0.526 . . . . 71.5 111.016 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.76 -14.08 60.67 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.374 0.67 . . . . 72.209999999999994 111.737 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -94.5 0.94 55.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.551 0.74 . . . . 74.109999999999999 110.33 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.18 23.6 10.9 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.879 1.671 . . . . 73.510000000000005 112.909 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -71.52 123.81 23.25 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.877 -1.157 . . . . 63.219999999999999 107.877 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t -96.01 111.26 25.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.468 -1.308 . . . . 61.520000000000003 107.468 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.19 136.89 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.515 -0.92 . . . . 73.219999999999999 108.515 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 42.3 t -107.61 117.55 34.4 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.003 -1.11 . . . . 64.420000000000002 108.003 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.81 164.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 54.119999999999997 109.812 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.44 141.43 73.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.324 -0.621 . . . . 73.209999999999994 109.324 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.06 -23.95 78.44 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.782 2.321 . . . . 64.030000000000001 112.765 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.71 31.48 5.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.591 0.757 . . . . 71.109999999999999 110.663 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 126.06 27.39 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -68.68 -30.17 68.79 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.614 0.766 . . . . 73.0 112.936 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -74.1 -23.36 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.986 0.514 . . . . 65.140000000000001 111.603 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.97 -21.81 65.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.841 0.856 . . . . 74.200000000000003 110.631 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -58.18 -30.8 66.7 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.105 0.962 . . . . 75.400000000000006 111.522 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -65.59 -36.93 85.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.408 0.683 . . . . 61.399999999999999 110.708 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.62 -37.28 65.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.272 0.629 . . . . 42.219999999999999 109.687 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -67.55 -33.27 74.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.776 0.83 . . . . 64.310000000000002 110.51 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -74.65 -36.96 62.85 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.899 1.28 . . . . 75.299999999999997 110.552 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -69.32 -35.43 75.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.441 0.697 . . . . 74.430000000000007 111.038 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.98 -7.81 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.233 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.05 -0.722 . . . . 45.049999999999997 109.05 175.183 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.451 -0.574 . . . . 70.129999999999995 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -110.28 10.14 23.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.907 0.883 . . . . 54.200000000000003 109.915 174.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.69 -82.5 1.07 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.778 0.704 . . . . 71.040000000000006 111.415 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.85 168.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.536 1.134 . . . . 72.310000000000002 109.955 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 HD11 ' HZ2' ' A' ' 61' ' ' TRP . 43.9 pt -123.75 144.07 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.805 -0.813 . . . . 75.340000000000003 108.805 167.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -77.24 -41.05 42.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.535 0.734 . . . . 54.219999999999999 111.328 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.5 p -81.85 144.71 30.82 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.223 1.009 . . . . 75.5 111.632 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.7 t -85.4 115.42 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.499 -0.926 . . . . 73.519999999999996 108.499 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.6 134.17 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.625 0.77 . . . . 65.140000000000001 109.523 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.13 140.07 30.51 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.762 0.664 . . . . 54.340000000000003 114.23 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.22 -37.15 71.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.996 0.918 . . . . 70.540000000000006 110.907 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.14 -21.63 60.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.404 0.682 . . . . 74.409999999999997 112.099 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.38 4.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 122.173 -0.329 . . . . 73.209999999999994 111.276 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 47.2 mm -74.23 123.4 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.842 0.857 . . . . 74.120000000000005 108.94 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.28 -55.92 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.999 0.52 . . . . 74.109999999999999 110.604 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -149.4 136.21 19.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.912 0.485 . . . . 54.210000000000001 110.165 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.94 145.01 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.476 1.11 . . . . 74.030000000000001 109.296 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -136.55 126.11 25.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.182 0.993 . . . . 70.420000000000002 108.543 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.87 112.54 40.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.445 0.698 . . . . 73.329999999999998 109.293 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 22.4 m -87.59 123.63 69.1 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.515 0.726 . . . . 64.219999999999999 109.489 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 27.4 Cg_exo -64.35 139.94 67.82 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.28 2.653 . . . . 73.5 113.789 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.78 99.99 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.292 2.662 . . . . 72.030000000000001 112.544 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.52 -45.74 0.26 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.985 -0.552 . . . . 41.32 112.207 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -83.03 75.01 9.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.578 0.751 . . . . 62.520000000000003 110.582 -173.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.67 26.7 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.709 0.643 . . . . 41.049999999999997 114.709 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 p -122.42 130.82 24.52 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.749 0.82 . . . . 73.230000000000004 108.957 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.48 -4.83 13.18 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.73 2.287 . . . . 73.549999999999997 113.352 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -123.06 161.56 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.83 0.852 . . . . 75.120000000000005 110.392 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.4 m -69.31 113.78 6.96 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.961 -0.755 . . . . 72.010000000000005 108.961 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 40.8 tt0 -96.49 130.44 43.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.351 0.66 . . . . 73.510000000000005 109.518 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.88 101.36 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.159 -1.052 . . . . 70.310000000000002 108.159 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -108.1 125.13 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.802 0.841 . . . . 64.230000000000004 109.037 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 63.2 mt -118.72 129.66 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.405 0.682 . . . . 61.409999999999997 109.829 -175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -86.96 124.73 33.48 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.751 -1.203 . . . . 73.340000000000003 107.751 167.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.5 p -81.96 173.53 12.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.228 0.611 . . . . 62.219999999999999 109.573 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.66 -12.0 60.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.943 0.402 . . . . 72.099999999999994 110.919 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -85.98 1.91 48.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.939 0.896 . . . . 74.420000000000002 110.773 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 67.72 11.69 8.49 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.589 1.556 . . . . 62.009999999999998 111.618 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -73.45 126.02 29.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.991 -0.744 . . . . 62.109999999999999 108.991 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.07 102.51 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.476 -1.305 . . . . 61.310000000000002 107.476 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.6 pt -98.92 154.01 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.361 -0.978 . . . . 74.319999999999993 108.361 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 t -135.46 128.79 32.11 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.948 -1.13 . . . . 63.210000000000001 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.3 160.11 29.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 123.919 0.888 . . . . 75.340000000000003 109.51 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.509 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.6 148.32 65.51 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.109 -1.071 . . . . 74.200000000000003 108.109 173.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.59 -28.19 64.02 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.76 2.306 . . . . 74.239999999999995 113.997 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -90.5 2.58 55.59 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.42 0.526 . . . . 72.510000000000005 112.42 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.31 30.84 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.796 0.839 . . . . 64.150000000000006 112.277 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -50.64 37.87 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.391 1.476 . . . . 65.010000000000005 112.334 -162.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.42 ' HZ2' HD11 ' A' ' 17' ' ' ILE . 51.9 p-90 -76.2 -20.19 57.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.046 0.139 . . . . 73.129999999999995 111.182 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.82 -28.67 69.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.461 0.705 . . . . 61.340000000000003 110.174 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -61.7 -19.05 61.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.708 . . . . 54.310000000000002 112.428 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -71.8 -38.02 70.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.994 0.517 . . . . 74.219999999999999 109.75 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.55 -37.05 65.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.764 0.826 . . . . 71.510000000000005 109.124 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -71.35 -29.54 65.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.233 -0.894 . . . . 64.099999999999994 110.875 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -81.47 -34.54 31.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.055 0.542 . . . . 73.040000000000006 110.794 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -67.83 -31.99 72.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.186 0.594 . . . . 75.129999999999995 111.001 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.99 -6.28 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.091 0.472 . . . . 73.439999999999998 110.873 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 N--CA 1.474 0.765 0 C-N-CA 124.015 0.926 . . . . 63.100000000000001 110.884 176.146 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.6 pt . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 121.479 0.657 . . . . 75.400000000000006 110.55 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.32 142.33 50.45 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.963 -0.562 . . . . 60.25 109.678 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 170.43 8.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.01 0.924 . . . . 73.049999999999997 109.146 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.63 99.35 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.666 0.787 . . . . 23.109999999999999 111.203 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -82.52 127.38 33.27 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.424 -0.807 . . . . 74.420000000000002 109.81 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -75.54 143.59 42.36 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.255 -1.017 . . . . 75.219999999999999 108.255 168.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -141.55 163.41 32.99 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.766 0.826 . . . . 73.040000000000006 109.562 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -67.76 136.97 55.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 109.052 -0.722 . . . . 72.129999999999995 109.052 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -152.0 163.85 38.41 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.759 -0.83 . . . . 72.219999999999999 108.759 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -141.62 -179.6 6.26 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.571 0.748 . . . . 72.040000000000006 110.403 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.1 p -64.65 114.96 4.77 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.319 -0.855 . . . . 60.43 109.642 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -73.27 120.53 19.02 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.394 -0.595 . . . . 71.329999999999998 109.394 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 14' ' ' SER . 47.1 t -81.03 168.13 19.01 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.626 0.77 . . . . 71.510000000000005 110.143 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 31.5 p -53.83 -47.14 71.21 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.427 -0.806 . . . . 73.019999999999996 110.235 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.34 168.1 40.71 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 115.835 -0.62 . . . . 73.049999999999997 113.298 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 172.41 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.688 1.195 . . . . 64.5 109.403 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -124.05 147.65 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.24 0.543 . . . . 72.25 111.496 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 p -97.52 -14.55 21.02 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.117 0.967 . . . . 75.430000000000007 111.219 168.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.3 m -99.24 143.28 29.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.89 0.876 . . . . 73.310000000000002 109.753 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.22 122.96 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.82 136.82 24.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 115.993 -0.549 . . . . 52.240000000000002 109.577 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 121.88 27.21 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.659 0.6 . . . . 72.319999999999993 112.477 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.49 -31.03 61.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.713 1.205 . . . . 73.409999999999997 110.777 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.58 -31.9 53.37 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.67 0.788 . . . . 73.439999999999998 111.373 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.5 pt -90.59 8.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 111.579 0.215 . . . . 71.239999999999995 111.579 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.451 HG13 HD11 ' A' ' 65' ' ' LEU . 29.8 mm -75.64 136.81 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.422 -0.955 . . . . 71.219999999999999 108.422 173.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.76 -55.44 2.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.948 0.499 . . . . 62.340000000000003 109.966 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 24.4 ptt180 -147.6 159.15 44.09 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.489 0.662 . . . . 73.439999999999998 110.769 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 43' ' ' VAL . 76.7 mt -111.53 110.76 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 114.23 -1.35 . . . . 74.099999999999994 108.741 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 26.7 tt0 -100.98 142.58 32.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.482 1.113 . . . . 54.240000000000002 108.125 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -112.74 136.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 122.882 0.473 . . . . 63.5 110.725 -174.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.7 m -114.37 97.09 45.12 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.605 -0.887 . . . . 71.019999999999996 108.605 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.39 167.24 27.8 Favored 'Trans proline' 0 CA--C 1.56 1.785 0 C-N-CA 122.428 2.085 . . . . 72.209999999999994 112.748 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.02 148.48 93.07 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.466 2.111 . . . . 51.310000000000002 112.194 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.39 -16.52 55.09 Favored Glycine 0 N--CA 1.474 1.218 0 CA-C-N 116.52 -0.309 . . . . 74.219999999999999 112.752 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 22.32 1.71 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.982 0.913 . . . . 73.450000000000003 111.103 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.97 -5.89 84.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.04 -0.424 . . . . 42.130000000000003 112.04 -166.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.9 m -99.02 116.78 65.05 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.34 1.056 . . . . 75.319999999999993 109.497 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.26 -20.09 49.56 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.429 2.086 . . . . 44.329999999999998 111.558 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -125.48 145.82 49.92 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.653 1.181 . . . . 73.030000000000001 110.089 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 m -72.61 115.52 11.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.362 -0.977 . . . . 61.109999999999999 108.362 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -120.08 140.43 51.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.1 0.409 . . . . 72.150000000000006 110.865 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG13 HG23 ' A' ' 29' ' ' ILE . 93.0 t -91.09 120.51 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.923 0.889 . . . . 52.530000000000001 110.145 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 54' ' ' CYS . 57.8 t -91.14 117.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.854 0.861 . . . . 75.420000000000002 108.814 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.12 128.68 44.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 109.633 -0.506 . . . . 51.439999999999998 109.633 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 50.0 m95 -104.64 116.28 31.78 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.452 -1.684 . . . . 64.329999999999998 106.452 166.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.8 p -87.19 172.14 10.14 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.959 0.409 . . . . 64.0 111.273 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -65.47 -22.29 66.73 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.895 0.878 . . . . 55.030000000000001 111.033 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 49' ' ' MET . 1.1 mpt? -83.72 -0.84 52.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.025 0.93 . . . . 71.120000000000005 111.246 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.67 19.37 9.77 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.183 1.393 . . . . 74.310000000000002 111.634 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -72.05 124.96 26.06 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.73 -0.841 . . . . 74.299999999999997 108.73 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.31 113.35 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.222 1.009 . . . . 71.209999999999994 108.32 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.26 154.48 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.895 0.878 . . . . 63.039999999999999 109.398 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 44' ' ' VAL . 24.2 m -116.93 117.95 31.1 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.385 -0.968 . . . . 72.219999999999999 108.385 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.11 160.33 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.814 0.846 . . . . 75.510000000000005 109.512 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.8 OUTLIER -62.94 133.64 95.4 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.043 0.537 . . . . 64.25 110.273 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 -32.87 59.32 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.825 2.35 . . . . 74.239999999999995 112.414 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -100.82 25.26 8.14 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.577 -0.738 . . . . 73.219999999999999 111.477 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.06 131.86 47.67 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.287 -0.635 . . . . 64.109999999999999 109.287 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -57.65 -34.03 68.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.857 1.263 . . . . 74.310000000000002 112.927 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -78.57 -34.43 46.96 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.39 0.676 . . . . 71.329999999999998 111.648 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.5 tp -70.59 -20.62 62.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.661 0.784 . . . . 72.400000000000006 111.457 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -51.99 -37.6 53.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.851 0.86 . . . . 73.299999999999997 111.706 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -72.38 -29.65 63.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 73.409999999999997 111.317 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -73.55 -38.33 65.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 63.119999999999997 109.71 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.63 -29.39 65.75 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.737 0.815 . . . . 71.150000000000006 110.427 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -81.13 -23.43 38.35 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.634 0.774 . . . . 72.329999999999998 110.805 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.13 -37.56 66.61 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.272 0.629 . . . . 73.099999999999994 111.28 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 m -69.79 -29.7 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.562 0.345 . . . . 65.120000000000005 111.919 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -95.26 159.46 15.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.114 0.566 . . . . 72.329999999999998 109.527 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.5 t -74.25 139.89 44.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 116.127 -0.488 . . . . 71.430000000000007 110.012 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -93.3 -55.4 3.32 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.069 -0.715 . . . . 72.140000000000001 109.069 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.1 t -167.74 -172.09 1.78 Allowed 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.07 0.948 . . . . 53.420000000000002 109.021 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 tt -153.51 135.24 14.49 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.978 -0.749 . . . . 51.420000000000002 108.978 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 t -148.2 148.03 30.08 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.443 0.697 . . . . 54.43 109.545 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.9 p -153.21 148.1 26.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.61 0.764 . . . . 70.430000000000007 109.71 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -112.64 92.02 18.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.858 0.863 . . . . 75.040000000000006 110.615 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.35 110.21 2.2 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.539 2.159 . . . . 72.530000000000001 111.317 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -148.98 135.52 19.5 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.423 0.689 . . . . 61.009999999999998 109.315 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.99 134.29 78.01 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.289 -0.862 . . . . 72.319999999999993 109.222 171.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.85 103.51 0.1 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.276 1.984 . . . . 64.150000000000006 111.813 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.7 85.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 122.706 1.241 . . . . 73.25 110.044 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 t -93.74 88.16 5.71 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.541 -1.209 . . . . 74.319999999999993 108.218 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -79.73 73.0 6.46 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.427 0.691 . . . . 63.149999999999999 109.904 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -65.17 118.13 8.78 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.966 -0.753 . . . . 73.150000000000006 108.966 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -158.9 96.67 1.36 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.828 -0.624 . . . . 74.310000000000002 109.393 -171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.12 -39.78 15.24 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.694 -0.685 . . . . 41.5 109.488 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.979 0 C-N-CA 125.395 1.478 . . . . 64.219999999999999 108.172 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.359 -0.608 . . . . 52.130000000000003 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.0 149.91 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.346 1.058 . . . . 61.299999999999997 108.697 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 136.94 33.83 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.897 -0.779 . . . . 70.400000000000006 108.897 175.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.31 114.15 8.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.187 -0.671 . . . . 73.099999999999994 109.187 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.92 97.41 6.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.944 0.498 . . . . 43.109999999999999 110.088 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -75.84 96.54 3.71 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.44 -0.8 . . . . 60.32 109.212 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.9 p -64.31 101.36 0.42 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.977 0.911 . . . . 43.140000000000001 111.636 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -99.0 93.68 6.14 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.069 -0.715 . . . . 63.039999999999999 109.069 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -81.98 97.87 8.31 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.747 -0.661 . . . . 73.319999999999993 110.659 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -156.95 -178.23 7.21 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.216 -1.031 . . . . 72.129999999999995 108.216 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 73.9 m -69.96 114.42 8.12 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.637 -0.875 . . . . 73.549999999999997 108.637 176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -79.39 118.85 21.66 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.909 -0.774 . . . . 64.030000000000001 108.909 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -99.17 110.76 23.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.835 -1.172 . . . . 53.329999999999998 107.835 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.5 p -55.31 -28.22 52.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.243 1.017 . . . . 64.140000000000001 111.866 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.16 161.94 15.19 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.093 -1.203 . . . . 62.039999999999999 110.093 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.2 m -102.81 143.24 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.21 -1.033 . . . . 70.209999999999994 108.21 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.9 pt -99.87 139.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.599 -0.728 . . . . 71.219999999999999 110.439 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m -103.48 7.54 37.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.908 0.883 . . . . 43.219999999999999 111.105 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 m -74.37 137.86 43.04 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.557 0.743 . . . . 53.219999999999999 110.321 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -73.05 111.75 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.102 -1.073 . . . . 64.140000000000001 108.102 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -114.27 128.2 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.958 0.903 . . . . 60.109999999999999 109.225 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.99 162.79 16.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.096 -0.502 . . . . 60.030000000000001 112.712 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.33 -21.99 60.61 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.824 0.85 . . . . 71.439999999999998 111.469 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -53.55 -30.72 43.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.952 1.301 . . . . 73.230000000000004 112.038 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 36.1 pt -119.8 -3.46 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 113.044 0.757 . . . . 71.409999999999997 113.044 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 mm -70.58 135.19 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 118.749 0.704 . . . . 72.219999999999999 109.704 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.91 -56.86 2.35 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.241 0.616 . . . . 52.0 110.411 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -143.42 147.55 34.77 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.566 0.746 . . . . 65.230000000000004 109.746 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.8 mt -108.16 112.33 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.928 -1.138 . . . . 71.420000000000002 107.928 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -107.16 104.42 14.05 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.097 -0.705 . . . . 73.349999999999994 109.097 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.85 140.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 108.922 -0.77 . . . . 62.229999999999997 108.922 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.9 m -111.99 92.9 19.24 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.793 -0.818 . . . . 73.329999999999998 108.793 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.74 149.87 38.93 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.365 2.71 . . . . 74.099999999999994 113.089 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 90.0 Cg_endo -74.36 2.26 6.45 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.719 2.28 . . . . 73.430000000000007 114.166 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.72 47.53 3.59 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 112.196 -0.362 . . . . 73.019999999999996 112.196 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -144.21 5.22 1.27 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.597 1.159 . . . . 74.319999999999993 110.683 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.95 44.79 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.675 -0.514 . . . . 73.319999999999993 112.739 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 28.6 m -82.68 126.61 72.88 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 108.595 -0.891 . . . . 75.420000000000002 108.595 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.61 -42.79 44.08 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.652 2.235 . . . . 62.210000000000001 113.565 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -107.92 164.56 12.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.22 0.608 . . . . 71.010000000000005 110.238 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 12.7 t -86.1 128.46 34.88 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.459 -0.941 . . . . 74.010000000000005 108.459 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 mm-40 -108.21 119.07 38.44 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.616 -0.513 . . . . 60.219999999999999 109.616 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.52 102.34 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.696 -0.483 . . . . 75.239999999999995 109.696 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.7 t -99.45 107.52 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.0 -1.111 . . . . 74.239999999999995 108.0 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -103.9 133.12 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.404 -0.591 . . . . 71.409999999999997 109.404 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -102.79 130.0 49.63 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.615 1.166 . . . . 74.219999999999999 108.422 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.5 p -87.07 176.89 7.39 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.388 0.675 . . . . 73.120000000000005 110.52 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 41.4 mtmt -71.58 -24.48 61.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.077 0.551 . . . . 72.329999999999998 110.726 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -77.76 -2.66 37.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.175 0.99 . . . . 74.099999999999994 110.569 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 68.84 14.64 8.94 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.462 1.505 . . . . 52.5 110.826 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.17 131.78 39.58 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.856 -1.164 . . . . 75.310000000000002 107.856 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.22 121.28 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 115.344 -0.844 . . . . 74.519999999999996 109.817 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -119.01 134.0 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.805 -0.813 . . . . 74.030000000000001 108.805 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 44.4 t -110.92 126.24 54.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.862 0.865 . . . . 74.040000000000006 109.568 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG11 ' HE1' ' A' ' 61' ' ' TRP . 19.2 m -137.42 164.29 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.218 1.007 . . . . 73.430000000000007 109.394 172.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -84.27 161.3 55.03 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 115.137 -0.938 . . . . 64.420000000000002 110.052 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.4 -18.19 63.49 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.84 2.36 . . . . 72.430000000000007 112.748 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.07 25.51 7.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.8 0.84 . . . . 75.349999999999994 110.62 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 136.09 36.11 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.85 0.46 . . . . 43.439999999999998 110.363 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.21 -50.52 71.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.008 0.923 . . . . 53.420000000000002 112.748 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.401 ' HE1' HG11 ' A' ' 55' ' ' VAL . 36.4 p-90 -66.86 -28.69 68.54 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.881 0.472 . . . . 71.299999999999997 110.948 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.2 tp -67.25 -30.3 70.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.216 1.006 . . . . 63.119999999999997 111.683 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -54.17 -35.92 62.82 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.764 0.826 . . . . 70.340000000000003 111.63 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -67.24 -42.22 84.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.103 -0.953 . . . . 73.299999999999997 109.651 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.86 -32.37 72.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.406 1.082 . . . . 63.549999999999997 110.443 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -38.57 79.47 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.444 0.698 . . . . 64.409999999999997 110.178 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -68.96 -37.73 79.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.324 -0.25 . . . . 63.240000000000002 110.324 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -66.54 -37.98 86.15 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.012 0.525 . . . . 54.219999999999999 112.15 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.16 -11.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-O 120.927 0.394 . . . . 71.430000000000007 111.117 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 72' ' ' LYS . 26.8 tp60 -80.14 124.84 29.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.92 -0.771 . . . . 72.439999999999998 108.92 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.7 p -68.99 -2.66 10.43 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.128 0.971 . . . . 64.349999999999994 113.175 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' A' ' 70' ' ' GLN . 24.0 tptp -71.86 -34.57 69.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.435 0.694 . . . . 72.129999999999995 109.928 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.7 m -85.39 147.28 26.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.868 0.867 . . . . 73.439999999999998 110.878 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.0 tp -77.14 89.15 3.63 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.054 -0.721 . . . . 25.219999999999999 109.054 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.8 m -148.11 -158.84 0.95 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.461 -1.311 . . . . 75.530000000000001 107.461 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.7 t -70.38 92.39 0.8 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.305 -0.998 . . . . 65.319999999999993 108.305 167.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.3 p -73.35 119.08 73.95 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.703 0.801 . . . . 71.329999999999998 110.614 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -91.51 110.51 0.31 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.444 2.096 . . . . 72.420000000000002 110.826 165.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -49.0 129.55 17.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.873 0.869 . . . . 55.350000000000001 111.302 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -112.86 93.25 23.61 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.057 0.943 . . . . 71.239999999999995 108.905 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 80.37 0.88 Allowed 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.55 2.166 . . . . 64.040000000000006 111.26 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.8 p -152.06 162.85 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.468 1.107 . . . . 73.019999999999996 108.779 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.3 p -62.48 97.96 0.11 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 109.063 -0.718 . . . . 74.540000000000006 109.063 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -131.37 156.81 44.89 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.093 0.957 . . . . 72.420000000000002 108.955 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -75.42 93.9 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.843 -0.799 . . . . 75.140000000000001 108.843 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -60.18 140.16 57.12 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.932 -1.031 . . . . 62.310000000000002 109.758 171.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.82 26.72 14.43 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.962 0.905 . . . . 75.319999999999993 112.331 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.673 -0.679 . . . . 65.549999999999997 110.578 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 110.369 -0.234 . . . . 75.409999999999997 110.369 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.03 116.84 23.05 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.225 -1.028 . . . . 74.140000000000001 108.225 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -71.06 91.23 0.88 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.69 0.796 . . . . 75.209999999999994 110.978 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.71 94.89 1.41 Allowed 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.612 -0.885 . . . . 61.340000000000003 108.612 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -66.96 117.61 9.28 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.973 0.909 . . . . 74.420000000000002 111.713 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -70.75 -9.73 57.96 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.092 0.957 . . . . 74.319999999999993 111.46 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 t -107.28 145.65 32.48 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.543 -0.91 . . . . 62.119999999999997 108.543 168.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -74.15 135.4 42.86 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 122.613 0.365 . . . . 40.310000000000002 110.059 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.6 mt -73.79 89.14 1.8 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.343 -0.984 . . . . 74.209999999999994 108.343 174.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.71 160.74 31.1 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.835 -1.075 . . . . 73.239999999999995 110.744 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 m -71.65 107.14 4.35 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.062 -0.718 . . . . 74.450000000000003 109.062 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.73 121.05 37.04 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.514 -1.291 . . . . 73.310000000000002 107.514 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -118.4 166.16 13.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.025 0.53 . . . . 74.030000000000001 110.123 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -57.35 -31.08 65.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.19 0.996 . . . . 72.019999999999996 112.212 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.46 -173.34 15.97 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.46 -0.791 . . . . 75.109999999999999 111.562 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 55' ' ' VAL . 99.5 t -99.68 129.35 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.17 -1.048 . . . . 71.349999999999994 108.17 -175.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 53' ' ' ILE . 37.9 pt -84.15 140.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 123.361 0.413 . . . . 72.0 110.228 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 p -90.39 -4.18 57.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.794 0.838 . . . . 65.019999999999996 111.446 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 59.9 m -88.41 142.84 27.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.598 0.759 . . . . 62.299999999999997 109.878 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -85.74 112.38 22.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.839 -1.171 . . . . 70.140000000000001 107.839 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -72.68 143.09 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.186 0.594 . . . . 55.219999999999999 110.556 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 123.27 30.18 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.83 0.706 . . . . 64.439999999999998 112.574 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.451 HD21 ' HG3' ' A' ' 64' ' ' ARG . 9.8 mp -67.41 -22.41 65.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.209 0.604 . . . . 71.019999999999996 111.428 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -74.43 -26.08 59.84 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.435 0.694 . . . . 74.519999999999996 111.683 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 47.8 pt -97.65 3.44 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 122.149 -0.344 . . . . 64.329999999999998 111.525 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 65' ' ' LEU . 27.5 mm -72.05 130.18 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 109.566 -0.531 . . . . 74.109999999999999 109.566 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -102.03 -59.43 1.7 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.452 0.701 . . . . 64.200000000000003 110.81 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -146.29 150.18 35.28 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.71 0.404 . . . . 70.439999999999998 110.684 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.24 107.87 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.115 0.966 . . . . 73.140000000000001 108.946 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -97.44 147.6 24.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.922 1.289 . . . . 75.25 109.101 174.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.17 142.9 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.677 -0.49 . . . . 64.209999999999994 109.677 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.2 m -121.78 109.78 33.89 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.992 0.917 . . . . 75.319999999999993 109.098 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.12 155.3 17.11 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.625 2.216 . . . . 53.329999999999998 113.085 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.1 173.66 14.06 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.733 2.289 . . . . 72.340000000000003 112.051 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.66 -26.13 8.66 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 116.775 -0.193 . . . . 74.420000000000002 113.384 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -91.8 23.49 3.6 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.135 0.974 . . . . 63.020000000000003 110.816 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.59 -19.53 44.63 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.905 -0.589 . . . . 51.219999999999999 112.235 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.8 m -80.46 119.3 75.93 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.034 0.417 . . . . 53.219999999999999 109.941 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.81 -22.7 74.92 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.13 2.553 . . . . 75.230000000000004 113.327 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 172.24 17.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.494 0.718 . . . . 75.150000000000006 109.713 177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -75.04 133.86 41.53 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.131 -0.692 . . . . 73.219999999999999 109.131 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.84 124.97 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.081 0.467 . . . . 73.109999999999999 110.532 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.27 113.84 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.223 1.009 . . . . 62.140000000000001 109.1 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.76 109.68 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.417 -0.957 . . . . 71.019999999999996 108.417 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.9 mt -98.65 136.35 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 109.431 -0.581 . . . . 70.340000000000003 109.431 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -114.39 129.03 56.63 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.121 1.369 . . . . 72.030000000000001 108.616 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 p -90.46 172.22 8.87 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.777 0.431 . . . . 75.340000000000003 110.758 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 19.5 ptpt -69.16 -31.25 69.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.681 0.793 . . . . 64.239999999999995 111.133 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.1 ptm -78.42 4.62 12.61 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.89 0.876 . . . . 74.430000000000007 110.729 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 63.36 25.0 14.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.839 1.656 . . . . 73.409999999999997 112.14 171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -76.5 128.57 35.02 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 107.276 -1.379 . . . . 64.329999999999998 107.276 171.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.9 t -100.56 131.0 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.66 1.184 . . . . 54.450000000000003 109.64 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 17' ' ' ILE . 32.2 pt -133.25 156.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.886 0.874 . . . . 63.140000000000001 108.672 171.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 23.1 p -137.15 122.48 19.4 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.128 -0.693 . . . . 63.43 109.128 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 16' ' ' VAL . 35.6 m -126.4 150.95 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.382 0.673 . . . . 75.439999999999998 109.785 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.57 152.97 67.77 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 109.349 -0.611 . . . . 71.310000000000002 109.349 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.53 -4.87 6.11 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.018 2.479 . . . . 73.25 115.259 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -84.07 -11.63 56.38 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.096 0.559 . . . . 72.109999999999999 112.147 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 113.63 3.57 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.65 -0.87 . . . . 63.240000000000002 108.65 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 17.5 mtpp -77.72 -20.86 52.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.722 0.638 . . . . 65.439999999999998 112.722 -171.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -75.5 -14.91 60.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.376 0.27 . . . . 62.340000000000003 111.171 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.5 tp -70.52 -29.4 65.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.672 0.389 . . . . 53.140000000000001 110.041 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -64.45 -19.69 65.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.455 0.302 . . . . 72.219999999999999 111.754 175.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 23' ' ' LEU . 1.1 tpm_? -65.76 -44.11 86.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.942 0.497 . . . . 74.310000000000002 109.691 170.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.448 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -66.78 -41.27 87.95 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.826 0.85 . . . . 64.209999999999994 110.28 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.35 -36.63 81.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.425 0.69 . . . . 65.120000000000005 110.759 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -76.72 -29.08 56.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.399 0.68 . . . . 74.209999999999994 110.956 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -74.26 -51.12 16.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.373 0.669 . . . . 74.200000000000003 111.072 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.77 -34.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 122.988 0.515 . . . . 72.040000000000006 110.747 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -102.92 96.87 7.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.031 -1.1 . . . . 75.439999999999998 108.031 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 t -157.85 108.56 2.2 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.495 -1.298 . . . . 54.350000000000001 107.495 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -76.76 -17.97 58.74 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.001 0.92 . . . . 74.329999999999998 110.719 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.0 p -117.97 74.06 0.93 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.965 0.906 . . . . 62.039999999999999 109.758 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 tt -140.56 104.79 4.82 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.287 -1.005 . . . . 72.120000000000005 108.287 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.8 p -96.5 128.1 43.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.679 -0.859 . . . . 63.210000000000001 108.679 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 m -82.77 115.51 21.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.486 0.714 . . . . 60.32 110.36 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 p -63.28 135.84 96.43 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.407 0.683 . . . . 72.0 110.466 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.54 94.87 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.732 2.288 . . . . 54.140000000000001 112.338 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -103.83 136.4 43.57 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.523 -1.217 . . . . 74.319999999999993 108.427 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -136.69 100.55 10.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.191 0.596 . . . . 43.399999999999999 110.145 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.48 -174.64 2.07 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.131 1.887 . . . . 72.340000000000003 111.438 169.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.79 78.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.526 -1.287 . . . . 75.209999999999994 107.526 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 p -84.01 75.71 10.12 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.822 0.82 . . . . 64.120000000000005 110.453 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -151.43 148.8 28.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.745 -1.116 . . . . 62.409999999999997 108.52 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -130.13 171.53 12.75 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.135 0.974 . . . . 73.340000000000003 109.341 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -17.58 61.16 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 121.97 0.108 . . . . 74.319999999999993 110.807 173.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -50.56 20.78 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.092 0.557 . . . . 72.409999999999997 109.743 169.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 124.324 1.05 . . . . 37.380000000000003 108.79 178.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.858 -0.423 . . . . 62.420000000000002 109.858 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.7 tp -130.36 151.64 50.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.495 1.118 . . . . 75.340000000000003 108.362 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -115.18 140.42 49.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.688 . . . . 61.210000000000001 109.676 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.27 105.02 17.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.932 0.893 . . . . 64.400000000000006 109.006 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -76.49 82.37 3.19 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 74.109999999999999 110.062 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.5 151.96 51.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.94 0.896 . . . . 74.409999999999997 109.787 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -75.48 85.96 2.59 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.464 -0.939 . . . . 44.25 108.464 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -87.65 107.32 18.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.473 -0.785 . . . . 72.549999999999997 109.266 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.82 -12.4 58.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.259 1.024 . . . . 52.219999999999999 110.913 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -82.24 174.59 11.02 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.565 0.746 . . . . 74.109999999999999 110.25 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.0 p -79.14 114.88 18.44 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.334 -0.988 . . . . 53.109999999999999 108.334 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -78.17 135.49 37.64 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.031 0.443 . . . . 73.450000000000003 110.049 -177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.44 149.47 32.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.125 0.97 . . . . 62.43 109.495 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 t -100.0 10.7 40.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.218 0.607 . . . . 72.420000000000002 111.01 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 172.3 46.83 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.3 -0.72 . . . . 33.109999999999999 111.3 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 33.9 m -100.21 140.13 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 117.325 0.562 . . . . 71.409999999999997 109.895 -174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.95 146.24 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.501 0.72 . . . . 60.229999999999997 110.705 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 p -92.87 -2.2 56.08 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.315 -0.857 . . . . 65.129999999999995 111.394 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.6 m -60.47 118.82 6.96 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.49 -0.559 . . . . 73.439999999999998 109.49 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.27 111.19 3.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 N-CA-C 108.822 -0.807 . . . . 53.350000000000001 108.822 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -92.52 132.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 123.249 0.62 . . . . 75.200000000000003 109.4 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.51 145.56 27.9 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.998 -0.546 . . . . 71.230000000000004 112.501 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.16 -33.66 72.49 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.103 0.961 . . . . 71.140000000000001 110.513 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.8 -28.71 68.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.834 0.853 . . . . 73.099999999999994 111.62 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 pt -103.92 12.42 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 111.931 0.345 . . . . 71.310000000000002 111.931 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 mm -76.9 122.24 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.196 -1.039 . . . . 64.319999999999993 108.196 169.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -90.06 -58.86 2.36 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.37 -0.604 . . . . 74.439999999999998 109.37 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -146.95 155.67 42.46 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.183 0.593 . . . . 65.310000000000002 109.749 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.8 mt -113.95 108.15 24.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.202 -1.036 . . . . 64.439999999999998 108.202 174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -99.47 137.75 37.53 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.616 0.766 . . . . 73.549999999999997 108.968 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.15 129.24 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.3 -0.63 . . . . 73.430000000000007 109.3 172.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 41.7 p -106.98 115.18 60.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.855 0.862 . . . . 70.310000000000002 108.984 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.35 166.17 29.31 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.724 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.73 84.09 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.434 2.089 . . . . 72.140000000000001 112.191 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.33 -179.48 39.77 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.676 -1.147 . . . . 70.129999999999995 110.677 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 65.42 18.89 11.47 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.636 1.174 . . . . 74.340000000000003 111.77 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.52 10.71 53.08 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 122.763 0.22 . . . . 34.409999999999997 113.568 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.36 117.43 33.09 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 108.059 -1.089 . . . . 64.540000000000006 108.059 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.4 5.86 5.79 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.566 2.178 . . . . 61.32 113.603 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -153.01 173.32 15.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.191 0.596 . . . . 73.409999999999997 110.776 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 m -86.8 121.29 29.1 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.55 -0.907 . . . . 65.5 108.55 169.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -131.9 134.51 45.78 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.052 0.541 . . . . 64.450000000000003 109.967 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -102.55 101.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 108.788 -0.819 . . . . 70.019999999999996 108.788 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.12 108.96 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.899 0.88 . . . . 74.530000000000001 109.262 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.41 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.5 mt -95.43 130.56 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.197 -0.668 . . . . 75.129999999999995 109.197 177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -97.68 125.78 42.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.662 -1.607 . . . . 74.400000000000006 106.662 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.9 p -89.47 169.42 11.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.025 0.375 . . . . 64.420000000000002 110.531 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.9 -25.99 63.96 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.988 0.915 . . . . 71.340000000000003 111.519 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -80.39 1.67 28.07 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.888 0.875 . . . . 70.319999999999993 110.542 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.03 22.92 11.16 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 126.151 1.78 . . . . 65.310000000000002 112.162 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -79.95 123.78 28.1 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 106.664 -1.606 . . . . 74.340000000000003 106.664 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.2 t -86.19 124.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.844 -0.799 . . . . 72.120000000000005 108.844 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.2 pt -132.67 158.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.123 0.969 . . . . 64.5 109.265 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 55.6 m -120.37 149.94 41.54 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.107 -1.072 . . . . 73.450000000000003 108.107 167.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.92 163.11 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.416 0.687 . . . . 62.340000000000003 109.817 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.37 128.24 84.72 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.051 0.54 . . . . 64.25 110.098 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.53 -29.97 80.73 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.55 2.833 . . . . 75.549999999999997 113.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -89.09 16.98 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.424 0.69 . . . . 72.219999999999999 112.702 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.24 125.9 28.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.587 -0.894 . . . . 63.43 108.587 171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.1 -37.36 81.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.675 0.79 . . . . 73.420000000000002 111.772 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 70.5 p-90 -63.49 -34.47 77.84 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.036 0.446 . . . . 74.319999999999993 110.474 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.11 -34.49 73.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.54 -0.754 . . . . 72.310000000000002 110.476 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -55.05 -38.95 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.708 0.803 . . . . 75.129999999999995 110.779 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -61.59 -48.43 80.99 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.86 -1.064 . . . . 71.310000000000002 110.072 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.44 -36.19 77.63 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.646 0.778 . . . . 62.0 111.025 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.95 -36.38 67.14 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.485 0.714 . . . . 62.130000000000003 110.637 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -75.36 -23.0 57.1 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 122.899 0.48 . . . . 74.530000000000001 110.284 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -67.1 -43.91 81.31 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.062 0.945 . . . . 71.319999999999993 110.716 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.9 m -90.78 -8.05 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 123.619 0.574 . . . . 75.129999999999995 112.045 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -79.11 167.46 21.0 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.379 0.672 . . . . 65.530000000000001 109.565 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -66.31 169.49 7.21 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.68 0.792 . . . . 54.329999999999998 111.203 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mttp 56.22 37.53 28.92 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.111 0.964 . . . . 71.439999999999998 110.929 -170.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 t -154.59 -161.47 1.22 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.558 1.143 . . . . 61.340000000000003 108.038 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 91.5 0.11 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.937 0.895 . . . . 71.420000000000002 110.055 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 p -101.83 129.5 48.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.328 -0.851 . . . . 60.219999999999999 109.394 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.0 p -79.0 -75.84 0.22 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.184 0.594 . . . . 61.219999999999999 110.858 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.7 p -90.57 120.25 68.95 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.381 0.672 . . . . 70.109999999999999 110.648 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.58 96.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.748 2.299 . . . . 73.239999999999995 111.334 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 50.5 tt0 -123.5 162.59 22.6 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.503 1.121 . . . . 73.129999999999995 108.646 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.11 98.13 5.23 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.081 0.953 . . . . 63.299999999999997 109.906 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 79' ' ' GLN . 93.3 Cg_endo -87.05 142.65 6.51 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.857 2.371 . . . . 74.540000000000006 111.676 175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.91 -19.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 123.442 0.697 . . . . 55.049999999999997 111.133 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.7 m -67.34 116.38 8.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.731 0.813 . . . . 64.129999999999995 109.803 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 10.4 mmpt? -67.74 133.29 49.02 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.745 0.818 . . . . 74.230000000000004 110.432 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -66.45 108.98 2.57 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.197 0.936 . . . . 53.329999999999998 109.795 -177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -65.6 103.51 0.87 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.066 -0.716 . . . . 75.400000000000006 109.066 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.63 71.73 10.36 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.711 0.804 . . . . 74.219999999999999 108.838 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 124.128 0.971 . . . . 64.450000000000003 108.738 -178.515 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.4 mt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 121.007 0.432 . . . . 71.019999999999996 109.875 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.66 106.45 18.41 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.757 -0.831 . . . . 73.219999999999999 108.757 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -88.04 97.66 11.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.203 0.601 . . . . 53.200000000000003 110.087 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.94 10.09 2.06 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.411 1.084 . . . . 73.019999999999996 112.418 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -129.82 113.06 14.21 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.631 1.173 . . . . 62.219999999999999 108.963 -178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -84.59 103.2 13.5 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.406 -0.961 . . . . 72.319999999999993 108.406 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -71.83 90.27 1.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.705 0.764 . . . . 75.340000000000003 109.26 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.66 137.1 32.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.805 -1.089 . . . . 65.150000000000006 111.408 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -84.54 -32.08 24.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 75.230000000000004 109.561 169.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -66.01 153.69 41.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.469 0.708 . . . . 74.439999999999998 111.822 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.638 ' SG ' HG21 ' A' ' 32' ' ' THR . 32.4 m -78.04 116.06 18.23 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.246 -1.02 . . . . 74.25 108.246 174.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -84.44 125.1 32.04 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.775 0.321 . . . . 72.319999999999993 110.838 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.504 ' SG ' HG22 ' A' ' 44' ' ' VAL . 55.5 m -142.32 150.72 41.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.21 1.004 . . . . 74.430000000000007 110.202 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -82.81 -153.16 0.12 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.677 -0.692 . . . . 71.209999999999994 109.403 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.72 158.27 36.95 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-O 120.955 0.197 . . . . 54.229999999999997 112.853 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.98 146.8 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.215 -1.032 . . . . 30.41 108.215 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.29 145.99 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.223 0.535 . . . . 71.129999999999995 110.904 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -128.72 31.1 5.01 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.749 1.22 . . . . 64.340000000000003 108.289 172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -140.57 142.21 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.708 1.203 . . . . 40.439999999999998 108.271 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.12 114.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.367 -0.605 . . . . 75.430000000000007 109.367 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.02 139.03 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.233 0.613 . . . . 74.150000000000006 109.583 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.92 131.81 11.0 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.796 0.685 . . . . 14.210000000000001 112.928 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' A' ' 68' ' ' HIS . 7.4 tt -54.46 -31.55 55.88 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.868 1.267 . . . . 74.099999999999994 110.747 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -58.35 -35.26 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.018 1.327 . . . . 51.549999999999997 112.445 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.4 pt -96.81 -6.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 119.098 -0.477 . . . . 71.409999999999997 111.46 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.7 mm -75.01 130.26 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.221 -0.659 . . . . 73.400000000000006 109.221 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.86 -53.94 2.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.212 0.605 . . . . 55.200000000000003 109.562 174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -139.11 141.14 38.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.011 0.524 . . . . 73.409999999999997 110.188 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 90.1 mt -119.22 107.94 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.37 -1.344 . . . . 73.519999999999996 107.37 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -105.3 138.99 40.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.141 -1.059 . . . . 61.100000000000001 108.141 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -116.33 110.97 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.43 -0.952 . . . . 44.350000000000001 108.43 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.638 HG21 ' SG ' ' A' ' 11' ' ' CYS . 9.6 m -89.43 121.09 69.6 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 109.505 -0.554 . . . . 65.519999999999996 109.505 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.1 148.89 83.38 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.33 2.687 . . . . 53.340000000000003 113.636 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.86 100.57 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.886 2.391 . . . . 72.219999999999999 112.142 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.97 -5.52 4.71 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-N 115.478 -0.783 . . . . 71.129999999999995 112.31 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -89.68 41.08 1.02 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.686 0.795 . . . . 70.510000000000005 111.047 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -19.75 47.92 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.501 -0.772 . . . . 63.100000000000001 112.775 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.37 116.11 39.58 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.125 -1.435 . . . . 74.140000000000001 107.125 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.02 -39.02 40.63 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.932 3.088 . . . . 75.319999999999993 113.48 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -106.58 157.81 17.4 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.666 0.786 . . . . 70.319999999999993 109.297 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -61.07 115.7 3.96 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.939 0.774 . . . . 75.310000000000002 109.703 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -110.87 110.79 21.54 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.713 -0.847 . . . . 74.409999999999997 108.713 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.34 103.04 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.732 -0.84 . . . . 73.530000000000001 108.732 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HA ' ' SG ' ' A' ' 54' ' ' CYS . 44.5 t -90.27 108.12 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.7 -0.852 . . . . 71.349999999999994 108.7 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 53' ' ' ILE . 62.3 mt -106.23 119.97 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.559 0.743 . . . . 73.140000000000001 109.133 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -94.71 124.86 38.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.117 -1.068 . . . . 75.25 108.117 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.8 p -84.81 163.68 18.93 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.906 -0.405 . . . . 52.310000000000002 109.906 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -71.61 -10.98 60.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.228 0.611 . . . . 71.5 111.512 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 ptp -90.81 4.79 50.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.54 0.736 . . . . 61.100000000000001 110.772 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 68.3 22.23 8.13 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.3 1.44 . . . . 74.409999999999997 112.648 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -84.74 128.95 34.86 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 108.538 -0.912 . . . . 75.120000000000005 108.538 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.45 114.02 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 45' ' ' ILE . 36.8 pt -125.16 128.5 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.257 -1.016 . . . . 72.049999999999997 108.257 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 44' ' ' VAL . 94.9 m -120.74 138.0 54.21 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.152 -0.343 . . . . 64.219999999999999 110.469 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG11 ' HE1' ' A' ' 61' ' ' TRP . 28.5 m -130.43 167.05 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.913 0.885 . . . . 73.329999999999998 110.958 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -73.75 153.92 89.28 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 114.427 -1.26 . . . . 70.340000000000003 110.329 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.4 -28.54 71.46 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.909 2.406 . . . . 61.020000000000003 113.2 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -107.48 24.71 12.46 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.419 0.687 . . . . 73.430000000000007 111.672 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 62' ' ' LEU . . . -65.24 124.32 21.87 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.398 -0.964 . . . . 42.009999999999998 108.398 169.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -70.83 -30.7 67.2 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.987 0.515 . . . . 63.32 111.502 -171.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.469 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.4 p-90 -64.34 -32.32 73.88 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.207 -0.664 . . . . 74.019999999999996 109.207 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 59' ' ' ALA . 64.1 tp -73.29 -37.86 66.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.775 . . . . 74.109999999999999 110.555 177.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -60.11 -44.16 95.07 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.993 0.517 . . . . 65.129999999999995 111.177 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' TRP . 13.5 ptm180 -67.86 -31.59 71.51 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.917 0.487 . . . . 75.120000000000005 111.2 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 61' ' ' TRP . 2.6 mm? -59.71 -47.94 83.63 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.596 0.759 . . . . 61.310000000000002 110.044 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.66 -34.77 78.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.914 0.886 . . . . 71.239999999999995 111.664 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -69.78 -32.61 71.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.632 0.773 . . . . 63.119999999999997 110.641 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' ND1' HD11 ' A' ' 23' ' ' LEU . 29.7 t-80 -74.64 -30.6 61.69 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.03 0.532 . . . . 72.530000000000001 111.545 175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 65' ' ' LEU . 80.6 t -64.76 -49.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 109.145 -0.687 . . . . 52.039999999999999 109.145 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -95.91 61.63 2.18 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.319 -0.993 . . . . 72.010000000000005 108.319 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -72.57 -27.72 62.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.209 -0.905 . . . . 72.400000000000006 109.43 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -86.16 117.87 25.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.949 . . . . 74.420000000000002 109.025 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.0 m -68.25 130.88 44.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.595 0.758 . . . . 63.409999999999997 110.887 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.8 tp 67.32 28.96 7.75 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.865 1.266 . . . . 72.010000000000005 111.107 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 t -86.72 121.56 29.4 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.945 -0.472 . . . . 64.040000000000006 110.299 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -114.57 25.79 10.73 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.28 1.032 . . . . 72.329999999999998 110.12 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 p -127.39 64.13 61.21 Favored Pre-proline 0 CA--C 1.56 1.345 0 C-N-CA 123.267 0.627 . . . . 64.400000000000006 110.997 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -86.31 145.01 8.23 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.188 1.925 . . . . 71.439999999999998 111.939 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -82.79 74.81 9.73 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.23 -1.026 . . . . 63.329999999999998 108.23 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.78 144.05 51.4 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 114.394 -1.275 . . . . 72.400000000000006 109.908 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HG3' ' O ' ' A' ' 29' ' ' ILE . 65.4 Cg_endo -65.98 87.87 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.967 2.445 . . . . 73.329999999999998 112.493 -175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.1 m -81.43 -15.89 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 115.244 -0.889 . . . . 53.520000000000003 110.944 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -68.82 91.74 0.47 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.583 0.706 . . . . 73.439999999999998 109.99 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -85.75 75.49 10.06 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.491 -1.3 . . . . 73.209999999999994 107.491 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -122.22 98.53 5.97 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.307 -0.861 . . . . 74.530000000000001 110.276 -170.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -97.0 74.86 2.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.525 -0.761 . . . . 75.219999999999999 109.477 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.7 154.92 33.74 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.543 -0.753 . . . . 75.319999999999993 109.467 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 109.233 -0.655 . . . . 71.040000000000006 109.233 178.689 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.977 -0.379 . . . . 74.239999999999995 109.977 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.8 tp -85.74 128.41 34.79 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.557 -0.534 . . . . 70.219999999999999 109.557 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.26 155.12 21.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.648 0.779 . . . . 65.0 109.198 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.74 121.98 45.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.207 0.603 . . . . 55.539999999999999 110.102 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.35 84.4 5.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.084 0.553 . . . . 73.239999999999995 110.044 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -61.93 143.42 56.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.833 -1.076 . . . . 72.219999999999999 111.225 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.4 m -141.93 123.0 14.6 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.888 0.875 . . . . 70.329999999999998 109.16 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.87 150.22 47.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.35 0.66 . . . . 50.119999999999997 110.018 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.36 90.19 0.94 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.485 0.714 . . . . 70.230000000000004 111.358 -172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -88.64 171.67 9.85 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.648 0.779 . . . . 73.540000000000006 109.101 168.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.1 m -75.69 113.03 12.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.411 -1.329 . . . . 73.409999999999997 107.411 168.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -71.77 120.87 17.98 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 120.953 0.406 . . . . 74.329999999999998 110.596 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.9 t -118.54 158.94 24.44 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.194 0.998 . . . . 63.439999999999998 109.851 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 p -104.26 -55.2 2.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.001 0.92 . . . . 71.540000000000006 109.364 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.18 167.96 35.7 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.247 -0.888 . . . . 73.219999999999999 111.186 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.26 156.44 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.257 0.528 . . . . 71.209999999999994 110.314 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.38 149.88 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 65.329999999999998 110.313 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -111.36 12.53 21.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 110.764 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.0 m -93.93 144.44 25.45 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.746 0.818 . . . . 74.109999999999999 109.88 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.26 110.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.701 -1.222 . . . . 73.040000000000006 107.701 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.77 124.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.894 -0.78 . . . . 71.099999999999994 108.894 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 147.57 30.35 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.774 0.671 . . . . 71.219999999999999 113.859 -174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.45 -33.36 65.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.974 0.909 . . . . 63.119999999999997 110.486 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.25 -34.28 72.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.986 0.914 . . . . 55.450000000000003 112.241 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.9 pt -107.0 13.36 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.693 0.397 . . . . 72.239999999999995 111.776 -175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.4 129.27 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.627 -0.879 . . . . 73.519999999999996 108.627 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -101.92 -59.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.822 -0.436 . . . . 63.310000000000002 109.822 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 -143.74 139.65 29.56 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.397 0.679 . . . . 64.209999999999994 109.703 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.7 mt -107.33 119.48 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.139 0.975 . . . . 71.099999999999994 109.638 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.419 ' HB3' ' O ' ' A' ' 44' ' ' VAL . 24.4 tp60 -105.68 135.24 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.321 -1.363 . . . . 74.319999999999993 107.321 170.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.4 ' N ' HE21 ' A' ' 30' ' ' GLN . 7.3 p -128.11 127.52 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.621 -0.511 . . . . 63.210000000000001 109.621 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -118.08 103.6 49.63 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 108.836 -0.802 . . . . 65.120000000000005 108.836 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.75 170.42 12.69 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.438 2.758 . . . . 72.299999999999997 112.063 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.82 99.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.263 1.975 . . . . 64.310000000000002 111.408 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.83 164.52 29.09 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.591 -1.404 . . . . 31.530000000000001 109.591 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.9 t30 66.09 19.43 11.16 Favored 'General case' 0 N--CA 1.508 2.439 0 CA-C-O 122.307 1.051 . . . . 63.43 110.363 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.32 8.46 87.56 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.205 -0.907 . . . . 73.439999999999998 113.325 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.2 m -84.87 136.87 38.34 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.305 0.642 . . . . 71.439999999999998 109.667 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.31 -52.72 0.77 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.845 2.363 . . . . 73.409999999999997 114.206 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -135.04 177.4 7.84 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.261 1.025 . . . . 63.450000000000003 109.647 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -67.17 110.37 3.44 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.203 -0.666 . . . . 74.25 109.203 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -111.41 112.5 24.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.714 1.206 . . . . 75.219999999999999 108.425 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.67 101.13 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.323 -0.991 . . . . 72.510000000000005 108.323 -177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 85.9 t -92.21 110.03 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.112 0.965 . . . . 71.519999999999996 108.814 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.57 128.81 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.006 -0.434 . . . . 72.439999999999998 110.557 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -88.76 123.9 33.62 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.448 -1.315 . . . . 75.329999999999998 107.448 168.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.1 p -84.87 174.41 9.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.812 0.445 . . . . 71.25 110.463 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.57 -21.88 65.41 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.497 0.719 . . . . 72.140000000000001 111.114 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 50.1 mtm -76.64 -4.4 42.88 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.438 1.095 . . . . 70.430000000000007 110.51 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm 60.58 23.56 13.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.839 1.656 . . . . 75.109999999999999 111.364 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -85.6 124.24 31.92 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 106.758 -1.571 . . . . 63.32 106.758 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.8 t -88.62 130.37 38.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.77 -0.826 . . . . 63.399999999999999 108.77 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.0 pt -129.68 157.36 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 75.120000000000005 109.114 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.3 m -126.8 118.1 23.98 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.246 -1.02 . . . . 52.450000000000003 108.246 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -123.58 155.26 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.946 0.498 . . . . 55.329999999999998 110.094 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.77 165.54 17.75 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.8 0.84 . . . . 73.349999999999994 109.181 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.88 0.19 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.436 2.091 . . . . 64.219999999999999 114.126 171.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -70.11 -25.48 63.52 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.523 0.729 . . . . 64.239999999999995 110.963 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.9 112.96 3.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.365 0.666 . . . . 61.130000000000003 110.427 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -70.49 -33.17 70.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.33 0.652 . . . . 73.239999999999995 111.389 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -65.46 -27.42 68.49 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.661 0.385 . . . . 63.520000000000003 111.132 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.4 tp -67.02 -33.5 75.69 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.016 0.926 . . . . 71.420000000000002 111.768 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.53 -22.46 66.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.297 0.239 . . . . 72.319999999999993 110.929 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -69.97 -39.25 76.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.389 0.676 . . . . 64.040000000000006 110.206 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.73 -41.88 74.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.138 0.975 . . . . 54.520000000000003 109.74 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.96 -25.63 61.94 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.054 -0.976 . . . . 61.43 111.656 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 -29.96 31.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.025 -0.732 . . . . 74.239999999999995 109.025 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -65.65 -28.64 69.25 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.03 0.532 . . . . 74.540000000000006 111.398 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.89 -3.44 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.2 0.6 . . . . 53.219999999999999 111.734 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -91.42 157.67 16.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.914 0.886 . . . . 72.299999999999997 110.393 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -60.8 132.99 55.62 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.201 1.0 . . . . 61.240000000000002 112.586 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -111.16 4.45 19.3 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.566 0.747 . . . . 62.32 111.034 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -75.23 90.78 2.6 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.091 0.472 . . . . 65.150000000000006 110.495 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -94.65 147.5 23.23 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.307 -0.627 . . . . 74.430000000000007 109.307 173.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.8 p -80.86 145.94 31.11 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.97 0.908 . . . . 54.130000000000003 110.196 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.4 p -65.35 109.47 2.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.395 0.678 . . . . 72.230000000000004 110.495 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.6 m -68.75 115.57 32.15 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.356 0.662 . . . . 73.519999999999996 109.336 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.48 174.13 13.1 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.571 2.181 . . . . 75.319999999999993 112.084 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -62.75 135.07 57.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.076 -0.511 . . . . 74.25 110.679 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.7 140.56 40.99 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.297 -0.865 . . . . 62.420000000000002 110.033 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 102.83 0.46 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.231 1.954 . . . . 73.230000000000004 110.915 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.99 109.22 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.067 0.947 . . . . 62.25 110.36 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.5 t -130.51 127.81 39.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.542 -0.91 . . . . 74.430000000000007 108.542 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -66.85 133.07 49.34 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.347 0.404 . . . . 62.219999999999999 110.124 177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -109.52 102.83 11.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.342 0.657 . . . . 74.430000000000007 109.48 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -82.32 108.24 15.61 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.678 -0.86 . . . . 72.329999999999998 108.678 170.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.78 161.37 24.54 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.748 -0.66 . . . . 32.049999999999997 110.187 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 C-N-CA 123.765 0.826 . . . . 73.519999999999996 109.221 179.46 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.9 pt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.979 0.419 . . . . 64.109999999999999 110.645 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.21 107.17 3.06 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.257 -1.757 . . . . 73.140000000000001 106.257 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -71.54 169.91 14.48 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.157 0.583 . . . . 74.140000000000001 111.97 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.18 30.5 1.27 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.685 1.194 . . . . 75.219999999999999 108.972 173.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -66.64 158.5 29.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.244 0.618 . . . . 74.209999999999994 111.674 -174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -64.83 92.33 0.1 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.269 1.027 . . . . 74.349999999999994 110.779 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -124.24 113.28 18.07 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.864 0.865 . . . . 53.450000000000003 110.228 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -167.61 148.79 5.45 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.172 1.389 . . . . 61.43 108.475 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp 62.87 24.44 14.55 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.159 0.984 . . . . 71.0 110.082 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -155.97 177.25 11.62 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.875 0.87 . . . . 75.430000000000007 110.636 -173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 61.7 m -71.79 115.85 11.48 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.195 0.998 . . . . 30.350000000000001 109.52 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.99 144.56 56.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.401 0.68 . . . . 75.540000000000006 110.765 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.5 166.59 22.85 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.255 0.622 . . . . 64.530000000000001 111.026 -173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -132.44 12.98 4.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.141 0.976 . . . . 64.140000000000001 110.979 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.37 175.99 50.59 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.766 -0.652 . . . . 73.310000000000002 112.996 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.31 170.93 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.447 0.699 . . . . 62.109999999999999 109.957 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.89 137.65 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.274 0.559 . . . . 73.409999999999997 111.639 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.1 m -83.54 -38.88 21.14 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.041 0.937 . . . . 73.430000000000007 110.042 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m -68.12 121.35 15.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.267 1.027 . . . . 75.209999999999994 110.125 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.0 116.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.748 0.655 . . . . 74.409999999999997 110.128 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.24 134.84 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.93 0.892 . . . . 70.450000000000003 109.446 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.7 139.28 22.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 113.987 0.355 . . . . 62.0 113.987 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.6 -37.53 65.66 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.483 1.113 . . . . 73.209999999999994 110.823 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -65.58 -34.07 77.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.733 0.813 . . . . 71.299999999999997 111.842 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 33.7 pt -90.74 -3.79 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-O 119.565 -0.255 . . . . 71.340000000000003 111.41 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 39.0 mm -71.97 137.47 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.698 -0.853 . . . . 75.129999999999995 108.698 170.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -104.95 -55.3 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.275 -0.639 . . . . 61.149999999999999 109.275 170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -143.01 142.11 31.51 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.342 -0.845 . . . . 65.200000000000003 109.342 -171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.24 106.57 21.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.029 -1.471 . . . . 73.439999999999998 107.029 171.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -95.02 103.5 15.35 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.05 -1.093 . . . . 71.340000000000003 108.05 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.64 109.44 21.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.616 -1.253 . . . . 71.150000000000006 107.616 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -106.54 114.37 62.08 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.389 0.676 . . . . 73.25 109.216 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 160.33 49.66 Favored 'Trans proline' 0 CA--C 1.557 1.655 0 C-N-CA 122.484 2.123 . . . . 55.340000000000003 111.797 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.67 150.96 74.99 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.095 1.864 . . . . 63.520000000000003 111.095 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.54 -52.61 0.04 OUTLIER Glycine 0 C--N 1.345 1.043 0 C-N-CA 121.357 -0.449 . . . . 35.409999999999997 112.556 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -146.66 107.9 4.23 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.32 0.648 . . . . 73.409999999999997 109.575 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.28 -17.73 9.52 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.76 -0.655 . . . . 52.219999999999999 114.578 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 21.4 m -88.52 115.52 63.6 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.571 -0.9 . . . . 63.229999999999997 108.571 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.79 -68.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.696 2.264 . . . . 73.010000000000005 111.665 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -103.79 179.22 4.33 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.547 0.739 . . . . 71.329999999999998 109.083 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.3 m -64.89 109.96 2.27 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.157 -0.683 . . . . 65.409999999999997 109.157 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -89.76 111.96 23.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.353 -0.98 . . . . 72.430000000000007 108.353 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.42 101.19 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.512 -0.921 . . . . 63.399999999999999 108.512 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 72.1 t -96.49 109.71 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.068 0.947 . . . . 61.409999999999997 108.572 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 58.5 mt -94.71 136.83 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.811 -0.811 . . . . 65.530000000000001 108.811 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -110.31 117.6 34.07 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.07 -1.456 . . . . 70.420000000000002 107.07 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HE1' ' A' ' 49' ' ' MET . 60.0 p -82.31 160.81 22.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.687 -0.486 . . . . 73.150000000000006 109.687 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 59.6 pttt -71.05 -10.95 60.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.76 0.824 . . . . 63.329999999999998 112.972 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.427 ' HE1' ' HB ' ' A' ' 47' ' ' THR . 3.1 mpp? -92.7 10.79 29.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.145 0.578 . . . . 72.239999999999995 110.153 170.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 69.82 15.2 7.97 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.2 1.4 . . . . 74.340000000000003 112.931 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -84.3 123.46 30.19 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 107.559 -1.275 . . . . 71.129999999999995 107.559 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 t -98.84 139.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.124 0.57 . . . . 71.519999999999996 109.478 -171.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.0 pt -139.57 156.21 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.077 0.951 . . . . 71.310000000000002 109.909 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -109.22 137.27 47.36 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.087 -1.449 . . . . 72.329999999999998 107.087 166.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.5 159.28 41.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.838 -0.801 . . . . 73.450000000000003 108.838 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -91.21 139.87 25.65 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 115.788 -0.642 . . . . 74.310000000000002 110.133 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.06 -12.08 32.98 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.025 2.484 . . . . 74.340000000000003 113.771 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -97.99 8.88 44.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.612 0.765 . . . . 65.140000000000001 112.357 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.59 122.58 20.0 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 109.037 -0.727 . . . . 53.420000000000002 109.037 171.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.76 ' HA ' HE21 ' A' ' 63' ' ' GLN . 21.7 ptmt -63.55 -39.39 94.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.978 0.911 . . . . 73.340000000000003 112.583 -167.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -68.16 -35.19 77.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.477 0.711 . . . . 74.319999999999993 110.64 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 54.6 tp -66.06 -36.22 82.63 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.411 0.684 . . . . 72.430000000000007 110.644 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.76 HE21 ' HA ' ' A' ' 60' ' ' LYS . 48.7 mt-30 -56.97 -42.05 79.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.735 0.647 . . . . 74.510000000000005 109.823 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -63.85 -36.13 82.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.327 0.651 . . . . 73.519999999999996 110.906 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.33 -43.29 99.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.248 0.619 . . . . 73.030000000000001 109.992 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 82.0 mt -71.98 -23.01 61.35 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.171 -0.922 . . . . 60.509999999999998 111.182 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 4.7 mmp_? -88.39 -20.68 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.43 0.692 . . . . 64.549999999999997 111.575 173.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -78.37 -30.61 48.04 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.192 0.597 . . . . 73.420000000000002 110.911 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 m -80.07 -13.85 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.679 0.276 . . . . 74.530000000000001 110.655 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.84 142.99 58.24 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.628 0.771 . . . . 74.310000000000002 109.403 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.98 94.22 0.13 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.543 0.687 . . . . 75.310000000000002 110.792 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -80.86 145.26 31.46 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.863 1.265 . . . . 65.5 110.287 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.3 t -69.67 82.82 0.43 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.855 0.836 . . . . 74.129999999999995 108.996 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -142.72 143.72 32.38 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 125.449 1.5 . . . . 64.099999999999994 107.704 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.7 m -58.23 101.12 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.585 0.754 . . . . 72.040000000000006 111.898 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -87.14 167.95 13.7 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.661 -0.7 . . . . 71.420000000000002 110.292 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.3 t -153.06 154.4 30.91 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.989 0.916 . . . . 74.310000000000002 108.777 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.61 103.95 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 121.967 1.778 . . . . 60.350000000000001 111.717 170.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -80.98 133.52 35.52 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.115 -0.698 . . . . 72.230000000000004 109.115 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.5 125.8 91.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.433 0.693 . . . . 73.549999999999997 109.611 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.83 144.08 94.37 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 121.911 1.74 . . . . 74.120000000000005 111.161 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.36 104.5 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.589 -0.893 . . . . 73.019999999999996 108.589 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.0 t -65.23 90.99 0.1 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.988 0.805 . . . . 53.439999999999998 109.509 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -91.41 128.82 37.39 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.325 -0.991 . . . . 70.150000000000006 108.325 176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -61.35 164.18 5.82 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.809 0.844 . . . . 73.030000000000001 112.648 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -77.53 87.58 3.86 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.773 -0.825 . . . . 72.140000000000001 108.773 171.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.53 88.7 7.02 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.57 -0.741 . . . . 71.340000000000003 109.356 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.442 0 CA-C-N 115.135 -0.939 . . . . 61.130000000000003 110.563 -176.563 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.297 0.094 . . . . 63.43 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 pp -166.34 11.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.385 0.513 . . . . 71.219999999999999 112.385 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.39 139.64 24.17 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.647 1.179 . . . . 72.519999999999996 112.222 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.04 124.73 25.07 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.585 0.754 . . . . 64.420000000000002 110.435 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -78.38 -29.14 47.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.426 0.691 . . . . 52.530000000000001 109.645 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -119.72 150.06 41.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.371 0.668 . . . . 74.340000000000003 109.698 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -152.32 -179.69 7.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.966 0.906 . . . . 75.120000000000005 109.639 -176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -138.76 126.46 22.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.85 0.86 . . . . 74.439999999999998 109.548 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -99.56 100.59 11.62 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.197 0.599 . . . . 71.129999999999995 109.493 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -90.91 166.35 13.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.956 0.902 . . . . 64.25 108.932 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 69.3 m -70.93 113.99 8.54 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.108 -0.701 . . . . 53.25 109.108 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -90.08 143.87 26.39 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.635 0.774 . . . . 75.340000000000003 111.55 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 14' ' ' SER . 9.8 t -146.56 163.91 34.27 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.533 1.133 . . . . 55.329999999999998 110.125 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.417 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 20.8 m -93.62 -50.08 5.57 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.59 0.756 . . . . 74.120000000000005 110.738 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.22 -121.54 0.83 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.788 -0.451 . . . . 73.519999999999996 112.682 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.12 162.66 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.599 1.159 . . . . 65.310000000000002 110.044 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.62 151.26 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.14 0.576 . . . . 72.299999999999997 110.727 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 m -110.56 11.78 22.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.034 0.934 . . . . 73.010000000000005 111.45 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 154.91 43.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.166 0.587 . . . . 72.409999999999997 110.417 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -80.89 141.93 14.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 109.197 -0.668 . . . . 74.450000000000003 109.197 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.79 144.34 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.467 1.107 . . . . 70.109999999999999 109.04 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' ILE . . . -62.7 123.39 30.41 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.912 -0.382 . . . . 45.0 113.426 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -57.54 -34.19 68.88 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.258 1.023 . . . . 71.010000000000005 110.755 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.55 -28.33 63.79 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.886 0.874 . . . . 62.25 111.998 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' GLY . 17.8 pt -90.72 -0.41 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-N 118.131 0.423 . . . . 74.239999999999995 111.152 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.57 HD12 HG21 ' A' ' 45' ' ' ILE . 36.4 mm -77.31 111.9 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.372 -0.603 . . . . 50.43 109.372 175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.15 -53.71 4.89 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.47 -0.566 . . . . 74.310000000000002 109.47 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -153.72 147.42 25.23 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.448 -0.797 . . . . 74.120000000000005 110.105 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -113.34 123.19 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.529 -0.915 . . . . 71.129999999999995 108.529 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -94.54 111.05 22.81 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.342 -0.985 . . . . 63.219999999999999 108.342 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.74 131.69 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.112 0.482 . . . . 72.439999999999998 109.9 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 p -122.49 136.23 26.37 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 124.1 0.96 . . . . 75.310000000000002 108.978 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -61.21 169.84 5.81 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.156 2.571 . . . . 74.439999999999998 113.814 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.37 170.99 14.84 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 121.805 1.67 . . . . 63.200000000000003 111.589 168.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.18 -177.18 48.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.55 -0.295 . . . . 43.130000000000003 112.523 -174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 64.17 14.31 8.52 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.743 1.217 . . . . 75.530000000000001 111.317 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.72 -20.27 36.98 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.947 0.784 . . . . 54.229999999999997 112.731 -175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 m -84.72 124.95 72.36 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 117.639 0.72 . . . . 61.310000000000002 109.073 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.0 -69.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.794 2.329 . . . . 63.030000000000001 113.696 -172.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -100.68 179.97 4.26 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.399 1.08 . . . . 62.140000000000001 108.579 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 m -64.12 109.13 1.73 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.022 -1.473 . . . . 63.43 107.022 162.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -90.54 112.78 24.6 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 72.109999999999999 109.682 -172.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 102.13 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.137 -0.69 . . . . 75.209999999999994 109.137 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.03 111.66 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.962 -1.125 . . . . 62.32 107.962 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.57 HG21 HD12 ' A' ' 26' ' ' ILE . 54.5 mt -94.39 136.27 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.805 -0.443 . . . . 65.219999999999999 109.805 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -114.71 114.0 25.04 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 124.878 1.271 . . . . 74.340000000000003 108.053 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.2 p -80.29 169.17 18.13 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.429 0.292 . . . . 53.229999999999997 111.073 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -68.75 -20.62 64.38 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.002 0.921 . . . . 73.310000000000002 112.0 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.8 ptp -91.49 8.86 34.39 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.515 0.726 . . . . 55.229999999999997 110.906 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 67.68 21.55 9.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.987 1.315 . . . . 64.450000000000003 111.523 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -81.01 123.06 28.04 Favored 'General case' 0 C--O 1.246 0.884 0 N-CA-C 107.011 -1.477 . . . . 74.530000000000001 107.011 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.1 t -92.86 130.19 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.603 -0.888 . . . . 64.219999999999999 108.603 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 45' ' ' ILE . 29.8 pt -134.38 153.96 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.263 0.625 . . . . 71.439999999999998 109.836 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 92.8 m -109.54 128.76 55.43 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.231 -0.895 . . . . 64.209999999999994 108.632 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.4 m -125.14 140.6 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.499 -0.926 . . . . 64.409999999999997 108.499 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -79.66 128.1 75.77 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.19 -21.32 27.8 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.923 3.082 . . . . 74.239999999999995 114.558 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -73.28 -7.48 51.72 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.202 0.601 . . . . 74.430000000000007 112.459 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.04 123.03 16.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.858 0.863 . . . . 64.519999999999996 110.696 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -66.5 -38.33 87.0 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.022 -0.99 . . . . 72.040000000000006 111.914 -172.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -65.3 -32.01 73.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.846 0.459 . . . . 72.010000000000005 111.425 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.55 -27.0 63.81 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.569 0.747 . . . . 71.310000000000002 110.921 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -59.95 -25.92 65.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.046 0.538 . . . . 72.239999999999995 111.698 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -63.77 -41.68 97.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.2 0.6 . . . . 75.219999999999999 109.903 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.04 -40.35 82.87 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.532 0.733 . . . . 43.219999999999999 110.0 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.86 -31.29 72.45 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.392 0.677 . . . . 74.430000000000007 110.812 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -78.23 -34.14 49.38 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.125 0.57 . . . . 73.030000000000001 111.058 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -68.61 -26.15 65.22 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.585 0.354 . . . . 73.299999999999997 111.64 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.43 -11.51 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.011 0.375 . . . . 74.319999999999993 112.011 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -65.84 157.57 30.11 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.175 0.99 . . . . 61.219999999999999 111.417 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.9 m -55.51 149.46 13.58 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.927 0.891 . . . . 63.140000000000001 111.549 174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? 78.98 -2.98 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.07 1.748 . . . . 55.439999999999998 112.374 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -78.04 150.1 33.88 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.543 -0.723 . . . . 72.230000000000004 110.156 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.606 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -87.82 20.66 2.94 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.873 0.469 . . . . 72.25 111.287 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.4 p -79.79 170.35 16.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.719 0.808 . . . . 74.450000000000003 110.087 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.7 m -82.27 90.33 6.62 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.173 -0.677 . . . . 65.109999999999999 109.173 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.8 p -93.29 156.4 40.09 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.86 0.864 . . . . 64.430000000000007 109.284 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.03 -171.21 0.64 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.317 2.012 . . . . 63.049999999999997 111.224 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -67.33 106.77 2.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.493 -0.929 . . . . 75.310000000000002 108.493 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.18 112.27 11.19 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 109.482 -0.562 . . . . 74.420000000000002 109.482 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.22 -172.9 1.49 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.848 2.366 . . . . 43.520000000000003 111.642 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.48 91.27 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-O 122.241 1.019 . . . . 72.239999999999995 110.141 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 p -75.51 131.19 39.91 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.512 -1.222 . . . . 45.119999999999997 108.831 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -53.56 110.75 0.6 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.168 0.987 . . . . 54.119999999999997 110.632 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 ttm180 -62.2 97.08 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.044 1.338 . . . . 73.310000000000002 111.929 -167.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.71 12.82 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.745 1.618 . . . . 63.409999999999997 112.613 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.95 167.34 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.192 0.997 . . . . 63.25 110.463 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.447 0.699 . . . . 37.5 110.085 179.407 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.723 -0.473 . . . . 63.039999999999999 109.723 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.89 19.89 3.85 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.542 0.737 . . . . 62.240000000000002 112.786 -174.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.7 166.5 12.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.677 0.791 . . . . 72.040000000000006 112.128 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 71.35 10.18 6.61 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.009 1.323 . . . . 65.109999999999999 112.133 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -100.86 129.71 46.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.923 0.889 . . . . 72.510000000000005 109.53 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -132.94 137.1 46.48 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.454 1.101 . . . . 72.540000000000006 109.001 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.3 p -75.6 86.92 2.68 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.121 0.568 . . . . 72.530000000000001 110.801 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -69.28 105.01 2.38 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.11 -0.7 . . . . 74.329999999999998 109.11 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.66 112.52 3.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.796 -0.816 . . . . 54.329999999999998 108.796 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -139.49 -164.46 1.68 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.219 1.008 . . . . 65.120000000000005 108.355 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.38 110.46 3.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.316 0.507 . . . . 72.519999999999996 109.986 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -91.95 120.78 32.92 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.392 -0.595 . . . . 73.409999999999997 109.392 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.1 t -92.96 115.27 27.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.74 -0.663 . . . . 74.540000000000006 109.665 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 t -51.97 -31.98 31.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.67 1.188 . . . . 63.0 112.125 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.73 -169.86 34.07 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.323 -0.711 . . . . 70.439999999999998 111.323 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.68 129.95 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 108.399 -0.963 . . . . 72.439999999999998 108.399 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 55' ' ' VAL . 2.2 pp -114.26 144.69 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.162 0.585 . . . . 70.140000000000001 109.584 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.0 m -133.95 34.2 3.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.91 0.884 . . . . 62.130000000000003 109.429 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.9 m -126.53 138.89 53.54 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.964 -1.016 . . . . 44.200000000000003 108.906 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -74.25 110.85 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 107.406 -1.331 . . . . 64.329999999999998 107.406 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.75 139.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.478 -0.564 . . . . 73.450000000000003 109.478 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.36 128.58 33.37 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.756 0.66 . . . . 45.43 113.28 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -56.65 -30.17 63.04 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.057 0.943 . . . . 61.229999999999997 109.943 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -54.77 -35.49 63.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 73.010000000000005 112.899 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.0 pt -104.49 -3.88 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 119.266 -0.397 . . . . 74.329999999999998 112.013 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 45' ' ' ILE . 41.1 mm -71.13 110.97 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.684 -0.858 . . . . 72.519999999999996 108.684 172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB2' ' HD2' ' A' ' 48' ' ' LYS . 24.0 t70 -85.75 -56.6 3.41 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.198 0.599 . . . . 75.150000000000006 110.712 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -160.69 143.88 13.26 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.209 -0.663 . . . . 75.430000000000007 109.209 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.12 123.99 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.215 -0.661 . . . . 64.140000000000001 109.215 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -103.98 116.82 32.94 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.864 0.866 . . . . 71.239999999999995 109.012 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.36 112.83 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.294 0.638 . . . . 52.409999999999997 110.165 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 11.0 m -89.84 116.65 66.88 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 108.935 -0.765 . . . . 75.540000000000006 108.935 169.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.81 157.73 36.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.812 2.341 . . . . 64.540000000000006 112.535 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.38 122.08 10.76 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.607 2.204 . . . . 74.25 111.294 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.64 -159.59 23.49 Favored Glycine 0 C--O 1.241 0.546 0 N-CA-C 110.221 -1.152 . . . . 72.230000000000004 110.221 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 63.82 30.09 14.56 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 72.430000000000007 111.641 177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.87 20.5 61.17 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.423 -0.353 . . . . 11.44 112.914 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 53.4 t -138.32 133.34 17.1 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.888 0.875 . . . . 71.540000000000006 109.965 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.72 -9.31 13.35 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.336 2.024 . . . . 63.509999999999998 112.616 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 38' ' ' CYS . 16.5 tppt? -101.29 155.09 18.24 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.806 1.242 . . . . 64.200000000000003 110.163 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -86.43 115.23 23.8 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.183 -1.043 . . . . 74.140000000000001 108.183 164.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 42.7 tt0 -83.21 112.97 20.33 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.014 -0.735 . . . . 75.120000000000005 109.014 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.04 102.15 13.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.539 -1.282 . . . . 63.539999999999999 107.539 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.11 135.27 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.934 0.894 . . . . 51.109999999999999 109.061 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.601 HG21 HD12 ' A' ' 26' ' ' ILE . 60.9 mt -110.29 121.78 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.624 0.37 . . . . 73.450000000000003 110.083 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.15 127.04 32.74 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.998 -1.112 . . . . 71.010000000000005 107.998 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 50.7 p -84.66 178.42 7.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.408 0.683 . . . . 75.439999999999998 110.359 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 27' ' ' ASP . 14.4 mmmm -66.02 -23.52 66.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.277 0.56 . . . . 73.230000000000004 110.728 175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.3 mtm -79.8 -1.45 38.88 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.458 1.103 . . . . 73.230000000000004 110.434 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 65.2 14.51 9.44 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.986 1.714 . . . . 65.25 111.919 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -79.77 125.97 30.35 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.248 -1.019 . . . . 72.319999999999993 108.248 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.92 122.65 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 41.020000000000003 109.386 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.1 pt -108.11 149.93 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.147 -1.057 . . . . 74.5 108.147 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.97 118.68 37.42 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.515 0.726 . . . . 63.109999999999999 109.355 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG12 HD11 ' A' ' 17' ' ' ILE . 32.8 m -124.69 156.06 32.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 123.524 0.73 . . . . 70.340000000000003 109.55 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -78.55 152.95 78.58 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.558 -0.904 . . . . 73.430000000000007 108.558 168.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.54 -27.0 69.69 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 121.839 1.693 . . . . 65.140000000000001 111.261 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.89 12.67 36.17 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.313 1.045 . . . . 72.329999999999998 112.208 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.5 133.97 56.58 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.041 0.536 . . . . 74.400000000000006 109.985 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -63.96 -40.99 97.67 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.973 0.731 . . . . 73.219999999999999 112.973 -166.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -77.84 -17.48 57.35 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.073 0.397 . . . . 63.43 112.073 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.7 tp -64.49 -21.59 66.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.675 0.79 . . . . 52.119999999999997 110.712 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -56.4 -23.97 41.66 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.092 0.957 . . . . 62.310000000000002 113.139 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -63.99 -46.94 82.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.927 0.491 . . . . 74.219999999999999 110.274 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.52 -37.96 55.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.369 -0.832 . . . . 73.409999999999997 110.472 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.05 -35.62 78.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.39 0.676 . . . . 74.340000000000003 110.547 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -75.03 -41.38 59.34 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.309 0.243 . . . . 65.450000000000003 110.682 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -68.66 -36.11 78.14 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.27 0.47 . . . . 64.349999999999994 112.27 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.0 -28.81 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.025 0.44 . . . . 70.329999999999998 110.137 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -78.97 -18.68 53.3 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.834 0.853 . . . . 53.43 111.049 176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -66.84 161.71 23.25 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.063 0.545 . . . . 71.019999999999996 111.343 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -63.54 101.29 0.32 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.166 0.586 . . . . 71.019999999999996 110.184 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 p -120.98 165.6 15.02 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.326 1.05 . . . . 74.209999999999994 110.492 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.0 79.43 2.19 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.609 0.719 . . . . 62.409999999999997 109.547 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.2 p -88.55 146.7 25.0 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.059 0.944 . . . . 71.150000000000006 110.584 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 p -65.7 -17.21 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.984 0.914 . . . . 74.049999999999997 111.9 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.4 m -124.93 106.33 28.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.016 0.926 . . . . 61.43 109.663 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.42 160.87 37.23 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.769 2.313 . . . . 74.030000000000001 111.674 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.55 128.91 50.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.784 -0.45 . . . . 74.109999999999999 109.784 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.65 129.56 93.4 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 108.999 -0.741 . . . . 62.240000000000002 108.999 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.07 140.7 95.03 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 121.998 1.798 . . . . 64.140000000000001 111.181 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.75 138.54 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.616 0.766 . . . . 73.439999999999998 112.015 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.9 m -77.76 71.04 4.22 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.632 0.729 . . . . 72.420000000000002 109.483 174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.29 166.98 22.15 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.992 -1.004 . . . . 74.420000000000002 110.048 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.06 142.28 51.59 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.825 0.45 . . . . 72.010000000000005 110.431 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -86.63 96.51 10.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.324 1.05 . . . . 74.510000000000005 109.423 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.07 88.65 0.29 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.303 -0.628 . . . . 71.019999999999996 109.303 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.013 0.925 . . . . 70.400000000000006 110.302 -175.446 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.712 -0.477 . . . . 53.210000000000001 109.712 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.14 120.62 33.64 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.682 -0.859 . . . . 75.439999999999998 108.682 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.45 143.45 40.34 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.915 0.886 . . . . 63.340000000000003 110.932 172.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.98 137.74 25.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.994 0.518 . . . . 43.130000000000003 110.197 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.14 151.03 33.5 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.304 0.642 . . . . 73.230000000000004 109.53 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.98 10.68 34.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.497 0.719 . . . . 72.120000000000005 111.583 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -63.92 93.03 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.079 0.952 . . . . 75.0 110.253 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.8 83.15 0.14 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.92 1.288 . . . . 64.430000000000007 110.659 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.4 134.29 34.89 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.458 0.647 . . . . 72.349999999999994 109.549 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -85.99 -170.28 3.03 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.678 -0.86 . . . . 53.539999999999999 108.678 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 42' ' ' GLU . 73.0 m -52.08 114.06 1.21 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.567 0.347 . . . . 51.409999999999997 110.99 174.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -86.46 120.61 27.97 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.216 -1.402 . . . . 75.420000000000002 107.216 173.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 16' ' ' VAL . 52.9 t -143.04 102.99 4.1 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.236 -0.653 . . . . 74.140000000000001 109.236 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.9 m -114.54 123.88 50.47 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 124.185 0.994 . . . . 71.439999999999998 109.777 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.33 90.24 0.06 OUTLIER Glycine 0 C--N 1.348 1.235 0 O-C-N 123.773 0.671 . . . . 50.149999999999999 111.736 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.662 HG22 ' SG ' ' A' ' 13' ' ' CYS . 22.7 t -100.5 128.44 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.808 -0.812 . . . . 64.329999999999998 108.808 -173.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.492 HD11 HG12 ' A' ' 55' ' ' VAL . 2.7 pp -124.74 147.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.082 0.553 . . . . 62.130000000000003 109.986 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.4 m -117.76 22.68 12.17 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.489 1.115 . . . . 72.5 109.122 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.5 m -93.72 146.57 23.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.753 1.221 . . . . 74.299999999999997 109.994 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -67.63 112.55 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.359 -0.978 . . . . 45.299999999999997 108.359 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.1 t -90.5 143.33 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.664 0.786 . . . . 74.25 109.548 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.36 118.09 13.73 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.881 0.738 . . . . 72.120000000000005 112.011 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.3 -30.81 52.22 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.767 1.227 . . . . 72.439999999999998 110.995 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -63.47 -35.79 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.399 0.679 . . . . 71.150000000000006 111.942 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 22.3 pt -86.19 -6.46 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 111.957 0.354 . . . . 73.109999999999999 111.957 -175.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD12 HG21 ' A' ' 45' ' ' ILE . 44.5 mm -72.9 129.85 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.364 -0.976 . . . . 70.420000000000002 108.364 176.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -117.16 -58.64 2.04 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.633 0.373 . . . . 63.450000000000003 111.055 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -144.81 127.47 16.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.849 0.46 . . . . 62.43 109.906 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -110.79 140.66 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.359 1.064 . . . . 51.030000000000001 109.71 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -137.37 127.17 25.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.979 1.312 . . . . 73.25 108.082 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.52 139.43 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 122.576 0.35 . . . . 55.329999999999998 111.253 -169.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 28.5 m -111.06 118.36 48.16 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.06 0.944 . . . . 71.099999999999994 109.099 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.44 147.18 36.19 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.025 1.816 . . . . 55.219999999999999 111.156 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.75 144.7 92.75 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.61 2.207 . . . . 63.310000000000002 112.59 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.02 -32.8 7.1 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.066 -0.516 . . . . 72.400000000000006 112.534 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -80.59 77.76 7.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.636 0.774 . . . . 72.530000000000001 110.426 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.37 -2.92 18.12 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 115.808 -0.633 . . . . 62.32 114.501 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.0 t -141.08 138.26 17.72 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 74.439999999999998 109.139 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.71 16.61 1.78 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.868 2.379 . . . . 73.209999999999994 114.034 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -152.16 173.21 15.23 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.277 0.631 . . . . 75.439999999999998 110.572 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 m -81.2 131.32 35.29 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.402 0.681 . . . . 73.510000000000005 110.114 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.64 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 19.9 tt0 -115.05 126.33 54.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.915 -1.143 . . . . 74.099999999999994 107.915 173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.08 102.68 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.283 -1.006 . . . . 64.400000000000006 108.283 173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -98.91 130.56 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 109.083 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 26' ' ' ILE . 52.3 mt -121.16 129.85 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.256 -0.646 . . . . 75.129999999999995 109.256 173.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -99.53 124.56 44.81 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.969 1.307 . . . . 75.140000000000001 107.523 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.8 p -84.9 170.64 12.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.883 0.473 . . . . 73.120000000000005 110.792 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 25' ' ' ILE . 18.6 ptpt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 75.510000000000005 110.845 170.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.96 -8.29 56.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.186 0.994 . . . . 73.519999999999996 110.647 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.09 21.17 7.41 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.074 1.349 . . . . 73.239999999999995 109.246 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -100.43 133.09 45.38 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.25 1.02 . . . . 65.519999999999996 108.364 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.1 t -87.42 124.04 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.128 0.971 . . . . 71.230000000000004 110.397 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.6 pt -120.61 139.04 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.901 -1.148 . . . . 54.409999999999997 107.901 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.62 117.02 32.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.228 -1.397 . . . . 51.409999999999997 107.228 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 17' ' ' ILE . 7.2 m -117.55 166.35 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.176 0.59 . . . . 75.510000000000005 111.073 -168.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.8 OUTLIER -79.18 139.09 56.21 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 115.299 -0.864 . . . . 72.329999999999998 109.512 174.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.1 -43.57 28.96 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.422 2.081 . . . . 72.510000000000005 112.721 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -85.08 21.96 1.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.93 0.492 . . . . 73.530000000000001 111.461 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.84 124.65 21.33 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.145 -0.687 . . . . 71.409999999999997 109.145 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.92 -32.89 74.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.252 1.021 . . . . 74.439999999999998 112.316 -169.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -74.12 -29.96 62.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.05 0.54 . . . . 73.430000000000007 111.154 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.7 tp -67.44 -23.55 65.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.674 0.79 . . . . 74.430000000000007 110.869 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -57.77 -38.04 74.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.753 0.821 . . . . 62.5 111.171 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -69.7 -31.39 69.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.119 0.568 . . . . 75.129999999999995 110.74 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.9 -35.58 69.75 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.454 -0.572 . . . . 61.420000000000002 109.454 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.4 mt -66.04 -40.33 90.9 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.342 0.657 . . . . 74.430000000000007 110.129 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -70.33 -35.84 73.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.31 0.644 . . . . 71.409999999999997 111.05 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.78 -44.84 92.21 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.736 0.414 . . . . 54.399999999999999 110.412 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 m -82.37 -20.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.85 -0.614 . . . . 55.350000000000001 111.534 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.99 153.25 38.61 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.024 0.529 . . . . 73.129999999999995 109.96 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.7 m -60.32 148.3 37.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.401 1.081 . . . . 74.120000000000005 111.205 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 1.0 OUTLIER 69.48 67.62 0.25 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.384 1.474 . . . . 63.25 109.177 -175.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.7 p -139.52 -176.22 4.47 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.84 -1.073 . . . . 64.049999999999997 109.566 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.33 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.574 0.75 . . . . 72.420000000000002 110.275 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.1 t -168.58 148.48 4.49 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.925 1.29 . . . . 54.520000000000003 108.704 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 p -97.02 77.59 2.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.245 0.618 . . . . 43.310000000000002 111.055 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 m -89.66 118.33 68.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 108.788 -0.819 . . . . 44.100000000000001 108.788 174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.13 89.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.622 2.215 . . . . 70.349999999999994 111.205 172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -136.18 130.43 33.19 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.494 1.118 . . . . 64.230000000000004 108.595 -170.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.11 134.54 90.46 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 123.41 0.684 . . . . 71.530000000000001 110.708 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.54 94.07 0.43 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.271 1.981 . . . . 73.239999999999995 111.687 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.44 146.86 12.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 116.074 -0.512 . . . . 71.099999999999994 110.49 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.3 t -66.42 152.39 45.2 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.394 -0.821 . . . . 63.119999999999997 110.327 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.63 114.93 26.73 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.332 -0.988 . . . . 72.140000000000001 108.332 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -61.36 115.86 4.19 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 123.674 0.609 . . . . 63.25 109.857 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -83.93 158.23 21.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.164 0.585 . . . . 72.319999999999993 109.897 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.04 105.25 9.13 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.193 -1.04 . . . . 73.439999999999998 108.193 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 123.721 0.808 . . . . 72.519999999999996 110.768 -175.104 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.15 -0.685 . . . . 70.109999999999999 109.15 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -72.92 159.02 34.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.127 0.971 . . . . 74.099999999999994 111.02 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -120.91 166.83 13.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.576 0.75 . . . . 70.099999999999994 110.762 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.99 -25.01 10.94 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.569 0.748 . . . . 72.420000000000002 111.824 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -144.69 95.37 2.69 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.325 0.65 . . . . 72.450000000000003 110.646 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -74.48 -27.87 60.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.158 0.583 . . . . 52.109999999999999 109.464 164.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 m -69.12 123.41 21.0 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.873 -1.058 . . . . 61.140000000000001 110.902 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -101.71 129.83 47.96 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.376 -0.972 . . . . 53.420000000000002 108.376 170.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.91 98.43 0.28 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.688 0.795 . . . . 75.129999999999995 110.541 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 99.3 mttt -110.07 -107.85 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.3 1.04 . . . . 65.239999999999995 109.196 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -88.61 113.66 24.41 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.948 -1.13 . . . . 74.310000000000002 107.948 171.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -85.12 118.33 24.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.614 0.766 . . . . 71.230000000000004 109.15 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.3 t -144.57 105.24 4.14 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.125 -0.695 . . . . 62.020000000000003 109.125 -174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 p -64.01 -49.58 71.86 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.745 0.818 . . . . 75.010000000000005 110.539 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.61 172.03 32.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.027 -0.988 . . . . 74.230000000000004 111.236 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.56 148.2 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.024 0.53 . . . . 64.209999999999994 109.788 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.8 pt -83.53 133.06 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.582 -0.735 . . . . 74.430000000000007 111.566 -172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.0 m -85.07 -41.04 16.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.374 -0.83 . . . . 74.219999999999999 109.354 166.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.8 m -92.45 129.29 38.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.216 1.007 . . . . 74.239999999999995 108.806 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.52 129.68 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 123.739 0.649 . . . . 64.120000000000005 109.627 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.596 HG21 HG21 ' A' ' 53' ' ' ILE . 71.1 t -84.23 130.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.508 0.723 . . . . 72.409999999999997 110.236 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.22 134.2 42.67 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.284 0.99 . . . . 63.119999999999997 113.602 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.63 -33.81 66.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.432 1.093 . . . . 63.509999999999998 110.474 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.05 -34.54 77.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.225 1.01 . . . . 54.149999999999999 111.913 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 25.4 pt -97.59 -5.78 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 118.925 -0.559 . . . . 64.510000000000005 112.096 -176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 45' ' ' ILE . 38.9 mm -65.58 103.55 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.215 -1.031 . . . . 71.349999999999994 108.215 171.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -85.72 -55.07 4.15 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.31 0.644 . . . . 63.149999999999999 109.618 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -148.99 143.4 26.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.987 -0.551 . . . . 72.120000000000005 110.526 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.2 mt -107.65 118.46 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.332 1.053 . . . . 71.319999999999993 108.647 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -106.62 143.88 34.09 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.036 -1.098 . . . . 74.099999999999994 108.036 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.5 t -120.1 124.95 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.167 -1.049 . . . . 62.310000000000002 108.167 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 m -88.48 111.37 43.3 Favored Pre-proline 0 C--O 1.251 1.156 0 N-CA-C 108.143 -1.058 . . . . 24.120000000000001 108.143 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.2 151.39 49.09 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.862 2.375 . . . . 74.239999999999995 112.266 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.76 158.07 43.35 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.342 2.028 . . . . 61.210000000000001 112.164 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.99 -19.1 44.17 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.738 -0.479 . . . . 73.109999999999999 113.734 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -83.45 66.17 8.75 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.736 0.814 . . . . 73.340000000000003 109.844 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.6 -18.12 6.04 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-N 115.422 -0.808 . . . . 41.299999999999997 113.839 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 10' ' ' LYS . 49.4 t -139.67 129.44 14.01 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.629 1.172 . . . . 70.409999999999997 108.563 -175.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.25 32.91 0.45 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.003 2.469 . . . . 62.119999999999997 112.676 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -121.31 126.78 50.35 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.565 0.746 . . . . 63.420000000000002 110.773 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -88.61 121.35 30.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.714 0.805 . . . . 75.120000000000005 108.914 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -144.3 163.6 33.22 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.29 0.567 . . . . 65.340000000000003 110.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.4 t -121.41 104.16 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.576 1.15 . . . . 75.420000000000002 108.277 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.54 108.98 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.616 1.166 . . . . 71.530000000000001 108.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.419 ' HB ' HG12 ' A' ' 53' ' ' ILE . 69.7 mt -107.91 134.38 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.562 -0.712 . . . . 75.019999999999996 110.391 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.17 124.89 48.55 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.831 1.252 . . . . 75.400000000000006 107.749 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 p -80.23 179.06 7.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.508 0.323 . . . . 35.039999999999999 110.302 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 25' ' ' ILE . 52.5 mtmt -62.35 -28.63 69.89 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.264 0.554 . . . . 62.100000000000001 110.617 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 49' ' ' MET . 0.9 OUTLIER -86.28 7.05 26.89 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.748 1.219 . . . . 72.109999999999999 111.028 177.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? 63.74 15.61 9.13 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.305 1.442 . . . . 74.129999999999995 111.793 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -72.68 128.46 35.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.789 -1.189 . . . . 63.530000000000001 107.789 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.83 118.5 35.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.033 -0.985 . . . . 73.230000000000004 109.051 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 21' ' ' VAL . 7.2 pt -110.98 157.11 11.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 107.626 -1.25 . . . . 74.400000000000006 107.626 167.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 20.9 t -139.83 116.61 10.9 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.482 -0.933 . . . . 73.230000000000004 108.482 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 158.12 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.089 0.956 . . . . 75.109999999999999 109.434 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -78.22 151.35 78.27 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 109.425 -0.583 . . . . 61.310000000000002 109.425 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -59.74 -16.41 37.18 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.262 2.641 . . . . 73.400000000000006 114.053 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -91.29 18.99 6.34 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.13 0.972 . . . . 62.310000000000002 112.386 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 128.07 34.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.152 -0.684 . . . . 63.509999999999998 109.152 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 11.1 mmpt? -66.99 -38.5 86.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.703 0.801 . . . . 64.510000000000005 112.584 -172.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -63.55 -33.24 75.15 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.131 0.491 . . . . 74.540000000000006 110.156 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.15 -31.15 43.91 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.057 -0.974 . . . . 74.310000000000002 110.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -31.95 73.14 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 110.143 -0.318 . . . . 72.120000000000005 110.143 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.7 -42.12 92.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.289 0.635 . . . . 70.120000000000005 110.199 173.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 69' ' ' VAL . 4.5 mm? -64.1 -42.7 96.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.444 0.698 . . . . 61.420000000000002 110.269 176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.77 -31.64 72.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.241 0.617 . . . . 70.230000000000004 111.072 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -78.77 -27.04 44.57 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.1 0.96 . . . . 73.439999999999998 110.804 175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -83.69 -29.27 27.72 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.252 0.621 . . . . 73.430000000000007 112.067 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 65' ' ' LEU . 24.4 m -70.45 -24.02 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 110.104 -0.332 . . . . 71.230000000000004 110.104 176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.03 122.12 14.16 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.441 -1.318 . . . . 44.420000000000002 107.441 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -55.68 142.96 32.1 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.486 1.114 . . . . 53.43 112.055 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? 62.54 52.81 2.81 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.111 0.965 . . . . 70.340000000000003 111.212 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.1 p -91.76 169.32 10.8 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.956 -1.02 . . . . 62.149999999999999 109.825 172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -53.88 103.08 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.656 0.782 . . . . 72.239999999999995 112.025 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 m -141.97 9.35 1.92 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.753 1.221 . . . . 62.100000000000001 110.348 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 t -98.15 111.48 23.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.093 0.957 . . . . 45.240000000000002 110.76 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -96.76 104.65 19.1 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.157 0.983 . . . . 45.210000000000001 109.299 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -55.76 95.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.448 2.765 . . . . 74.140000000000001 113.89 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -85.38 94.34 8.94 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.187 -1.042 . . . . 55.049999999999997 108.187 170.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.03 107.73 33.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 73.200000000000003 110.013 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -54.66 111.52 0.75 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.019 2.479 . . . . 65.129999999999995 111.896 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.15 121.36 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 O-C-N 123.814 0.696 . . . . 70.409999999999997 109.492 -171.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.9 p -99.55 30.84 3.4 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 73.209999999999994 111.492 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -84.65 80.59 9.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.422 0.629 . . . . 75.549999999999997 110.508 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.25 140.79 1.18 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.375 1.47 . . . . 64.219999999999999 107.8 175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.77 -62.63 1.57 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.7 -1.222 . . . . 75.239999999999995 107.7 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.94 73.65 6.71 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.394 0.677 . . . . 63.299999999999997 110.444 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 C-N-CA 123.913 0.885 . . . . 52.109999999999999 109.061 -178.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.567 -0.16 . . . . 53.439999999999998 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 pp -103.56 171.39 7.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.895 -0.78 . . . . 65.430000000000007 108.895 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 169.39 17.74 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.316 0.579 . . . . 72.450000000000003 111.119 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.28 139.02 37.24 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.43 -1.322 . . . . 65.030000000000001 107.43 169.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -74.65 91.72 2.37 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 109.258 -0.645 . . . . 72.510000000000005 109.258 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -73.75 89.9 1.82 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 115.69 -0.687 . . . . 71.439999999999998 109.346 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.4 t -66.54 2.57 1.25 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.841 1.256 . . . . 62.200000000000003 112.747 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -45.29 99.93 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.086 1.354 . . . . 72.439999999999998 110.588 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.8 tp -81.35 77.37 8.23 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.895 0.855 . . . . 74.200000000000003 109.417 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.34 155.56 45.18 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.437 -1.256 . . . . 65.430000000000007 109.568 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 85.2 m -66.43 133.41 50.39 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.593 -0.891 . . . . 74.310000000000002 108.593 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -83.55 128.18 34.31 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.248 -0.649 . . . . 72.420000000000002 109.248 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.2 t -144.73 133.74 22.64 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.357 0.663 . . . . 73.230000000000004 110.166 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' A' ' 54' ' ' CYS . 23.1 t -87.34 31.29 0.74 Allowed 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 125.092 1.357 . . . . 75.109999999999999 111.212 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.06 -142.23 20.52 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.365 -0.294 . . . . 54.109999999999999 112.365 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.03 133.38 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.644 -1.243 . . . . 73.329999999999998 107.644 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.402 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.7 pp -125.52 150.43 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 122.862 0.465 . . . . 73.540000000000006 111.424 -175.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 54.8 m -97.32 2.21 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.285 1.034 . . . . 62.210000000000001 110.982 174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.1 m -74.9 98.08 3.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.251 0.62 . . . . 51.219999999999999 109.523 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.9 t -73.66 109.69 6.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.124 -1.436 . . . . 55.439999999999998 107.124 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.1 t -100.39 139.41 21.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.429 0.691 . . . . 72.200000000000003 109.987 -173.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.77 136.8 38.65 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 124.015 0.822 . . . . 75.239999999999995 112.565 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 64' ' ' ARG . 10.8 mp -60.89 -29.41 69.55 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.936 0.894 . . . . 71.510000000000005 110.542 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.61 -33.19 67.97 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.327 1.451 . . . . 74.420000000000002 112.794 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.572 HG22 ' HE2' ' A' ' 48' ' ' LYS . 43.4 pt -110.21 7.46 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.519 0.328 . . . . 73.239999999999995 111.869 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.472 HD12 HG21 ' A' ' 45' ' ' ILE . 39.5 mm -73.86 111.48 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.393 -0.966 . . . . 64.319999999999993 108.393 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.2 -56.66 3.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.484 0.713 . . . . 74.510000000000005 110.652 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -153.58 138.26 16.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.200000000000003 109.856 -174.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.0 mt -106.7 128.8 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.122 -1.066 . . . . 73.310000000000002 108.122 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' VAL . 19.4 mt-30 -116.88 138.99 51.15 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.632 -0.877 . . . . 74.129999999999995 108.632 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.69 119.24 49.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.683 -0.858 . . . . 71.230000000000004 108.683 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.7 p -101.37 112.76 65.54 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.423 -0.954 . . . . 72.540000000000006 108.423 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.63 161.05 47.43 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.373 2.715 . . . . 73.219999999999999 112.677 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 119.72 6.14 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.526 2.151 . . . . 62.43 111.453 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 144.74 -39.08 1.24 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 116.131 -0.486 . . . . 74.540000000000006 112.231 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -77.22 77.99 3.76 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.219 0.607 . . . . 50.119999999999997 110.144 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.68 14.51 55.22 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.17 -0.468 . . . . 60.539999999999999 113.872 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 31.9 p -139.89 133.79 15.59 Favored Pre-proline 0 C--N 1.356 0.881 0 C-N-CA 123.422 0.689 . . . . 72.409999999999997 110.161 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' CYS . 17.2 Cg_exo -68.94 -38.19 10.04 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.132 2.554 . . . . 45.030000000000001 112.914 175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -118.43 159.24 23.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.769 0.828 . . . . 64.030000000000001 110.491 -174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -62.96 120.86 12.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.102 0.961 . . . . 64.230000000000004 109.9 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -108.55 117.55 34.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.501 0.72 . . . . 55.119999999999997 109.299 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -106.35 106.49 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.816 0.846 . . . . 75.319999999999993 109.423 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 30' ' ' GLN . 5.8 m -104.71 125.33 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.046 0.539 . . . . 63.539999999999999 109.789 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 26' ' ' ILE . 46.3 mt -114.37 120.11 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.728 0.811 . . . . 74.439999999999998 108.978 -175.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.435 ' HE1' ' NE2' ' A' ' 30' ' ' GLN . 66.9 m95 -86.57 128.25 34.97 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.236 1.014 . . . . 75.400000000000006 108.484 174.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.6 p -83.62 179.68 7.55 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.328 0.651 . . . . 74.409999999999997 110.17 172.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE2' HG22 ' A' ' 25' ' ' ILE . 41.8 mtmt -66.2 -29.67 69.98 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.394 0.278 . . . . 54.149999999999999 111.065 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -77.09 -7.3 55.5 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.501 0.72 . . . . 64.230000000000004 110.294 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 70.04 23.51 5.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 125.934 1.694 . . . . 75.150000000000006 111.408 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.01 123.69 25.62 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.278 -1.378 . . . . 74.319999999999993 107.278 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.19 126.58 43.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.342 0.657 . . . . 72.219999999999999 109.422 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HB ' HG12 ' A' ' 17' ' ' ILE . 46.6 pt -117.64 157.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.479 -1.304 . . . . 71.430000000000007 107.479 170.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.612 ' HB2' ' H ' ' A' ' 14' ' ' SER . 13.4 t -133.93 134.15 42.27 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.203 0.456 . . . . 52.140000000000001 109.939 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.7 HG11 ' HE1' ' A' ' 61' ' ' TRP . 31.0 m -133.95 164.94 33.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 C-N-CA 124.344 1.058 . . . . 73.150000000000006 109.598 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -81.57 159.16 67.46 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.367 -1.288 . . . . 65.0 109.846 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.68 -12.95 37.97 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.928 2.419 . . . . 74.209999999999994 112.028 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -83.52 -8.65 59.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.811 0.844 . . . . 54.219999999999999 111.432 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.87 132.37 49.23 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.735 0.814 . . . . 62.210000000000001 112.161 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.2 -36.45 69.21 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 74.099999999999994 112.491 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.7 ' HE1' HG11 ' A' ' 55' ' ' VAL . 7.7 p-90 -74.75 -23.15 58.51 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.565 0.346 . . . . 74.420000000000002 110.368 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.81 -28.5 69.61 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.097 0.959 . . . . 71.349999999999994 110.59 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.77 -34.78 73.44 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.632 0.773 . . . . 74.540000000000006 110.571 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.476 ' HB3' HD21 ' A' ' 23' ' ' LEU . 95.5 mtt180 -66.95 -39.49 87.29 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.572 0.749 . . . . 72.230000000000004 111.009 176.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.2 mp -71.1 -38.08 72.36 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.544 0.738 . . . . 65.5 110.858 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.53 -49.66 57.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.611 -0.722 . . . . 70.310000000000002 109.682 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -67.62 -24.03 65.42 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.315 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.658 0.783 . . . . 63.549999999999997 111.119 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.89 -29.78 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 122.723 0.409 . . . . 62.149999999999999 111.039 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -88.55 154.7 20.13 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.467 0.707 . . . . 70.239999999999995 110.45 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -65.86 125.5 25.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.336 -0.616 . . . . 54.340000000000003 109.336 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -90.0 -73.4 0.52 Allowed 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.975 -0.75 . . . . 71.230000000000004 108.975 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.3 m -156.62 100.2 1.92 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.166 0.986 . . . . 63.210000000000001 108.78 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tt -69.34 93.21 0.63 Allowed 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.206 -1.035 . . . . 71.430000000000007 108.206 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -107.66 176.59 5.1 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.974 -1.012 . . . . 70.349999999999994 108.983 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.1 p -75.04 127.69 33.82 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.056 -0.72 . . . . 61.340000000000003 109.056 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.6 t -72.7 123.53 89.66 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.171 -0.678 . . . . 42.530000000000001 109.171 176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 122.78 12.28 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.295 1.997 . . . . 73.530000000000001 112.269 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.37 141.76 58.16 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.945 0.498 . . . . 71.239999999999995 111.084 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.52 123.76 20.59 Favored Pre-proline 0 C--O 1.244 0.791 0 C-N-CA 123.843 0.857 . . . . 74.310000000000002 108.795 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.79 101.73 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.09 1.86 . . . . 75.219999999999999 111.143 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.12 146.89 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 75.25 110.973 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -78.15 73.58 4.71 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.759 0.79 . . . . 75.319999999999993 109.829 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -163.61 111.31 1.18 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.633 -1.988 . . . . 73.510000000000005 105.633 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.65 162.31 14.87 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.026 0.93 . . . . 72.540000000000006 108.666 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -67.14 -34.27 77.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.734 0.813 . . . . 72.310000000000002 110.552 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.8 -0.3 37.33 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.773 0.829 . . . . 71.510000000000005 111.947 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.143 0 C-N-CA 122.804 0.441 . . . . 71.540000000000006 110.161 -177.448 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 75.510000000000005 108.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.04 92.1 3.79 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.574 0.75 . . . . 71.510000000000005 109.348 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -90.28 84.11 6.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.53 0.732 . . . . 70.420000000000002 109.349 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.13 162.93 16.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.662 0.385 . . . . 53.329999999999998 110.524 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -84.07 88.2 7.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.409 0.684 . . . . 62.299999999999997 110.135 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -100.45 141.76 32.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.041 -0.726 . . . . 74.230000000000004 109.041 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 m -69.28 86.6 0.41 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.883 0.849 . . . . 62.399999999999999 109.725 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -122.49 138.28 54.61 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.738 -1.119 . . . . 71.209999999999994 108.828 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.77 95.73 2.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.377 -0.971 . . . . 74.519999999999996 108.377 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -142.55 173.76 11.25 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.914 1.286 . . . . 74.040000000000006 108.208 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.577 ' SG ' HG21 ' A' ' 32' ' ' THR . 14.0 m -77.42 117.07 18.54 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.956 0.502 . . . . 72.120000000000005 110.066 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -67.37 132.79 48.38 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.176 0.591 . . . . 73.129999999999995 110.081 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 41.8 t -146.57 155.61 42.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.526 0.73 . . . . 73.299999999999997 110.056 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.9 m -99.18 -6.91 27.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.288 0.635 . . . . 64.409999999999997 111.255 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.92 165.23 10.18 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 111.521 -0.632 . . . . 72.510000000000005 111.521 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -103.08 129.01 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 108.228 -1.026 . . . . 75.349999999999994 108.228 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.87 143.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.062 0.458 . . . . 74.400000000000006 110.581 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -100.5 -57.1 2.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.016 0.926 . . . . 52.340000000000003 108.733 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.0 m -67.32 127.54 33.04 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.814 0.846 . . . . 71.549999999999997 110.45 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.89 139.47 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 124.007 0.817 . . . . 62.149999999999999 110.668 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.97 144.66 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.361 1.064 . . . . 73.540000000000006 109.949 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.64 135.62 25.22 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.561 0.538 . . . . 72.219999999999999 114.253 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.71 -18.76 63.05 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.176 0.99 . . . . 63.109999999999999 111.578 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -59.52 -35.79 74.86 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.413 1.085 . . . . 72.150000000000006 111.746 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.7 pt -102.85 -1.92 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 119.324 -0.37 . . . . 75.420000000000002 111.793 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 45' ' ' ILE . 50.2 mm -78.37 124.62 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.963 -0.755 . . . . 62.409999999999997 108.963 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.13 -57.15 2.08 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.172 0.589 . . . . 71.219999999999999 110.26 -176.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -142.99 153.81 43.37 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.142 0.977 . . . . 74.219999999999999 109.519 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.03 113.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.747 0.819 . . . . 63.109999999999999 109.103 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -96.93 106.66 19.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.652 0.781 . . . . 61.219999999999999 109.139 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.4 t -89.89 117.73 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.033 -0.729 . . . . 65.530000000000001 109.033 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.577 HG21 ' SG ' ' A' ' 11' ' ' CYS . 8.4 m -89.47 112.68 53.02 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.701 0.8 . . . . 72.340000000000003 108.949 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.63 152.48 64.83 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.08 1.853 . . . . 60.340000000000003 111.999 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.79 109.38 0.89 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.828 2.352 . . . . 62.539999999999999 111.928 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.53 -27.79 0.96 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.868 -0.606 . . . . 41.229999999999997 112.181 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.36 68.88 10.62 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.748 0.819 . . . . 54.450000000000003 110.515 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.62 -3.79 40.02 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 115.338 -0.846 . . . . 62.530000000000001 114.145 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -132.89 125.55 19.28 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 124.233 1.013 . . . . 74.120000000000005 109.443 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.45 -17.79 30.1 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.498 2.132 . . . . 52.009999999999998 112.941 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -110.77 173.75 6.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.787 0.835 . . . . 72.120000000000005 110.165 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -85.43 113.82 22.0 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.867 -0.79 . . . . 75.040000000000006 108.867 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -101.74 111.13 23.27 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.21 -0.663 . . . . 74.200000000000003 109.21 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.3 t -92.63 99.81 10.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.328 -0.99 . . . . 71.109999999999999 108.328 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.11 107.02 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.093 -1.077 . . . . 73.439999999999998 108.093 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.604 ' HB ' HG13 ' A' ' 53' ' ' ILE . 58.5 mt -98.1 128.74 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.507 0.723 . . . . 63.43 109.493 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -102.91 121.45 42.54 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.137 0.975 . . . . 73.409999999999997 108.712 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -80.95 170.66 15.98 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.695 0.398 . . . . 74.310000000000002 111.106 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -69.31 -12.32 61.56 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.89 0.876 . . . . 75.109999999999999 111.605 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 ptp -101.94 18.28 21.03 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.921 0.888 . . . . 71.329999999999998 110.302 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 61.6 7.48 1.88 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.381 1.473 . . . . 31.530000000000001 113.902 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -73.14 128.52 35.71 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.281 -1.007 . . . . 72.040000000000006 108.281 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.95 119.21 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.867 -1.06 . . . . 73.319999999999993 109.791 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.604 HG13 ' HB ' ' A' ' 45' ' ' ILE . 23.9 pt -127.71 145.12 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.06 -1.089 . . . . 72.129999999999995 108.06 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 58.9 m -120.44 142.51 49.17 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.708 -0.479 . . . . 62.310000000000002 109.708 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG11 ' HE1' ' A' ' 61' ' ' TRP . 29.9 m -126.37 159.67 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 122.969 0.508 . . . . 70.530000000000001 109.712 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -74.96 146.32 82.42 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.085 -0.962 . . . . 74.349999999999994 109.476 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.87 -23.72 76.33 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.981 2.454 . . . . 60.310000000000002 113.1 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -106.23 22.91 14.94 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.714 0.806 . . . . 63.310000000000002 111.405 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.82 135.03 49.18 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.136 -0.69 . . . . 53.109999999999999 109.136 171.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -65.81 -39.53 90.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 71.510000000000005 111.703 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.546 ' HE1' HG11 ' A' ' 55' ' ' VAL . 2.4 p-90 -69.36 -30.16 68.1 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.77 0.428 . . . . 71.310000000000002 110.035 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.5 tp -68.27 -34.22 75.79 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 123.247 0.619 . . . . 55.32 110.838 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -57.19 -32.69 66.72 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.128 0.49 . . . . 72.409999999999997 110.976 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.31 -45.48 80.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.105 -0.952 . . . . 73.310000000000002 109.582 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.73 -42.99 97.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.834 . . . . 63.43 110.599 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.62 -49.16 74.37 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.963 0.79 . . . . 55.439999999999998 110.506 -178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -72.34 -27.11 62.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.308 0.485 . . . . 64.420000000000002 112.308 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.18 -42.12 47.43 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.361 0.664 . . . . 62.520000000000003 110.995 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.3 m -79.32 -28.24 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 116.389 -0.369 . . . . 73.420000000000002 110.493 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -81.3 149.58 28.89 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.187 0.595 . . . . 71.340000000000003 110.02 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m 71.31 16.44 6.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.42 1.488 . . . . 71.239999999999995 110.945 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -109.34 103.1 11.97 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.664 0.786 . . . . 74.209999999999994 109.107 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 t -85.78 64.01 8.37 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.705 0.802 . . . . 72.420000000000002 109.406 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.23 113.3 21.01 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.046 -1.094 . . . . 63.219999999999999 108.046 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.2 m -76.87 81.42 3.44 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.397 0.617 . . . . 71.239999999999995 110.373 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.4 t -81.07 116.31 20.95 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.965 -0.754 . . . . 73.129999999999995 108.965 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 p -95.24 137.49 22.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.605 0.762 . . . . 62.43 110.611 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.95 170.29 20.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.512 2.142 . . . . 74.430000000000007 113.064 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.35 147.43 41.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.133 0.973 . . . . 75.430000000000007 109.349 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.16 111.17 12.45 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.666 0.787 . . . . 62.039999999999999 111.359 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.87 150.25 26.83 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.153 1.902 . . . . 52.119999999999997 112.511 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p 40.45 82.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 126.274 1.83 . . . . 65.030000000000001 114.125 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.6 t -85.93 95.0 9.33 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 74.439999999999998 108.871 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -165.18 150.02 9.13 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.956 0.502 . . . . 74.420000000000002 111.265 -171.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -136.47 158.35 44.63 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.985 1.314 . . . . 60.43 108.897 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -80.66 87.83 5.77 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.65 -0.87 . . . . 63.119999999999997 108.65 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.46 65.68 9.3 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.573 0.749 . . . . 73.230000000000004 110.16 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.898 -1.046 . . . . 65.25 109.513 -176.002 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 108.735 -0.839 . . . . 62.219999999999999 108.735 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.19 156.96 45.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.033 0.933 . . . . 74.129999999999995 108.979 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -99.43 139.3 35.28 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.82 0.848 . . . . 44.310000000000002 109.337 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.99 116.22 21.51 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.123 0.569 . . . . 73.25 109.62 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -72.73 100.75 2.92 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.249 -0.649 . . . . 74.019999999999996 109.249 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -76.65 126.75 31.52 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.551 -0.749 . . . . 74.420000000000002 109.973 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 140.37 38.11 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.002 0.921 . . . . 71.319999999999993 109.041 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -90.87 42.81 1.12 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.192 0.597 . . . . 73.099999999999994 110.265 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tt -61.03 -39.79 91.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 74.510000000000005 110.215 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -132.05 175.59 9.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 122.989 0.515 . . . . 73.239999999999995 111.477 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.0 p -62.0 115.73 4.32 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.287 -0.869 . . . . 51.119999999999997 110.137 176.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -90.13 122.02 32.71 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.221 0.608 . . . . 73.239999999999995 110.682 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 t -143.4 126.07 15.98 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.838 0.855 . . . . 73.219999999999999 109.267 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.8 t -93.37 99.6 12.08 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.247 0.619 . . . . 60.549999999999997 109.43 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.03 -148.11 50.83 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.516 0.51 . . . . 13.039999999999999 113.152 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.21 129.12 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.365 -0.976 . . . . 71.140000000000001 108.365 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.8 pt -102.03 119.01 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.368 -0.604 . . . . 71.430000000000007 109.368 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 p -97.49 5.98 48.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.609 0.764 . . . . 74.439999999999998 110.833 174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.9 m -77.69 127.67 32.82 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.882 0.873 . . . . 64.310000000000002 109.798 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.78 111.12 10.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 107.274 -1.38 . . . . 71.519999999999996 107.274 172.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -80.43 139.06 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 109.022 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.65 124.63 36.9 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 124.005 0.816 . . . . 54.439999999999998 112.496 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.32 -34.29 70.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.508 0.723 . . . . 72.040000000000006 109.491 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -65.84 -34.13 77.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.781 0.832 . . . . 74.140000000000001 111.681 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.4 pt -92.06 3.61 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 122.049 -0.407 . . . . 70.420000000000002 112.067 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 35.3 mm -78.96 132.41 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 108.546 -0.909 . . . . 65.329999999999998 108.546 168.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.15 -56.03 2.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.218 0.607 . . . . 72.329999999999998 109.893 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -144.83 155.88 43.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.328 0.651 . . . . 72.040000000000006 110.974 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.73 112.05 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.759 1.223 . . . . 74.409999999999997 108.058 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -103.69 127.36 51.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.799 -0.815 . . . . 72.040000000000006 108.799 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.26 120.6 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.371 0.668 . . . . 62.43 109.406 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.1 m -95.12 110.35 49.65 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.549 -0.908 . . . . 71.109999999999999 108.549 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.49 156.44 64.03 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.871 2.38 . . . . 71.319999999999993 112.638 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.11 165.3 21.66 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.383 2.055 . . . . 75.510000000000005 112.026 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.43 -51.9 4.63 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.496 -0.32 . . . . 64.150000000000006 112.425 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -76.55 80.68 3.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.946 0.898 . . . . 75.120000000000005 110.856 -177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.3 -15.14 9.49 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.657 -0.701 . . . . 43.0 114.66 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.9 t -131.91 132.96 23.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 109.097 -0.705 . . . . 23.34 109.097 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -81.89 5.74 6.13 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.665 2.243 . . . . 74.099999999999994 112.912 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.2 159.61 42.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.404 1.082 . . . . 71.230000000000004 109.52 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.6 m -80.78 114.31 19.58 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.267 -1.012 . . . . 70.019999999999996 108.267 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.27 117.22 33.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.936 0.894 . . . . 64.209999999999994 109.733 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.67 102.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 108.706 -0.85 . . . . 72.150000000000006 108.706 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.1 t -92.05 108.53 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.874 -1.158 . . . . 74.510000000000005 107.874 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 60.2 mt -94.56 138.02 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.155 -0.683 . . . . 70.420000000000002 109.155 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -104.58 119.91 40.09 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.268 -1.382 . . . . 70.319999999999993 107.268 171.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.3 p -77.09 168.63 19.76 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.331 0.395 . . . . 74.439999999999998 110.215 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -73.47 -10.87 60.17 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.114 0.566 . . . . 54.43 111.226 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.2 mtt -82.72 -5.34 58.84 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.584 1.154 . . . . 53.539999999999999 110.127 168.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.97 18.91 10.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.16 1.784 . . . . 62.530000000000001 112.234 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -79.03 133.74 36.8 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.755 -0.657 . . . . 74.450000000000003 109.913 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.01 117.77 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 114.47 -1.241 . . . . 75.540000000000006 108.46 177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 45' ' ' ILE . 24.4 pt -126.64 148.05 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.258 0.623 . . . . 62.450000000000003 109.478 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -111.85 130.96 55.65 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.171 -1.048 . . . . 43.530000000000001 108.171 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.03 165.6 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.31 0.644 . . . . 72.200000000000003 110.25 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -74.35 135.55 75.85 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 123.274 0.629 . . . . 74.010000000000005 109.885 174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.69 -29.07 69.1 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.762 2.308 . . . . 71.129999999999995 112.831 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -88.76 4.57 47.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.698 0.799 . . . . 64.109999999999999 112.313 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.1 120.31 8.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.837 -0.431 . . . . 72.409999999999997 109.837 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.49 -36.73 74.22 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.241 1.016 . . . . 54.210000000000001 113.078 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -68.46 -31.59 70.99 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.234 0.614 . . . . 74.230000000000004 111.106 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 tp -73.72 -37.75 65.04 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.095 0.958 . . . . 73.430000000000007 110.84 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -42.69 82.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.891 0.877 . . . . 70.420000000000002 112.565 -173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -71.4 -27.69 63.5 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 116.112 -0.495 . . . . 72.140000000000001 111.464 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.5 tp -78.28 -25.83 46.85 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.494 0.718 . . . . 73.019999999999996 110.097 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -77.09 -28.61 54.58 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.73 0.812 . . . . 75.209999999999994 109.99 171.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -74.49 -31.12 62.09 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.591 0.356 . . . . 73.109999999999999 110.544 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.57 -37.36 85.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.237 0.615 . . . . 70.439999999999998 111.514 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.8 m -75.39 -12.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 116.096 -0.502 . . . . 60.350000000000001 111.104 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.16 111.07 21.76 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.678 0.791 . . . . 71.329999999999998 109.881 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 p -89.73 130.14 36.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.449 0.699 . . . . 74.329999999999998 110.336 175.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -74.04 93.16 2.22 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.813 -0.81 . . . . 54.030000000000001 108.813 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 p -145.77 19.64 1.47 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.37 1.068 . . . . 73.310000000000002 109.965 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 55.37 73.58 0.41 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.88 1.272 . . . . 50.25 108.561 -168.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.8 m -70.97 106.88 3.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.622 -1.172 . . . . 71.420000000000002 109.631 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -80.05 154.32 28.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.144 0.578 . . . . 71.409999999999997 110.299 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.0 p -62.49 136.67 96.01 Favored Pre-proline 0 CA--C 1.556 1.192 0 O-C-N 123.959 0.787 . . . . 72.420000000000002 110.492 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.52 127.09 7.44 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.661 2.907 . . . . 60.539999999999999 114.153 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -82.39 13.31 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.911 0.884 . . . . 72.409999999999997 111.641 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.67 83.06 20.38 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.227 1.011 . . . . 74.409999999999997 108.301 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.17 160.5 47.14 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.301 2.001 . . . . 55.530000000000001 110.757 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.78 109.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.34 -0.985 . . . . 63.409999999999997 108.34 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.1 m -75.16 73.13 2.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.91 0.884 . . . . 61.439999999999998 111.128 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -108.25 104.35 13.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.077 -1.453 . . . . 52.119999999999997 107.077 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -114.97 150.33 35.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.415 0.686 . . . . 72.209999999999994 109.441 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -129.08 122.81 30.73 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.903 -1.147 . . . . 75.010000000000005 107.903 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -115.58 145.05 43.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.57 0.748 . . . . 65.230000000000004 109.403 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.445 0.698 . . . . 72.409999999999997 110.945 -179.452 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.617 -0.512 . . . . 61.140000000000001 109.617 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.97 103.06 9.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.737 -1.579 . . . . 51.350000000000001 106.737 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.95 90.13 2.98 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.44 -0.578 . . . . 63.130000000000003 109.44 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.64 142.78 58.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.231 0.613 . . . . 72.409999999999997 109.937 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -63.86 112.11 2.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.282 0.633 . . . . 71.450000000000003 109.304 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.16 137.45 54.89 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.109 0.963 . . . . 74.329999999999998 110.921 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -60.09 161.22 7.08 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.857 1.263 . . . . 74.239999999999995 112.386 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -102.01 174.71 5.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.689 0.796 . . . . 74.329999999999998 109.997 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp 65.67 26.12 11.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.886 1.274 . . . . 73.200000000000003 110.172 -175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -96.54 174.27 6.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.887 -1.051 . . . . 73.099999999999994 110.73 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 32' ' ' THR . 72.7 m -76.23 125.28 28.87 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.784 0.833 . . . . 75.439999999999998 110.109 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -76.33 117.38 17.95 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.68 -0.859 . . . . 75.120000000000005 108.68 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.48 109.84 20.78 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.732 -1.21 . . . . 75.530000000000001 107.732 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -81.46 73.4 8.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.763 0.825 . . . . 60.549999999999997 110.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.71 -142.53 48.22 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.492 -0.776 . . . . 71.209999999999994 113.181 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.87 153.74 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.75 0.82 . . . . 45.350000000000001 109.264 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.401 HG12 ' HB ' ' A' ' 53' ' ' ILE . 2.3 pp -128.69 131.28 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 121.249 0.547 . . . . 72.310000000000002 109.875 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -89.93 -10.16 46.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.726 0.811 . . . . 44.240000000000002 111.596 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 m -64.19 127.21 30.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.709 0.803 . . . . 72.319999999999993 111.247 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.0 p -69.65 114.26 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 108.276 -1.009 . . . . 75.329999999999998 108.276 172.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.53 127.0 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.468 0.707 . . . . 74.420000000000002 109.63 -174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.0 160.67 17.7 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.777 -0.647 . . . . 52.399999999999999 113.378 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.6 -33.82 68.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.012 1.325 . . . . 63.130000000000003 111.215 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -58.97 -32.22 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.044 0.938 . . . . 73.340000000000003 111.865 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.11 5.83 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 112.435 0.532 . . . . 72.120000000000005 112.435 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.548 HG13 HD11 ' A' ' 65' ' ' LEU . 21.7 mm -77.42 113.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.786 -0.82 . . . . 71.530000000000001 108.786 170.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -85.58 -55.97 3.73 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.697 -0.482 . . . . 62.210000000000001 109.697 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -157.34 143.62 17.88 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.673 0.789 . . . . 71.040000000000006 109.891 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 45' ' ' ILE . 65.7 mt -120.88 139.73 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.276 1.03 . . . . 54.32 109.493 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.41 143.09 47.39 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.682 -0.858 . . . . 71.239999999999995 108.682 171.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.2 138.02 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 109.229 -0.656 . . . . 72.209999999999994 109.229 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 71.8 p -119.9 143.2 34.7 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 123.626 0.77 . . . . 71.239999999999995 109.279 -174.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.77 163.45 26.27 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.077 2.518 . . . . 75.510000000000005 113.652 -170.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.94 130.04 14.01 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 110.878 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.68 -162.01 30.03 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.356 -0.698 . . . . 74.310000000000002 111.356 -170.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 65.35 17.48 11.0 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.03 0.932 . . . . 72.239999999999995 111.451 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.35 -21.44 41.21 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.674 -0.694 . . . . 73.310000000000002 112.828 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.5 m -85.06 135.75 39.15 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.763 0.825 . . . . 61.43 109.398 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.55 -63.34 0.19 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.994 2.463 . . . . 75.219999999999999 113.333 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.66 -177.27 4.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.323 -0.991 . . . . 74.430000000000007 108.323 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' THR . 24.2 m -57.59 110.13 0.83 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.806 -0.813 . . . . 61.109999999999999 108.806 166.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -104.33 119.39 38.85 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.959 -0.756 . . . . 71.109999999999999 108.959 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.45 102.48 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.885 -0.783 . . . . 55.130000000000003 108.885 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.61 134.35 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.553 -0.906 . . . . 72.439999999999998 108.553 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.41 HG12 HG12 ' A' ' 29' ' ' ILE . 61.8 mt -133.01 125.54 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.329 -0.619 . . . . 72.120000000000005 109.329 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.82 123.43 36.08 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.064 -1.087 . . . . 73.420000000000002 108.064 166.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.0 p -84.58 179.46 7.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.247 0.619 . . . . 74.030000000000001 110.87 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.93 -24.41 64.28 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.119 0.568 . . . . 71.219999999999999 111.809 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.549 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 25.0 ptp -90.93 12.4 19.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.271 0.628 . . . . 61.130000000000003 110.766 172.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.56 22.44 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.839 1.656 . . . . 65.409999999999997 112.461 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 49' ' ' MET . 2.0 tmtp? -74.75 123.77 25.56 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.622 -1.622 . . . . 72.329999999999998 106.622 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.34 121.53 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 124.301 1.041 . . . . 72.030000000000001 108.523 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 ' HB ' HG12 ' A' ' 17' ' ' ILE . 30.0 pt -125.56 147.51 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 108.522 -0.918 . . . . 71.019999999999996 108.522 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.35 118.42 25.02 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.813 -1.18 . . . . 74.129999999999995 107.813 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.88 164.57 21.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.582 0.753 . . . . 72.510000000000005 109.911 -174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -71.45 147.56 92.74 Favored Pre-proline 0 N--CA 1.474 0.744 0 O-C-N 123.936 0.773 . . . . 72.439999999999998 110.186 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -64.42 -9.19 19.26 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.981 2.454 . . . . 74.109999999999999 113.582 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -111.44 26.15 10.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.989 0.916 . . . . 73.349999999999994 111.952 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.5 131.46 44.06 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 108.643 -0.873 . . . . 50.310000000000002 108.643 168.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.23 -47.94 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 71.329999999999998 112.844 -167.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.9 -24.47 64.31 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.673 0.389 . . . . 74.230000000000004 111.849 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.02 -32.13 72.3 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.033 0.533 . . . . 75.510000000000005 110.237 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.72 -23.63 67.44 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.172 0.589 . . . . 71.549999999999997 111.476 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -69.58 -40.55 76.67 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.415 0.686 . . . . 73.140000000000001 110.3 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 26' ' ' ILE . 4.5 mm? -71.33 -34.73 70.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.499 0.72 . . . . 73.109999999999999 110.26 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -71.15 -37.81 72.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.539 0.736 . . . . 70.329999999999998 110.012 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.85 -40.82 97.47 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.755 0.822 . . . . 75.230000000000004 109.96 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -59.12 -40.65 86.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.565 1.146 . . . . 64.310000000000002 112.056 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -85.93 -14.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 115.9 -0.591 . . . . 73.129999999999995 112.346 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.3 -25.42 11.95 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.716 0.406 . . . . 70.209999999999994 111.783 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 97.5 p -127.36 -159.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.176 0.591 . . . . 61.219999999999999 110.282 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -59.5 162.36 5.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.133 0.973 . . . . 65.299999999999997 112.276 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.0 t -144.77 153.82 42.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.586 -0.733 . . . . 64.239999999999995 110.923 -173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.74 104.0 14.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.907 -0.775 . . . . 61.350000000000001 108.907 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -72.02 113.99 9.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.996 0.919 . . . . 61.509999999999998 109.822 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.8 m -76.02 160.59 29.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.368 0.667 . . . . 74.109999999999999 110.19 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.8 p -61.17 132.05 92.31 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.499 1.12 . . . . 61.130000000000003 110.923 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.29 104.88 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.339 2.692 . . . . 74.530000000000001 112.297 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.09 127.06 37.42 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.673 -1.149 . . . . 74.129999999999995 110.229 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -118.69 107.01 43.2 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.912 0.885 . . . . 53.420000000000002 109.092 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.25 151.64 58.5 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.663 2.242 . . . . 53.32 112.317 171.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.63 123.94 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.291 -0.633 . . . . 73.109999999999999 109.291 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -78.0 157.79 29.52 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.034 0.533 . . . . 64.349999999999994 109.684 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -60.19 122.31 14.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.585 0.754 . . . . 72.310000000000002 109.729 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.92 123.39 11.4 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.316 1.01 . . . . 75.549999999999997 110.986 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -111.01 111.91 23.36 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.512 0.725 . . . . 73.420000000000002 109.147 -171.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.03 81.71 0.67 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.85 -0.796 . . . . 50.25 108.85 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 C-N-CA 124.389 1.076 . . . . 65.219999999999999 110.283 -169.554 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 110.22 -0.289 . . . . 64.129999999999995 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -155.8 130.86 9.33 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.03 0.932 . . . . 61.130000000000003 108.546 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.78 157.74 27.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.212 0.605 . . . . 62.140000000000001 109.871 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.97 68.1 9.33 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.47 0.708 . . . . 32.340000000000003 110.469 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.79 121.77 41.77 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.062 -1.088 . . . . 74.239999999999995 108.062 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -97.97 -37.71 9.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.337 0.655 . . . . 74.310000000000002 109.955 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 t -149.39 144.1 26.17 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.608 -0.724 . . . . 75.140000000000001 110.366 -171.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -127.04 115.48 19.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.646 1.178 . . . . 72.439999999999998 107.833 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.59 135.75 50.07 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.767 0.427 . . . . 73.239999999999995 111.013 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 pttt 179.74 174.25 0.85 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.918 1.687 . . . . 71.329999999999998 108.145 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' SG ' HG21 ' A' ' 32' ' ' THR . 11.2 m -81.59 121.21 26.03 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.564 0.746 . . . . 23.539999999999999 109.638 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.0 mtm180 -78.99 138.14 37.91 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.916 -0.772 . . . . 74.049999999999997 108.916 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.6 t -144.76 148.3 33.96 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.546 0.739 . . . . 63.43 110.431 -170.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.5 t -83.8 -28.18 28.28 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.995 0.918 . . . . 65.230000000000004 110.611 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.63 174.89 15.73 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 109.849 -1.3 . . . . 71.129999999999995 109.849 -173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 28.3 m -101.76 147.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 117.273 0.537 . . . . 71.120000000000005 110.468 -173.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.95 131.98 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.853 -0.612 . . . . 74.219999999999999 109.531 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.2 m -85.73 -47.94 9.3 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.524 0.73 . . . . 72.430000000000007 110.017 172.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -83.28 122.26 28.2 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.011 0.924 . . . . 74.230000000000004 108.822 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -54.54 113.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.688 0.795 . . . . 54.030000000000001 111.502 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.77 141.6 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 115.691 -0.686 . . . . 75.219999999999999 109.98 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.19 131.23 32.95 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.674 0.609 . . . . 70.150000000000006 112.569 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.1 -33.13 68.77 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.159 0.984 . . . . 40.229999999999997 109.716 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.06 -34.48 77.78 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.203 1.001 . . . . 73.129999999999995 111.815 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -95.4 16.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 122.222 -0.299 . . . . 71.5 111.395 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 45' ' ' ILE . 50.4 mm -79.94 129.22 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 109.006 -0.738 . . . . 71.010000000000005 109.006 168.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -94.89 -56.13 2.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.856 0.862 . . . . 64.239999999999995 110.535 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -156.03 142.47 18.52 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.737 -0.665 . . . . 71.010000000000005 109.414 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -108.82 138.13 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.392 1.077 . . . . 75.140000000000001 108.821 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HG3' ' HB ' ' A' ' 44' ' ' VAL . 26.6 pt20 -136.66 111.55 8.86 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 108.687 -0.857 . . . . 72.439999999999998 108.687 171.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -90.9 123.15 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.102 -0.703 . . . . 74.030000000000001 109.102 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.474 HG21 ' SG ' ' A' ' 11' ' ' CYS . 22.3 m -87.28 110.88 37.2 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.043 0.937 . . . . 71.439999999999998 109.241 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.41 154.14 55.75 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.911 2.407 . . . . 74.349999999999994 112.877 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.25 164.81 33.35 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.353 2.035 . . . . 63.43 112.235 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.38 -53.49 4.8 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 112.712 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.51 88.94 0.35 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.271 1.028 . . . . 55.32 110.451 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.9 -18.54 3.87 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.067 0.841 . . . . 32.520000000000003 114.625 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.2 m -139.19 132.62 15.8 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.797 1.239 . . . . 63.299999999999997 109.43 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.5 -9.97 20.25 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.734 2.289 . . . . 53.539999999999999 112.088 176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 10.3 mmpt? -116.1 137.64 51.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.165 0.986 . . . . 71.129999999999995 110.248 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.5 m -69.19 138.48 54.11 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.725 0.81 . . . . 70.230000000000004 109.423 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.23 145.99 49.68 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.274 -1.01 . . . . 64.230000000000004 108.274 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.19 103.32 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.067 -1.086 . . . . 74.549999999999997 108.067 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 30' ' ' GLN . 61.6 t -94.04 124.05 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.235 -1.024 . . . . 73.230000000000004 108.235 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.574 HG21 HD12 ' A' ' 26' ' ' ILE . 66.8 mt -119.39 137.22 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 123.271 0.628 . . . . 55.43 110.002 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -91.62 131.93 36.68 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.923 -1.14 . . . . 75.010000000000005 107.923 166.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.5 p -86.43 172.07 10.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.368 0.667 . . . . 74.310000000000002 109.895 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -75.61 -7.61 54.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.372 0.669 . . . . 72.510000000000005 111.328 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.5 mtm -83.61 -7.09 59.58 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.942 0.897 . . . . 75.530000000000001 109.435 167.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 65.18 24.6 12.35 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.207 1.803 . . . . 74.329999999999998 110.536 -176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.46 125.97 32.84 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 106.737 -1.579 . . . . 73.140000000000001 106.737 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.53 122.85 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.101 -1.074 . . . . 75.319999999999993 108.101 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -127.19 155.89 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 108.648 -0.871 . . . . 72.129999999999995 108.648 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 39.6 m -111.63 151.19 29.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.91 -1.515 . . . . 64.450000000000003 106.91 165.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.06 129.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.602 -1.259 . . . . 71.310000000000002 107.602 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -54.07 129.08 57.96 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.493 0.717 . . . . 64.25 109.734 176.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.02 -14.45 41.6 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.511 2.141 . . . . 61.450000000000003 113.59 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -85.91 3.89 39.89 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.081 0.552 . . . . 74.109999999999999 111.947 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 120.85 10.53 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 123.414 0.686 . . . . 61.130000000000003 109.747 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -67.23 -31.54 71.97 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.762 1.225 . . . . 74.219999999999999 112.082 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -79.51 -23.51 42.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.25 1.02 . . . . 73.319999999999993 111.418 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.96 -27.58 68.35 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.892 0.877 . . . . 71.329999999999998 111.347 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.1 -35.86 69.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.817 0.847 . . . . 74.420000000000002 111.545 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -69.0 -34.06 74.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.405 0.682 . . . . 73.530000000000001 110.57 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.4 mp -70.22 -41.7 73.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.248 -0.649 . . . . 61.009999999999998 109.248 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.77 -38.35 88.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.749 0.82 . . . . 74.329999999999998 110.516 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -63.72 -34.16 77.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.863 0.865 . . . . 74.310000000000002 110.785 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -71.98 -33.71 68.36 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.922 0.489 . . . . 60.310000000000002 110.619 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 65' ' ' LEU . 97.4 t -71.99 -30.03 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.348 0.659 . . . . 62.509999999999998 109.414 175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -71.88 90.19 1.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.854 -1.165 . . . . 61.399999999999999 107.854 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.3 p -108.86 177.86 4.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.776 1.231 . . . . 71.319999999999993 110.886 -170.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -73.94 151.22 40.42 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.517 0.727 . . . . 74.109999999999999 109.298 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 p -69.14 76.1 0.34 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.724 1.21 . . . . 72.230000000000004 111.753 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.69 131.47 40.9 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.63 1.172 . . . . 50.340000000000003 108.065 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.0 p -66.43 90.37 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.302 0.641 . . . . 72.5 110.167 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.4 t -63.26 113.45 3.2 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.491 1.116 . . . . 73.239999999999995 110.28 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.0 t -79.02 141.2 58.28 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 118.421 -0.799 . . . . 73.510000000000005 109.142 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.76 83.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.723 2.282 . . . . 75.400000000000006 112.425 171.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.2 -20.78 54.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.514 -0.766 . . . . 72.299999999999997 111.014 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 142.08 84.33 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.233 0.613 . . . . 50.109999999999999 109.621 174.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.03 150.67 38.38 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.269 1.979 . . . . 75.120000000000005 112.007 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.91 110.64 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.67 -1.233 . . . . 72.439999999999998 107.67 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.0 t -137.22 168.34 19.81 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.044 0.938 . . . . 64.010000000000005 109.992 -171.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -66.36 129.08 38.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.463 0.705 . . . . 73.239999999999995 111.828 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -120.93 98.41 5.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.714 1.205 . . . . 72.109999999999999 107.845 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -72.58 -40.02 66.93 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.692 -0.855 . . . . 71.430000000000007 108.692 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.94 164.5 15.11 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.845 -1.07 . . . . 51.310000000000002 110.215 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.893 0 C-N-CA 124.385 1.074 . . . . 61.25 108.954 177.09 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.164 -1.05 . . . . 51.340000000000003 108.164 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.0 mt -102.53 124.5 48.19 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.498 -0.927 . . . . 73.540000000000006 108.498 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.9 134.99 35.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.119 0.567 . . . . 65.109999999999999 110.631 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.96 97.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.037 0.935 . . . . 72.400000000000006 111.565 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -66.49 123.4 19.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.284 -0.636 . . . . 65.25 109.284 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.59 138.91 41.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.44 -0.578 . . . . 70.420000000000002 109.44 -175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -82.74 155.13 24.44 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 123.886 0.741 . . . . 62.310000000000002 110.346 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -74.69 -3.97 34.57 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.632 0.773 . . . . 64.420000000000002 111.481 175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.28 149.71 44.97 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.114 0.965 . . . . 73.219999999999999 111.358 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -53.87 131.48 40.0 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.048 -0.978 . . . . 73.099999999999994 110.618 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.526 ' SG ' ' HG3' ' A' ' 40' ' ' LYS . 26.3 p -67.32 135.57 53.5 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.222 1.009 . . . . 65.140000000000001 112.02 -169.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -91.79 161.55 14.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.126 . . . . 74.319999999999993 109.635 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 t -94.76 119.96 34.21 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.501 -1.296 . . . . 74.349999999999994 107.501 165.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.2 t -72.36 94.18 1.59 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.277 0.631 . . . . 61.420000000000002 111.08 -170.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.1 67.6 0.24 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 111.708 -0.557 . . . . 42.340000000000003 111.708 177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.62 170.1 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.541 0.737 . . . . 71.030000000000001 110.882 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.53 147.42 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.37 0.668 . . . . 71.030000000000001 110.822 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.9 p -108.76 17.71 21.57 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.974 0.909 . . . . 64.120000000000005 110.679 174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.5 t -143.9 150.09 37.87 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.909 0.884 . . . . 73.310000000000002 109.176 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 p -63.02 130.49 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 108.99 -0.745 . . . . 74.310000000000002 108.99 168.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.34 147.22 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.525 -0.916 . . . . 62.43 108.525 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.44 118.99 10.42 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.568 0.543 . . . . 72.540000000000006 112.836 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.32 -34.49 73.89 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.686 0.794 . . . . 75.439999999999998 110.216 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -62.67 -32.36 73.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.831 0.852 . . . . 75.549999999999997 111.765 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.5 pt -98.11 15.03 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 111.733 0.271 . . . . 61.109999999999999 111.733 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.72 122.88 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.989 -0.745 . . . . 54.009999999999998 108.989 168.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -90.69 -56.24 3.27 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.101 -0.703 . . . . 74.200000000000003 109.101 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -160.86 137.06 8.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.327 -0.851 . . . . 74.109999999999999 110.44 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.69 108.54 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 108.68 -0.859 . . . . 74.439999999999998 108.68 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -101.63 115.28 30.16 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.425 -0.954 . . . . 72.219999999999999 108.425 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -85.94 121.88 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 107.96 -1.126 . . . . 74.019999999999996 107.96 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.4 m -105.68 126.3 31.11 Favored Pre-proline 0 C--O 1.247 0.973 0 C-N-CA 123.572 0.749 . . . . 73.329999999999998 109.777 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.02 153.3 58.87 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.541 2.16 . . . . 73.519999999999996 112.219 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HB3' ' H ' ' A' ' 40' ' ' LYS . 11.1 Cg_endo -52.76 92.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.419 2.746 . . . . 73.150000000000006 114.109 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.4 14.52 10.07 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.334 -0.848 . . . . 75.430000000000007 111.487 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -73.23 -14.53 61.36 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.427 1.091 . . . . 74.430000000000007 111.124 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.03 -14.66 48.55 Favored Glycine 0 C--N 1.35 1.348 0 C-N-CA 123.834 0.73 . . . . 52.229999999999997 111.289 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -131.54 156.73 79.73 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.335 1.454 . . . . 75.510000000000005 109.002 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.52 81.96 0.55 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.085 2.523 . . . . 74.310000000000002 112.325 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 27.8 mmmt -142.77 121.26 12.44 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.946 0.898 . . . . 72.239999999999995 110.087 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 m -79.23 114.74 18.41 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.995 -1.113 . . . . 73.129999999999995 107.995 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -94.56 108.29 20.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.526 -0.916 . . . . 75.510000000000005 108.526 -173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.8 101.57 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.3 -1.0 . . . . 64.040000000000006 108.3 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.2 t -96.2 108.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.359 -0.837 . . . . 64.319999999999993 109.057 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.447 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.0 mt -104.75 121.92 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.925 -0.769 . . . . 64.109999999999999 108.925 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -95.23 131.71 40.99 Favored 'General case' 0 C--O 1.248 0.993 0 C-N-CA 124.175 0.99 . . . . 75.200000000000003 108.899 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.8 p -90.46 169.75 10.79 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 123.214 0.606 . . . . 73.129999999999995 110.278 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -73.37 -17.13 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.637 0.775 . . . . 51.140000000000001 110.891 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.7 mtt -79.86 6.72 10.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.482 0.713 . . . . 45.329999999999998 110.837 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 65.7 17.21 10.81 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.486 1.114 . . . . 65.120000000000005 111.877 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -91.8 130.28 37.6 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.357 -0.979 . . . . 75.340000000000003 108.357 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.6 t -85.92 128.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.207 -0.906 . . . . 63.130000000000003 109.84 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 45' ' ' ILE . 42.8 pt -128.53 156.08 40.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 108.013 -1.106 . . . . 72.120000000000005 108.013 167.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -133.07 136.02 45.66 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.962 -0.755 . . . . 70.319999999999993 108.962 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.43 163.57 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.507 0.723 . . . . 64.140000000000001 109.728 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -86.0 146.18 42.55 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.78 -1.1 . . . . 72.420000000000002 108.391 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.16 -10.06 24.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.074 2.516 . . . . 75.230000000000004 113.522 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -75.2 -12.54 60.31 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.139 0.576 . . . . 70.239999999999995 111.712 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.96 115.36 2.36 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.09 0.956 . . . . 72.239999999999995 110.573 177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HA ' HE21 ' A' ' 63' ' ' GLN . 50.6 mtpt -66.32 -32.6 74.1 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.007 0.923 . . . . 64.209999999999994 112.278 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.3 p-90 -70.92 -26.23 63.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.933 0.493 . . . . 75.340000000000003 110.936 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.4 -30.17 70.49 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.536 0.734 . . . . 73.230000000000004 110.761 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 60' ' ' LYS . 47.3 mt-30 -59.26 -27.07 65.47 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 63.130000000000003 111.399 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -62.63 -47.54 83.31 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.863 0.727 . . . . 75.400000000000006 110.037 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.3 mm? -69.84 -46.52 65.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.15 -0.932 . . . . 73.450000000000003 110.189 -177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.22 -46.16 90.72 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.1 0.875 . . . . 74.129999999999995 111.222 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -79.03 -18.35 53.71 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.715 -0.675 . . . . 72.120000000000005 110.965 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.26 -30.43 64.85 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.469 0.308 . . . . 75.219999999999999 110.473 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 65' ' ' LEU . 49.0 t -68.65 -23.62 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 109.805 -0.443 . . . . 72.420000000000002 109.805 176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.71 85.12 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.901 0.858 . . . . 70.120000000000005 109.553 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.7 t -117.77 174.62 6.07 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.565 -1.198 . . . . 74.400000000000006 109.303 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -76.99 172.29 13.42 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.919 0.488 . . . . 71.409999999999997 110.901 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.5 m -68.14 85.66 0.25 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.386 0.675 . . . . 64.430000000000007 110.586 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 mt -82.24 83.7 7.32 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.674 -1.232 . . . . 64.099999999999994 107.674 175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.4 t -65.76 98.54 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.969 -1.014 . . . . 64.120000000000005 110.204 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 p -75.28 161.16 29.55 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.061 -0.972 . . . . 74.549999999999997 110.19 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -77.04 151.6 81.87 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.158 0.583 . . . . 74.140000000000001 110.041 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.18 148.47 49.38 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 72.230000000000004 112.498 171.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -140.91 130.52 24.06 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.399 0.68 . . . . 74.219999999999999 109.948 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.57 123.48 66.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.643 0.777 . . . . 42.130000000000003 109.744 175.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.09 107.84 0.29 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.622 2.215 . . . . 74.319999999999993 112.202 169.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.95 136.3 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 115.789 -0.641 . . . . 55.210000000000001 110.328 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.0 p -166.89 84.26 0.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.315 0.646 . . . . 63.299999999999997 110.387 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -86.15 107.58 17.93 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.058 0.543 . . . . 71.409999999999997 110.045 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -73.03 99.0 2.64 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.032 -0.729 . . . . 73.239999999999995 109.032 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.29 115.94 11.04 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 108.413 -0.958 . . . . 73.129999999999995 108.413 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.55 105.58 1.54 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.106 -1.072 . . . . 70.109999999999999 108.106 169.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 O-C-N 124.35 1.031 . . . . 72.519999999999996 111.014 -173.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.9 pt . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 109.573 -0.529 . . . . 75.340000000000003 109.573 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -76.43 -12.46 60.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.01 0.524 . . . . 64.510000000000005 111.42 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.12 145.29 46.53 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.101 -0.703 . . . . 64.439999999999998 109.101 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.63 -178.25 6.15 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.462 0.705 . . . . 73.540000000000006 110.348 -172.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -68.54 127.8 34.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.482 0.713 . . . . 73.409999999999997 110.85 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -110.78 128.97 55.95 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.804 1.242 . . . . 73.230000000000004 109.575 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -89.43 112.8 24.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.592 0.757 . . . . 70.420000000000002 110.188 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.74 -60.48 1.69 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.777 -0.453 . . . . 62.409999999999997 109.777 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 53.4 65.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.066 1.346 . . . . 74.140000000000001 112.662 174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -163.99 -173.72 3.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.23 1.012 . . . . 75.310000000000002 109.257 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.493 ' SG ' HG21 ' A' ' 32' ' ' THR . 2.6 m -53.02 137.57 32.7 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.092 0.957 . . . . 71.420000000000002 109.699 170.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -65.32 118.34 9.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.999 -0.741 . . . . 73.439999999999998 108.999 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.3 m -143.7 132.04 22.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 71.129999999999995 109.662 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 t -102.98 39.02 1.62 Allowed 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.343 -0.984 . . . . 50.140000000000001 108.343 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.18 -149.07 24.77 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.211 -0.904 . . . . 31.109999999999999 111.037 -171.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.56 170.08 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.911 0.884 . . . . 62.439999999999998 109.76 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.417 HD13 ' O ' ' A' ' 19' ' ' THR . 2.6 pp -81.82 150.64 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.283 0.563 . . . . 60.32 110.524 175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.5 p -113.65 8.18 17.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.037 0.935 . . . . 62.240000000000002 111.435 171.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.417 ' O ' HD13 ' A' ' 17' ' ' ILE . 41.0 m -136.71 129.7 30.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.913 0.885 . . . . 70.430000000000007 109.251 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.3 t -65.85 113.3 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.658 -0.867 . . . . 63.340000000000003 108.658 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.4 t -77.01 126.59 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.186 -0.915 . . . . 72.340000000000003 110.554 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.03 137.4 38.39 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.924 0.765 . . . . 24.420000000000002 113.596 -175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.3 -36.53 71.2 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.022 0.929 . . . . 73.209999999999994 110.39 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -61.82 -34.18 75.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.852 0.861 . . . . 72.239999999999995 111.98 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.52 -4.82 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 119.278 -0.392 . . . . 70.310000000000002 111.742 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.3 mm -68.51 114.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.832 -0.803 . . . . 73.340000000000003 108.832 171.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -89.81 -52.85 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.412 -0.588 . . . . 74.319999999999993 109.412 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 46' ' ' TRP . 6.2 ptp180 -152.05 145.63 24.93 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.3 -0.409 . . . . 62.030000000000001 110.3 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.51 108.63 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.838 -1.171 . . . . 73.150000000000006 107.838 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -103.0 121.93 43.57 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.772 -0.825 . . . . 64.319999999999993 108.772 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.53 113.54 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.837 -1.171 . . . . 70.129999999999995 107.837 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' SG ' ' A' ' 11' ' ' CYS . 7.2 m -96.4 106.91 32.42 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 109.59 -0.522 . . . . 73.340000000000003 109.59 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.41 163.82 37.45 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.104 1.869 . . . . 74.329999999999998 111.522 174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.81 97.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.468 2.778 . . . . 74.519999999999996 112.98 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -92.22 0.09 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.413 -0.358 . . . . 63.140000000000001 113.164 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.77 79.34 6.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.384 0.673 . . . . 72.439999999999998 111.692 -170.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.32 -20.85 3.82 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.105 -0.952 . . . . 73.230000000000004 114.638 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 98.7 m -89.73 114.54 61.03 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 108.503 -0.925 . . . . 64.329999999999998 108.503 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.41 -6.54 10.93 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.614 2.209 . . . . 44.039999999999999 113.504 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 172.09 12.05 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.084 0.954 . . . . 64.239999999999995 109.209 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.3 m -73.05 115.61 12.58 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.679 -0.692 . . . . 64.319999999999993 110.183 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -124.04 114.44 19.74 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.223 1.009 . . . . 53.409999999999997 108.479 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.43 104.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.923 0.489 . . . . 60.399999999999999 110.063 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG12 ' SG ' ' A' ' 54' ' ' CYS . 35.3 m -92.37 111.69 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 121.814 0.816 . . . . 64.319999999999993 109.238 176.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.71 134.53 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.264 0.626 . . . . 74.230000000000004 109.565 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 28' ' ' ARG . 66.4 m95 -96.34 130.03 43.54 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 78.3 p -84.13 169.02 15.28 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 123.477 0.486 . . . . 73.040000000000006 109.704 169.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -21.47 66.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.178 0.591 . . . . 74.5 110.533 172.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 52.0 mtm -85.02 2.35 43.55 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.829 1.252 . . . . 71.530000000000001 110.915 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp 62.86 38.57 11.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.895 1.678 . . . . 70.040000000000006 112.704 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -90.73 135.65 33.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.472 -1.24 . . . . 63.420000000000002 109.467 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 t -98.1 115.8 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.429 -0.952 . . . . 73.450000000000003 108.429 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 46.4 pt -119.16 149.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.291 0.636 . . . . 70.030000000000001 109.478 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.575 ' SG ' HG12 ' A' ' 44' ' ' VAL . 92.6 m -115.07 117.83 31.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.391 0.676 . . . . 70.439999999999998 109.532 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -131.55 154.29 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.274 1.03 . . . . 72.340000000000003 108.877 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -77.21 148.26 77.66 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 122.874 0.47 . . . . 71.519999999999996 110.477 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -64.47 -13.67 39.86 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.879 2.386 . . . . 64.310000000000002 113.078 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -107.42 18.41 21.59 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.716 0.806 . . . . 71.530000000000001 111.871 -175.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.84 123.21 19.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.851 -1.166 . . . . 55.329999999999998 107.851 167.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -56.25 -44.52 79.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.219 1.008 . . . . 54.329999999999998 112.19 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 64.0 p-90 -64.24 -38.16 90.05 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.814 0.445 . . . . 74.140000000000001 111.135 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.93 -33.65 76.06 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.559 0.744 . . . . 63.149999999999999 110.99 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -54.26 -38.61 66.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.337 0.655 . . . . 72.030000000000001 111.132 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.48 -37.95 86.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.643 . . . . 73.040000000000006 110.372 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.81 -41.93 91.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.767 0.827 . . . . 73.439999999999998 109.924 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 -24.97 62.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.231 1.012 . . . . 73.299999999999997 110.984 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -83.46 -35.64 24.78 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.951 0.5 . . . . 55.310000000000002 109.844 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -75.88 -23.13 55.59 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.957 0.503 . . . . 73.150000000000006 111.626 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 5.4 p -77.22 -17.86 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 110.032 -0.359 . . . . 71.329999999999998 110.032 174.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.68 138.41 40.01 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.35 -0.982 . . . . 73.129999999999995 108.35 168.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.9 t 63.65 37.97 9.78 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.484 1.114 . . . . 73.319999999999993 109.23 -174.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 69' ' ' VAL . 59.3 tttm -59.64 -36.95 77.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.72 1.608 . . . . 62.0 112.337 -173.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.8 p -121.87 73.2 1.06 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.777 0.831 . . . . 75.010000000000005 109.19 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.8 tp -95.12 142.85 27.09 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.942 -1.026 . . . . 65.010000000000005 108.471 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.5 p -60.65 107.74 0.73 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.592 -0.522 . . . . 71.109999999999999 109.592 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.4 t -69.82 151.46 45.71 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.927 -0.579 . . . . 62.539999999999999 109.915 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.0 p -78.18 156.71 78.98 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 123.406 0.682 . . . . 63.009999999999998 110.018 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 -171.12 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.127 1.885 . . . . 53.420000000000002 112.942 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -139.08 28.67 2.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.784 0.834 . . . . 65.310000000000002 110.101 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 72.03 134.86 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 125.48 1.512 . . . . 53.409999999999997 111.604 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.85 177.78 2.71 Favored 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 123.043 2.495 . . . . 72.439999999999998 112.376 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG13 ' HE3' ' A' ' 84' ' ' LYS . 9.5 p -48.76 107.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.573 0 CA-C-O 122.018 0.913 . . . . 72.420000000000002 112.855 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 t -78.03 111.89 14.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.555 -1.202 . . . . 72.129999999999995 109.274 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.43 ' HE3' HG13 ' A' ' 82' ' ' VAL . 34.5 mmtp -74.93 100.25 4.07 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.109 0.564 . . . . 71.219999999999999 109.959 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -69.04 147.26 51.79 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.343 -0.844 . . . . 74.019999999999996 109.8 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -65.83 100.87 0.59 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.792 0.683 . . . . 60.420000000000002 110.078 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.7 175.97 8.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.918 0.887 . . . . 51.329999999999998 109.84 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.422 0.689 . . . . 75.519999999999996 109.53 -178.062 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 112.286 0.476 . . . . 74.510000000000005 112.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -69.68 102.71 1.94 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.438 0.695 . . . . 62.210000000000001 110.387 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.92 131.63 36.1 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.317 1.047 . . . . 65.409999999999997 111.438 172.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.54 133.93 35.19 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.352 0.661 . . . . 75.209999999999994 111.154 -173.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -117.1 -60.07 1.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.393 1.077 . . . . 72.230000000000004 109.71 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -66.75 -46.94 73.79 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.708 0.63 . . . . 72.439999999999998 110.293 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -83.34 137.31 34.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.636 -0.875 . . . . 41.0 108.636 168.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -93.71 107.3 19.19 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.978 -1.119 . . . . 75.450000000000003 107.978 169.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.31 -46.17 81.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.679 -0.86 . . . . 72.230000000000004 108.679 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.45 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 14.0 ptmm? -98.8 171.67 7.94 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.597 -0.728 . . . . 74.420000000000002 110.478 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 5.5 p -59.99 149.98 30.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.705 1.202 . . . . 60.210000000000001 111.485 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' NH2' HE22 ' A' ' 30' ' ' GLN . 24.6 ttp180 -64.78 118.81 9.51 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.878 0.736 . . . . 64.530000000000001 110.411 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t -146.32 107.17 4.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.611 -1.177 . . . . 44.409999999999997 107.91 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -86.71 40.51 0.9 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.138 0.975 . . . . 53.109999999999999 111.188 -174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' CYS . . . 74.21 165.65 12.82 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.826 -0.624 . . . . 74.420000000000002 112.284 -174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -100.0 168.61 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 109.282 -0.636 . . . . 72.430000000000007 109.282 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.92 138.15 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.129 0.572 . . . . 71.409999999999997 110.086 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.2 t -98.18 7.04 46.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.796 0.839 . . . . 73.230000000000004 109.638 172.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -118.28 128.61 54.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.293 1.037 . . . . 55.149999999999999 109.283 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.44 126.92 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 109.156 -0.683 . . . . 74.200000000000003 109.156 170.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.65 142.21 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 122.803 0.441 . . . . 71.5 110.167 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.66 135.82 15.95 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 116.268 -0.424 . . . . 41.009999999999998 112.35 178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.35 -34.25 70.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.45 0.7 . . . . 72.019999999999996 109.962 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -62.25 -32.64 73.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.295 1.038 . . . . 54.299999999999997 112.309 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 pt -98.42 4.18 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 111.905 0.335 . . . . 71.010000000000005 111.905 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 45' ' ' ILE . 32.7 mm -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.371 -0.603 . . . . 74.349999999999994 109.371 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.32 -57.95 2.1 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 109.796 -0.446 . . . . 53.509999999999998 109.796 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -145.9 144.37 30.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.043 0.937 . . . . 75.230000000000004 109.364 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -107.9 109.33 27.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.226 -1.027 . . . . 73.140000000000001 108.226 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.52 HE22 ' NH2' ' A' ' 12' ' ' ARG . 31.7 tt0 -93.06 127.2 38.51 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.535 -0.913 . . . . 74.329999999999998 108.535 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.6 111.51 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 107.956 -1.127 . . . . 74.299999999999997 107.956 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 m -113.74 127.28 27.0 Favored Pre-proline 0 C--O 1.254 1.323 0 N-CA-C 109.143 -0.688 . . . . 72.109999999999999 109.143 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.24 154.44 5.78 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.574 3.516 . . . . 74.409999999999997 114.159 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.97 -177.05 2.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.224 2.616 . . . . 71.319999999999993 113.63 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 -4.13 76.55 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 116.018 -0.537 . . . . 52.530000000000001 113.288 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -90.51 72.35 6.91 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.465 -0.939 . . . . 52.310000000000002 108.465 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 10' ' ' LYS . . . 77.42 -13.45 11.12 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.384 -0.676 . . . . 73.310000000000002 114.601 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.53 146.39 47.84 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.915 0.886 . . . . 70.230000000000004 109.874 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.04 -7.56 19.23 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.239 2.626 . . . . 73.319999999999993 113.915 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -100.13 150.45 22.49 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.095 0.558 . . . . 71.409999999999997 109.994 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.9 m -67.57 134.16 50.74 Favored 'General case' 0 C--O 1.242 0.666 0 O-C-N 123.93 0.768 . . . . 63.020000000000003 109.757 170.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 6.4 pt-20 -87.88 119.79 28.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.099 -0.704 . . . . 74.109999999999999 109.099 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.77 103.5 15.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.265 -1.013 . . . . 54.43 108.265 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.22 114.56 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 108.779 -0.823 . . . . 53.109999999999999 108.779 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 26' ' ' ILE . 54.7 mt -95.06 121.61 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.351 -0.611 . . . . 74.209999999999994 109.351 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -86.95 123.67 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.912 -1.144 . . . . 72.450000000000003 107.912 173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.3 p -87.78 179.22 6.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.015 0.526 . . . . 71.5 111.016 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.76 -14.08 60.67 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.374 0.67 . . . . 72.209999999999994 111.737 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -94.5 0.94 55.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.551 0.74 . . . . 74.109999999999999 110.33 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 66.18 23.6 10.9 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.879 1.671 . . . . 73.510000000000005 112.909 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -71.52 123.81 23.25 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.877 -1.157 . . . . 63.219999999999999 107.877 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 t -96.01 111.26 25.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.468 -1.308 . . . . 61.520000000000003 107.468 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.19 136.89 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.515 -0.92 . . . . 73.219999999999999 108.515 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 42.3 t -107.61 117.55 34.4 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.003 -1.11 . . . . 64.420000000000002 108.003 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.1 m -129.81 164.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 C-N-CA 123.76 0.824 . . . . 54.119999999999997 109.812 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.44 141.43 73.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.324 -0.621 . . . . 73.209999999999994 109.324 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.06 -23.95 78.44 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.782 2.321 . . . . 64.030000000000001 112.765 176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.71 31.48 5.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.591 0.757 . . . . 71.109999999999999 110.663 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.0 126.06 27.39 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -68.68 -30.17 68.79 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.614 0.766 . . . . 73.0 112.936 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -74.1 -23.36 59.31 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.986 0.514 . . . . 65.140000000000001 111.603 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.97 -21.81 65.95 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.841 0.856 . . . . 74.200000000000003 110.631 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -58.18 -30.8 66.7 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.105 0.962 . . . . 75.400000000000006 111.522 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -65.59 -36.93 85.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.408 0.683 . . . . 61.399999999999999 110.708 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.62 -37.28 65.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.272 0.629 . . . . 42.219999999999999 109.687 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -67.55 -33.27 74.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.776 0.83 . . . . 64.310000000000002 110.51 175.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -74.65 -36.96 62.85 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.899 1.28 . . . . 75.299999999999997 110.552 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -69.32 -35.43 75.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.441 0.697 . . . . 74.430000000000007 111.038 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.98 -7.81 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 111.233 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.18 124.97 34.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.05 -0.722 . . . . 45.049999999999997 109.05 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.7 t -108.51 147.58 31.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.908 0.483 . . . . 63.299999999999997 110.303 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -146.55 119.02 8.45 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.66 1.184 . . . . 71.030000000000001 108.057 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -67.04 134.17 51.36 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.544 -0.909 . . . . 65.140000000000001 108.544 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.48 97.17 0.13 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.743 0.817 . . . . 73.420000000000002 110.287 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 m -116.02 178.96 4.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.858 0.863 . . . . 71.109999999999999 111.226 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.8 t -70.5 92.72 0.84 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.461 0.704 . . . . 71.140000000000001 109.601 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 t -101.89 107.08 50.74 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.82 0.848 . . . . 73.129999999999995 110.505 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.57 126.67 19.67 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.894 2.396 . . . . 72.150000000000006 113.118 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -104.0 145.73 29.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.507 0.723 . . . . 72.329999999999998 110.261 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.35 148.32 88.27 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.539 0.736 . . . . 60.109999999999999 109.515 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -55.51 137.97 79.19 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.935 2.424 . . . . 55.109999999999999 112.098 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.2 m -64.79 92.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 122.168 0.985 . . . . 73.239999999999995 110.905 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.7 p -68.72 141.62 55.22 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.282 -1.326 . . . . 64.230000000000004 109.571 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.01 148.11 44.82 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.298 0.639 . . . . 52.299999999999997 110.182 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -75.1 102.84 5.05 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.094 -1.447 . . . . 65.200000000000003 107.094 170.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -56.61 101.85 0.07 Allowed 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.35 1.06 . . . . 64.510000000000005 110.512 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.37 147.99 35.8 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.392 0.677 . . . . 74.430000000000007 110.491 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 C-N-CA 123.491 0.716 . . . . 64.439999999999998 110.054 179.116 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.643 -0.502 . . . . 65.530000000000001 109.643 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.49 162.8 13.49 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.43 0.692 . . . . 73.140000000000001 110.292 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.11 85.49 2.35 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 121.687 0.756 . . . . 64.010000000000005 109.934 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.37 119.8 8.66 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.078 -0.964 . . . . 55.399999999999999 110.104 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -59.79 -24.9 64.5 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.66 0.784 . . . . 63.039999999999999 111.737 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 t80 61.07 59.48 2.01 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.587 1.155 . . . . 74.340000000000003 110.688 168.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -76.06 84.32 2.93 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 123.17 1.462 . . . . 55.219999999999999 110.786 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -118.96 18.87 13.16 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.198 -1.364 . . . . 64.25 110.737 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.93 -18.7 65.46 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.294 0.638 . . . . 55.229999999999997 111.025 168.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.743 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -88.05 127.43 35.4 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.351 -0.981 . . . . 55.399999999999999 108.351 172.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 39.8 m -58.28 124.52 19.77 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.864 0.865 . . . . 64.0 111.611 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -90.68 120.15 31.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.203 0.601 . . . . 75.219999999999999 110.558 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.3 t -140.34 167.8 21.31 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.928 0.891 . . . . 70.129999999999995 109.451 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.6 t -110.28 10.14 23.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.907 0.883 . . . . 54.200000000000003 109.915 174.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.69 -82.5 1.07 Allowed Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.778 0.704 . . . . 71.040000000000006 111.415 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.85 168.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.536 1.134 . . . . 72.310000000000002 109.955 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 HD11 ' HZ2' ' A' ' 61' ' ' TRP . 43.9 pt -123.75 144.07 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.805 -0.813 . . . . 75.340000000000003 108.805 167.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -77.24 -41.05 42.68 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.535 0.734 . . . . 54.219999999999999 111.328 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.5 p -81.85 144.71 30.82 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.223 1.009 . . . . 75.5 111.632 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.7 t -85.4 115.42 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.499 -0.926 . . . . 73.519999999999996 108.499 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.6 134.17 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.625 0.77 . . . . 65.140000000000001 109.523 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.13 140.07 30.51 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.762 0.664 . . . . 54.340000000000003 114.23 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.22 -37.15 71.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.996 0.918 . . . . 70.540000000000006 110.907 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.14 -21.63 60.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.404 0.682 . . . . 74.409999999999997 112.099 -176.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.8 pt -100.38 4.33 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 122.173 -0.329 . . . . 73.209999999999994 111.276 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 45' ' ' ILE . 47.2 mm -74.23 123.4 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.842 0.857 . . . . 74.120000000000005 108.94 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.28 -55.92 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.999 0.52 . . . . 74.109999999999999 110.604 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -149.4 136.21 19.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.912 0.485 . . . . 54.210000000000001 110.165 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.94 145.01 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.476 1.11 . . . . 74.030000000000001 109.296 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -136.55 126.11 25.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.182 0.993 . . . . 70.420000000000002 108.543 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.87 112.54 40.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.445 0.698 . . . . 73.329999999999998 109.293 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 42' ' ' GLU . 22.4 m -87.59 123.63 69.1 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.515 0.726 . . . . 64.219999999999999 109.489 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' THR . 27.4 Cg_exo -64.35 139.94 67.82 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 123.28 2.653 . . . . 73.5 113.789 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.78 99.99 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 123.292 2.662 . . . . 72.030000000000001 112.544 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.52 -45.74 0.26 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.985 -0.552 . . . . 41.32 112.207 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.482 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.5 t30 -83.03 75.01 9.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.578 0.751 . . . . 62.520000000000003 110.582 -173.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 10' ' ' LYS . . . 85.18 -18.67 26.7 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 114.709 0.643 . . . . 41.049999999999997 114.709 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.9 p -122.42 130.82 24.52 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 123.749 0.82 . . . . 73.230000000000004 108.957 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.48 -4.83 13.18 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.73 2.287 . . . . 73.549999999999997 113.352 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -123.06 161.56 24.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.83 0.852 . . . . 75.120000000000005 110.392 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.4 m -69.31 113.78 6.96 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.961 -0.755 . . . . 72.010000000000005 108.961 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 40.8 tt0 -96.49 130.44 43.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.351 0.66 . . . . 73.510000000000005 109.518 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.88 101.36 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.159 -1.052 . . . . 70.310000000000002 108.159 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -108.1 125.13 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.802 0.841 . . . . 64.230000000000004 109.037 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 26' ' ' ILE . 63.2 mt -118.72 129.66 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.405 0.682 . . . . 61.409999999999997 109.829 -175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -86.96 124.73 33.48 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.751 -1.203 . . . . 73.340000000000003 107.751 167.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.5 p -81.96 173.53 12.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.228 0.611 . . . . 62.219999999999999 109.573 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.66 -12.0 60.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 120.943 0.402 . . . . 72.099999999999994 110.919 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -85.98 1.91 48.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.939 0.896 . . . . 74.420000000000002 110.773 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 67.72 11.69 8.49 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.589 1.556 . . . . 62.009999999999998 111.618 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -73.45 126.02 29.25 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.991 -0.744 . . . . 62.109999999999999 108.991 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.0 t -86.07 102.51 11.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.476 -1.305 . . . . 61.310000000000002 107.476 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.6 pt -98.92 154.01 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.361 -0.978 . . . . 74.319999999999993 108.361 174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 19.4 t -135.46 128.79 32.11 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.948 -1.13 . . . . 63.210000000000001 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.3 160.11 29.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 123.919 0.888 . . . . 75.340000000000003 109.51 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.509 ' N ' HD22 ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.6 148.32 65.51 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.109 -1.071 . . . . 74.200000000000003 108.109 173.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.59 -28.19 64.02 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.76 2.306 . . . . 74.239999999999995 113.997 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -90.5 2.58 55.59 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.42 0.526 . . . . 72.510000000000005 112.42 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.31 30.84 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.796 0.839 . . . . 64.150000000000006 112.277 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -50.64 37.87 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.391 1.476 . . . . 65.010000000000005 112.334 -162.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.42 ' HZ2' HD11 ' A' ' 17' ' ' ILE . 51.9 p-90 -76.2 -20.19 57.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.046 0.139 . . . . 73.129999999999995 111.182 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.82 -28.67 69.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.461 0.705 . . . . 61.340000000000003 110.174 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -61.7 -19.05 61.95 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.708 . . . . 54.310000000000002 112.428 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -71.8 -38.02 70.3 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.994 0.517 . . . . 74.219999999999999 109.75 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.55 -37.05 65.71 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.764 0.826 . . . . 71.510000000000005 109.124 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -71.35 -29.54 65.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.233 -0.894 . . . . 64.099999999999994 110.875 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -81.47 -34.54 31.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.055 0.542 . . . . 73.040000000000006 110.794 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -67.83 -31.99 72.21 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.186 0.594 . . . . 75.129999999999995 111.001 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.99 -6.28 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.091 0.472 . . . . 73.439999999999998 110.873 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -106.15 19.36 20.64 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.015 0.926 . . . . 63.100000000000001 110.884 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.8 m -66.24 137.29 56.86 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.441 -0.578 . . . . 65.150000000000006 109.441 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -56.91 151.83 13.93 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.226 0.611 . . . . 65.099999999999994 110.929 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t -81.54 25.46 0.52 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.445 0.698 . . . . 71.510000000000005 111.025 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.71 97.1 0.2 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.92 1.288 . . . . 74.120000000000005 108.837 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 m -81.86 71.16 8.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.742 0.817 . . . . 41.039999999999999 109.62 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.9 p -74.45 116.03 14.66 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.679 -1.146 . . . . 72.219999999999999 109.965 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.4 m -73.31 111.92 13.75 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.814 0.846 . . . . 74.109999999999999 110.247 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.28 111.95 3.37 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 121.824 1.683 . . . . 74.439999999999998 111.407 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.59 143.08 27.18 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.948 -0.76 . . . . 75.540000000000006 108.948 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.86 161.42 43.04 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.762 0.825 . . . . 53.32 109.033 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.33 154.32 53.64 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.044 1.83 . . . . 73.400000000000006 112.222 167.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.0 t 71.1 4.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 C-N-CA 124.853 1.261 . . . . 74.450000000000003 111.655 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -72.93 146.28 46.2 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 121.585 -0.697 . . . . 72.140000000000001 109.748 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.43 109.6 2.8 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.836 0.854 . . . . 75.420000000000002 109.993 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -73.16 98.86 2.69 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.95 0.5 . . . . 71.319999999999993 110.579 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -71.99 122.56 21.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.878 0.871 . . . . 55.530000000000001 109.165 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.82 73.76 4.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.726 0.774 . . . . 71.019999999999996 109.843 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-N 115.06 -0.973 . . . . 52.399999999999999 108.827 179.959 . . . . . . . . 0 0 . 1 stop_ save_